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Résumé
Les études d’imagerie par résonance magnétique fonctionnelle (IRMf) ont pour 
prémisse générale l’idée que le signal BOLD peut être utilisé comme un 
succédané direct de l’activation neurale. Les études portant sur le vieillissement 
cognitif souvent comparent directement l’amplitude et l’étendue du signal BOLD 
entre des groupes de personnes jeunes et âgés. Ces études comportent donc un a 
priori additionnel selon lequel la relation entre l’activité neurale et la réponse 
hémodynamique à laquelle cette activité donne lieu restent inchangée par le 
vieillissement. Cependant, le signal BOLD provient d’une combinaison ambiguë de 
changements de métabolisme oxydatif, de flux et de volume sanguin. De plus, 
certaines études ont démontré que plusieurs des facteurs influençant les 
propriétés du signal BOLD subissent des changements lors du vieillissement. 
L’acquisition d’information physiologiquement spécifique comme le flux sanguin 
cérébral et le métabolisme oxydatif permettrait de mieux comprendre les 
changements qui sous-tendent le contraste BOLD, ainsi que les altérations 
physiologiques et cognitives propres au vieillissement. Le travail présenté ici 
démontre l’application de nouvelles techniques permettant de mesurer le 
métabolisme oxydatif au repos, ainsi que pendant l’exécution d’une tâche. Ces 
techniques représentent des extensions de méthodes d’IRMf calibrée existantes. 
La première méthode présentée est une généralisation des modèles existants pour 
l’estimation du métabolisme oxydatif évoqué par une tâche, permettant de prendre 
en compte tant des changements arbitraires en flux sanguin que des changements 
en concentrations sanguine d’O2. Des améliorations en terme de robustesse et de 
précisions sont démontrées dans la matière grise et le cortex visuel lorsque cette 
méthode est combinée à une manipulation respiratoire incluant une composante 
d’hypercapnie et d’hyperoxie. Le seconde technique présentée ici est une 
extension de la première et utilise une combinaison de manipulations respiratoires 
incluant l’hypercapnie, l’hyperoxie et l’administration simultanée des deux afin 
d’obtenir des valeurs expérimentales de la fraction d’extraction d’oxygène et du 
métabolisme oxydatif au repos. Dans la deuxième partie de cette thèse, les 
changements vasculaires et métaboliques liés à l’âge sont explorés dans un 
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groupe de jeunes et aînés, grâce au cadre conceptuel de l’IRMf calibrée, combiné 
à une manipulation respiratoire d’hypercapnie et une tâche modifiée de Stroop. 
Des changements de flux sanguin au repos, de réactivité vasculaire au CO2 et de 
paramètre de calibration M ont été identifiés chez les aînés. Les biais affectant les 
mesures de signal BOLD obtenues chez les participants âgés découlant de ces 
changements physiologiques sont de plus discutés. Finalement, la relation entre 
ces changements cérébraux et la performance dans la tâche de Stroop, la santé 
vasculaire centrale et la condition cardiovasculaire est explorée. Les résultats 
présentés ici sont en accord avec l’hypothèse selon laquelle une meilleure 
condition cardiovasculaire est associée à une meilleure fonction vasculaire 
centrale, contribuant ainsi à l’amélioration de la santé vasculaire cérébrale et 
cognitive.
mots-clés:
IRMf calibré, métabolisme oxydatif, vieillissement, santé vasculaire, flux sanguin 
cérébral, condition cardiovasculaire, cognition
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Abstract
Functional MRI (fMRI) studies using the BOLD signal are done under the general 
assumption that the BOLD signal can be used as a direct index of neuronal 
activation. Studies of cognitive aging often compare BOLD signal amplitude and 
extent directly between younger and older groups, with the additional assumption 
that the relationship between neuronal activity and the hemodynamic response is 
unchanged across the lifespan. However, BOLD signal arises from an ambiguous 
mixture of changes in oxidative metabolism, blood flow and blood volume. 
Furthermore, previous studies have shown that several BOLD signal components 
may be changed during aging. More physiologically-specific information on blood 
flow and oxidative metabolism would allow a better understanding of these signal 
changes and of the physiological and cognitive changes seen with aging. The work 
presented here demonstrates techniques to estimate oxidative metabolism at rest 
and during performance of a task. These techniques are extensions of previous 
calibrated fMRI methods and the first method presented is based on a 
generalization of previous models to take into account both arbitrary changes in 
blood flow and blood O2 content. The improved robustness and accuracy of this 
method, when used with a combined hypercapnia and hyperoxia breathing 
manipulation, is demonstrated in visual cortex and grey matter. The second 
technique presented builds on the generalization of the model and uses a 
combination of breathing manipulations including hypercapnia, hyperoxia and both 
simultaneously, to obtain experimentally-determined values of resting oxygen 
extraction fraction and oxidative metabolism. In the second part of this thesis, age-
related vascular and metabolic changes are explored in a group of younger and 
older adults using a calibrated fMRI framework with a hypercapnia breathing 
manipulation and a modified Stroop task. Changes in baseline blood flow, vascular 
reactivity to the CO2 challenge and calibration parameter M were identified in the 
older participants. Potential biases in BOLD signal measurements in older adults 
arising from these physiological changes are discussed. Finally, the relationship 
between these cerebral changes and performance on the modified Stroop task, 
central vascular health and cardiovascular fitness are explored. The results of this 
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thesis support the hypothesis that greater cardiovascular fitness is associated with 
improvements in central vascular function, contributing in turn to improved brain 
vascular health and cognition.
Keywords: calibrated fMRI, oxidative metabolism, aging, vascular health, cerebral 
blood flow, cardiovascular fitness, cognition. 
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 Preface
Longevity is a vascular question. A man is only as old as his arteries. 
" " " " " " " " " -- Dr William Osler
Aging is associated with a variety of cognitive and behavioral changes. In order to 
understand the cognitive changes associated with normal and pathological aging, 
we need to investigate the anatomical and physiological correlates of these 
changes. While cortical atrophy and white matter lesions are known to occur at the 
later stages in life even in healthy older adults, functional changes that go beyond 
the straight-forward effects of the loss of grey-matter can also be observed. 
However, while the study of the anatomical changes associated with aging is 
becoming well established, the investigation of dynamic changes in the brain still 
remains a technical challenge. The technique of choice to study brain function non-
invasively is functional magnetic resonance imaging (fMRI) using the blood oxygen 
level-dependent (BOLD) contrast. This technique’s popularity can be attributed to 
the fact that it is fairly simple to implement on any modern MRI scanner and is 
sensitive to the local activity of brain regions at the millimeter scale. Thanks to 
these characteristics, it can yield robust results with adequate spatial and temporal 
resolution that allow inferences to be made about local brain function. 
The effect of aging on BOLD signal changes evoked by a variety of tasks has been 
the subject of intense research in recent years. However, while BOLD contrast is a 
useful measure of local brain activity, the information that can be derived from it is 
intrinsically ambiguous in nature. This is because the BOLD signal arises from an 
ambiguous combination of changes in oxidative metabolism, blood flow and blood 
volume. Furthermore, the BOLD signal is measured as a relative change from an 
unknown baseline. These characteristics call for caution when comparing BOLD 
signal changes between groups, especially when either the baseline or the 
dynamic range of any of its component is suspected to differ between them. Aging 
is known to be associated with vascular and metabolic changes that can potentially 
influence all components of the BOLD signal. Therefore, while BOLD studies of 
aging can be helpful in identifying potential loci of task-related differences between 
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young and old, more physiologically-specific information is needed to understand 
the underlying differences in neuronal usage.
The work presented in this thesis was motivated by the need to both characterize 
the vascular and metabolic changes associated with aging and provide a more 
physiologically-specific context in which to discuss the functional changes we 
observe in BOLD studies of cognitive aging. The body of this thesis will be 
comprised of four manuscripts. Two of these will present the technical and 
modeling development work done in the course of my project. These techniques 
were developed in parallel with the aging study forming Chapter 4 of this thesis and 
therefore represent separate novel findings. The first manuscript, entitled “A 
generalized procedure for calibrated MRI incorporating hyperoxia and hypercapnia” 
presents a new generalized model based on the hypercapnia and hyperoxia 
calibration models that can be used with breathing manipulations causing any 
arbitrary change in cerebral blood flow and arterial oxygen content. This model will 
be used to perform calibrated fMRI in the aging manuscripts. The second 
manuscript is entitled “Magnetic resonance imaging of resting OEF and CMRO2 
using a generalized calibration model for hypercapnia and hyperoxia” and 
demonstrates the use of the generalized model in combination with at least two 
breathing manipulations to estimate baseline oxygen extraction fraction and 
oxidative metabolism. The third and fourth manuscripts will focus on quantitative 
studies of aging. In the third manuscript entitled “Age-dependence of hemodynamic 
response characteristics in human fMRI”, the changes in hemodynamic 
components with aging will be explored. This manuscript explores the potential 
confounds associated with hemodynamic imaging in aging. The fourth manuscript 
entitled “Relationship between cardiovascular health, cerebral physiology and 
cognition in healthy aging” will discuss changes in vascular physiology in the brain 
and at the level of the aorta, and their link to hemodynamic signal changes will be 
discussed. Finally, two additional manuscripts will be presented as appendices to 
this thesis, since they provide additional support for the studies shown here. The 
first appendix will comprise a manuscript entitled “Elimination of visually evoked 
BOLD responses during carbogen inhalation: implications for calibrated MRI”, 
which presents a direct measurement through a breathing manipulation of the 
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calibration parameter we seek to determine through modeling in standard 
calibrated fMRI experiments. The second appendix is a manuscript entitled 
“Absolute quantification of resting oxygen metabolism and metabolic reactivity 
during functional activation using QUO2 MRI”. This manuscripts demonstrates the 
comprehensive set of measurements that can be obtained using a combination of 
all the techniques presented in Chapters 2 and 3. While these were not all applied 
in our studies of aging, future studies will include them to provide an improved 
quantification of BOLD signal sub-components.
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1. Introduction
Neurological components of aging can be detected by decreased accuracy and 
speed of cognitive and sensory responses, as well as structural and functional 
changes. These include atrophy and decreased cerebral perfusion and 
metabolism. While cortical thinning and decreases in white matter integrity can be 
found throughout the brain during old age, frontal and parietal cortex and the 
hippocampus, may be more vulnerable to the effects of age (Salat et al. 2004; Raz 
et al. 2010; Chen et al. 2011; Salat et al. 2012). The rate and severity of cortical 
thinning and white matter lesions is furthermore highly variable between individuals 
(Raz et al. 2010; Salat et al. 2012). The underlying causes of these anatomical 
changes are still unclear, but it may be that some of these changes have a 
vascular origin or contribution. 
1.1. Vascular and metabolic changes with aging
Vascular changes may be an inevitable fact of aging, but the severity and rapidity 
of the progression of these changes show great heterogeneity within the population 
of older adults. The arterial network has two main functions: to deliver blood to all 
tissues in the body and dampen heart pulsations so that when blood reaches the 
capillaries, flow is continuous rather than pulsatile. As blood flow reaches the high 
resistance small diameter vessels (arterioles and capillaries) after going through 
the more elastic larger vessels, the remainder of the pressure wave is reflected 
back up the arterial tree so that flow in these small vessels becomes continuous. In 
young individuals, the arterial system can perform both of its functions very well 
and flow is continuous at the level of arterioles in all organs, except those with 
higher baseline blood flow such as the kidneys and the brain (O'Rourke et al. 
2007). 
The dampening of pulsatile flow is achieved by laminae of the protein elastin in 
blood vessel walls. This protein acts like rubber to allow vessel walls to be 
distended during the systolic phase of the cardiac cycle and return to their original 
shape during the diastolic phase (O'Rourke et al. 2007). This protein is the most 
inert in the body and has a half-life of decades. However, like all material, elastin 
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undergoes fatigue. Over an entire lifetime of being stretched at every heart beat, 
the laminae fracture and become less efficient. Laminae become thinner and since 
elastin is not replenished readily, the space created between laminae is filled with 
collagen (Figure 1). Collagen filling with age is thought to prevent overly large 
deformations of blood vessel walls. However, because collagen is not elastic, the 
decreased elastin to collagen ratio results in stiffer blood vessels with a larger 
diameter (Fritze et al. 2012). As this process unfolds, the vessels become partially 
distended and undergo little change in diameter to absorb the heart pulse and the 
added pressure of the reflection wave. As vessels harden, there is more and more 
mechanical stress on the already weakened elastin laminae and these processes 
of thinning and collagen filling accelerate. Larger vessels become more hardened 
and ever smaller arteries are affected by this phenomenon. Furthermore, lifestyle 
choices may also have a strong impact on this hardening mechanism through 
mitochondrial oxidative stress (Davenport et al. 2012; Zhou et al. 2012) and plaque 
deposition which further harden vessels (O'Rourke et al. 2007). High calorie intake 
and low exercise may lead to increased production of reactive oxygen species 
(ROS), which may contribute to elastin protein damage. ROS are highly reactive 
molecules since they have an unpaired valence shell electron. To fill their valence 
shell, ROS steal electrons from larger molecules such as DNA, proteins and lipids, 
thereby degrading them (Wallace 2005). Furthermore, ROS may cause decreased 
nitric oxide (NO) bioavailability, thereby reducing overall vascular tone and reserve 
(Pialoux et al. 2009). The mitochondrial theory of aging, which includes these 
phenomena, will be further discussed in the next section. 
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be significantly related to segregated MMP-2 (F(2,12) = 
0.211; p = 0.810), MMP-9 (F(2,12) = 1.811; p = 0.205), 
TIMP-1 (F(2,12) = 0.505; p = 0.616) or TIMP-2 (F(2,12) = 
0.187; p = 0.832).
 Desmosine Content Is Not Decreasing with Age 
 The results of the radioimmunoassays are summa-
rized in  figure 5 g. Differences in the desmosine content 
for all three groups proved not significant (F(2,15) = 
3.103; p = 0.075).
 Marked Decrease in the Elastogenic Potential 
Revealed by Gene Expression Analyses 
 Quantitative analysis of tropoelastin mRNA levels re-
vealed that TE-mRNA was detectable in all three age 
groups ( fig. 6 ).
 We observed a strong variation of tropoelastin levels 
within each age group. Even in patients younger than 60 
years, some individuals expressed very low amounts (5%) 
of tropoelastin. However, gene expression analyses also 
suggested that, with increasing age, tropoelastin expres-
sion decreases (group I: 0.28  8 0.25; group II: 0.14  8 
0.08; group III: 0.07  8 0.06), as displayed in  figure 6 (left 
panel). We found a significant effect of age on tropoelas-
tin mRNA levels (F(2,58) = 10.266; p  ! 0.001). A post hoc 
Fisher LSD test revealed that tropoelastin mRNA levels 
did not differ significantly between group I and group II 
(t(32) = 1,066; p = 0.301). This result is probably influ-
enced by a high variance of tropoelastin mRNA levels in 
young patients ( fig. 6 ) as well as the lower number of in-
vestigated younger patients due to the fact of substantial-
ly lower probability of CVD’s. Significant differences of 
tropoelastin levels were observed between group II and 
group III (t(45) = 3.933; p  ! 0.001).
 Next, a logistic regression model was employed to de-
termine the impact of age, gender and DM on tropoelas-
tin expression levels. This model was specified with the 
equation: log 10 (TE-mRNA) = –0.249 –0.019  ! age 
–0.029  ! gender –0.022  ! DM and revealed a highly 
significant overall correlation (F(3,57) = 6.09; p = 0.001). 
Subsequent t tests demonstrated that age was a significant 
predictor for TE-mRNA (t(57) = –4.035; p  ! 0.001), 
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 Fig. 4. Near-infrared multiphoton LSM. 
Elastin autofluorescence signals (green) 
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Figure 1. Near-infrared multiphoton LSM. 
Elastin autofluorescence signals (green) and SHG signals of collagen (red) are depicted for aortic 
cross sections (circumferential view) of 49- (a),58- (b) and 73- (c) y ar-old p tients. This figure 
illustrates changes in elastin and collagen ratio and structure with age. This figure and its caption 
w re r produced from (Fritz  et al. 2012).
Arterial hypertens on is both the caus  and effect of ev n gr ater vessel wall 
stiffening. As vessels harden, the pulse pressure wave from th  heart increases in 
velocity. This leads to an increased amplitude and velocity of the reflection wave, 
as blood flow with higher pressure reaches high resistance vessels and is reflected 
b ck. This positive feedb ck loop acc le ates, leading to increasing blood pressure 
nd ev r mor  damage to progressively maller blood ve els (O'Rourke et al. 
2007; Redheuil et al. 2010). Arterial hypertension is therefore an indication that 
damage has already started to occur. Though decreases in arterial elasticity are 
general and affect the whole body, the aorta may be the most representative of the 
state of other arteries. This is because the aorta may be the first to be affected 
since much of the pulsatile flow absorption and therefore the mechanical damage 
to elastin laminae occurs at this level (Laurent et al. 2006; Redheuil et al. 2010). 
The relationship between aortic hardening and measures of cerebral health will be 
discussed in Chapter 5 of this thesis.
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Inflammation may be an important contributing factor to vascular stiffening. Arterial 
hypertension has been found to be associated with the presence of inflammatory 
markers such as interleukin-6, tumor necrosis factor-alpha and C-reactive protein 
(CRP) (Amar et al. 2005; Laurent et al. 2007). Though the mechanisms leading to 
this association are not well known, molecules released as a consequence of 
endothelial dysfunction are thought to lead to this chronic elevation of inflammatory  
markers (Devaraj et al. 2011). Furthermore, CRP level was found to be predictive 
of pulse pressure and treatment to lower CRP levels has been shown to have a 
positive effect on pulse pressure (Amar et al. 2005; Devaraj et al. 2011). 
1.1.1. Vascular aging in the brain
Arterial hypertension has long been known as a risk factor for stroke and is now 
recognized as playing a role in cognitive decline (Robbins et al. 2005; Waldstein et 
al. 2008; Elias et al. 2009; Brown et al. 2011; Gorelick et al. 2011). The brain may 
be particularly vulnerable to the effects of arterial hardening and it is thought that 
there is a link between arterial stiffening and cognitive decline (Waldstein et al. 
2008; Elias et al. 2009; Brown et al. 2011). Several mechanisms have been 
proposed to contribute to this relationship. First, the brain is one of the only organs 
without protection against the pulsatile nature of blood flow. With age, cerebral 
arteries suffer from the loss of elastin (O'Rourke et al. 2007) and a decrease in 
microvascular density (Sonntag et al. 1997). The increased pulsatility associated 
with less elastic arteries may lead to distal cerebral lesions and impaired distal 
microcirculation (O'Rourke et al. 2007). Secondly, the severity of white matter 
hyperintensities is increased with hypertension and these have been shown to be 
associated with cognitive decline and dementia (Sierra et al. 2004; Au et al. 2006). 
Finally, impaired endothelial function leading to circulation of cellular debris (Wang 
et al. 2007; Wang et al. 2009) has also been proposed to lead to microvascular 
lesions (O'Rourke et al. 2007) and hence cognitive deficits. This may also be 
reflected in the fact that elevated CRP levels, indicative of endothelial dysfunction, 
are an independent risk factor for age-associated cognitive decline (Yaffe et al. 
2003). 
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1.1.2. Mitochondrial theory of aging
While aging cannot be reduced to a single phenomenon, one of the most enduring 
theories of the cellular mechanisms of aging relates accumulating damage in the 
cellular environment to progressive breakdown of membrane integrity and of the 
electron transport chain of the mitochondria. Mitochondrial damage leads to an 
increased formation of reactive oxygen species (ROS). The progression of 
mitochondrial damage in normal aging, leading eventually to disease, is presumed 
to progress as described in the remainder of this section and summarized in Figure 
2. Though mitochondrial aging occurs throughout the body, it is here discussed in 
the context of the brain.
The electron transport chain, which is used for oxidative phosphorylation and 
production of extra ATP molecules from glycolysis end-products, is the main source 
of ROS. These are created at all times even in the best of cases, but their 
production can be increased by several factors including a high-calorie diet and low 
exercise (Wallace 2005; Pialoux et al. 2009). Because electrons from fat and 
carbohydrate oxidation are produced even when there is no ADP to be 
phosphorylated (because, for example, of lack of exercise), excess protons from 
metabolism of fats and carbohydrates cause hyperpolarization of the mitochondrial 
membrane. Excess electrons fill all binding sites on electron carriers within the 
membrane and these electrons can then be added to O2 to form ROS. These ROS 
diffuse and degrade DNA, proteins and lipids. Because ROS are mainly created in 
mitochondria and are very reactive, these organelles are the first and worst 
affected (Wallace 2005). 
Since mitochondria are continually produced and destroyed in post-mitotic cells, 
mutations in mitochondrial DNA (mtDNA) can affect the function of cells even when 
they have stopped replicating. Throughout a lifetime, ROS will create somatic 
mutations in mtDNA and affect the functioning of proteins encoded by this mtDNA. 
Complexes I, III and IV of the electron transport chain (ETC) are especially prone 
to the effects of ROS-mediated damage, since they reside within mitochondria and 
some of their components are encoded by mtDNA (Aleardi et al. 2005; Coskun et 
al. 2011). Mitochondria become more and more inefficient as electron transport 
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becomes progressively uncoupled from proton pumping due to damage to these 
protein complexes (Wallace 2005). As the process to produce ATP loses efficiency, 
more and more protons are required to make ATP. 
the NADH þ Hþ and reduces the lipid-soluble electron
carrier coenzyme Q10 (CoQ). CoQ or ubiquinone incor-
porates twoelectrons successively, the first electrongener-
ating ubisemiquinone and the second ubiquinol. Electrons
from other dehydrogenases are also transferred to CoQ.
This includes complex II, succinate dehydrogenase,which
collects electrons from the TCAcycle intermediate, succi-
nate. From CoQ, the electrons are transferred to complex
III (b–c1 complex), then to cytochrome c, then to complex
IV (cytochrome c oxidase, COX), and finally toO2 to gen-
erate H2O. As the electrons traverse complexes I, III, and
IV, the energy released is used to pump protons out across
the mitochondrial inner membrane to create the electro-
chemical gradient:DP ¼ DC þ DmHþ (Fig. 3). The accu-
mulated power generated by 1000 mitochondria within
each of 100 trillion cells or 1017 mitochondria provides
the energy that powers our lives.
The mitochondrial capacitors provide energy to drive a
wide range of biological processes, but to extend mito-
chondrial utility to fueling reactions and performing
work, it needs to convert the capacitor’s potential energy
into the high-energy chemical intermediate ATP. This is
accomplished by the Hþ-transporting ATP synthase,
complex V, bound to the mitochondrial inner membrane
and pointing into the matrix. Mitochondrial ATP is then
exchanged by cytosolic ADP by the adenine nucleotide
translocators (ANTs). Therefore, the proton-pumping
complexes I, III, and IV of the ETC are coupled to ATP
synthesis through the proton gradient. The efficiency by
which complexes I, III, and IV pump protons out of the
mitochondrion and by which the ATP synthase converts
the proton gradient intoATP is known as the coupling effi-
ciency. Because the calorie is a unit of heat, themore calo-
ries that are burned by the cell, the more heat that is
generated, whether the energy goes through the high-
energy intermediateATPor not.As it turns out, people dif-
fer significantly in their coupling efficiencies. Therefore,
those that aremore tightly coupled generate themaximum
ATP per calorie burned and the minimum heat, whereas
individuals that are less tightly coupled have to burn
more calories for the same amount of ATP and thus gener-
atemore internal heat. This provides one of the fundamen-
tal connections between our genes and our environment.
The biophysics of the linkage among calorie oxidation,
the proton gradient, and ATP synthesis is now being elu-
cidated by defining the composition and structure of the
Figure 3. Mitochondrial energy production and its reaction to the pathophysiology of disease. Five features of mitochondrial metab-
olism are central to the pathophysiology of the common age-related diseases: (1) energy production by OXPHOS; (2) regulation of
cellular oxidation–reduction (redox) state; (3) ROS generation as a by-product of OXPHOS; (4) buffering of the cytosolic and mito-
chondrial Ca2þ levels; and (5) regulation of apoptosis through activation of the mtPTP. ADP or ATP, adenosine di- or triphosphate,
ANT, adenine nucleotide translocator; cytc, cytochrome c; GPx, glutathione peroxidase-1; LDH, lactate dehydrogenase; MnSOD,
manganese superoxide dismutase or SOD2; NADH, reduced nicotinamide adenine dinucleotide; TCA, tricarboxylic acid cycle;
VDAC, voltage-dependent anion channel; I, II, III, IV, and V, OXPHOS complexes I–V. Complex I is composed of 45 polypeptides,
seven (ND1, 2, 3, 4L, 4, 5, 6) encoded by the mammalian mtDNA; complex II consists of four nDNA-encoded polypeptides; complex
III consists of 11 polypeptides, one (cytb) encoded by the mtDNA; complex IV is composed of 13 polypeptides, three (COI, II, III)
encoded by the mtDNA; and complex V is composed of !15 polypeptides, two (ATP6, 8) encoded by the mtDNA. (Modified from
Wallace 2005, 2007; Ruiz-Pesini et al. 2007.)
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Figure 2. Mitochondrial energy production  
This figure and its caption were reproduced from (Wallace 2011).
Eventually, mitochondria become so inefficient that energy production falls below 
the so-called bioenerg tic threshold. At this oin , the cell reduces its functions to 
adapt to its own inefficient energy production and enters a steady-state that 
enables only a basic operational level of functioning. This is the stage where 
damage and progressi n to disease start to occur. For exa ple, the symptoms that 
form the hallmark of Alzheimer’s disease (AD) (including amyloid-β producti n and 
deposition) d velop at this point (Wallace 2005; Bonda et al. 2010; Coskun et al. 
2011).  
As oxidative stress damages the cell, a variety of protective mechanisms are put in 
plac . On  of these is the cleavage of the amyloid precursor protein into amyloid-
β1-42 by presenilin 1 and 2. amyloid-β1-42 has been found o have antioxidant 
properties a d is p oduced as a defensive mechanism against the effects of 
excess ROS (Kontush et al. 2001; Bonda et al. 2010; Coskun et al. 2011; Bartley et 
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al. 2012). However, as it accumulates, amyloid-β becomes toxic and leads to a 
decrease in the activity of complexes I, III and IV (cytochome c oxidase) (Canevari 
et al. 1999; Aleardi et al. 2005), the inhibition of Mn superoxide dismutase (Aleardi 
et al. 2005; Anantharaman et al. 2006) and perturbation in the functioning of the 
mitochondrial permeability transition pore (Bartley et al. 2012). These lead to 
decreased O2 consumption and ATP synthesis and to an increase in ROS 
production (Aleardi et al. 2005). Leakage through the permeability transition pore 
leads to the last stages of cell life as it triggers the induction of apoptosis cascades 
(Wallace 2005; Coskun et al. 2011; Bartley et al. 2012). This leads to the loss of 
neurons and brain atrophy. Though markers of these mechanisms are present in 
normal aging brains, these effects are more pronounced in the case of diseases 
such as AD. It may be, however, that these effects contribute to the atrophy and 
cognitive decline observed even in healthy aging (Wallace 2005), especially in 
individuals that adopt a less healthy lifestyle. However, the specific effects of these 
mechanisms on cognitive processes is largely unknown. Atrophy and vascular 
changes are known to occur at different rates in different brain regions (Salat et al. 
2004; Chen et al. 2011) and the link between mitochondrial health and regional 
deficits still remains to be determined. 
1.2. Aging and physical fitness
The effects of aging often result in a significantly poorer quality of life and much 
research effort has been dedicated to alleviating the effects of aging. Lifestyle has 
a very substantial impact on health and quality of life. A healthy diet and regular 
exercise are, by far, the best recognized means to aging gracefully (Wallace 2005). 
However, the exact impact of regular exercise on cerebrovascular and cognitive 
aging remains in part unknown. 
Studies on the effects of exercise can take two forms. In the first, participants with 
a history of regular exercise and sedentary participants are compared (Rogers et 
al. 1990; Yaffe et al. 2001; Churchill et al. 2002; Podewils et al. 2005; Etnier et al. 
2006; Kramer et al. 2006; Larson et al. 2006; Brown et al. 2010; Brown et al. 2011). 
While these studies have the advantage of taking into account the long-term 
effects of exercise, they are subject to various confounds because the people who 
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exercise regularly may also be more likely to have a healthy lifestyle in other 
respects (Churchill et al. 2002; Kramer et al. 2006). People that engage in regular 
exercise may also be more likely to have a healthy diet, refrain from smoking and 
excessive drinking for example. The other type of study follows individuals with a 
similar background through a regular exercise training intervention and, typically, 
some other form of activity such as cognitive training in a control group of matched 
participants (Colcombe et al. 2006; Voss et al. 2010; Erickson et al. 2011; Prakash 
et al. 2011; Hopkins et al. 2012). While this type of study avoids the potential 
confounds of unmatched lifestyle choices, it does not address the question of long-
term effects of regular exercise. However, with the combined information of these 
two types of studies, a cohesive picture of the effects of physical fitness on 
vascular and cognitive health is starting to emerge. 
Retrospective population studies of questionnaire-based self-reported physical 
activity and cross-sectional studies including a cardiorespiratory fitness test have 
suggested that regular exercise may be partly protective for dementia (Podewils et 
al. 2005; Larson et al. 2006) and cognitive decline (Rogers et al. 1990; Yaffe et al. 
2001; Churchill et al. 2002; Etnier et al. 2006; Kramer et al. 2006; Brown et al. 
2010; Brown et al. 2011). Typically, recent studies quantify VO2max, to estimate 
cardiorespiratory fitness by measuring the amount of O2 used for metabolism 
during maximal effort.  
Despite the potential confounds of cross-sectional studies, a lifetime of regular 
exercise seems to have a beneficial effect on cognitive health. The effects of a 
physical training regimen on cognitive health are, however, more subtle (Churchill 
et al. 2002; Kramer et al. 2006) and may depend on many factors including the 
amount of exercise done on the day of the experiment and genetic polymorphisms 
(Hopkins et al. 2012). A meta-analysis of fitness training studies showed that 
fitness training results in improved cognitive scores, especially for tasks requiring 
executive control processes (Colcombe et al. 2003). Older adults’s performance on 
executive function tasks may be improved by an aerobic physical training regimen. 
Furthermore, this type of intervention may also lead to patterns of functional 
connectivity more similar to those seen in younger adults (Voss et al. 2010; 
Prakash et al. 2011). Furthermore, grey matter atrophy associated with aging may 
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be reduced by a similar physical training program (Colcombe et al. 2006; Erickson 
et al. 2011).   
Cardiorespiratory fitness also has a positive effect on vascular health. Physically fit 
older women were found to have lower blood pressures and higher 
cerebrovascular reserve (Brown et al. 2010). Results in animals have also shown 
that regular exercise leads to increased cerebrovascular reserve, possibly through 
angiogenesis (Swain et al. 2003). The positive effects of regular exercise on 
cognition and cerebral blood flow (CBF) in aging may be due in part to increased 
antioxidant activity leading to increased NO bioavailability and improvements in 
vascular tone (Pialoux et al. 2009; Davenport et al. 2012) (Figure 3). In a study of 
post-menopausal women, Pialoux and colleagues (Pialoux et al. 2009) found an 
inverse relationship between VO2max and oxidative stress markers, but a positive 
relationship between antioxidant activity and VO2max, indicating better 
mitochondrial function in more active older women. A similar relationship was seen 
between cerebrovascular conductance and oxidative stress markers, indicating 
that part of these effects may be due to changes in the regulation of vascular tone.  
Animal studies suggest that exercise may result in increased serotonin and brain-
derived neurotrophic factor (BDNF) levels in the brain, which may in turn lead to 
neurogenesis and cognitive improvement (Churchill et al. 2002; Vaynman et al. 
2004; Hopkins et al. 2010; Spoelgen et al. 2011; Davenport et al. 2012). Though 
difficult to establish non-invasively, some of the same mechanisms may be 
involved in cognitive improvements following regular exercise regimen that have 
been detected in adult human populations (Hopkins et al. 2012). IGF-1, VEGF and 
BDNF, by their role in initiating both the angiogenesis and neurogenesis cascades, 
are thought to be the main effectors in regulating the effects of regular exercise on 
cerebrovascular function(Cotman et al. 2007; Davenport et al. 2012) (Figure 3).
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Figure 3. Exercise and cognition
Proposed vascular mechanisms in the association between exercise training and increased 
cognitive plasticity. This figure and its caption were reproduced from (Davenport et al. 2012).
Though the link between vascular health, fitness and cognition is becoming more 
established, some of the difficulties in pinning down the relationship between 
vascular health and cognition may arise from the fact that the exact impact of aging 
on cognition is still a much debated subject. 
1.3. Aging and cognition
Aging is associated with changes in cognitive processing. While decreases in 
processing speed have been observed across the majority of cognitive tasks 
studied in older adults, there is some debate as to their specificity and source. 
One of the most obvious confounds to take into account is that all sensory systems 
degrade with age. Within the visual system, for example, aging leads to hardening 
and increased density of the crystalline lens, a decrease in resting pupil diameter, 
increased opacity of the lens and retinal cell loss. All these factors combine to 
greatly reduce the light that enters the eye as we age. By 60 years of age, it is 
estimated that two thirds of retinal luminance has been lost (Cabeza et al. 2005). 
Because less informat o reaches the brai , this means that older br ins must 
process information with a lower starting signal-to-noise ratio (SNR). This is true of 
other sensory systems as well, and must be kept in mind when assessing the 
effects of aging in cognitive tasks that include a significant sensory component. 
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Some of the decreased performance, both in terms of errors and reaction time, 
may therefore be attributed to the effects of decreased sensory system 
performance (Cabeza et al. 2005). However, certain tasks seem to be specifically 
impacted by age over and beyond these general sensory slowing effects. 
Furthermore, though decreased hemodynamic responses are expected in a 
system showing the effects of wear, it is the presence of specific and reproducible 
patterns of increased functional signals in specific types of task which has most 
intrigued the cognitive neuroscience community and will be a focus of the following 
discussion.
The functions thought to be most affected by the physiological changes associated 
with age fall under the category of ‘executive functions’. This term is used to 
describe a range of functions such as planning, working memory, inhibition, 
problem-solving and monitoring. These functions generally involve a network of 
structures that includes some frontal component (Petrides 2005). This, combined 
with the ubiquitous observation of an increased frontal component in functional 
imaging studies of cognitive aging and the known plasticity of the brain even in 
later life, has led to the formulation of several theories of neuronal processing 
changes in healthy cognitive aging. 
Recently, Spreng and colleagues published a meta-analysis of age-related 
differences reported across many cognitive domains in BOLD and positron 
emission tomography (PET) studies (Spreng et al. 2010). This study shows that it 
is possible to generalize across cognitive domains to find reliable age-related 
differences in activation foci (Figure 4). Most of these foci fell within the task 
positive network, which is known to be activated across many tasks and is one of 
the most reliable networks found in functional connectivity analyses (Fox et al. 
2005; Toro et al. 2008). This study compared maps of various cognitive tasks 
acquired in high-performing and more poorly performing older adults. While left 
frontal areas showed consistently higher signals in older adults when age groups 
were matched for performance, frontal areas on the right hemisphere showed 
higher signal changes when older adults’ performance was poorer than their 
younger counterparts’. When looking more specifically at studies of executive 
function, a bilateral increase in functional signal was seen over frontal areas, likely 
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because performance was not used to distinguish groups of older adults. There 
may therefore be a selective advantage to greater involvement of the left prefrontal 
areas, and older adults showing enhanced left frontal recruitment may be better 
able to maintain their performance at the level achieved by young subjects. 
Increased right prefrontal signal changes on the other hand, may reflect degrading 
of specialized neural constructs and therefore recruitment of brain areas not 
specific for the task. 
not contribute to this cluster), consistent with the TPN. Old adults
who performedmore poorly also activated right RLPFC and the left
thalamus (Fig. 1D and Table 3).
3.5. Domain specific results
Perception, memory encoding, memory retrieval and executive
function independently demonstrated a pattern of activity consis-
tent with the TPN, including reliable clusters in lateral prefrontal
regions, aIfO, SMA, and vOC (Figs. 2–5). These findings are consistent
with a previous large-scale meta-analysis of domain specific
cognition (Cabeza and Nyberg, 2000). Notable domain specific
clusters were also apparent and the results are discussed in turn.
3.6. Perception
Perceptual studies, most of which were in the visual modality,
showed extensive visual cortical activation, as would be expected
Fig. 1.Reliable patterns of brain activity across studies. A: Activation likelihood clusters across all studies and age groups. B: Age differences fromall studies. C: Age differences
from those studies where old and young adults had equivalent performance. D: Age differences from those studies where old adults had poorer performance relative to young
adults. Red = young adults > old adults, Blue = old adults > young adults. Activation likelihood clusters (FDR p < .01) are shown on an inflated surface map in Caret (Van
Essen, 2005). Some clusters may not appear contiguous due to mapping clusters on the surface maps; for example, this can occur when neighboring gyri, but not the
intermediary sulcus, were included in a statistically reliable cluster in the original image volume.
R.N. Spreng et al. / Neuroscience and Biobehavioral Reviews 34 (2010) 1178–11941184
Figure 4. Reliable patterns f brain activity across studies of aging 
A: Activation likelihood clusters across all studies and age groups. B: Age differences from all 
studies. C: Age differences from those studies where old and young adults had equivalent 
performance. D: Age differences from those studies ere old adults had poorer perfor ce 
relative to young adults. Red = young adults > old adults, Blue = old adults > young adults. Figure 
reproduced from (Spreng et al. 2010).
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The theories addressing the hemodynamic signal changes observed across 
cognitive studies seek to address two aspects: the localization of signal changes 
(with particular attention being given to signal increases) and the underlying cause 
of these changes. While both aspects inform each other to some extent, the most 
difficult to address is no doubt the underlying cause of these changes. Two main 
ideas are proposed to explain these phenomena. One is the idea of compensation 
and the other is the idea of dedifferentiation. 
1.3.1. Mechanisms leading to changes in activation patterns
Compensation hypotheses express the idea that as the brain ages, there is an 
accumulation of damage that will eventually lead to deficits, and that deficits can be 
alleviated at least partially by recruiting additional neural resources. These can be 
in the same area, so that a given area normally used for a given task is now more 
active than previously, or by recruiting additional brain regions that are not normally  
involved in the task in younger individuals (Cabeza 2002; Reuter-Lorez et al. 2008; 
Reuter-Lorenz et al. 2010). This type of theory implies that additional recruitment 
will provide a processing advantage that is usually observed as lower error rates or 
faster reaction times.  
Dedifferentiation hypotheses state that as we age, the specialization of brain 
regions acquired during development breaks down, so that tasks which in early 
adulthood gave rise to very localized hemodynamic signal increases, now give rise 
to more loosely localized networks (Baltes et al. 1997; Park et al. 2009; Cappell et 
al. 2010; Reuter-Lorenz et al. 2010). Thus, aging leads to similar or the same 
functional responses to different tasks. In other words, there is an increased 
correlation amongst the activation patterns and observed performance on a variety 
of tasks.  
Evidence for dedifferentiation was identified in a study by Baltes and colleagues 
(Baltes et al. 1997), showing that as participants age the intercorrelation between 
different cognitive scores, perceptual speed and sensory information all increase. 
While visual and auditory performance can explain a large proportion of cognitive 
score variability during aging, the authors privilege a general dedifferentiation 
process to explain their results. According to this view, the degradation of sensory 
40
and cognitive constructs are both the results of a third factor that reflects the ‘true’ 
effects of aging. 
The effects of aging that lead to dedifferentiation could arise from several 
phenomena. Even in health aging, decreases in anatomical and vascular integrity 
may lead to decreased specificity of neuronal signals (Park et al. 2009). It may also 
be that neuromodulators such as the monoamines (especially dopamine) play a 
role in reducing the SNR of neural information. Aging is associated with a decrease 
in the density of dopamine receptors and it is thought that decreased efficiency in 
this, and possibly other neuromodulatory systems, could lead to what would be 
equivalent to a reduced gain of neural systems. This in turn may cause neural 
representations to become less distinct and lead to a more uniform pattern of 
neuronal responses than in younger participants (Li et al. 2002).
1.3.2. Cognitive theories
Theories of cognitive aging have progressed from descriptions of changes in 
localization (with little information on the underlying causes) towards more 
integrated theories with testable predictions. One of the earliest reported patterns 
of change with aging is decreased lateralization of prefrontal BOLD activation 
patterns in a variety of cognitive tasks (Cabeza et al. 1997; Reuter-Lorenz et al. 
2000; Cabeza 2002). This led to the Hemispheric asymmetry reduction in older 
adults (HAROLD) hypothesis (Cabeza 2002). In the original proposal of the 
HAROLD model, it was also hypothesized that decreased lateralization could arise 
from compensation or dedifferentiation. On the compensation side, recruitment of 
the hemisphere not normally recruited in younger adults serves to provide the 
additional neuronal units necessary for efficient performance of the task when 
neuronal units in the specialized hemisphere have been lost. Implied by this theory 
is that performance on the task can be improved by bilateral frontal recruitment. 
There is some evidence that this is the case in older adults (Reuter-Lorenz et al. 
2000; Cabeza 2002) and young adult may also recruit bilateral frontal areas in 
more demanding tasks (Nolde et al. 1998). There is some ambiguity, however, as 
to the benefit to be derived from right prefrontal activation; a meta-analysis from 
Spreng et al. showed that right frontal recruitment mainly seen in poorer performing 
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groups of older adults (Spreng et al. 2010). In the dedifferentiation view, the brains 
of older adults show a gradual decrease in regional specialization so that tasks 
associated with recruitment of highly specialized areas in younger participants are 
now associated with the recruitment of a more diffuse network of less-specialized 
brain regions.  
The Posterior anterior shift in aging (PASA) hypothesis was devised to explain a 
pattern observed in a variety of tasks whereby older adults showed higher frontal - 
but lower parieto-occipital signal increases - than their younger counterparts 
(Grady et al. 1994; Davis et al. 2008). When younger and older adults are matched 
according to performance on both an episodic memory and perceptual task, older 
adults show a negative correlation between occipital and prefrontal cortex activity. 
Older individuals with higher prefrontal BOLD signal change have the lowest signal 
changes in occipital areas and are the best performers on these tasks (Davis et al. 
2008). This theory is most compatible with a compensation explanation, since 
frontal areas are here thought to compensate for degraded perceptual 
representations in more posterior areas (Grady et al. 1994; Davis et al. 2008). 
Another compensation-based theory is called CRUNCH or Compensation-Related 
Utilization of Neural Circuits (Reuter-Lorenz et al. 2008; Reuter-Lorenz et al. 2010). 
In this model, the increases in hemodynamic signals in older adults reflect neuronal 
activation used to compensate for functional loss in areas normally sufficient for 
younger adults to perform a given task. Older adults are hypothesized to recruit 
additional neural units to meet the task demands. One of the tenets of this 
hypothesis is that the additional units recruited by older adults are units that would 
also be recruited in younger adults if demands of the task were increased beyond 
their capacity to perform it with the neural constructs specific for it (Mattay et al. 
2006; Cappell et al. 2010; Schneider-Garces et al. 2010). In other words, there is 
some hierarchy of regions that could be used to perform a given task and, as the 
initial choices are found lacking, reinforcements are brought in and the brain brings 
in more and more units as they become required to perform the task. However, in 
the context of finite time, attention, motivation and neuronal resources, these 
strategies eventually fail and lead to decreases in activation and performance 
when task demands are very high (Reuter-Lorenz et al. 2008; Schneider-Garces et 
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al. 2010). Because older adults need to engage this compensatory recruitment 
mechanism for lower task loads, this also means that they do not have the 
additional resources to meet even greater task demands. Therefore, as task 
difficulty increases, a pattern becomes apparent whereby younger adults engage 
these compensatory regions, while these mechanisms now fail in the elderly. The 
failure to engage additional resources in the elderly to meet task demands results 
in a decreased hemodynamic signal pattern (Cappell et al. 2010; Schneider-
Garces et al. 2010). 
An extension the CRUNCH model to take into account dedifferentiation was 
subsequently proposed (Park et al. 2009). This theory is called the Scaffolding 
theory of aging and cognition (STAC) (Park et al. 2009; Reuter-Lorenz et al. 2010) 
(Figure 5). If the brain of older adults works under tighter SNR constraints than that 
of older adults, more or different neural resources may be necessary to achieve 
equivalent levels of performance. The authors posit that throughout life, the brain 
must update its connections and structures in the context of challenging situations. 
In the STAC theory, some brain structures may be recruited when a new ability is 
learned at any point during one’s lifetime. These structures serve to create the 
neural scaffolds that will be increasingly used as a task becomes familiar. Once the 
task is well honed, the areas initially recruited may not be used in normal contexts. 
However, when more difficult circumstances arise, such as increased task difficulty, 
sleep deprivation or in the presence of large amounts of conflicting information, the 
brain may fall back on the structures initially used to learn the task to help it meet 
these new challenges. In older adults, because of anatomical, vascular or 
neuromodulatory declines (Li et al. 2002; Salat et al. 2004; Chen et al. 2011), the 
brain is less able to meet task demands.  As ever more trivial demands become 
challenging  the brain relies more on those units initially used to learn the task 
(Cappell et al. 2010; Schneider-Garces et al. 2010). Changes in fMRI activation 
loci therefore reflect a compensation for age-related losses, as well as the effects 
of dedifferentiation (Park et al. 2009; Reuter-Lorenz et al. 2010). Prefrontal areas 
are involved in a variety of tasks and these areas may be recruited in cases of high 
task demands even in younger adults. Therefore, the increased reliance on a 
series of common frontal structures to perform various task may be a hallmark of 
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dedifferentiation. This theory is attractive in that it integrates the complexity of the 
different sources of age-related differences seen in many other studies, and 
provides a framework of testable hypotheses with good explanatory power. 
However, as will be seen later, much of the work used to generate these 
hypotheses has been based on assumptions about the meaning of BOLD signal 
changes that may be severely weakened by more careful consideration.
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Figure 4
A conceptual model of the scaffolding theory of aging and cognition (STAC).
(Petersen et al. 1998; see alsoChurch et al. 2008
for an example of scaffolding in early develop-
ment). As learning proceeds, performance be-
comes less effortful and with enough practice,
becomes overlearned. By this stage of over-
learning (some would call this skilled perfor-
mance), the circuitry has shifted from a broader,
dispersed network to a specific, honed, and op-
timal circuit of neural regions that are function-
ally interconnected to mediate efficient pro-
cessing and storage. Petersen et al. (1998) noted
that the regions that provided scaffolding at the
early stages of practice continue to be mini-
mally active even as more-specific regions as-
sume task control. This suggests that the initial
scaffolding may remain available as secondary
or functionally ready circuitry that can be re-
cruited when performance takes place under
challenge.
Extending Petersen et al.’s (1998) argument,
we suggest that reliance on such secondary net-
works or scaffolds may be an important aspect
of healthy cognitive aging and provide con-
siderable support toward the maintenance of
cognitive function as age-associated structural
deterioration increases. We presume that scaf-
folding processes operate with more efficiency
in youth, when scaffolding is typically and fre-
quently engaged to meet novel situations and
to achieve new learning. With age, scaffold-
ing processes may be invoked to perform famil-
iar tasks and basic cognitive operations as these
processes become increasingly challengingwith
the degredation of existing neural circuitry.We
speculate that perhaps the maintenance of lan-
guage in old age results from the continuous use
of language throughout life and a particularly
elaborate scaffolding network for this behavior
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Figure 5. A concep ual model f the scaff lding theory of aging and cognition (STAC). 
This figure and its caption were reproduced from (Park et al. 2009). 
1.4. The BOLD contrast mechanism
BOLD contrast phenomenon arises from the fact that oxygenated and 
deoxygenated hemoglobin have different magnetic properties: oxyhemoglobin is 
diamagnetic while deoxyhemoglobin is paramagnetic. The para agnetic nature of 
deoxyhemoglobin means that blood that is not fully oxygenated causes an 
attenuation of the T2*-weighted signal from increased dephasing of nearby water 
spins. Since arterial blood is al ost fully oxygenated in healthy hu ans, there is 
specific attenuation of the T2* signal from venous blood and tissue containing 
parenchymal deoxyhemoglobin (Ogawa et al. 1990a; Ogawa et al. 1990b). During 
performance of a task, active brain regions consume oxygen to function, causing a 
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local increase in deoxyhemoglobin. It is debatable whether the local increase in 
deoxyhemoglobin is actually detectable using MRI scanners, especially at 1.5 or 3 
Tesla (Kim et al. 2012). However, concomitant with this increased 
deoxyhemoglobin production comes a local vasodilation of blood vessels, which in 
turn causes an increase in local blood flow. This fractional increase in blood flow is 
much larger than the fractional increase in deoxyhemoglobin that it accompanies. 
This is thought to reflect the need for the O2 gradient from arterial blood to 
metabolizing tissue to be steep for effective diffusion of blood O2 into active tissue 
more distal to vessels (Buxton et al. 1997; Buxton et al. 1998b; Buxton 2010; 
Devor et al. 2011). One of the corollaries of this larger fractional blood flow change 
is that for a given increase in deoxyhemoglobin concentration through local 
metabolism, there is a corresponding larger increase in blood flow to the same 
area. Because the inflowing blood is fully oxygenated, this causes an increase in 
BOLD signal from a local reduction in the deoxyhemoglobin concentration. This 
vascular response is called the hemodynamic response. Functional MRI 
techniques measure it to make inferences about the underlying neuronal activity 
that triggers it. The exact characteristics of this hemodynamic response function, 
both in terms of shape and underlying physiology, have been and still are the 
subject of much debate (Glover 1999; Buxton 2010; Kim et al. 2012). 
1.4.1. Underlying neuronal activity
Functional imaging using hemodynamic methods such as BOLD are based on the 
assumption that the signal changes observed are strongly correlated with 
underlying neuronal activity. Convincing evidence that this is the case comes from 
simultaneous electrophysiological and fMRI recordings in monkeys (Logothetis et 
al. 2001; Shmuel et al. 2002; Logothetis et al. 2004). In these studies, electrodes 
are implanted in monkey visual cortex and simultaneous recordings during 
spontaneous or visual task-elicited activity of neuronal currents and fMRI signal are 
made. Electrophysiological recordings can capture three types of neuronal 
electrical activity. The first and most obvious is the spiking activity. In this type of 
recording, a high impedance electrode is inserted in the cortex and action 
potentials of nearby neurons can be recorded. This method predominantly 
measures the action potentials coming from the largest neurons within 50–100 μm 
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of the electrode. A second type of recording involves the insertion of a lower 
impedance electrode (larger tip). Two sources of information are present within this 
signal: the high frequencies are isolated using a high-pass filter with a cutoff 
frequency of 300-400 Hz and the lower frequencies using a low-pass filter with a 
cutoff at 200 Hz. The high frequency component is called multi-unit activity (MUA) 
and is thought to represent spiking activity from more distant neurons. The low 
frequency component, called local field potentials (LFP) is thought to reflect 
predominantly sub-threshold somato-dendritic currents, with some contributions 
from voltage-gated membrane oscillations and membrane after-potentials 
(Logothetis et al. 2004). THE BOLD SIGNAL C-3
Figure 4 A cortical site in which the LFP and MUA predictions of the BOLD response
differ significantly. Responses to a 24-s (upper) and 12-s (lower) stimulation are
shown. The blue trace measures the LFP, the green trace measures the MUA, and the
red-shaded trace measures the BOLD response. The MUA signal is brief and approxi-
mately the same in both experiments. The LFP and BOLD responses covary with the
stimulus duration. At this cortical site and in 25% of the measurements, the LFP
response matched the BOLD response but the MUA did not. There were no instances
in which the MUA matched the BOLD response, but the LFP did not.
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Figure 6. Electrical underpinnings of the BOLD signal
A cortical sit  in which the LFP and MUA predictions of the BOLD respo se differ significantly. 
Responses to a 24-s (upper) and 12-s (lower) stimulation are shown. The blue trace measures the 
LFP, the green trace mea ures the MUA, and the red-sha ed trac m asures the BOLD response. 
The MUA signal is brief and approximately the same in both experiments. The LFP and BOLD 
responses covary with the stimulus duration. This figure and its caption were reproduced from 
(Logothetis et al. 2004).
Early studies of this type have established that while BOLD signal amplitude is 
correlated with all aspects of neuronal firing, it is most closely linked with local field 
potentials (LFPs) than with other electrical activity such as spikes from action 
potential firing (Logothetis et al. 2001) (Figure 6). LFPs are thought to reflect a 
variety of neural processes including synaptic potentials, somato-dendritic spikes 
and voltage-gated membrane oscillations (Logothetis et al. 2004; Magri et al. 
46
2012). More recent research has investigated the link between BOLD signal 
response components and frequency bands within the LFP signal. Magri and 
colleagues (Magri et al. 2012) have shown that the gamma band, including the 
higher frequencies within the LFP signal, is the most closely related component to 
the BOLD response. This band was found to contribute the most information in 
determining the overall shape of the hemodynamic response function (HRF). It was 
correlated with both amplitude and lag of the response and was found to be 
stimulus-dependent. The beta band of the spectrum, containing intermediate 
frequencies, also contained some information determining the shape of the HRF. It 
was found to be correlated with the time of the initial rising phase of the HRF. The 
alpha band, consisting of the lower frequencies within the LFP spectrum, was 
found to contain little information beyond what the other bands could contribute. 
However, the relative power distribution across all bands contributed to the shape 
of the HRF measured (Magri et al. 2012). In agreement with a heuristic theory of 
the relationship between frequency distribution of neural signals and BOLD signal 
amplitude (Kilner et al. 2005), a relative shift in frequency distribution towards 
higher frequencies was found to correlate with BOLD signal activation. In other 
words, while alpha band power did not add much information on its own, a relative 
decrease in power in this band as compared to the gamma band (containing higher 
frequencies) was an independent source of information about BOLD signal 
increases. All these relationships were found to be true also for BOLD signal 
decreases, with shifts towards lower frequencies indicative of a deactivation. Taken 
together, these results argue strongly for a neuronal activity contribution to the 
BOLD signal. However, the quantification of this underlying contribution may not be 
straightforward in the context of non-invasive human studies. Furthermore, the 
relationship between electrical signaling and downstream metabolic effects that 
lead in turn to the vascular response, present their own quantification challenges.  
1.4.2. Oxidative metabolism
While little doubt now remains that the bulk of metabolism in the brain is oxidative, 
there was heated debate on this topic in the early days of functional neuroimaging. 
This debate was triggered by early PET results showing an unexpected 
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discrepancy between changes in glucose metabolism and oxygen consumption 
during activation (Fox et al. 1986).
The main energy expenditure of neurons is to maintain membrane potential to be 
ready to fire and integrate synaptic information when the need arises. To do so, the 
brain uses energy in the form of ATP, which is derived from the metabolism of 
glucose. Two forms of glucose metabolism exist: anaerobic, which does not use 
oxygen, and aerobic, which uses oxygen in the mitochondrial electron transport 
chain. Aerobic glycolysis is highly efficient, as it can lead to the formation of as 
many as 38 ATP molecules from a single glucose molecule. Anaerobic glycolysis 
is, on the other hand, faster but only produces 2 ATP molecules per glucose. The 
first steps of both pathways are the same, with the formation of two pyruvate 
molecules and two NADH molecules. In anaerobic glycolysis the pyruvate is then 
simply converted to lactate in the cytoplasm and not used for further energy 
production, while pyruvate goes to the mitochondria to generate more ATP 
molecules by going through the Krebs cycle and oxidative phosphorylation during 
aerobic metabolism. Because aerobic glycolysis is much more efficient at energy 
production and because the brain is known to be an avid user of oxygen, it was 
expected that oxidative metabolism would be the main form of metabolism used in 
the brain. Indeed, interruption of the brain's oxygen supply leads to 
unconsciousness within seconds and irreversible tissue damage within minutes 
(Levy et al. 1975).
The most likely interpretation of the early PET results (Fox et al. 1986) showing a 
coupling ratio between glucose and oxygen consumption more compatible with 
anaerobic glycolysis is that there were important quantification difficulties involved 
in the techniques used and possible biases that lead to underestimation of the O2 
consumption (Hattori et al. 2004; Buxton 2010). Glucose metabolism and O2 
consumption are both not trivial to quantify using MRI or PET techniques, and 
require a substantial modeling component that is difficult to validate. However, 
more recent experiments have yielded results much more compatible with the 
predicted predominant role of oxidative metabolism (Ishii et al. 1996; Mintun et al. 
2002; Yamauchi et al. 2002; Hattori et al. 2004; Ito et al. 2005; Ibaraki et al. 2008; 
Ibaraki et al. 2010). 
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In order to make inferences about neuronal activity from the BOLD response, 
questions pertaining to the relative contribution of oxidative and non-oxidative 
metabolism will have to be elucidated. However, researchers who use the BOLD 
signal alone make the implicit assumption that oxidative metabolism is the main 
energy production pathway and that the amplitude of the BOLD response is in 
some way, directly or indirectly, proportional to the amount of oxidative metabolism 
(and therefore total metabolism) evoked by neuronal activity.  
1.4.3. Neurovascular coupling
Because the brain has no stores of oxygen and glucose, increases in metabolic 
activity must be met with increases in metabolic substrate availability and waste 
removal. These increases are achieved through local blood flow increases. The 
signaling cascades that underlie this process of neurovascular coupling (flow 
increases following neuronal activity) are complex and may be regionally 
dependent. While research in this area has identified the main mediators and 
modulators of this pathway (Lauritzen et al. 2003; Girouard et al. 2006; Lecrux et 
al. 2011), their relative importance and the cellular environment variables that 
determine their function are still largely unknown. 
The neurovascular unit is composed of different cells which work together to 
orchestrate the blood flow increase required by increased metabolic demand. The 
neurovascular unit includes neurons, glia and vascular cells, including vessel 
endothelium, smooth muscle cells, pericytes and adventitial cells (Girouard et al. 
2006). The general structure of the neurovascular unit is shown in Figure 7. 
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membrane enters into direct contact with the astrocytic end
feet. Arterioles become progressively smaller, lose the smooth
muscle cell layer, and become cerebral capillaries. The density
of brain capillaries within the brain is regionally heterogeneous
and varies according to regional blood flow and regional
metabolic demands (81). Capillaries consist of endothelial
cells, pericytes, and the capillary basal lamina on which astro-
cytic feet are attached (68) (Fig. 1). Brain endothelial cells are
unique in that they are not fenestrated and are sealed by tight
junctions, features that underlie the blood-brain barrier. Endo-
thelial cells play an important role in the regulation of vascular
tone by releasing potent vasoactive factors, such as nitric oxide
(NO), free radicals, prostacyclin, endothelium-derived hyper-
polarizing factor, and endothelin (19). Pericytes have contrac-
tile properties and may modulate capillary diameter (31).
Perivascular astrocytes surround most of the capillary ablumi-
nal surface with their end feet. There is close association
between cerebral arteries, arterioles, and capillaries with nerves
originating from central and peripheral sources (Fig. 1). These
relationships are addressed elsewhere in this series (see
Ref. 25a).
Mechanisms of Neurovascular Coupling: The Quest for
the Mediators
The mechanisms underlying neurovascular coupling have
been the subject of enquiry for more than a century (31), and
numerous vasoactive factors have been implicated in neuro-
vascular coupling (Table 1). These include ions, metabolic
by-products, vasoactive neurotransmitters, and vasoactive fac-
tors released in response to neurotransmitters.
Vasoactive ions. K! and H! are generated by the extracel-
lular ionic currents induced by action potentials and synaptic
transmission. Elevations in extracellular K! up to 8–10 mM
cause dilation of arterioles both in vitro and in vivo (45, 54).
This effect is mediated by the opening of K! channels, mainly
of the inward rectifier type, on the membrane of arterial smooth
muscle cells (20, 54), leading to their hyperpolarization and
subsequent relaxation. During sustained activation, ATP de-
pletion could lead to opening of ATP-sensitive K! channels
(KATP) on vessels. Therefore, KATP channels have been impli-
cated in the mechanisms of neurovascular coupling (54). Fur-
thermore, KATP could also participate in neurovascular cou-
pling by mediating the vasodilation produced by agents that
increase cAMP, such as adenosine or prostacyclin (20). The
vasodilatatory effect of increased concentrations of H! is also
mediated, at least in part, by the opening of K! channels (20).
It has also been suggested that activity-induced reductions in
extracellular Ca2! may produce vasodilation (28).
Vasoactive factors related to energy metabolism. The brain
has little energy reserve and requires a continuous supply of
glucose and O2 through CBF. A sudden increase in the demand
Fig. 1. Relationship of cerebrovascular cells with neurons, glia, and perivascular nerves. Pial arteries and arterioles are innervated by nerve fibers arising from
cranial autonomic ganglia. Smaller cerebral arterioles ("100 #m) come in contact with nerve terminals arising from local interneurons and from central pathways
originating from distant sites in the brain stem or basal forebrain. These neurovascular associations often terminate on astrocytic end feet lining the abluminal
vascular surface. Pericytes, contractile cells embedded in the capillary wall, are closely associated with astrocytic end feet and endothelial cells. The term
“neurovascular unit” has been coined to define the close structural and functional relationships between brain cells and vascular cells. In diseases states, such
as ischemic stroke, Alzheimer disease, and hypertension, the function of the neurovascular unit is profoundly disrupted resulting in alterations in cerebrovascular
reactivity that compromise brain function.
Table 1. Factors implicated in neurovascular coupling
Agent References
Vasoactive ions
K! 45
H! 45
Ca2! 28
Metabolic factors
Lactate, CO2 71, 73
Hypoxia 73
Adenosine 72
Vasoactive neurotransmitters
Dopamine 43
GABA 22
Acetylcholine 74
Vasoactive intestinal peptide 83
Other
NO 61
COX-2 products 55
P450 products 67
CO 51
NO, nitric oxide; COX-2, cyclooxygenase-2; CO, carbon monoxide.
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Figure 7. Neurovascular unit
Pial  art ries and art rioles (on the surface of the brain) are innervated by nerve fibers rising from 
cranial autonomic ganglia. Smaller cerebral arterioles (<100 μm) come in contact with nerve 
terminals arising fr m local interneurons and from central pathways originating from distant sites in 
the brain stem or basal forebrain. These neurovascular associations often terminate on astrocytic 
end feet lining the abluminal vascular surface. Pericytes, contractile cells embedded in the capillary 
wall, are closely a sociated with astrocytic end feet and endotheli l cells. The term “neurovas ular 
unit” has en coin d to define the close structural and fun tional relati nships between brai  cells 
and vascular cells. This figure and its caption are reproduced from (Girouard et al. 2006).
As arteries and arterioles branch out and penetrate deeper into the brain, the 
smooth muscle layer surrounding arteries becomes thinner and eventually 
disappears at the level of capillaries, where it is replaced by other contractile cells 
called pericytes. In the maller arteri les and capillaries, there is irect c nt ct 
between the vessel wall and astro ytic end-feet as w ll as neuro s from a variety 
of sources (Girouard et al. 2006). Endothelial cells, perivascular astrocytes and 
neurons may all release molecules that lead to changes in arteriole diameter. 
Furthermore, there is some indications that pericytes may also contribute to 
changes in capillary diameter (Girouard et al. 2006; Lecrux et al. 2011). 
One of the main contentious issue in the field of neurovascular coupling is the 
relative role of excitatory and inhibitory synaptic activity in triggering a CBF 
increase (Lecrux et al. 2011). The majority of research efforts have investigated 
excitatory transmission. Strong experimental evidence showed that glutamate, the 
main excitatory neurotransmitter in the brain, can trigger CBF increases through an 
indirect pathway involving both NMDA and AMPA glutamate receptor subtypes 
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(Gsell et al. 2006; Lecrux et al. 2011). The effects of glutamate may be mediated 
through the nitric oxide (NO) pathway, with neuronal NO release upon NMDA 
receptor activation (Yang et al. 1996; Bhardwaj et al. 2000; Lecrux et al. 2011). 
These effects may also be partially mediated through calcium waves in astrocytes, 
where glutamate-dependent increases in the concentration of Ca2+ ions in 
astrocytic end-feet may lead to changes in arteriolar diameter (Yang et al. 1996; 
Zonta et al. 2003; Girouard et al. 2006; Lecrux et al. 2011). 
GABA interneurons may also play a role in mediating the CBF increases 
associated with LFPs. Immunocytochemistry studies of GABA interneurons have 
shown that subpopulations express a variety of vasoactive molecules including 
NO, neuropetide Y, somatostatin, vasoactive intestinal polypeptide and 
acetylcholine (Valtschanoff et al. 1993; Kubota et al. 1994; Abounader et al. 1997; 
Lecrux et al. 2011). Through release of these mediators, GABAergic interneurons 
may contribute to the neurovascular coupling response (Kocharyan et al. 2008; 
Lecrux et al. 2011).
Beyond these indirect effects of neurotransmitter release, a variety of mediators of 
neurovascular coupling have been identified (Figure 8). 
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vasoactive messengers (Fig. 4) allowed a better under-
standing of the pathways involved in the neurovascu-
lar coupling response. To achieve pharmacological
investigation of the CBF response, systemic drug
administration is usually performed, using either
intraperitoneal (Wang et al. 2006, Stefanovic et al.
2007), intravenous (Dauphin et al. 1991, Gsell et al.
2006, Stefanovic et al. 2006, Takano et al. 2006) or
topical application through superfusion over the
somatosensory cortex in a closed (Peng et al. 2002,
Takano et al. 2006, Wang et al. 2006) or open
(Lindauer et al. 1999, Niwa et al. 2000a) cranial
window or through injection in the cisterna magna
(Yu et al. 2004, Kocharyan et al. 2008). Disseminated
effects are, however, a major limitation of systemic
injections, such as an alteration of blood pressure
following injection of non-selective NO synthase
inhibitors (Rees et al. 1989). Intracisternal injection
represents a good compromise between peripheral and
direct applications, as it does not require an invasive
approach to the cortical region, leaving it totally
intact.
Main mediators of the neurovascular coupling response to
sensory stimulation
Nitric oxide has long been identified as a modulator of
the haemodynamic response to neuronal activation in
the cortex. NO exerts its dilatory effects mostly by
binding to soluble guanylyl cyclase found not only in
smooth muscle cells (Friebe & Koesling 2003), but
also in endothelial cells, astrocytes and neurons
(Sporbert et al. 1999, Baltrons et al. 2004). Inhibition
of NO production by a non-selective NO synthase
inhibitor (N-nitro-l-arginine, L-NNA) produced a
significant reduction (approx. 50%) of the CBF
response to whisker stimulation (Dirnagl et al. 1993).
Specific inhibition of neuronal NO synthase by 7-
nitroindazole (7-NI) similarly reduced the cortical CBF
response (approx. 50%) to forepaw stimulation (Lin-
dauer et al. 1999). Of note, NO is not considered as a
primary mediator of this CBF response, but rather as a
permissive factor which is required for vasodilation by
other pathways (Cholet et al. 1997, Lindauer et al.
1999).
Adenosine, a product of cellular activity, is another
mediator (Morii et al. 1987, Iadecola 2004) implicated
in neurovascular coupling. Adenosine can bind to four
different receptors: A1, A2A, A2B and A3. In vitro
studies suggested that the A2 receptor, expressed by
endothelial and smooth muscle cells (Kalaria & Harik
1986), neurons and astrocytes (Trincavelli et al. 2008),
is primarily responsible for the cerebral vasodilatory
effect of adenosine (Ngai et al. 2001). In vivo, the role
of adenosine was established using either the non-
specific adenosine receptor antagonist theophylline (Ko
et al. 1990, Dirnagl et al. 1994) or the selective A2B
receptor antagonists alloxazine and MRS-1754 (Shi
et al. 2008) that decreased up to 40% the evoked CBF
response. In contrast, neither the selective A3 receptor
antagonist, MRS-1191 nor the selective A2A receptor
antagonists, ZM-241385 and SCH-58261, had any
inhibitory effect, which implies that these receptors do
not contribute to the evoked CBF response (Shi et al.
2008). However, ZM-241385 reduced pial arterial
dilation to sciatic nerve stimulation (Meno et al.
2001), suggesting an effect of A2A receptors on the
upstream vasodilatory response.
Arachidonic acid (AA) metabolites are synthesized
and released in response to glutamate release by
neuronal activation (Stella et al. 1994). Vasomediators
derived from AA can be produced by several enzymatic
pathways, including cyclo-oxygenase (COX) enzymes
and cytochrome P450 (CYP450) epoxygenases or
hydroxygenases (Fig. 4) (Kroetz & Xu 2005, Bosetti
2007). COX enzymes consist of COX-1, present in
glial cells, and COX-2, constitutively expressed by
cortical glutamatergic neurons, which ultimately lead
Figure 4 Schematic representation of mediators of the neuro-
vascular coupling response and of pharmacological blockers of
these pathways. Increased intracellular calcium levels following
stimulation lead to the activation of phospholipases and
production of arachidonic acid (AA). AA is processed by either
COX-1 or COX-2 to release diverse prostaglandins or by the
cytochrome P450: epoxygenases or x-hydroxylases to produce
EETs and 20-HETE. Other key pathways in the haemo-
dynamic response to sensory stimulation include nitric oxide,
potassium and adenosine. See text for details of magnitude
of effects and references.
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Figure 8. Neurovascular coupling response
 Increased intracellular calcium levels following stimulation lead to the activation of phospholipases 
and production of arachidonic acid (AA). AA is processed by either COX-1 or COX-2 to release 
diverse prostaglandins or by the cytochrome P450: epoxygenases or x-hydroxylases to produce 
EETs and 20-HETE. Other key pathways in the haemodynamic response to sensory stimulation 
include nitric oxide, potassiu  and aden sine. Thi  figure and its caption were r produced from 
(Lecrux et al. 2011).
The most importan  ignali g cascades include the NO pathway, present in smooth 
muscle cells, endothelial cells, astrocytes and neurons (Lecrux et al. 2011). 
Inhibition of this pathway with NO synthase antagonists leads to less pronounced 
CBF increases in response to a variety of stimuli, including sensory stimulation 
(Dirnagl et al. 1993; Lindauer et al. 1999; Lecrux et al. 2011), direct cerebellar 
stimulation (Yang et al. 1996; Girouard et al. 2006) and hypercapnia (Yang et al. 
1996). 
Other frequently observed mediators include vasoactive ions such as potassium (K
+) and hydrogen (H+). Both show increased extracellular concentration following 
action potential firing and synaptic transmission leading to vasodilation (Kuschinsky  
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et al. 1972; Girouard et al. 2006; Lecrux et al. 2011). Adenosine, also a product of 
metabolism through the catabolism of ATP, is also recognized as a potent 
vasodilator. Neurons, astrocytes and smooth muscle cells all express an adenosine 
receptor subtype and may mediate the neurovascular role of adenosine (Ngai et al. 
2001; Lecrux et al. 2011). 
Another group of mediators are derived from metabolism of arachidonic acid. 
Cyclo-oxygenase enzyme 2 breaks down arachidonic acid to form prostaglandin 
molecules. Prostaglandins may be produced in active neurons and act as 
vasodilator agents, but their role and locus of activity has not yet been fully 
elucidated (Stella et al. 1994; Niwa et al. 2000; Andreasson 2010; Lecrux et al. 
2011). Other molecules have been shown to be vasoactive, but their role in activity-
dependent CBF increases remains unclear (Lecrux et al. 2011). 
From this branch of research it may be inferred that the regulation of blood flow in 
neurovascular coupling is complex and that the amplitude of the hemodynamic 
response may depend strongly on the specific cellular environment of brain 
regions. However, one encouraging conclusion to be drawn from these results is 
that in all cases, there is some relationship between aspects of neuronal signaling 
and the release of vasoactive molecules. Therefore, though the exact underpinning 
of this blood flow response may be difficult to untangle, the response itself can be 
taken as a surrogate for neuronal activity. 
1.4.4. Blood flow response
The main component of the hemodynamic response resulting in BOLD signal 
changes during activation is the increase in blood flow. During performance of a 
task, the coupling ratio between the increase in blood flow to the increase in 
oxidative metabolism is thought to be around two under normal circumstances 
(Buxton 2010). In other words, during local brain activity in the absence of disease 
or pharmacological agents, the fractional blood flow change is thought to be about 
two times larger than the fractional change in oxidative metabolism. This 
measurement, however, remains somewhat speculative, given the low SNR of 
blood flow and oxidative metabolism measurement. 
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Cerebral blood flow can be directly measured non-invasively using MRI through 
techniques such as Arterial Spin Labeling (ASL). ASL measurements have the 
advantage over BOLD of yielding an absolute and unambiguous measure of a 
physiological quantity. However, widespread adoption of ASL as a functional 
contrast mechanism has been slowed by the fact that ASL is an intrinsically low 
SNR technique. This is because in all of its implementations it relies on image 
subtractions to provide functional contrast, thereby leading to addition of errors in 
measurements. Furthermore, the effect sizes are generally on the order of a 
fraction of a percent. 
Though there exists a wide variety of ASL pulse sequences, all function under the 
same general principle. A magnetic tag is added to the inflowing blood in every 
other image of a time series and adjacent image pairs are subtracted to isolate the 
flow dependent component of the signal (Detre et al. 2012). There are two main 
families of ASL sequences in current use, pulsed and continuous ASL techniques. 
The terms ‘pulsed’ and ‘continuous’ refer to the tagging method used (Williams et 
al. 1992; Edelman et al. 1994; Wong et al. 1998). In modern ASL techniques, the 
blood is tagged at the level of the carotid arteries. More specifically, the spins in the 
blood of the main arteries flowing into the brain are inverted so that the signal of 
the tagged blood will not contribute to the image. Once the spins are inverted, 
there is a waiting period for inflowing blood to reach the volume we wish to image 
and, after the appropriate delay, an image of the brain is acquired. The blood that 
was tagged at the level of the neck is now darker (on a T2* acquisition) than the 
blood that was already in the volume imaged (the static signal). For the following 
image, the procedure is repeated, but this time the tagging is not performed, so 
that all the blood has the signal intensity provided by the image acquisition 
excitation pulse. By subtracting these two images, we can isolate the decreased 
signal component created by tagging the blood at the level of the neck. This is the 
flow dependent component, since only the inflowing blood has been labeled 
(Williams et al. 1992; Detre et al. 2012). 
In pulsed ASL sequences (PASL), a large slab of blood is inverted by a single 
electromagnetic pulse at the level of the neck (Edelman et al. 1994; Wong et al. 
1998). Continuous sequences label a thin slab for a longer period of time to 
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achieve an equivalent volume of labeled blood (Williams et al. 1992). True 
continuous sequences are technically challenging, but in recent years, techniques 
termed pseudo-continuous have been developed that provide several advantages 
over other techniques. Pseudo-continuous sequences (pCASL) use a train of short 
RF pulses to achieve a near continuous labeling. This provides a superior SNR 
and implicit control over label duration of continuous approaches, without the strain 
on scanner gradients that true continuous sequences represent (Wu et al. 2007; 
Dai et al. 2008; Detre et al. 2012). 
With recent improvements in ASL techniques, local changes in CBF caused by 
task-induced oxidative metabolism are readily detectable. However, global flow 
changes such as those caused by blood gas changes provide a more difficult 
challenge to ASL techniques. In a paper recently published by our group (Tancredi 
et al. 2012), we have shown that pCASL sequences may provide improved 
accuracy and sensitivity to these changes as compared to PASL. This is likely due 
to the fact that, in the case of global flow increases, blood flow velocity increases in 
the carotid arteries results in tag compression effects in PASL sequences. Under 
certain conditions, uncontrolled shift in tag delivery dynamics can lead to 
systematic underestimation of CBF (Bolar et al. 2012). 
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Figure 9. Tag delivery in ASL during normocapnia and hypercapnia
Kinetic modeling of tag delivery from multiple inversion time data during normocapnia and 
hypercapnia in a single subject. With standard parameters, ASL images are acquired during the 
outflow phase of this curve (around 1.4 seconds), where the two curves overlap. Using this set of 
parameters underestimates the effects of hypercapnia on flow. This figure was included with the 
permission of its authors (unpublished preliminary data). 
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Since measurement of the blood flow increase caused by hypercapnia is a crucial 
part of all studies presented in this thesis, a pseudo-continuous ASL approach has 
been used in all experiments.
1.4.5. Blood volume
Cerebral blood volume (CBV) changes with neuronal activity are strongly 
correlated with changes in CBF. This relationship was first estimated by Grubbs 
and colleagues from experiments in anesthetized rhesus monkeys during 
hypercapnia to be a power law relationship with an exponent value of 0.38 (Grubb 
et al. 1974). However, because this measurement was not done in awake humans, 
and because the exponent reflects total blood volume rather than venous blood 
volume, which is the quantity expected to affect BOLD signal changes, there have 
been recent attempts to revisit this exponent value. 
Several MRI techniques exist to measure CBV changes. While some of these 
require the injection of a contrast agent such as MION, some non-invasive 
techniques using endogenous contrast mechanisms have also been developed. 
The most widely used of these techniques is called vascular space occupancy 
(VASO) and yields a measure of total blood volume (Lu et al. 2003). This technique 
uses a non-specific inversion recovery sequence to null the blood signal. The 
functional contrast arises from the fact that as blood volume increases during 
activation more spins move into the nulled compartment. While the VASO 
technique is not specific to the blood volume change that contributes to the BOLD 
signal change (i.e. venous blood), it is a measure of a physiological quantity and 
may be used as a functional contrast mechanism in its own right (Lu et al. 2003; 
Donahue et al. 2006; Lu et al. 2012a). 
For a more specific depiction of the CBV changes that contribute to BOLD signal 
changes, a sequence called venous refocussing for volume estimation (VERVE) 
can be used to specifically measure venous blood volume changes (Stefanovic et 
al. 2005; Chen et al. 2009a; Chen et al. 2010c). This sequence uses the 
dependence of venous blood on T2 and refocussing interval in a Carr Purcell 
Meiboom Gill (CPMG) sequence to isolate CBV changes specific to the venous 
compartment. It has been used by Chen and colleagues to estimate the flow-
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volume exponent. The exponent was found to be lower than previously thought, 
with values around 0.18-0.23 for activation in visual and motor task, as well as for a 
hypercapnic manipulation (Chen et al. 2009a; Chen et al. 2010c).  
1.4.6. Limitations of the BOLD signal
While the BOLD contrast may be a sensitive measure of neuronal activity, it is 
limited in terms of physiological specificity since it arises from a mixture of oxidative 
metabolism, blood flow and blood volume. Its amplitude is dependent on 
neurovascular coupling, which may vary with age and vascular health status. 
Furthermore, because much of the complexity of the underlying molecular 
signaling pathways still remains to be elucidated, we cannot yet determine the 
degree of regional and pathway-specific heterogeneity to be expected even in 
healthy individuals. 
1.4.6.1. Confounds in aging studies
Aging studies may be particularly vulnerable to the limitations of the BOLD contrast 
(Figure 10). Because older adults show altered vascular function and because their 
oxidative metabolism is also likely affected by life-long mitochondrial stress, all 
aspects of the BOLD signal may be affected by aging. This is likely the case both 
for the baseline and dynamic range of the signal. This renders interpretation of 
BOLD signal differences even more problematic since BOLD signals are relative 
changes from an unknown baseline. 
Beyond the difficulties of interpretation of the BOLD signal itself, functional studies 
of aging suffer from a variety of other confounds. For example, aging studies suffer 
from an increased likelihood of partial volume effect biases. As grey matter density 
decreases with age, the signal within a given voxel contains a greater proportion of 
white matter and CSF. It should also be noted that the normalization procedure 
preformed in group studies will inflate the grey matter, making it appear thicker 
than it really is and lead to an underestimation of atrophy. Another confound arises 
from the fact that most aging studies quantify the BOLD signal within a region-of-
interest derived from group analyses. While some voxels are always expected to 
include some white matter and CSF when using this technique to draw ROIs, this 
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effect may be exacerbated in older cohorts with more heterogeneous degrees of 
grey matter atrophy (Samanez-Larkin et al. 2008).
set of rules of thumb for conducting studies of the aging
brain using functional neuroimaging.
PROBLEMS
Group differences in hemodynamics
The most investigated methodological question in the neu-
roimaging and aging literature is whether the coupling
between neural activity and the blood-oxygen-level-
dependent (BOLD) signal changes with age (D’Esposito
et al., 2003). Common age-related changes in vasculature
can lead to age-related differences in the BOLD signal that
might not be due to true differences in neural computation
(for a review, see Gazzaley and D’Esposito, 2005). One
primary goal of functional brain imaging is to identify
regions of the brain whose activation correlates with psycho-
logical events of interest. Standard brain imaging analysis
programs begin by constructing a regression model with
the predicted timecourses for these psychological events.
These predictors are then convolved with a standard
hemodynamic response function (HRF) to account for the
lag and shape of the BOLD response measured by fMRI. If
the shape of this HRF significantly deviates from the HRF of
an individual!for example, if vascular rather and not neural
changes result in age-related differences in the peak ampli-
tude or shape of the HRF!the model may fit less well and
become biased.
Group differences in brain morphology
A second important issue in studies comparing groups
differing in age is that there is great anatomical variability
between the brains of younger and older adults and within
a random sample of older adults (Raz et al., 2005; Raz et al.,
2007). Gray matter atrophy and sulcal expansion in older
adults contributes to a more uneven cortical surface which
can lead to distortions in automatic spatial normalization
(Crinion et al., 2007). Spatial normalization is an image
processing step commonly utilized in brain imaging analysis
packages to enable group-averaged statistical comparisons
Fig. 1 This figure displays hypothetical results from a cross-sectional study examining differences in brain activity between younger and older adults. Although, the results of this
hypothetical study may seem to suggest that the poorer performance of older adults is due to their showing less brain activation than the younger adults in these regions, there
are several reasons detailed in the text to be skeptical of these conclusions. (A) A whole brain analysis reveals a main effect of age (Young > Old) in three regions: lateral
prefrontal cortex, anterior cingulate and medial caudate. (B) An example of BOLD signal change plotted from one of these regions reveals significantly greater activation in
younger adults. (C) A scatter plot displays a significant simple correlation between neural signal (x-axis) and behavior (y-axis) across all participants (younger and older adults
combined). (D) The individual data points (used in the previous bar graph and the x-axis in the scatter plot) plotted here by age group reveal a nonnormal (bimodal) distribution
of the data for the older adults. About half of the sample has BOLD signal change values near zero. (E) The data plotted in panels (B)–(D) were extracted using a single ROI mask
shown here overlaid on a random sample of individual participants’ T1 anatomy (axial; TT S¼ 10; MNI S¼ 12). The participant ages are listed below each image. It is clear in
these images that this single mask does not align well with the individual participants’ anatomy. The data points for each of these four sample participants have been highlighted
with red dots and labeled with the participant ages in panels (C) and (D).
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Figure 10. Example case of BOLD comparisons across lifespan
This figure displays hypo hetical r sults from a cross-sectional study ex mining diff rences in brain 
activity between younger and older adults. Although, the results of this hypothetical study may seem 
to suggest that the poorer performance of older adults is due to their showing less brain activation 
than the younger adults in these reg ons, there are several reasons detailed in the text to be 
skeptical of these conclusions. (A) A whole brain analysis reveals a main effect of age (Young > 
Old) in three regions: lateral prefrontal cortex, anterior cingulate and medial caudate. (B) An 
example of BOLD signal change plotted from one of these regions reveals significantly greater 
activation in younger adults. (C) A scatter plot displays a significant simple correlation between 
neural signal (x-axis) and behavior (y-axis) across all participants (younger and older adults 
combined). (D) The individual data points (used in the previous bar graph and the x-axis in the 
scatter plot) plotted here by age group reveal a non-normal (bimodal) distribution of the dat  for the 
older adults. About half of the sample has BOLD signal change values near z ro. (E) The d a 
plotted in panels (B)–(D) were extracted using a single ROI ma k shown here overlaid on a random 
sample of individual participant ’ T1 a atomy. The participant ages are listed below each image. It 
is cle r i  thes  images that this single mask does not align well with the individual participants’ 
anatomy. The data points for each of these four sample participants have been highlighted with red 
dots and labeled with the participant ages in panels (C) and (D). This figure and its caption were 
reproduced from (Samanez-Larkin et al. 2008). 
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While all these sources of ambiguity limit the inferences that can be made about 
neuronal activity from the BOLD signal, the fact remains that its amplitude is 
correlated with synaptic activity and oxidative metabolism. Techniques have been 
developed that can isolate this metabolic component and thereby obtain a 
physiologically-specific quantity more closely related to neuronal activity. These 
techniques are called calibrated fMRI techniques and will be discussed in the next 
section.
1.5. Calibrated fMRI techniques
Calibrated fMRI techniques have been developed to extract the oxidative 
metabolism component from the BOLD signal measured in response to a task. 
Oxidative metabolism is isolated by first estimating the vascular component of the 
BOLD response through a calibration manipulation. Once estimated, this vascular 
contribution can be used to estimate the signal attenuation from the metabolic 
increase in deoxyhemoglobin (dHb) during performance of a task. Such a 
determination requires expressing the activation-induced BOLD signal as a fraction 
of the total attenuation of T2*-weighted signal attributable to dHb at baseline. The 
calibration procedure is typically done by measuring the BOLD and CBF responses 
during a breathing manipulation. Using a biophysical model of the BOLD signal, we 
can extrapolate from these measurements to an estimate of the calibration 
parameter M, which corresponds to the maximal possible BOLD signal change that 
would occur upon removal of all dHb. 
1.5.1. Hypercapnia calibration method
The first calibrated fMRI method developed used a hypercapnia (increases in 
inhaled CO2 concentration) breathing manipulation (Davis et al. 1998; Hoge et al. 
1999a). During this calibration procedure, the BOLD and ASL responses to a 
hypercapnia manipulation are measured. CO2 is a potent vasodilator and its 
inhalation causes large CBF increases all over grey matter without, presumably, 
causing any change in oxidative metabolism (McPherson et al. 1991; Hino et al. 
2000; Chen et al. 2010a). Therefore, measurements acquired during this 
manipulation can, in the context of a biophysical model, yield the BOLD to CBF 
relationship in the absence of metabolism. The same measurements are then done 
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during a cognitive task and BOLD reduction for a given amount of CBF increase, 
as compared to the ideal relationship found for hypercapnia, can be directly 
attributed to an increased dHb concentration from oxidative metabolism (Hoge et 
al. 1999b). This concept is graphically depicted in Figure 11. 
that 16 slices with an isotropic resolution of 4! 4! 4 mm3 were
acquired.
Visual Stimulation.Visual stimuli were generated in real time
by using a Silicon Graphics (Mountain View, CA) O2 computer
with OpenGL-based software (GLSTIM, available via public file
transfer protocol). The red-green-blue output was used to drive
a NEC MT820 LCD projector operating in 640 ! 480 mode at
60 Hz. Subjects viewed stimuli projected onto a screen mounted
above their heads via amirror while they lay prone in the scanner.
Stimulus presentation was automatically synchronized to data
acquisition, and alertness and fixation were continually verified
and logged in all subjects by requiring them to report, at 3-s
intervals throughout all experiments, the orientation of a small
low-contrast triangular fixation marker that was present at the
center of the display in a left–right orientation (Š or ‹) that was
varied at random intervals. Feedback was given via an MRI-
compatible two-button mouse.
The four-cycle-per-degree black and white squarewave grating
stimulus used to match hypercapnia-induced perfusion increases
drifted across the visual field at one degree per second at
systematically varied orientations. This stimulus has been found,
in previous autoradiographic studies (45, 46), to selectively acti-
vate interblob regions in primate V1 (particularly in cortex
projecting to peripheral visual field, where the spatial frequency
of this stimulus relative to receptive field sizes is higher). A red
uniform field, changed to isoluminant grey and back at 3 Hz, was
used in subsequent experiments to bias activation towardV1 blob
domains, which contain higher levels of cytochrome oxidase.
Radial checkerboard patterns were used as nonspecific stimuli.
These contained both color (yellow!blue) and luminance con-
trast, with 30 spokes and 6.5 rings (counting from 0.5–10°
eccentricity) of equal radial thickness, modulated in a temporal
squarewave at various frequencies. The same baseline condition,
consisting of a uniform grey field at the mean luminance of the
stimulus patterns, was presented at the beginning and end of all
scanning runs in this study, as indicated in Fig. 1b. Potency of the
various stimuli was varied by changing their luminance contrast
and, where applicable, color saturation (by dilution with variable
amounts of white). All stimuli converged in appearance to the
uniform grey field as contrast!saturation approached zero.
Hypercapnic Modulation of CBF. We induced graded hyper-
capnia by administering different concentrations of a CO2!air
mixture through a nonrebreathing face mask (Hudson RCI
Model 1069, Temecula, CA) worn by subjects. The baseline
condition was always inhalation of atmospheric composition
medical air ([CO2] " 300 ppm) delivered at 16 L!min while
attending to the standard baseline visual display (uniform grey
field with attention!fixation task). Hypercapnic episodes were
initiated during scanning runs by switching the breathing gas to
a mixture of 5:21:74% CO2!O2!N2 (BOC Canada) and medical
air. Different levels of hypercapnia (inhaled CO2 concentrations
of 1.25%, 2.5%, 3.75%, and 5%) were achieved by combining the
premixed CO2!air preparation with medical air in a Y-connector
and adjusting respective flow rates to achieve the desired pro-
portions while maintaining a total flow rate of 16 L!min. End-
tidal CO2, which was measured via a nasal cannula with moni-
toring aspirator [Normocap 200, Datex (Oakville, Ontario, Can-
ada)], increased by 5# 1 mmHg (1 mmHg$ 133 Pa) on average
during inhalation of the highest concentration CO2 mixture.
Subjects were instructed to breathe at a constant rate, which was
easily maintained to within # one breath per minute. Pulse rate
and arterial oxygen saturation were also monitored [Oxygen!
Pulse Monitor, Nonin Medical, Plymouth, ME], and these re-
mained constant throughout hypercapnia experiments.
CMRO2 Calculation. The method of Davis et al. (10) was
extended to incorporate our graded hypercapnia measurements
and a formalism for interpreting simultaneously acquired BOLD
andCBFdata in terms of iso-CMRO2 contours in theBOLD–CBF
plane. All rawBOLDand perfusionmeasurements were spatially
averaged within peripheral V1 and then pooled across subjects
before subsequent display and processing, although averaging of
multiple sessions performed on a single subject suggested that
individual responses resemble group averages. BOLD vs. perfu-
sion data measured during graded hypercapnia (Fig. 4a) were fit
with the function
%BOLD
BOLD0
! M"1 " " CMRO2CMRO2#0$
# " CBFCBR0$
$&#$ [1]
by settingCMRO2!CMRO2#0 to one and adjusting the parameterM
(zero subscripts denote baseline values). The value ofM, which is
specific to a given baseline physiological state and pulse sequence,
is equivalent to the fractional BOLD signal increase that would
occur if all deoxyhemoglobin were eliminated from the tissue
sample. The constants $ and #, which respectively reflect the
influences of blood volume and deoxyhemoglobin concentration,
were assigned values of $ $ 0.38 and # $ 1.5 (10, 52, 53).
Iso-CMRO2 contours in the BOLD vs. perfusion plane were then
calculated at 10% intervals by using the experimentally deter-
minedM value of 0.22# 0.03. Solution of the fitted equation for
CMRO2!CMRO2#0 permitted calculation of fractional CMRO2
changes from the measured BOLD and perfusion data.
RESULTS
Fig. 3a shows perfusion as a function of time, averaged over
twelve subjects, for four levels of hypercapnia (black) and for
visual stimulation with the high-spatial frequency squarewave
grating (red) at contrast levels adjusted tomatch the hypercapnia-
induced perfusion increases. The corresponding BOLD signals
(Fig. 3b) reveal significant attenuation of the visually evoked
responses compared with those produced by hypercapnia. The
degree of attenuation increased systematically with perfusion,
indicating that CBF and CMRO2 underwent coupled increases.
It is unlikely that differences in blood volume during hyper-
capnia and visual stimulation caused these signal reductions. The
BOLD signal depends exclusively on the volume fraction of
deoxygenated blood in tissue, which can be increased only by
distension of venous vessels. Because available evidence (54–57)
indicates that this is a passive biomechanical process, venous
blood volume can be considered a simple correlate of perfusion.
Matching perfusion levels therefore implies matching of blood
volume.
It is also unlikely that shifts in the hemoglobin O2 saturation
curve caused by alterations in pCO2 could account for the
observ d BOLD signal diffe ences. The change in hemogl bin
saturation produced by a change in partial pressure of blood
carbon dioxide of 5 mmHg (the increase in end-tidal CO2
FIG. 3. Perfusion and BOLD signals as a function of time during
graded hypercapnia and visual stimulation (n $ 12; stimulation
intervals indicated by grey background). (a) Relative perfusion as a
function of time during graded hypercapnia (black curve) and graded
visual stimulation (red curve) with contrasts adjusted to match hy-
percapnia-induced CBF increases. (b) BOLD signal as a function of
time during perfusion increases shown in a. BOLD signals during
visual stimulation are significantly lower than those observed during
hypercapnia at matched perfusion levels, revealing graded increases in
oxygen consumption.
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Figure 11. BOLD attenuation from metabolism
Perfusion and BOLD as a fun tion of tim  during graded hypercapnia and visual stimulation (n = 12; 
stimulation intervals indicated by grey background). (a) Relative perfusion as a function of time 
during graded hypercapnia (black curve) and graded visual stimulation (red curve) with contrasts 
adjusted to match hypercapnia-induced CBF increases. (b) BOLD signal as a function of time 
during perfusion increases show  in a. BOLD signals during visual stimulation are significantly 
lower than those observed during hypercapnia at matched perfusion levels, revealing graded 
increases in oxygen consumption. This figure and its caption were reproduced from (Hoge et al. 
1999b).
In the hypercapnia method, small amounts of carbon dioxide (typically 5-10% CO2 
by volume) are added to the air breathed by subjects during acquisition of BOLD 
and CBF image series. The vasodilatory properties of CO2 lead to increases in 
cerebral blood flow and tissue oxygen delivery, producing BOLD signal increases 
throughout grey matter as well as in large veins. The maximal BOLD signal M at a 
given location can then be extrapolated using the Davis model of BOLD as a 
function of CBF, assuming a constant arterial saturation of 100% and unchanged 
metabolism during hypercapnia (Figure 12a). 
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The curve in Fig. 1a can be viewed as the baseline
iso-CMRO2 contour in the BOLD-CBF plane. The shape of
this function, and hence the extent of the linear domain,
depends entirely on the difference ! " #; only the vertical
scale factorM is unknown. Inspection of Eq. [7] reveals that
M depends on the pulse sequence echo time, the static
magnetic field strength, and MRI-relevant structural prop-
erties of the tissue sample (via the constantA) as well as its
baseline blood volume and dHb concentration.
In the more general case, where CMRO2 is not constant,
Eq. [10] must be replaced with the following expression for
normalized [dHb]v, based on Eq. [9]:
[dHb]v
[dHb]v0
$ 1
CMRO2
CMRO2 0 0
2 1CBF0CBF 2. [12]
This results in a modified form of Eq. [11]:
%BOLD
BOLD0
$ M 11 " 1
CMRO2
CMRO2 0 0
2
#
1CBFCBF02
!"#
2. [13]
The above expression can be used to generate a set of
iso-CMRO2 contours by plotting the BOLD signal as a
function of CBF at different levels of oxygen consumption.
This is illustrated in Fig. 1b, which shows iso-CMRO2
curves plotted over a region of the BOLD-CBF plane using
Eq. [13].
Figure 1 shows the expected shape of the BOLD-CBF-
CMRO2 relationship given the values of ! and # believed to
apply in typical fMRI experiments. Because the horizontal
scaling of the plot is based on experimentally determined
parameter estimates, the BOLD and CBF increases ob-
served in most fMRI experiments should be restricted to
the linear regime of the relationship, in which the iso-
CMRO2 contours are approximately straight and parallel.
One of the goals of this study was to confirm these
predictions experimentally by mapping out iso-CMRO2
contours using graded hypercapnia and visual stimulation.
If the positions of one or more iso-CMRO2 contours are
known, then pairs of BOLD and CBF measurements can be
translated into relative CMRO2 increases by examining their
position with respect to the contours. It is also possible to
compute relative CMRO2 increases from BOLD-CBF mea-
surement pairs by solving Eq. [13] for the oxygen consump-
tion term, as in the method of Davis et al. (2):
CMRO2
CMRO2 0 0
$ 11 " 1
%BOLD
BOLD0 2
M
2
1/#
1CBFCBF02
1"!/#
[14]
Davis’ approach is equivalent to solving Eq. [11] for M
using BOLD and CBF measurements at a single level of
hypercapnia and using Eq. [14] to calculate CMRO2 during
activation. In the present study, M was estimated using an
optimization procedure to fit Eq. [11] to BOLD and CBF
data acquired during graded hypercapnia. The symbol
CMRˆO2 ! CMRO2/CMRO2 0 0 will be used as a concise
notation for relative (baseline-normalized) CMRO2 in the
remainder of the text.
Measurement of relative CMRO2 from MRI-based BOLD
and CBF measurements can thus be summarized as a
two-part process. First, the positions of iso-CMRO2 con-
tours in the BOLD-CBF plane must be determined. Then
the BOLD signal and perfusion increases during activation
must be measured. It is sufficient to map out the baseline
iso-CMRO2 contour, because once M is known the other
contours can be computed using Eq. [13]. Ideally, the
baseline contour would be measured over a wide range of
CBF values spanning both the linear region and the asymp-
totic portion at high perfusion levels. Unfortunately, this is
not possible using hypercapnia in human subjects, because
FIG. 1. Relationships between BOLD MRI signal, CBF, and CMRO2 predicted by the dHb dilution model. a: Fractional BOLD signal change,
plotted as a function of fractional CBF change, calculated using Eq. [11] with ! $ 0.38 and # $ 1.5. The predicted function has a linear domain
for perfusion increases up to approximately 50%, and becomes nonlinear at higher CBF levels. In the theoretical limit of very high perfusion
rates, venous blood approaches complete oxygenation, leading to a sample-dependent asymptotic upper limit of M for BOLD signal increases.
b: Iso-CMRO2 contours predicted by the dHb dilution model at 10% intervals. Increases in CMRO2 lead to reductions in the BOLD signal
observed at a given level of CBF, producing BOLD-CBF data in the zone labeled CMRO2&. Every point along an iso-CMRO2 contour
corresponds to a different CBF:CMRO2 coupling ratio. Iso-CMRO2 contours are evenly spaced and approximately parallel over small patches of
the BOLD-CBF plane, as indicated in the small box in the lower left corner of the plot.
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Figure 12. Deoxyhemoglobin dilution model
Relationships between BOLD MRI signal, CBF, and CMRO2 predicted by the dHb dilution model. a: 
Fractional BOLD signal change, plotted as a function of fractional CBF change, calculated using Eq. 
[11] with α = 0.38 and β = 1.5. The predicted fu ction has a linear domain for erfusi n increases 
up to approximately 50%, and becomes nonlinear at higher CBF levels. In the theoretical limit of 
very high perfusion rates, venous blood approaches complete oxygenation, leading to a sample-
dependent asymptotic upper limit of M for BOLD signal increases. b: Iso-CMRO2 contours predicted 
by the dHb dilution model at 10% interval . Increases in CMRO2 lead to reductions in the BOLD 
signal observed at a given level of CBF, producing BOLD-CBF data in the z ne labeled CMRO2 +. 
Every point along an iso-CMRO2 contour corresponds to a different CBF:CMRO2 coupling ratio. Iso-
CMRO2 contours are evenly spaced and approximately parallel over small patches of the BOLD-
CBF plane, as indicated in the small box in the lower left corner of the plot. This figure and its 
caption were reproduced from (Hoge et al. 1999a).
The equation tha  relates M to the BOLD and CBF signal changes measured 
during the hypercapnia procedure in the original Davis model is as follows:
M =
ΔBOLD
BOLD −1
1− ΔCBFCBF
⎛
⎝⎜
⎞
⎠⎟
− β−α( )       [1]
Where α corresponds to the exponent in the power law relationship relating 
changes in CBF to changes in venous cerebral blood volume (CBV) during the 
manipulation. Though this value was originally measured by Grubb and colleagues 
to be 0.38 in anesthetized monkeys (Grubb et al. 1974), it is now understood to be 
much lower in adult humans. Chen and colleagues have measured it to be 0.18, 
using an MRI technique specific to changes in venous blood volume (Chen et al. 
2009a; Chen et al. 2010c). This is t  value used in the current literature and in the 
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manuscripts presented here. The β parameter corresponds to influence of 
deoxygenated hemoglobin on transverse relaxation (Boxerman et al. 1995). The 
value of this parameter β depends on field strength and was originally estimated to 
be 1.5. Recent studies have questioned the validity of this value as well as its 
interpretation and suggested that β should instead be viewed as a lumped 
parameter with a value closer to 0.91 (Griffeth et al. 2011). Throughout the 
manuscripts included in this thesis however, the original meaning of β was 
preserved and the value of 1.5 used. 
Following estimation of the M parameter, percent changes in CMRO2 evoked by a 
task are estimated using the BOLD and CBF changes measured during the task 
and relating these parameters using the following expression:
CMRO2 =
CBF
CBF0
⎛
⎝⎜
⎞
⎠⎟
1−α /β
1−
BOLD
BOLD0
−1
M
⎛
⎝
⎜
⎜
⎜
⎞
⎠
⎟
⎟
⎟
1/β
       [2]
The BOLD to CBF relationship during a task can be conceptualized as a point on a 
curve parallel to the curve determined in the absence of metabolism (during 
hypercapnia) These curves are called iso-CMRO2 contours (Figure 12b). By 
measuring the BOLD and CBF changes during a task, we can find which contour 
the measurement falls on, informing us on the BOLD attenuation attributable to the 
metabolic component. Equation 2 allows us to quantify this component in terms of 
percent change CMRO2. 
This method has been used in a number of studies (Davis et al. 1998; Hoge et al. 
1999b; Stefanovic et al. 2006; Leontiev et al. 2007b; Ances et al. 2008; Lin et al. 
2008; Perthen et al. 2008; Ances et al. 2009; Bulte et al. 2009; Chen et al. 2010a; 
Mark et al. 2011; Gauthier et al. 2012b), but has recently lost in popularity to the 
newer hyperoxia method (Chiarelli et al. 2007b; Goodwin et al. 2009; Mark et al. 
2011; Mohtasib et al. 2012).
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1.5.2. Hyperoxia calibration method
In the hyperoxia method, participants inhale high levels of oxygen (typically 
50-100% O2 with balance nitrogen where applicable) during acquisition of BOLD 
image series while expired oxygen concentration is recorded. The enriched O2 
raises the total oxygen content of the arterial blood, leading to increases in venous 
hemoglobin saturation SvO2 and hence increases in BOLD signal. The maximal 
BOLD signal M can then be extrapolated using the hyperoxia calibration model of 
BOLD as a function of SvO2. 
End-tidal concentrations are used in this model as a surrogate for arterial O2 partial 
pressure (PaO2). From this measurement, arterial O2 saturation (SaO2) can be 
estimated using the Severinghaus equation:
SaO2 =
1
23400
PaO2( )
3
+150 PaO2( )
+1
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
       [3]
Arterial O2 content (CaO2) can then be estimated as follows:
CaO2 = ϕ ⋅ Hb[ ] ⋅SaO2( ) + PaO2 ⋅ ε( )        [4]
where φ represents the O2-carrying capacity of hemoglobin, which corresponds to 
1.34 ml O2/g Hb for humans, and ε is the solubility coefficient of oxygen in blood 
with a value of 0.0031 ml O2/(dlblood * mm Hg). [Hb] corresponds to the 
hemoglobin concentration. In the original demonstration of this method, the value 
for this parameter was assumed to be 15 gHb/dl blood. However, hemoglobin can 
readily be determined individually using a blood test. 
From the arterial content of O2, venous content of O2 (CvO2) can be estimated 
using an assumed value for oxygen extraction fraction (OEF):
CvO2 = CaO2 − CaO2 0 ⋅OEF( )       [5]
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In all expressions, a subscript of 0 is used to denote the baseline state measure. 
From this expression, a value for venous O2 saturation (SvO2) can be estimated 
using the following expression
SvO2 =
CvO2 − PvO2 ⋅ ε( )
ϕ ⋅ Hb[ ]
       [6]
where PvO2 represents an estimate of oxygen dissolved in venous plasma. This is 
expected to be a negligible fraction (<1%) of the total O2 content in venous blood, 
due to the high affinity of Hb for O2 in the partially saturated state expected in 
venous blood even at high inspired O2 fractions. Therefore, this term is assumed to 
have a value of zero and is dropped from the expression. 
All previous expressions are solved twice, once using the end-tidal O2 values 
measured during baseline and once using the end-tidal O2 values measured during 
the hyperoxia breathing manipulation. This allows the calculation of the fractional 
change in dHb concentration, which corresponds to: 
dHb[ ]v
dHb[ ]vo
=
1− SvO2( )
1− SvO2 0( )
       [7]
In this model, the expression that relates the M parameter to BOLD and CBF 
changes during the manipulation is as follows:
ΔBOLD
BOLD0
= M 1− CBFCBF0
⎛
⎝⎜
⎞
⎠⎟
α dHb[ ]v
dHb[ ]v0
+
CBF0
CBF −1
⎛
⎝
⎜
⎞
⎠
⎟
β⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
      [8]
In all implementation of this method, an approximated correction for the small 
decreases in CBF known to occur during hyperoxia is used (Chiarelli et al. 2007b; 
Goodwin et al. 2009; Mark et al. 2011). Because these small CBF changes are 
difficult to measure with the somewhat noisy ASL method, a fixed value for the 
hyperoxia-induced CBF decrease is generally assumed.
Once M has been estimated, percent change CMRO2 is estimated using the 
expression first proposed by Davis and colleagues (Equation 2) (Davis et al. 1998). 
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The hyperoxia model (Chiarelli et al. 2007b) can be generalized for arbitrary 
changes in cerebral blood flow during hyperoxia (Gauthier et al. 2011, included as 
Appendix A), rendering it valid for conditions such as simultaneous hyperoxia and 
hypercapnia (as would be produced during breathing of carbogen, a mixture 
composed largely of O2 with a balance of 5-10% CO2). The manuscript detailing 
this technique is included as Chapter 2 of this thesis. 
1.5.3. R2' method
Recently, an alternative method has been proposed that does not require the use 
of a breathing manipulation for calibration (Blockley et al. 2011b). This method 
uses the information in a spin echo and a gradient echo sequence to estimate R2’ 
and thereby obtain the M parameter. R2’, also called the reversible transverse 
relaxation rate, is a component of the R2* signal used to obtain the BOLD contrast 
and is thought to be dependent on venous blood volume and dHb concentration 
(Yablonskiy et al. 1994; Blockley et al. 2011b). Though this approach was shown to 
be fairly robust to differences in underlying physiology, it was found by Blockley et 
al. to be less robust than the original hypercapnia calibration model (Davis et al. 
1998), but more than the hyperoxia calibration model (Chiarelli et al. 2007b). The 
lower robustness to the effects of physiological variations of the hyperoxia model 
may arise from the fact that both OEF and hematocrit must be assumed in the 
hyperoxia model, rendering it more sensitive to variations of these parameters. 
Even though the R2’ may not perform quite as well as the hypercapnia calibration 
method in the context of physiological variability, it does provide the advantages of 
not requiring a breathing manipulation and a reduced dependence on various 
modeling parameters such as OEF, α and β to determine the calibration constant 
M. Implicit within this technique is however another set of assumptions about tissue 
compartment contributions to R2’. 
1.6. Baseline CMRO2
Calibrated fMRI techniques allow the estimation of a valuable physiologically-
specific quantity from the BOLD signal. However, the fractional change in CMRO2 
estimated using these techniques preserves the ambiguity of an unknown baseline 
state. Therefore, though the measured changes can be directly compared between 
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groups with different vascular function, the meaning of these changes is weakened 
by the fact that we are ignorant of the baseline value from which this fractional 
change arises. The case could therefore arise where a seemingly higher percent 
CMRO2 change in one group may actually reflect a similar absolute increase in 
metabolism in terms of μmol O2/100g tissue/min, but from a lower absolute 
baseline value. Therefore, there is great interest in developing MRI-based 
techniques to measure absolute resting CMRO2. One such technique was 
developed during the course of this thesis and the manuscript detailing this method 
is included as Chapter 3. Other techniques have also recently been developed to 
estimate this value and will be discussed here. 
While CMRO2 can be measured by MRI using 17O2 labeling methods (Fiat et al. 
1992; Fiat et al. 1993; Fiat et al. 2004), these techniques are impractical due to the 
limited availability and high cost of 17O. More accessible alternatives are being 
developed using proton MRI. Some of these recently-proposed techniques yield 
whole-brain or single vessel estimates (An et al. 2000; Xu et al. 2009; Jain et al. 
2010; Fan et al. 2011), but more recent efforts have focussed on mapping of these 
parameters (He et al. 2007; He et al. 2008; Bolar et al. 2011b; Bulte et al. 2011).
The T2 relaxation under spin tagging (TRUST) (Lu et al. 2008) technique can be 
used to obtain a whole brain estimate of oxidative metabolism by measuring T2 
values in the sagittal sinus (Xu et al. 2009; Xu et al. 2011c; Liu et al. 2012; Lu et al. 
2012b). This sequence uses a scheme reminiscent of ASL to isolate the venous 
signal, by tagging a large slab in one out of every two images and subtracting 
adjacent images. A T2 preparation is added to quantify T2 at various echo times. An 
exponential decay curve is then fit to the value obtained at each echo to estimate 
T2 values within selected voxels in the sagittal sinus. These T2 estimates can be 
converted to venous saturation using literature values from in vitro studies. Since 
arterial oxygen saturation can be measured using pulse oximetry and CBF in the 
sagittal sinus can be determined using ASL or phase contrast sequences, baseline 
CMRO2 can be estimated using the following expression:
CMRO2 = (SvO2 − SaO2 ) ⋅CBF ⋅ϕ        [9]
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where φ is the O2 carrying capacity of Hb, SaO2 represents arterial O2 saturation 
and SvO2 venous O2 saturation. The fact that this technique yields a single sagittal 
sinus estimate means that its use is limited to cases where a global effect is 
expected. In the case of more subtle local changes in baseline metabolism, dilution 
by venous blood from the rest of the brain may lead to underestimation or even 
disappearance of the effect. 
Another recently proposed method uses values obtained through BOLD signal 
modeling in different tissue compartments to estimate baseline OEF and CMRO2. 
The technique described by An and colleagues is an early, simplified version of the 
technique presented by He and colleagues termed quantitative BOLD (qBOLD) (An 
et al. 2000; He et al. 2007; He et al. 2008).This technique uses the MR signal 
modeling of the static dephasing regime to determine baseline hemodynamic 
parameters from a gradient echo sampling of the spin echo (GESSE) signal (He et 
al. 2007; He et al. 2008). This technique is based on a similar principle as the R2’ 
calibrated technique discussed above. It uses a multi-compartment model to 
determine the venous oxygen saturation in extravascular tissue and obtain maps of 
OEF. Though promising, the qBOLD method is limited because it depends on a 
fitting procedure involving a large number of parameters, some of which are 
simultaneously optimized as part of the model fit, and others which must be 
assumed based on previously determined values. The uniqueness of parameter 
combinations yielding convergent fits can be difficult to guarantee, and the 
remaining fixed parameters reflect fundamental magnetic properties of tissue which 
are difficult to measure directly on an individual basis.
The alternate approach proposed by Bolar et al., a sequence called quantitative 
imaging of extraction of oxygen and tissue (QUIXOTIC), uses velocity-sensitive 
ASL with a T2 preparation module to directly target the oxygenation signal from 
small venules (Bolar et al. 2011b). This two-step ASL-type sequence works as 
follows (Figure 13 for visual depiction). The first part of the sequence removes 
signal from all blood outside of capillaries using velocity encoding. Capillary spins 
are isolated by subtracting an image where only spins going at a speed below 2 
cm/s (which all presumably reside in capillaries) from an image where no flowing 
spins are selected. A second module allows isolation of spins which, after being 
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selected in capillaries, have now progressed towards venules. During the second 
module applied a short time (725ms) after the first module to allow spins to flow 
into the venous system, velocity gradients are used to select spins going now 
faster than 2 cm/s. These are the spins which are now speeding up after leaving 
the capillaries, reflecting a selective venular component. A T2 preparation module is 
integrated in the second velocity-selective module, allowing the quantification of T2 
within this venular compartment. By specifically measuring the signal from venules, 
a localized measure of oxygen extraction and metabolism can be obtained. 
VCUTOFF, but the control experiences no velocity weight-
ing. Spins that have accelerated above VCUTOFF during
TO are dephased by the tag acquisition but left unal-
tered in the control (Fig. 4d). As imaging starts immedi-
ately after VS2, subtraction of tag from control yields an
image weighted to blood that has accelerated from
below VCUTOFF to above VCUTOFF, during TO (Fig. 4e).
Assuming flow always progresses from arteries to capil-
laries to veins, these spins are venous only. Signal from
other sources (static, CSF, nonvenular blood) is elimi-
nated via subtraction. If VCUTOFF and TO are chosen
properly, signal from PCV blood is exclusively targeted.
Due to the tortuous nature of human vasculature, the
spatial direction of flow naturally varies as blood
migrates from arteries to capillaries to veins. This phe-
nomenon, however, is not expected to appreciably affect
the venular selectivity of the VT-VSSL experiment for
the following reasons: first, as phase encoding does not
occur during TO (the longest interval of the experiment),
the directional changes during this interval have no
impact on velocity selection. Conversely, directional
changes during the VS module will affect selectivity.
However, because the encoding time is so short (approxi-
mately 20 ms), directional changes are both minor and
expected to average out given the broad distribution of
vessel orientation in a parenchymal voxel. In this way,
as long as there exists some flowing blood with a veloc-
ity component aligned with the encoding direction
greater than VCUTOFF, VT-VSSL can occur. A more
detailed discussion of the directional sensitivity of the
VS module is discussed by Frank et al. (20).
T1 relaxation complicates the idealized model depicted
in Fig. 4. Spins dephased by VS1 at t ¼ 0 experience
longitudinal magnetization recovery. Because velocity
selection via VS2 occurs only for the tag but not control,
spins from unwanted compartments will partially
recover in the control, but dephase in the tag at TOþ.
Without compensation, these unwanted spins will not
subtract completely, and QUIXOTIC loses venous selec-
tivity. To address this effect, we place an inversion pulse
at time TO1 to null recovering blood at TO; conse-
quently, signal from spins in this unwanted population
is eliminated in both control and tag at TO, leaving only
desired PCV blood on subtraction.
To generate the PCV blood-weighted maps at different
echo times, T2 preparation is integrated into the VS2
pulse train. For the shortest effective echo time (TEeff),
the VS2 module is exactly as pictured in Fig. 2. For each
successive TEeff, an additional pair of adiabatic 180
#
pulses is added between the flip-up 90# pulse and first
VS gradient lobe. In this way, the duration of VS2 will
increase by DTEeff for each successive TEeff. Importantly,
this is done while keeping an identical readout onset
time regardless of TEeff. Using T2 preparation and fixing
the readout module timing makes the T2 encoding flow
insensitive; in other words, images at successive TEeff
should differ only by T2 weighting, not by volume of
blood delivered during TO (18).
Signal intensity (SI) in the acquired blood-weighted
images can be plotted versus TEeff and fit exponentially
on a voxel-by-voxel basis to generate T2 maps of PCV
blood. T2 values are then calibrated to Yv and Eqs. 1 and
FIG. 4. Idealized cartoon of venular blood signal targeting in QUIXOTIC approach, as told via spin configuration throughout the experi-
ment. Relaxed spins are denoted by upright arrows; dephased spins by hollow circles. Dotted vertical lines correspond to 1 cm/s blood
velocity (i.e., the cutoff velocity in b and d).
4 Bolar et al.
Figure 13. QUIXOTIC
Idealized cartoon of venular blood signal targeting in QUIXOTIC approach, as told via spin 
configuration throughout the experiment. Relaxed spins are denoted by upright arrows; dephased 
spins by hollow circles. Dotted vertical lines correspond to 1 cm/s blood velocity (i.e., the cutoff 
velocity in b and d). This figure and its caption were reproduced from (Bolar et al. 2011b).
T2 relaxation c n be converted to venous saturation using a biophysical model a d 
relaxation parameters measured using bovine blood (van Zijl et al. 1998; Golay et 
al. 2001). Venous saturation is then converted to OEF and CMRO2 using the same 
principles as for the TRUST approach (Xu et al. 2009) (Equation 9). The 
QUIXOTIC m thod yield d very promising early results, with maps of CMRO2 and 
OEF values within the exp cte  range (Bolar t al. 2011b). However, the one 
drawback of the QUIXOTIC method is that it requires knowledge of the flow 
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velocity range required to selectively image the venular signal, a value which is 
likely to change with age and health status. 
A further approach consists of using phase information to determine the 
susceptibility difference between a blood vessel and the surrounding tissue (Jain et 
al. 2010; Fan et al. 2011). Since this susceptibility effect arise from the 
paramagnetic effects of deoxyhemoglobin, it can be related to venous saturation 
which can, in turn, be used to measure CMRO2 using Fick’s principle of 
arteriovenous saturation differences (Equation 9). The initial implementation of this 
idea was used to obtain a global brain measure in the superior sagittal sinus (Jain 
et al. 2010). A more recent implementation, called phase-based regional oxygen 
metabolism (PROM) can be used to obtain a measure in single cortical veins (Fan 
et al. 2011). These techniques however are limited to single vessels and for them 
to work using the current models, the vessels chosen must be oriented parallel to 
the main magnetic field. 
Finally, an alternative approach to estimating baseline OEF and CMRO2 using MRI 
was devised to use the information provided by the hypercapnia and hyperoxia 
calibration techniques (Bulte et al. 2011). For this approach, both a hyperoxia and 
a hypercapnia breathing manipulations are performed. The M parameter is 
determined using the hypercapnia manipulation as in Equation 1 (Davis et al. 
1998). The hypercapnia M parameter is then used in the expression originally 
derived to determine M in the hyperoxia calibration technique (Equation 8) 
(Chiarelli et al. 2007b) but now solving for OEF. This OEF can then be used to 
derive absolute baseline CMRO2 when combined with measures of baseline CBF 
and end-tidal O2 concentrations. Though this technique is somewhat similar to the 
one presented in Chapter 3 of this thesis, some additional assumptions make the 
modeling used in the method presented by Bulte and colleagues less exact and 
more prone to systematic errors (see Chapter 2). Furthermore, since these 
assumptions differ between the hypercapnia and hyperoxia techniques, the results 
suffer from an additional source of physiological ambiguity.
While MRI-based measures of metabolism are just starting to emerge, PET 
estimates can also be obtained using 15O labeled PET tracers. These PET 
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measures of CMRO2 require three separate acquisitions with injection of 15O 
labeled O2, H2O and CO. These three measurements are necessary to take into 
account the combined contribution of O2 diffusion into tissue, its conversion to 
water during oxidative metabolism, as well as the dependence on blood volume, 
assessed with C15O (Mintun et al. 1984; Buxton 2010). However, the use of three 
separate injections of positron emitting tracers greatly increases the radiation dose 
associated with this measurement. Furthermore, the short half-life (about two 
minutes) of 15O means that this technique is not possible without an on-site 
cyclotron (Miller et al. 2008).
1.7. Quantitative studies of brain aging 
There have been few attempts to quantify the effects of vascular and metabolic 
aging using MRI. Only two calibrated studies of aging can currently be found in the 
literature. One study looked at the effects of aging on hemodynamic and metabolic 
parameters during a visual task using the hypercapnia method (Ances et al. 2009) 
and the other investigated the effects of aging on these parameters during a 
cognitive task using the hyperoxia calibration method (Mohtasib et al. 2012). While 
the two studies do not agree on all fronts, both report significant changes in the 
hemodynamic components underlying the BOLD contrast. The study by Ances and 
colleagues found differences in reactivity, M and BOLD signal responses to visual 
stimulation. However, these differences did not translate into changes in CMRO2 
(Figure 14). The study by Mohtasib and colleagues did not find as clear a 
difference in M, but did find a difference both in task-evoked BOLD and CMRO2 
(Figure 15). While each study is subject to different confounds and investigate the 
effects of aging on different parts of the brain, both studies warrant caution when 
interpreting BOLD signal differences in aging.
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Figure 2.
Covariance of calculated and measured parameters. (A) Fractional changes in CBF as a function
of CMRO2 showing a similar slope, n, for both younger and older subjects. (B) Comparison of n
with baseline CBF, showing no significant correlation. Younger subjects did have a significantly
higher mean baseline CBF than older subjects. [Color figure can be viewed in the online issue,
which is available at www.interscience.wiley.com.]
Figure 1.
Functional changes in the blood oxygen level dependent (BOLD)
and cerebral blood flow (CBF) response in the VC for mild
hypercapnia and functional activation. The panels show average
response curves and standard errors for the CBF activated vox-
els within healthy younger (n 5 10) and older (n 5 10) subjects.
(A) Fractional changes in the CBF responses to hypercapnia, (B)
Changes in the BOLD responses to hypercapnia, (C) Fractional
changes in the CBF responses to activation, and (D) Changes in
the BOLD responses to activation. A significant increase in the
fractional changes in the CBF response to hypercapnia was seen
in older subjects compared to younger subjects leading to a
decrease in the M value for older subjects. For the functional
activation task the BOLD response was greater for younger
compared to older subjects. For all panels the solid bars indicate
stimulus presentation. For all time series data the error bars are
presented at every other time point that was sampled. [Color
figure can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
Figure 14. Calibrated fMRI of visual activation in aging
Functional changes in the blood oxygen level dependent (BOLD) and cerebral blood flow (CBF) 
response in the VC (visual cortex) for mild hypercapnia and functional activation. The panels show 
average respo se curves nd standard errors for the CBF activated voxels within h althy younger 
(n 5 10) and older (n 5 10) subjects. (A) Fractional changes in the CBF responses to hypercapnia, 
(B) Changes in the BOLD responses to hypercapnia, (C) Fractional changes in the CBF responses 
to activation, and (D) Changes in the BOLD responses to activation. This figure and its caption are 
reproduced from (Ances et al. 2009).
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and, indeed, the increase was signiﬁcant in these regions: M1
(p=0.003), LMFG (p=0.02) and RMFG (p=0.02). Further regression
tests on the other 3 parameters within these 3 regions show no
signiﬁcant change for ΔCBF and M, but a signiﬁcant reduction in
ΔCMRO2 within M1 and LMFG (Table 4). Regions showing the largest
change in calibration constant M were the left insular, left DLPFC and
right DLPFC.
Re-analysis using the data within the restricted end-tidal O2 range
showed very similar results to Table 4, identifying the same three
regions with the largest, and signiﬁcant, age-related increase in BOLD
response. None of the results in Table 4 changed in terms of their
signiﬁcance (i.e. results remained above or below the p=0.05
threshold), except for M within the right DLPFC where p increased
from 0.01 to 0.06.
Relationship with performance
We determined the relationship between the measured/estimated
parameters and performance accuracy in the 3 regions showing an
age-related effect (L and R MFG and M1) in the BOLD response. We
split the subjects into 3 groups as described in the Methods (Table 1):
young, old high performers and old low performers. Table 5 shows the
mean parameter estimates across each of these groups in each of the
regions. It can be seen that in LMFG and M1, the BOLD and ΔCMRO2
responses are signiﬁcantly different for the low performing old group
in comparison to the young group. In LMFG the BOLD response (but
not the ΔCMRO2 response) is signiﬁcantly different for the low
performing old group in comparison to the high performing old group.
None of the parameters showed any signiﬁcant difference between
the high performing old group and the young group.
Discussion
Mean response over all activated regions
Initially, the estimated calibration constantMwas found to decline
with increasing age (Fig. 7c), consistent with a previous study
considering age-related alterations in the response of the visual
cortex (Ances et al., 2009). However, on re-analysis within a narrow
range of end-tidal values, this age-dependence is no longer present,
suggesting that the age-related differences in end-tidal O2 were
driving the changes seen in M. M reﬂects the amount of deoxyhe-
moglobin present in the baseline state. As such, M depends on a
number of physiological parameters including baseline CBV, resting
oxygen extraction fraction (OEF), the constant β, and the hematocrit,
Fig. 7. The age-related change in the measured/estimated parameters ((a) ΔBOLD, (b) ΔCMRO2, (c)M and (d) ΔCBF), averaged over the ten activated regions. Each point shows the
average value for an individual over the ten activated regions.
Table 4
Regression of the measured/estimated parameters with age in the 10 activated regions. Slope represents the change in the measured/estimated value per year. Signiﬁcant values
(pb0.05) are highlighted in bold.
Region ΔBOLD M ΔCBF ΔCMRO2
Slope× 10−3 r p Slope r p Slope r p Slope r p
M1 4.9 0.40 0.003 −0.02 −0.26 0.06 −0.03 −0.06 0.7 −0.13 −0.42 0.004
SMA 1.0 0.06 0.7 −0.03 −0.17 0.2 −0.14 −0.20 0.1 −0.13 −0.30 0.03
LPL 1.5 0.10 0.4 −0.03 −0.20 0.2 0.09 0.16 0.2 0.008 0.02 0.9
RPL 1.4 0.09 0.5 −0.02 −0.12 0.4 0.09 0.20 0.1 −0.03 −0.10 0.5
LMFG 4.8 0.31 0.02 −0.02 −0.22 0.1 −0.04 −0.07 0.6 −0.12 −0.34 0.03
RMFG 5.1 0.31 0.02 −0.01 −0.14 0.4 0.09 0.16 0.2 −0.05 −0.15 0.3
LDLPFC −1.3 −0.10 0.4 −0.05 −0.37 0.008 −0.11 −0.16 0.2 −0.15 −0.38 0.01
RDLPFC −1.7 −0.19 0.1 −0.04 −0.35 0.01 0.06 0.01 0.9 −0.03 −0.09 0.5
LI −0.02 0.00 1.0 −0.05 −0.31 0.03 0.05 0.08 0.5 −0.07 −0.19 0.2
RI 0.08 0.01 0.9 0.001 0.01 0.9 0.02 0.04 0.8 −0.07 −0.28 0.06
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Figure 15. Calibrated fMRI of Stroop activation in aging
The age-related change in the measured/estimated parameters ((a) ΔBOLD, (b) ΔCMRO2, (c) M 
and (d) ΔCBF), averaged over the ten activated regions. Each point shows the average value for an 
individual over the ten activated regions. This figure and its caption are reproduced from (Mohtasib 
et l. 2012).
While calibrated fMRI studies of aging are still rare, other groups have sought to 
quantify some of the hemodynamic parameters underlying the BOLD signal across 
the lifespan, showing important differences with age in various BOLD signal 
components. A rigorous quantification of age-related absolute baseline CBF 
changes using ASL has shown that, while CBF showed d creases with i creasing 
age th ughout the brain, some regions may be more vulnerable than others (Chen 
et al. 2011). Furthermor , the observed CBF d creases wer  not found to be an 
effect f atrophy as there was little overlap between regions showing the greatest 
ra  of atrophy and the r i n  showing the gr atest rate of CBF decrease (Figure 
16). However, an interesting finding of this study was that the regions most affected 
by age-related atrophy largely overlapped with the areas with highest absolute 
baseline CBF during early adulthood. Some of the regions with significant CBF 
decreases with age were found to be the regions involved in the default-mode 
network. Overall, CBF decreases across all regions was found to be 0.38% per 
year. This value is similar to the estimated decrease of 0.45% found in an earlier 
study (Parkes et al. 2004).
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546 Age-related and comparable decreases in CBF and CMRO2 have been
547 reported previously (Leenders et al., 1990; Pantano et al., 1984),
548 particularly in the parietal (Burns and Tyrrell, 1992), frontal and temporal
549 lobes (Burns and Tyrrell, 1992; Leenders et al., 1990), coinciding with
550 locations showing CBF reduction in this study. It is unclear whether basal
551 ﬂow and/or metabolism are related to resistance to cerebrovascular
552 degeneration in aging/dementia. Our results qualitatively demonstrate a
553 parallel between reduced CBF and elevated resting oxidative metabolism
554 (Buckner et al., 2005; Gjedde et al., 2005; Raichle et al., 2001), a set of
555 regions widely referred to as part of the default-mode network. The
556 signiﬁcance of this ﬁnding will be further investigated. Finally, the
557 development of hyper- or hypotension, particular in the MA and OA
558 populations, has been suggested as a contributor to CBF changes (Alves
559 and Busatto, 2006; Gruhn et al., 2001).
560 While the relationship between concurrently observed CBF reduction
561 and cortical atrophy has previously been investigated using a voxel-based
562 morphometric (VBM) approach, existing VBM results have not been
563 consistent (Ito et al., 2006; Van Laere and Dierckx, 2001), perhaps due to
564 such limiting factors as spatial resolutionandcommonuncertainties in the
565 accuracyof volume-based registration for atlas-basedanalyses (Greve and
566 Fischl, 2009; Zollei et al., 2010), particularly in view of complications
567 introduced by age-related atrophy (Dai et al., 2008a). Our ﬁndings build
568 upon prior work by Tosun et al. (2010), in which surface mapping was
569 used to demonstrate dissociations between CBF and cortical thickness
570 reductions in individualswith AD.We did not compensate the CBF values
571themselves for intra-voxel tissue heterogeneity (Asllani et al., 2008), but
572instead regressed out the contribution of grey-matter volume variations
573fromtheassociationbetweenCBFandage. Finally, our results arebasedon
574the largest perfusion and structuralMRI datasets acquired to-date for such
575investigations on aging, and the outcome of our surface-based group-
576analyses was further conﬁrmed by the results of our subject-speciﬁc
577native-space volume-based ROI-analyses.
578Limitations and caveats
579Pulsed ASL is known for its sensitivity to arterial-transit delay, which
580may be lengthened in aging. In addition, in the healthy subjects, the
581inferior half of the brain is reportedly associatedwith longer transit delays
582(Qiu et al., 2010), while relatively long delays have also been associated
583the frontal andoccipital lobes (MacIntosh et al., 2010). As these factors are
584important determinants of CBF accuracy, our PASL parameters were
585chosen tominimize velocity-related bias. Speciﬁcally, a relatively short TI1
586of 600 ms facilitated the minimization of bolus-width sensitivity even for
587rapid ﬂow, common to younger subjects, while a TI2 of 1600 ms exceeds
588the longestgrey-matter transitdelay(cortical andsubcortical) expected in
589healthy adults (Qiu et al., 2010), accommodating the slower ﬂow which
590may be expected in certain older adults. Furthermore, the cortical and
591subcortical CBF reduction patterns in aging observed in this study differ
592spatially from the patterns of transit delay heterogeneity. Thus, it is not
593likely that the observed changes are driven primarily by the above PASL-
Fig. 6. The association between age and regional CBF as well as cortical thickness. The colour scale in (a) indicates the amplitude of age-associations in CBF, while those in (b) and (c)
indicate statistical signiﬁcance, with light blue and yellow denoting the strongest negative and positive associations, respectively. Regions exhibiting the largest magnitude of CBF
reduction (a) and cortical thinning with age (b) did not spatially coincide. The signiﬁcance map of CBF reductions before (c) and after vertex-wise covariation for age-associations in
cortical-thickness (d) only subtly differed. Greatest statistical effects were found in the left supramarginal and occipital gyri, and the right anterior cingulate, as well as bilaterally in
the right rostral middle-frontal, superior parietal, middle-inferior temporal and insular regions, medial superior frontal, orbito-frontal and precuneus regions. Furthermore, the
localization of regions exhibiting the most rapid age-related CBF decline appeared to coincide with regions showing the highest statistical effects of age on CBF. (For interpretation of
the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Figure 16. The association between age and regional CBF as well as cortical thickness. 
The colour scale in (a) indicates the amplitude of age-associations in CBF, while those in (b) and (c) 
indicate statistical significance, with light blue and yellow denoting the strongest negative and 
positive associations, respectively. Regions exhibiting the largest magnitude of CBF reduction (a) 
and cortical thinning with age (b) did not spatially coincide. The significance map of CBF reductions 
before (c) and after vertex-wise covariation for age-associations in cortical-thickness (d) only subtly 
differed. Greatest statistical effects were found in the left supramarginal and occipital gyri, and the 
rig t a terior cingulate, as well as bilaterally in the right rostral middle-frontal, superi r pariet l, 
middle-inferior temporal and insular regions, medial superior frontal, orbito-frontal and precuneus 
regions. F rthermor , th  localization of r gi ns exhibiting the most rapid age-related CBF decline 
appeared to coincide with regions showing the highest statistical effects of age on CBF. This figure 
nd its caption were r produced from (Chen et al. 2011).
Baseline CBF is one of the components that h lp determin  h  amplitude of th  
BOLD response and differ nces in ba line can lead to err neous conclusions 
about neuron l signaling. For example, a similar flow incr ase from a lower 
baseline CBF may lead to overestimation of the neural response, since the percent 
CBF increase from this lower baseline will be higher for an absolute increase of 
similar amplitude (a 10% increase from a baseline of 50 ml/100g/min will be 
smaller in absolute terms than a 10% increase from a baseline of 100 ml/100g/
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min). This will lead to an inflated BOLD response and the conclusion that neuronal 
signaling is larger in the group with lower baseline CBF. This can easily be 
accounted however, as baseline CBF is a robust measurement that can be 
obtained using a short ASL acquisition.
Age-related changes in baseline CMRO2 have also been investigated in the whole 
brain using the TRUST technique in a large cohort of 152 healthy participants 
between the ages of 20 and 90 (Lu et al. 2011). Venous saturation was found to 
decrease by about 1.4% per decade while global CBF, measured using phase 
contrast imaging of the carotids, was found to decrease by about 0.8 ml/100g/min 
per decade. Together, these measurements indicate that global oxidative 
metabolism is increased by about 2.6 μmol/100g/min in healthy aging, when 
corrected for grey matter volume loss (Figure 17). This finding could have a 
significant impact on the BOLD signal, by determining the amount of dHb present 
before any task-specific increase. This would affect the baseline state from which a 
task-evoked fractional BOLD signal change would arise, as well as the dynamic 
range of BOLD signal. However, this result is somewhat surprising given previous 
PET results showing the opposite trend in CMRO2 (Yamaguchi et al. 1986; 
Leenders et al. 1990; Marchal et al. 1992). It may be that the difficulties in 
accounting for partial volume effects in PET images lead to an underestimation or 
inadequate correction for volume loss. The results of this study indicate that, as we 
age, an increased oxygen demand is met with a reduced baseline CBF, leading to 
a decrease in venous oxygenation. 
altered with age. A quadratic model with age2 as an additional
regressor did not improve the fit.
Intersubject variability in Yv was also assessed on a decade-
by-decade basis, and it showed a significant increase with age
(cross-correlation coefficient between decade and standard
deviation of Yv within the decade R = 0.81, P = 0.0272). That is,
with age, Yv not only shows a gradual decrease but the
intersubject heterogeneity also becomes greater.
Global CBF Decreases with Age
Figure 3a illustrates the location of the 4 feeding arteries, from
which global CBF was measured. Figure 3b shows the scatter
plot between CBF and age (N = 232). Regression analysis
revealed an age-related decrease (P = 0.0065) of global CBF at
a rate of 0.8 ml/100 g/min per decade, from an average CBF of
58.1 ml/100 g/min in typical 20-year-old subjects.
Global CMRO2 Increases with Age
Figure 4 shows the scatter plot between CMRO2 and age (N =
232). Regression analysis revealed that there is paradoxical
increase of CMRO2 with age (P = 0.0101). Average CMRO2 of
typical 20-year-old subjects is approximately 164.1 lmol/100
g/min, and it increases with age at a rate of 2.6 lmol/100 g/min
per decade. Therefore, the aging brain appears to suffer from
double insults of decreased oxygen supply and increased
oxygen demand, resulting in an age-related decrease in venous
oxygenation. Note that the CMRO2 value reported in our study
is for unit mass brain parenchyma, thus the brain atrophy effect
has been accounted for. As far as the total brain oxygen con-
sumption is concerned, an age-related decrease was observed
because the brain size is smaller in older subjects (see
Discussion for more details).
Regional Specificity of Age-Related CBF Alterations
Figure 5 shows averaged CBF maps for each decade. Visual
inspection suggested that age-related CBF decline is heteroge-
neous across brain regions. Figure 6a,b shows the voxels that
revealed a significant age-related decrease using voxel-based
linear regression (N = 226). These regions were found to be
prefrontal cortex (including anterior cingulate cortex), insular
cortex, and caudate nucleus. All regions were located in the
rostral half of the brain. There also appears to be a hemispheric
asymmetry in the prefrontal region with the right brain
showing more pronounced CBF decline. ROI analysis revealed
similar findings. Of the 8 major regions assessed, frontal lobe
(corrected P = 0.002), insula cortex (P < 0.001), and subcortical
gray matter (P = 0.016) showed significant age-related decline.
Figure 2. Scatter plot between global venous oxygenation (Yv) and age (total N 5
232). Each dot represents data from one subject. The data from women and men are
shown with different symbols. The dashed line is a linear fitting of the experimental
data from both sexes. Regression analysis showed that age has a significant effect on
Yv (P\ 0.0001), but a quadratic model did not improve the fitting. Women showed
higher Yv compared with men (P 5 0.0205).
Figure 3. Global CBF alterations with age. (a) Illustration of the imaging slice
(yellow) with regards to the major feeding arteries. (b) Scatter plot between global
CBF and age (total N 5 232). The data from women and men are shown with
different symbols. The dashed line is a linear fitting of the experimental data from
both sexes. Regression analysis showed that age has a significant effect on CBF (P5
0.0065). Women showed higher CBF compared with men (P\ 0.0001).
Figure 4. Scatter plot between global CMRO2 and age (total N 5 232). The data
from women and men are shown with different symbols. The dashed line is a linear
fitting of the experimental data. Regression analysis showed that age has a positive
effect on CMRO2 (P 5 0.0101). Women showed higher CMRO2 compared with men
(P\ 0.0001).
Figure 5. Regional CBF maps as a function of age. Subjects from each decade were
grouped, and their CBF maps were averaged for display. Six representative brain
sections are shown.
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which global CBF was measured. Figure 3b shows the scatter
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revealed an age-related decrease (P = 0.0065) of global CBF at
a rate of 0.8 ml/100 g/min per decade, from an average CBF of
58.1 ml/100 g/min in typical 20-year-old subjects.
Global CMRO2 Increases with Age
Figure 4 shows the scatter plot between CMRO2 and age (N =
232). Regression analysis revealed that there is paradoxical
increase of CMRO2 with age (P = 0.0101). Average CMRO2 of
typical 20-year-old subjects is approximately 164.1 lmol/100
g/min, and it increases with age at a rate of 2.6 lmol/100 g/min
per decade. Therefore, the aging brain appears to suffer from
double insults of decreased oxygen supply and increased
oxygen demand, resulting in an age-related decrease in venous
oxygenation. Note that the CMRO2 value reported in our study
is for unit mass brain parenchyma, thus the brain atrophy effect
has been accounted for. As far as the total brain oxygen con-
sumption is concerned, an age-related d crease was obs rved
because the brain size is smaller in lder subj cts (see
Discussion for more details).
Regional Specificity of Age-Related CBF Alterations
Figure 5 shows averaged CBF map for each d cade. Visual
inspection suggested that age-related CBF decline is h teroge-
neous across brain regions. Figure 6a,b shows the voxels that
revealed a significant age-related decrease using voxel-based
linear regression (N = 226). These regions were found to be
prefrontal cortex (including anterior cingulate cortex), insular
cortex, and caudate nucleus. All regions were located in the
rostral half of the brain. There also appears to be a hemispheric
asymmetry in the prefrontal region with the right brain
showing more pronounced CBF decline. ROI analysis revealed
similar findings. Of the 8 major regions assessed, frontal lobe
(corrected P = 0.002), insula cortex (P < 0.001), and subcortical
gray matter (P = 0.016) showed significant age-related decline.
Figure 2. Scatter plot between global venous oxygenation (Yv) and age (total N 5
232). Each dot represents data from one subject. The data from women and men are
shown with different symbols. The dashed line is a linear fitting of the experimental
data from both sexes. Regression analysis showed that age has a significant effect on
Yv (P\ 0.0001), but a quadratic model did not improve the fitting. Women showed
higher Yv compared with men (P 5 0.0205).
Figure 3. Global CBF altera ions with age. (a) Illustration of the imaging slice
(yellow) with regards to the ajor f eding arteries. (b) Scatter plot between global
CBF and age (total N 5 232). The data from women and men are shown with
different symbols. The dashed line is a linear fitting of the experimental data from
both sexes. Regression analysis showed that age has a significant effect on CBF (P5
0.0065). Women showed higher CBF compared with men (P\ 0.0001).
Figure 4. Scatter plot between global CMRO2 and age (total N 5 232). The data
from women and men are shown with different symbols. The dashed line is a linear
fitting of the experimental data. Regression analysis showed that age has a positive
effect on CMRO2 (P 5 0.0101). Women showed higher CMRO2 compared with men
(P\ 0.0001).
Figure 5. Regional CBF maps as a function of age. Subjects from each decade were
grouped, and their CBF maps were averaged for display. Six representative brain
sections are shown.
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altered with age. A quadratic model with age2 as an additional
regressor did not improve the fit.
Intersubject variability in Yv was also assessed on a decade-
by-decade basis, and it showed a significant increase with age
(cross-correlation coefficient between decade and standard
deviation of Yv within the decade R = 0.81, P = 0.0272). That is,
with age, Yv not only shows a gradual decrease but the
intersubject heterogeneity also becomes greater.
Global CBF Decreases with Age
Figure 3a illustrates the location of the 4 feeding arteries, from
which global CBF was measured. Figure 3b shows the scatter
plot between CBF and age (N = 232). Regression analysis
revealed an age-related decrease (P = 0.0065) of global CBF at
a rate of 0.8 ml/100 g/min per decade, from an average CBF of
58.1 ml/100 g/min in typical 20-year-old subjects.
Global CMRO2 Increases with Age
Figure 4 shows the scatter plot between CMRO2 and age (N =
232). Regression analysis revealed that there is paradoxical
increase of CMRO2 with age (P = 0.0101). Average CMRO2 of
typical 20-year-old subjects is approximately 164.1 lmol/100
g/min, and it increases with age at a rate of 2.6 lmol/100 g/min
per decade. Therefore, the aging brain appears to suffer from
double insults of decreased oxygen supply and increased
oxygen demand, resulting in an age-related decrease in venous
oxygenation. Note that the CMRO2 value reported in our study
is for unit mass brain parenchyma, thus the brain atrophy effect
has been accounted for. As far as the total brain oxygen con-
sumption is concerned, an age-related decrease was observed
because the brain size is smaller in older subjects (see
Discussion for more details).
Regional Specificity of Age-Related CBF Alterations
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inspection suggested that age-related CBF decline is heteroge-
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linear regression (N = 226). These regions were found to be
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Figure 3. Global CBF alterations with age. (a) Illustration of the imaging slice
(yellow) with regards to the major feeding arteries. (b) Scatter plot between global
CBF and age (total N 5 232). The data from women and men are shown with
different symbols. The dashed line is a linear fitting of the experimental data from
both sexes. Regression analysis showed that age has a significant effect on CBF (P5
0.0065). Women showed higher CBF compared with men (P\ 0.0001).
Figure 4. Scatter plot between global CMRO2 and age (total N 5 232). The data
from women and men are shown with different symbols. The dashed line is a linear
fitting of the experim ntal data. Regression analysis showed that age has a positive
effect on CMRO2 (P 5 0.0101). Women showed higher CMRO2 compared with men
(P\ 0.0001).
Figure 5. Regional CBF maps as a function of age. Subjects from each decade were
grouped, and their CBF maps were averaged for display. Six representative brain
sections are shown.
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A B C
Figure 17. Whole brain hemodynamic ag -relat d changes
Each dot represents data from on  subject (n = 232). The data from women and men are shown 
with different symbols. The da hed line is a linear fitting of the experimental data from both sexes. 
A. Scatter pl  between glob l venous oxygenation (Yv) and age. B. Global CBF alterations with 
age. C. Scatter plot between global CMRO2 and age. This figure and its caption were reproduced 
from (Lu et al. 2011). 
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This study also investigated possible changes in cerebrovascular reactivity (CVR) 
with age by acquiring ASL data during a hypercapnic challenge. Age-dependent 
effects on flow reactivity were larger and more pervasive than baseline flow 
decreases, which affected mostly the frontal areas of the brain. However, the 
largest CVR decreases were also found in frontal areas. CVR is also of importance 
when investigating BOLD changes with aging, since reactivity will determine the 
amplitude of CBF increase for a given amount of vasodilatory signaling and 
therefore the amplitude of the BOLD signal change evoked by a given amount of 
metabolism.
of CBF and CVR alterations in prefrontal cortex. It can be seen
that CVR shows a faster decay with age. Comparing subjects in
the 80s with those in the 20s, the averaged CBF decreased by
18%, whereas the CVR decreased by 54%. This observation is
also consistent with the above findings that CVR decline
involves a larger portion of the brain than CBF.
Gender Differences in Physiologic Parameters
Gender effects were also obtained from the regression analysis
described above. It was found that female subjects had
significantly higher Yv (P = 0.0205), CBF (P < 0.0001), and
CMRO2 (P < 0.0001) compared with male subjects. The
differences were 2.1%, 10.0 ml/100 g/min, and 22.0 lmol/100
g/min for Yv, CBF, and CMRO2 respectively. No gender effects
were observed for CVR.
Discussion
In the present study, we conducted an investigation of age-
related differences in brain metabolism and vasculature in
a relatively large cohort of healthy subjects. We found that the
brain’s energy homeostasis is disturbed in aging due to an
increase in oxygen demand and a concomitant reduction in
blood supply. Such an alteration occurred early in middle age.
The pattern of CBF decline is heterogeneous across the brain
with prefrontal cortex, insular cortex, and caudate being the
most affected regions. Aside from the age-related differences in
resting state CBF, the blood vessels’ ability to dilate and to
dynamically adjust CBF was also reduced with age, the extent
of which is more prominent than that of the resting state CBF.
To our knowledge, this work represents the most thorough
investigation of metabolic and vascular physiology in aging with
multiple static and dynamic parameters assessed in the same
cohort. Age-related CBF differences have been extensively
studied in the literature using various imaging modalities and
our finding of a CBF decrease with age is in general agreement
with most previous reports (Devous et al. 1986; Hagstadius and
Risberg 1989; Leenders et al. 1990; Martin et al. 1991; Bertsch
et al. 2009; Heo et al. 2010). A novel finding from the present
study is that we observed a highly significant decrease in venous
oxygenation (i.e., an increase in oxygen extraction fraction, OEF)
with age. Very few studies in the literature assessed OEF in
normal aging due to the need of radiotracer injection and arterial
blood sampling. The few studies that measured OEF all failed to
identify a significant effect of age (Frackowiak et al. 1980;
Yamaguchi et al. 1986; Leenders et al. 1990; Marchal et al. 1992),
possibly because of variations in individual values and a relatively
small sample size (ranging from 12--34 subjects). Owing to the
recent development in noninvasive oxygenation mapping
techniques (Lu and Ge 2008), we were able to measure venous
oxygenation in 232 subjects, and the results unequivocally
showed an age-related difference in OEF, demonstrating
a disturbed balance between oxygen supply and consumption
in aging. We should note that the TRUST MRI technique, by its
design principle, is not susceptible to brain atrophy because the
method is based on the MR T2 decay time constant rather than
on the MR signal itself (Lu and Ge 2008). Thus, the age-related
reduction in tissue volume is not a confounding factor in our
oxygenation measurement.
Another interesting observation was that the oxygen
metabolic rate, CMRO2, was found to increase with age. This
is opposite to most of the reports in literature, where CMRO2
was found to decrease with age (Kety 1956; Yamaguchi et al.
1986; Leenders et al. 1990; Marchal et al. 1992). We hypo-
thesized that this discrepancy is due to brain parenchyma
volume reduction that is difficult to correct in previous PET
and SPECT imaging studies, which would allow CSF to be
partial-volumed in the measurement and result in an undere-
stimation in CMRO2 in elderly subjects. To test this hypothesis,
we re-analyzed our data by calculating CMRO2 per unit volume
of intracranial space (instead of per unit volume of pure tissue).
The results then became consistent with the previous findings,
showing a significant CMRO2 decrease with age (P = 0.008,
slope = --2.4 lmol/100 g/min per decade, see Supplementary
Fig. S5 for scatter plot). Therefore, our results suggest that the
age-related metabolic decline reported previously may be
largely driven by a reduced brain volume in older subjects.
For the brain tissue that remained, the metabolic rate is actually
higher in the elderly. Such a change may reflect an age-related
reduction in neuronal computational efficiency or possible
leakage in membrane ion channels, which necessitates more
active Na+/K+-ATPase pumps to maintain the membrane
polarity (D’Esposito et al. 2003; Iadecola et al. 2009). For
comparison, we note that a few studies have measured whole-
body metabolic rate as a function of age (Krems et al. 2005;
Frisard et al. 2007; St-Onge and Gallagher 2010). It was found
that whole-body metabolic rate decreases with age. Much of
these age-related changes can be explained by the change in
body composition (i.e., more fat mass and less fat-free mass)
and a reduction in physical activity (Luhrmann et al. 2009)
Interestingly, after adjusting for body composition and physical
activity, the remaining energy expenditure actually increased
with age, a finding similar to the present study conducted for
the brain.
The spatial patterns of CBF decline are comparable with
those reported previously, with prefrontal cortex and insular
cortex among the most affected regions (Leenders et al. 1990).
A noteworthy observation is that the right prefrontal cortex
showed considerably greater affected areas compared with the
left hemisphere (see Fig. 6), suggesting that the right prefrontal
cortex may be more vulnerable to age-related changes. This
finding is interesting because there are numerous reports from
the fMRI literature that the right prefrontal cortex is activated
more in old compared with young adults on tasks that are
typically left-lateralized in young (Cabeza et al. 1997; Gutchess
et al. 2005; Duverne et al. 2009). The present data, when
Figure 8. Decade-by-decade alterations in prefrontal CVR and CBF. Display scales for
CVR and CBF are shown on the left and right axis, respectively. The display scales
were set such that the first points of the 2 curves overlapped. It can be seen that CVR
manifests a more rapid decay with age compared with CBF. The subjects in each
decade were grouped, and the data shown are the mean and standard error of the
group.
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Figure 18. Decade-by-decade lterati ns in prefrontal CVR and CBF. 
Display scales for CVR nd CBF a e shown on the left and right axis, re pectively. The display 
scales were set such that the first points of the 2 curves overlapped. It can be seen that CVR 
manifests a more rapid decay with age compared with CBF. The subjects in each decade were 
grouped, and the data shown are the m n and standard error of the group. This figure and its 
caption were reproduced from (Lu et al. 2011).
While the quantitative studies presented h re su gest that simpl  group 
comparisons of BOLD signal changes in participants of different ages may lead to 
errors and systematic biases, together they provide only a fragmentary window into 
this problem. In the aging study presented in Chapter 4 of this thesis, we have 
sought to go further in bringing all these observations together in an integrated set 
of experiments to probe into vascular changes with aging. The effects of th se 
changes on hemodynamic measures are addressed in the context of a calibra ed 
fMRI investigation in Chapter 4.
In summary, the BOLD signal is a physiologically-relevant, but ambiguous measure 
of neuronal activity. This limits the specific physiological inferences that can be 
made in the context of studies in young and healthy adults, a challenge that is 
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exacerbated in the case of comparisons between groups of different ages and 
health status. Chapter 2 of this thesis presents a generalization of previous 
techniques for the extraction of fractional changes in CMRO2 (a quantity more 
physiologically-specific and comparable between groups) from the BOLD signal 
evoked by a task. Chapter 3 presents a technique that allows estimation of 
baseline CMRO2 and OEF, which are not only highly relevant clinical parameters 
but will also allow a more in-depth investigation of age-related vascular and 
metabolic changes. Chapter 4 presents the results of a subset of these techniques 
in groups of younger and older adults. This allows a discussion of the physiological 
changes that occur with aging and the confounds present in the conclusions drawn 
from BOLD-only studies of cognitive aging. Finally, Chapter 5 will explore some of 
the central and cerebral vascular changes that occur with aging and their 
relationship with cognitive performance and cardiovascular fitness.
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2. A generalized procedure for calibrated MRI 
incorporating hyperoxia and hypercapnia
Gauthier, C.J.1,2, Hoge, R.D.1,2 
1 Physiology/Biomedical Engineering, Université de Montréal, Montreal, Quebec, 
Canada, 2 CRIUGM, Montreal, Quebec, Canada
Human Brain Mapping, Accepted 22 September 2011, in press
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2.1. Preface 
Calibrated fMRI was developed almost fifteen years ago by Davis et al. (Davis et 
al. 1998) and the original technique uses a hypercapnia manipulation combined 
with a biophysical model to decompose a task-evoked BOLD response into its 
vascular and oxidative metabolism components. This original technique uses the 
flow and BOLD responses to a hypercapnia manipulation to estimate the 
calibration factor M, corresponding to the maximal possible BOLD signal change 
from baseline. This calibration parameter is then used to estimate relative task-
evoked increases in the cerebral metabolic rate of O2 consumption (CMRO2). 
Because hypercapnia may cause discomfort when given in higher concentrations, 
other groups have developed alternative techniques using instead either hyperoxia 
(Chiarelli et al. 2007b) or the information present in gradient and spin echoes, 
without any gas manipulation (Blockley et al. 2011b), to calibrate the BOLD signal. 
Despite this decreased discomfort however, these two methods may be more 
sensitive to errors from misassignment of assumed parameters than the original 
method (Blockley et al. 2011b). 
In this chapter, an extension of the hypercapnia and hyperoxia calibration models 
is presented, which can take into account both arbitrary changes in blood flow and 
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in blood O2 content. This generalized model, combined with a simultaneous 
hypercapnia and hyperoxia breathing manipulation (carbogen inhalation), is 
compared to the hypercapnia and hyperoxia methods. The generalized model was 
not compared to the method by Blockley et al. however, since the last method was 
not published at the time of this study. The generalized model, combined with 
carbogen inhalation is shown to compare advantageously to the hypercapnia and 
hyperoxia methods, in terms both of accuracy of the M parameter and robustness 
to measurement error.
2.2. Abstract
Calibrated MRI techniques use the changes in cerebral blood flow (CBF) and blood 
oxygenation level-dependent (BOLD) signal evoked by a respiratory manipulation 
to extrapolate the total BOLD signal attributable to deoxyhemoglobin at rest (M). 
This parameter can then be used to estimate changes in the cerebral metabolic 
rate of oxygen consumption (CMRO2) based on task-induced BOLD and CBF 
signals. Different approaches have been described previously, including addition of 
inspired CO2 (hypercapnia) or supplemental O2 (hyperoxia). We present here a 
generalized BOLD signal model that reduces under appropriate conditions to 
previous models derived for hypercapnia or hyperoxia alone, and is suitable for use 
during hybrid breathing manipulations including simultaneous hypercapnia and 
hyperoxia. This new approach yields robust and accurate M maps, in turn allowing 
more reliable estimation of CMRO2 changes evoked during a visual task. The 
generalized model is valid for arbitrary flow changes during hyperoxia, thus 
benefiting from the larger total oxygenation changes produced by increased blood 
O2 content from hyperoxia combined with increases in flow from hypercapnia. This 
in turn reduces the degree of extrapolation required to estimate M. The new 
procedure yielded M estimates that were generally higher (7.6 ± 2.6) than those 
obtained through hypercapnia (5.6 ± 1.8) or hyperoxia alone (4.5 ± 1.5) in visual 
areas. These M values and their spatial distribution represent a more accurate and 
robust depiction of the underlying distribution of tissue deoxyhemoglobin at rest, 
resulting in more accurate estimates of evoked CMRO2 changes.
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2.3. Introduction
The blood oxygenation level-dependent (BOLD) MRI signal reflects local changes 
in blood flow, blood volume, and oxygen consumption. The amplitude of the signal 
measured depends on both the baseline value and the reactivity of these 
physiological quantities. Increases in neuronal signaling are associated with local 
increases in arterial blood flow, which in turn cause a reduction in deoxygenated 
hemoglobin (dHb) concentration in the venous circulation serving the activated 
region. This increase in the local arterial blood flow raises the mean O2 saturation 
along the capillary bed, increasing the diffusion-limited delivery of O2 to neural 
tissues (Buxton et al. 1997). Given that virtually all dHb in the venous circulation of 
healthy individuals is generated as a result of metabolic O2 extraction, the relative 
change in venous dHb level measured through BOLD during stimulation should 
depend partly on the relative change in the cerebral metabolic rate of O2 
consumption, or CMRO2 (Buxton et al. 1997). 
The dependence of the BOLD signal on baseline physiology complicates the 
comparison of BOLD response amplitudes between groups or individuals. This is 
particularly problematic for groups expected to have different vascular tone and 
reactivity (such as elderly populations or cardiovascular patients), because 
baseline blood flow, oxygenation, and cerebrovascular reactivity (CVR) will greatly 
affect the dynamic range of the BOLD signal (Gauthier et al. 2011b). The 
dissociation of metabolic and vascular factors contributing to the BOLD response is 
thus essential for meaningful comparisons between populations with disparate 
physiology.
If the vascular contribution to the BOLD signal can be quantified and factored out, 
then in theory it should be possible to obtain a quantitative estimate of the 
fractional change in CMRO2 evoked by stimulation. This notion is the foundation for 
various MRI-based methods for CMRO2 estimation (Davis et al. 1998; Chiarelli et 
al. 2007b; Gauthier et al. 2011b). The BOLD signal change observed during 
activation is not itself sufficient to determine the relative change in venous dHb 
concentration. Such a determination requires expressing the activation-induced 
BOLD signal as a fraction of the total attenuation of T2*-weighted signal 
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attributable to dHb at baseline (equivalent to the maximum possible BOLD signal 
increase, usually denoted M). For this reason, various calibration methods have 
been proposed in which the maximal BOLD increase M is estimated through 
extrapolation of BOLD signal increases observed during mild hypercapnia (Davis et 
al. 1998), hyperoxia (Chiarelli et al. 2007b) or a combination of the two (Gauthier et 
al. 2011b). Note that, although M is commonly referred to as the "maximal BOLD 
signal", it could also be described as the "resting BOLD signal" in the same sense 
that the baseline ASL difference signal represents resting cerebral blood flow. That 
is, it is the factor by which activation-induced changes must be normalized to 
recover the fractional change in a specific physiological quantity (i.e. blood flow or 
venous deoxyhemoglobin content). Unlike ASL however, there is no simple 
subtractive scheme allowing isolation of the T2*-weighted signal component 
associated specifically with deoxygenated hemoglobin at rest (although methods 
based on T2' show some promise (Blockley et al. 2011a)). Current quantitative 
BOLD approaches thus rely on extrapolative blood-gas manipulation techniques.
In the hypercapnia method, small amounts of carbon dioxide (typically 5-10% CO2 
by volume) are added to the air breathed by subjects during acquisition of BOLD 
and CBF image series. The vasodilatory properties of CO2 lead to increases in 
cerebral blood flow and tissue oxygen delivery, producing BOLD signal increases 
throughout grey matter as well as in large veins. The maximal BOLD signal M at a 
given location can then be extrapolated using the Davis model of BOLD as a 
function of CBF, assuming a constant arterial saturation of 100% and unchanged 
metabolism during hypercapnia. This is the original calibration method, introduced 
by Davis et al. and since used in a number of studies (Davis et al. 1998; Hoge et 
al. 1999b; Stefanovic et al. 2006; Leontiev et al. 2007b; Ances et al. 2008; Lin et al. 
2008; Perthen et al. 2008; Ances et al. 2009; Bulte et al. 2009; Chen et al. 2009b; 
Mark et al. 2011). 
In the hyperoxia method, subjects inhale high levels of oxygen (typically 50-100% 
O2 with balance nitrogen where applicable) during acquisition of BOLD image 
series and recordings of expired oxygen concentration (a surrogate for the arterial 
partial pressure of O2). The enriched O2 raises the total oxygen content of the 
arterial blood, leading to increases in venous hemoglobin saturation SVO2) and 
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hence increases in BOLD signal. The maximal BOLD signal M can then be 
extrapolated using the hyperoxia calibration model of BOLD as a function of SVO2, 
with an approximated correction for the small decreases in CBF known to occur 
during hyperoxia (Chiarelli et al. 2007b; Goodwin et al. 2009; Mark et al. 2011). 
Due to the difficulty of measuring small CBF changes with the somewhat noisy 
ASL method, a fixed value for the hyperoxia-induced CBF decrease is generally 
assumed.
The hyperoxia model (Chiarelli et al. 2007b) can be generalized for arbitrary 
changes in cerebral blood flow during hyperoxia (Gauthier et al. 2011b), rendering 
it valid for conditions such as simultaneous hyperoxia and hypercapnia (as would 
be produced during breathing of carbogen, a mixture composed largely of O2 with 
a balance of 5-10% CO2). This article presents a detailed description of this 
generalized calibration model (GCM), examines the sensitivity of the different 
methods to errors in CBF measurement, and compares values of visually-evoked 
CMRO2 change obtained using the different calibration approaches.
2.3.1. Theory
Oxygen is a mild vasoconstrictor, and hyperoxia during inhalation of 100% O2 has 
been associated with small reductions in cerebral blood flow (Bulte et al. 2007). 
The hyperoxia calibration method introduced by Chiarelli et al. (Chiarelli et al. 
2007b), was thus derived for conditions where cerebral blood flow would be 
expected to undergo little or no change. To generalize the model to be valid under 
an arbitrary change in cerebral blood flow, Equation 12 in Chiarelli et al. can be 
replaced with the following expression:
CBF ⋅CvO2 = CBF ⋅CaO2 − CBF0 ⋅ CaO2 0 ⋅OEF0( )     [1]
where, as in Chiarelli, CBF is the cerebral blood flow in milliliters per second, CvO2 
is the venous oxygen content in milliliters of O2 per deciliter of blood, CaO2 is the 
arterial oxygen content (also in ml O2/dl blood), and OEF is the oxygen extraction 
fraction (dimensionless, and assumed here to be 0.3 as in Chiarelli et al.). The 
subscript ‘0’ is used to denote resting values for CaO2, OEF, and CBF. The value 
OEF0 used in this equation reflects the resting value, which is assumed to be 
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constant throughout the brain and across individuals (Frackowiak et al. 1980; Ito et 
al. 2004; Ashkanian et al. 2008; Bremmer et al. 2010; Sedlacik et al. 2010). 
Whereas the expression proposed by Chiarelli balances O2 concentrations, the 
new expression balances the temporal fluxes of O2 at the level of the capillaries. 
The above expression can be readily solved for the venous O2 content during an 
arbitrary change in blood flow and oxygenation:
CvO2 = CaO2 −
CaO2 0 ⋅OEF0( )
CBF
CBF0
⎛
⎝⎜
⎞
⎠⎟           [2]
Values for CaO2 at baseline and during the breathing manipulations are obtained 
using the end-tidal O2 measurements as in Chiarelli et al. End-tidal O2 values are 
used here as a surrogate for PaO2, the arterial partial pressure of O2. The total 
arterial O2 content during carbogen inhalation is obtained from Equation 11 of 
Chiarelli:
CaO2 = ϕ ⋅ Hb[ ] ⋅SaO2( ) + PaO2 ⋅ ε( )          [3]
where φ is the O2 carrying capacity of hemoglobin (1.34 mlO2/gHb), [Hb] is the 
concentration of hemoglobin in blood (15 gHb/dl), SaO2 is the hemoglobin 
saturation, and ε represents the solubility of O2 in plasma (0.0031 mlO2/
(dlblood*mmHg)). The constants used here are the same as those in Chiarelli et al. 
The measured end-tidal O2 values were considered equivalent to PaO2, and used 
to determine SaO2 using the Severinghaus equation:
SaO2 =
1
23400
PaO2( )
3
+150 PaO2( )
+1
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
     [4]
The value for CaO2|0, used above in Equation 2, is determined using the PaO2 value 
at normoxia, the OEF0 value of 0.3 is assumed from literature, and the baseline-
normalized CBF value is measured during pCASL imaging. 
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As a penultimate step, we can estimate the venous O2 saturation using Equation 
14 from Chiarelli et al. (assuming that plasma O2 content in venous blood is zero 
as long as there is any dHb available for binding) and the CvO2 value computed 
above:
SvO2 =
CvO2 − PvO2 ⋅ ε( )
ϕ ⋅ Hb[ ]
    [5]
We can now estimate an M value based on values for SvO2, BOLD signal increase, 
and CBF increase during simultaneous hypercapnia and hyperoxia. With variable 
CBF incorporated explicitly in our revised expression for CvO2, we no longer need 
the CBF correction term ‘C’ from Equation 8 in Chiarelli et al., and the expression 
becomes:
ΔBOLD
BOLD0
= M 1− CBFCBF0
⎛
⎝⎜
⎞
⎠⎟
α [dHb]
[dHb]0
⎛
⎝⎜
⎞
⎠⎟
β⎛
⎝
⎜
⎞
⎠
⎟
= M 1− CBFCBF0
⎛
⎝⎜
⎞
⎠⎟
α (1− SvO2 )
(1− SvO2 0 )
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
β⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
    [6]
where the term (CBF/CBF0)α is used to model cerebral blood volume, assuming α 
= 0.38 (Grubb et al., 1974), and β = 1.5 is used to model the influence of 
deoxygenated hemoglobin on transverse relaxation (Boxerman et al., 1995). The 
above expression can be readily solved for M:
M =
ΔBOLD
BOLD0
1− CBFCBF0
⎛
⎝⎜
⎞
⎠⎟
α (1− SvO2 )
(1− SvO2 0 )
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
β     [7]
Calculation of relative CMRO2 during a task can then be performed using the 
expression proposed by Davis et al. (Davis et al. 1998):
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CMRO2 =
CBF
CBF0
⎛
⎝⎜
⎞
⎠⎟
1−α /β
1−
ΔBOLD
BOLD0
⎛
⎝⎜
⎞
⎠⎟
M
⎛
⎝
⎜
⎜
⎜
⎜
⎞
⎠
⎟
⎟
⎟
⎟
1/β
     [8]
A detailed theoretical comparison of the different models is given in the Appendix.
2.4. Methods
Acquisitions were conducted in eight healthy subjects (seven male and one female, 
aged 21 to 38 years) on a Siemens TIM Trio 3T MRI system (Siemens Medical 
Solutions, Erlangen, Germany) using the Siemens 32-channel receive-only head 
coil for all acquisitions. All subjects gave informed consent and the project was 
approved by the Comité mixte d’éthique de la recherche du Regroupement 
Neuroimagerie/Québec. 
2.4.1. Image acquisition
Sessions included an anatomical, 1mm3 MPRAGE acquisition with TR/TE/alpha = 
2300ms/3ms/9°, 256x240 matrix and a GRAPPA acceleration factor of 2 (Griswold 
et al. 2002). 
Functional image series were acquired using a dual-echo pseudo-continuous 
arterial spin labeling (pCASL) acquisition (Wu et al. 2007) to measure changes in 
cerebral blood flow (CBF). The parameters used include: TR/TE1/TE2/alpha = 
3000ms/10ms/30ms/90° with 4x4mm in-plane resolution and 11 slices of 7mm 
(1mm slice gap) on a 64x64 matrix (at 7/8 partial Fourier), GRAPPA acceleration 
factor = 2, post-labeling delay = 900ms, label offset = 100mm, Hanning window-
shaped RF pulse with duration/space = 500μs/360μs, flip angle of labeling pulse = 
25°, slice-selective gradient = 6mT/m, tagging duration = 2s (Wu et al. 2007).
In one subject, five susceptibility-weighted images (SWI) (Reichenbach et al. 2001; 
Rauscher et al. 2005a) were obtained to provide a qualitative assessment of the 
venous oxygenation increase with each breathing manipulation. One image was 
acquired during inhalation of, respectively: air, 7% CO2/93% air (HC), 100% O2 
(HO), 7% CO2/93% O2 (HO-HC 7%) and 10% CO2/90% O2 (HO-HC 10%). For all 
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images, the acquisition was started after an initial one minute period of gas 
breathing to allow oxygen saturation and vasodilation to reach a plateau. 
Parameters used for the SWI acquisition were: TR/TE/alpha = 27ms/20ms/15° with 
0.9x0.9mm in-plane resolution with 56 slices of 1.5mm on a 256x192 matrix.
2.4.2. Manipulations
Each session consisted of four functional runs: one run with visual stimulation and 
three runs each including a different gas manipulation. During each gas 
manipulation run, a single three-minute block of gas inhalation was preceded with 
one minute and followed by two minutes of medical air breathing. The three gas 
manipulations used were: 100% O2 (hyperoxia, or HO), 7% CO2/93% air 
(hypercapnia, or HC) and 7% CO2/93% O2 (simultaneous hyperoxia and 
hypercapnia, or HO-HC). The latter gas is a specific formulation of carbogen, which 
in general may contain different O2/CO2 ratios.
2.4.2.1. Visual stimulus
The visual stimulus used was a black and white radial checkerboard, with annuli 
scaled logarithmically with eccentricity, luminance modulated in a temporal 
squarewave at 8 Hz (equivalent to 16 contrast reversals per second) presented 
using an LCD projector (EMP-8300, Epson, Toronto, ON, Canada) onto a 
translucent screen viewed by subjects through a mirror integrated into the Siemens 
head coil. This stimulation was initiated one minute into the acquisition and lasted 
three minutes, followed by two minutes of rest. 
2.4.2.2. Gas manipulations
At the beginning of the experiment, subjects were fitted with a non-rebreathing face 
mask (Hudson RCI, #1059, Temecula, California, USA). To avoid discomfort from 
outward gas leakage blowing into the subject’s eyes, skin tape (Tegaderm Film, 
#1626W, 3M Health Care, St-Paul, MN, USA) was used to seal the top of the mask 
to the face. Plastic tubing (AirlifeTM Oxygen tubing #001305, Cardinal Health, 
McGraw Park, IL, USA) and a series of two Y-connectors were used to connect 
pressure/flow-meters for medical air, 100% O2 (hyperoxia, or HO), 7% CO2/93% air 
(hypercapnia, or HC) and 7% CO2/93% O2 (simultaneous hyperoxia and 
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hypercapnia, or HO-HC) tanks (Vitalaire, Missisauga, ON, Canada) to the mask. 
Gas flows were adjusted manually on the pressure/flow-meters (MEGS, Ville St-
Laurent, QC, Canada) to keep a total flow rate of 16L/min. Gas flow was kept at 
16L/min at all times except during administration of the HO-HC and the HC gas 
mixtures. To accommodate the hyperventilation caused by CO2 breathing, gas flow 
rates were increased to the maximal possible rate (25L/min) achievable with our 
pressure/flowmeters. Pulse rate and arterial O2 saturation were monitored in all 
subjects using a pulse-oximeter (InVivo Instruments, Orlando, USA) as a safety 
measure and to observe the effects of carbogen breathing. 
End-tidal O2 and CO2 values were monitored during all acquisitions. Gases were 
sampled via an indwelling nasal cannula (AirlifeTM Nasal Oxygen Cannula 
#001321, Cardinal Health, McGraw Park, IL, USA) using the CO2100C and 
O2100C modules of the MP150 BIOPAC physiological monitoring unit (BIOPAC 
Systems Inc., Goleta, CA, USA). Calibration of the unit was done by taking into 
account an expired partial pressure of water of 47mmHg (Severinghaus 1989). 
Subjects were instructed to breathe through their nose, which ensured that only 
expired gas was sampled by the nasal cannula. End-tidal CO2 and O2 values were 
selected manually from continuous respiratory traces sampled at 200 Hz. The first 
10 breaths of the first baseline period and the last 10 breaths of the gas-inhalation 
block were averaged to give baseline values and gas manipulation values 
respectively.
Following acquisition, all subjects were debriefed to assess the level of discomfort 
associated with the manipulation. The subjects were asked to rate the air hunger 
and breathing discomfort associated with the HO-HC and HC mixtures on a french 
language version of the scale proposed by Banzett et al. (Banzett et al. 1996). 
2.4.3. Data analysis
Individual subject analyses for ROI quantifications, absolute CBF, M and CMRO2 
mapping were done using the NeuroLens data analysis software package 
(www.neurolens.org). Time-series data from each echo were motion corrected 
(Cox et al. 1999) and spatially smoothed with a 6 mm 3D Gaussian kernel. ASL 
data were similarly processed, and the CBF signal was isolated from the first echo 
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(TE = 10ms) through surround subtraction using linear interpolation between 
neighboring points (Liu et al. 2005). A BOLD time series was isolated through 
surround addition using linear interpolation of neighboring points of the second 
echo (TE = 30ms). A general linear model (GLM) including a single-block response, 
a linear drift, and constant offset terms was applied, to obtain effect sizes and T-
maps for each condition. The first 60s after each transition in gas composition were 
excluded from the analyses by zeroing out relevant rows in the GLM computational 
matrices, to select responses at (or close to) steady-state.
Fractional changes were then calculated by dividing effect sizes over the visual 
ROI by the constant DC term from the GLM averaged within the same region. 
Group average values ± standard deviation are reported. 
Uncertainties on the estimates for M and CMRO2 were computed through 
numerical propagation of errors. This was performed by evaluating M and CMRO2 
for all combinations of input values evaluated at the upper and lower bounds of 
their respective confidence intervals (based on ± SE). The resultant ranges of M 
and CMRO2 values were then taken as the uncertainty for the respective 
parameter.
Absolute CBF maps were generated as in (Wang et al. 2003b). A binary mask was 
generated from the absolute flow map to remove all voxels with an absolute 
baseline CBF below 25 mL/100g/min, as a means of selecting cortical grey matter. 
Percent CBF and BOLD maps in response to the breathing manipulations as well 
as the visual task were multiplied by this mask to exclude white matter and CSF, as 
the low resting CBF levels in these tissue compartments preclude stable estimation 
of fractional CBF changes required by the model.
Arterial spin-labeling measurements acquired during hyperoxia alone and 
combined hyperoxia and hypercapnia were corrected for T1 changes using the 
approach described in (Chalela et al. 2000; Zaharchuk et al. 2008). Arterial blood 
T1 values were estimated based on measured PETO2 (partial end-tidal pressure of 
O2) values for each subject and T1 vs. PETO2 values tabulated in Bulte et al. (Bulte 
et al. 2007). Since the T1 depends specifically on the level of dissolved O2 in the 
plasma, and since we obtained different PaO2 (arterial partial pressure of O2) 
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values at a given FiO2 (fraction of inspired O2) than the latter study (their PaO2 
values were higher, likely due to the use of a tightly sealed face mask), the values 
were interpolated to account for this difference (i.e. the table from Bulte was 
converted to T1 vs. group average PaO2, and the T1 corresponding to each 
subject’s PETO2 during hyperoxia manipulations was interpolated). Values for the 
absolute blood flow at the air-breathing baseline were computed using Equation 1 
from Wang et al. (Wang et al. 2003b), assuming the same constant values as in 
this reference. 
The resultant values of percent change in ASL and BOLD signals (and where 
appropriate PETO2) were input to the applicable BOLD signal models to generate 
maps of the M parameter. More specifically, ASL and BOLD responses during 
hypercapnia were input to the hypercapnia model (Davis et al. 1998), while BOLD, 
and PETO2 data were input to the hyperoxia model (Chiarelli et al. 2007b) with an 
assumed flow decrease of 5% (based on PETO2 values obtained in our subjects 
and the flow decrease observed by Bulte et al. for similar PETO2 levels (Bulte et al. 
2007). The generalized calibration model (GCM) was applied to ASL, BOLD, and 
PETO2 data for all manipulations.
2.4.3.1. Visual
Regions of interest (ROIs) were derived from the intersection of the flow and BOLD 
thresholded (p ≤ 0.01 corrected) (Worsley et al. 2002) visual activation T-maps for 
each individual subject from the NeuroLens analysis. One subject (subject 1) fell 
asleep during the visual task and was therefore excluded from all analyses 
requiring a visual ROI. 
2.4.3.2. Grey matter
A grey matter ROI was defined for each subject using the automatic tissue 
segmentation functionality of the CIVET software package (Tohka et al. 2004). 
2.4.3.3. Analysis of sensitivity to errors in CBF
One of the limiting factors in the application of calibrated MRI methods has been 
the low signal-to-noise ratio of ASL measurements. To assess the sensitivity of 
different M estimation methods to possible errors in cerebral flow change, we 
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computed M values based on group average ROI and respiratory measures with 
simulated errors in the gas-induced CBF response. In these simulations, the input 
value of baseline-normalized CBF was varied over a range corresponding to the 
measurement uncertainty exhibited by our data while other input parameters 
(BOLD response and, where applicable, end-tidal O2 values) were held constant. 
This computation was carried out for the Davis model with HC data, for the 
Chiarelli model with HO data, and for the GCM with HC, HO, and HO-HC data.
2.5. Results
End-tidal partial pressures of O2 (PETO2) and CO2 (PETCO2) achieved during each 
gas manipulation for each subject are shown in Table 1. While PETCO2 values 
were very similar between HC and HO-HC, PETO2 values tended to be lower for 
HO-HC than for HO alone (possibly reflecting the 90% vs. 100% O2 content of the 
two gases). 
Subject 
1
Subject 
2
Subject 
3
Subject 
4
Subject 
5
Subject 
6
Subject 
7
Subject 
8 Average
PETCO2 
baseline 37.7 41.7 38.3 41.9 39.3 42.0 40.4 34.5 39.5
PETCO2 HC 51.2 52.2 47.5 46.9 51.9 46.9 47.8 42.3 48.3
PETO2 
baseline 113.9 114.1 113.0 139.0 125.4 125.0 92.3 106.3 116.1
PETO2 HO 578.4 621.6 509.3 569.8 583.6 380.0 560.8 513.1 539.6
PETCO2 
baseline 41.8 42.0 37.2 40.8 41.2 41.3 40.1 35.1 40.0
PETCO2 
HO-HC 48.9 51.0 46.1 46.9 50.8 46.7 45.9 45.5 47.7
PETO2 
baseline 102.9 104.0 135.7 125.2 114.0 130.3 106.4 105.4 115.5
PETO2 HO-
HC 447.5 480.8 400.8 425.1 486.7 303.8 403.5 375.6 415.5
Table 1. End-tidal values for each breathing manipulation 
Average end-tidal values for individual subjects. The top subsection shows end-tidal partial 
pressures of CO2 (PETCO2) for the hypercapnia (HC) breathing manipulation during baseline (top 
row) and during the hypercapnia block (second row). The second subsection shows end-tidal partial 
pressures of O2 (PETO2) for the hyperoxia (HO) breathing manipulation during baseline (third row) 
and during the hyperoxia block (fourth row). The third section shows PETCO2 and PETO2 (baseline 
and block) for combined hypercapnia and hyperoxia (HO-HC).
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The changes in blood oxygenation resulting from these three gas manipulations 
can be appreciated from the ROI-average values for BOLD signal change (Figure 
1B), while the vasodilatory effect of CO2 is demonstrated by the CBF changes 
within the same ROI’s (Figure 1A). Percent changes in CBF (Figure 1A) for HC and 
HO-HC were not found to be significantly different (paired two-tailed Student’s T-
test, p>0.3) in both visual and GM ROI’s. Average CBF changes in the visual ROI 
were 63.3 ± 6.7% and 68.9 ± 12.2%, while average changes throughout GM were 
37.3 ± 4.8% and 40.7 ± 3.7% for HC and HO-HC respectively. Average flow 
changes for HO in visual and GM ROI’s were, respectively, -7.3 ± 3.7% and -3.1 ± 
3.1%. BOLD percent changes (Figure 1B) for HC and HO were similar, with 
averages of 2.3 ± 0.2% and 1.9 ± 0.2% in the visual ROI and 2.3 ± 0.1% and 1.7 ± 
0.2% in GM for HC and HO respectively. Average ROI values for HO-HC were 
about double those of HO and HC alone, with averages of 4.1 ± 0.4% and 3.6 ± 
0.4% respectively for visual and GM ROI’s. 
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Figure 1. Group average percent CBF and BOLD for each breathing manipulation
Group average percent CBF (A) and percent BOLD (B) changes over visual and grey-matter ROI’s 
for hyperoxia (HO), hypercapnia (HC) and combined hypercapnia and hyperoxia (HO-HC). 
Individual subjects’ ROI-based M values for visual cortex are summarized in Figure 
2A and Table 2. Values of M are shown for each gas manipulation (HC, HO and 
HO-HC), calculated with the original model for that manipulation. Group average M 
values were 5.6 ± 1.8%, 4.5 ± 1.5%, and 7.6 ± 2.6% for HC, HO and HO-HC 
respectively over the visual ROI. The M values estimated using the HO-HC 
technique were generally found to be the highest, while HO tended to give the 
lowest values. Application of the GCM to ROI-average CBF and BOLD signals as 
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well as PETO2 values measured during hypercapnia yielded slightly lower values 
than those of the Davis model (M values with GCM were on average lower by 0.5 ± 
0.2%). On the other hand, application of the GCM to the BOLD and PETO2 values 
recorded during hyperoxia (with an assumed flow decrease of 5%) yielded 
systematically higher M values than the Chiarelli model (M values with GCM were 
on average 1.7 ± 1.1% higher; data not shown). 
Some similarities were observed when M was estimated over all grey matter 
(Figure 2B). Group average M values were 7.9 ± 0.8%, 4.0 ± 0.8% and 7.9 ± 0.6% 
for HC, HO and HO-HC respectively. The tendency toward higher M values with 
HO-HC and lower M values with HO is clearer here with a lower inter-subject 
variability. Application of the GCM to data obtained during HC yielded lower M 
values than the Davis model (values computed with GCM were on average 0.8 ± 
0.3% lower than those from the Davis model). On the other hand, M values 
estimated using the GCM during HO were higher than those obtained using the 
Chiarelli model (1.3 ± 0.4% higher for GCM as compared to the Chiarelli model; 
data not shown). 
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Figure 2. Individual and average M values over the visual and grey-matter ROI’s for each 
breathing manipulation
Individual and group average M values over visual (A) and grey-matter (B) ROI’s for hyperoxia 
(HO), hypercapnia (HC) and combined hypercapnia and hyperoxia (HO-HC). The Chiarelli, Davis 
and GCM formulae were used to process data from the respective gas manipulations.
Maps of M for each breathing manipulation using the model originally derived for 
the respective procedures are shown in Figure 3. A similar pattern may be 
observed between subjects whereby HO yields lower and more uniform maps of M 
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values, with few localized enhancements compared to HC and HO-HC. The maps 
created using HC show a speckled pattern of focal M hotspots, some of which 
appear (based on placement with respect to sulcal anatomy) to be veins, while 
others appear artifactual, likely from instabilities in the model under high CBF 
errors (Figure 4). Maps from HO-HC exhibit an intermediate pattern with more 
uniform M values throughout cortex combined with local enhancements associated 
with larger veins. The reduced prevalence of questionable hot spots in the HO-HC 
maps, as compared to the HC maps can be appreciated in the example maps 
shown in Figure 4. In this figure, the window display levels were adjusted to 
highlight the differences in the high amplitude local enhancements in these maps, 
as opposed to the scale used in Figure 3, chosen to show general trends over all 
techniques and subjects. 
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Figure 3. Individual M maps for each breathing manipulation
Individual M maps for hyperoxia (HO) (top row), hypercapnia (HC) (second row) and combined 
hypercapnia and hyperoxia (HO-HC) (third row). The Chiarelli, Davis, and GCM expressions were 
used to process data from the respective gas manipulations. Display window levels have been 
adjusted to emphasize detail in all maps.
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Figure 4. Spatial heterogeneity of M maps
Maps of M from one subject for HC and HO-HC (using Davis model and GCM, respectively). The 
display window levels have been adjusted to highlight the differences in the magnitude of M 
estimates within local enhancements.
The susceptibility-weighted venograms acquired in one subject provide a 
qualitative depiction of the venous saturation provided by each breathing 
manipulation (Figure 5). In this subject, the prominent veins visible in the baseline 
image acquired during air breathing can be seen to fade due to increasing levels of 
oxygen saturation for 100% O2 (HO) breathing and 7% CO2/93% air (HC) mixtures. 
While a carbogen mixture with 10% CO2/90% O2 (HO-HC 10%) composition yields 
a complete loss of venous contrast, the carbogen mixture with 7% CO2/93% O2 
(HO-HC 7%) shows an intermediate pattern with complete loss of venous contrast 
in smaller veins, but some residual contrast in the largest veins. 
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Figure 5. Susceptibility-weighted venograms during each breathing manipulation
Susceptibility-weighted venograms acquired in a single subject during breathing of either air, 100% 
O2 (HO), 7% CO2/93% air (HC), 7% CO2/93% O2 (HO-HC 7%) and 10% CO2/90% O2 (HO-HC 
10%).
Simulations of the effect of CBF error on apparent M value are shown in Figure 6. 
Estimates of M based on manipulations including hypercapnia exhibited greater-
than-linear increases in the error on M as a function of CBF underestimation (for 
both Davis model and GCM). However this non-linearity and resultant errors on M 
were far smaller, over the entire range of CBF errors examined, for GCM in 
combination with HO-HC than for other methods (Figure 6A). Estimates of M based 
on hyperoxia alone exhibited marked instabilities for relatively small errors in CBF 
(for both the Chiarelli model and GCM) (Figure 6B).
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Figure 6. Effect of CBF errors on M estimates from different models and breathing 
manipulations
Solid lines show M estimates as a function of the error in CBF, while the broken lines (nearly 
overlapping) show the values of the actual M estimates from the group average visual ROI flow 
response (i.e. without error) for the different methods. All estimates use group average values for 
BOLD and respiratory measures, as well as for the central (zero error) value of CBF. For 
manipulations and models with a HC component (A), HC/Davis, HC/GCM and HO-HC/GCM, 
greater-than-linear error occurs with progressive underestimation of the flow response to 
hypercapnia. The combination of HO-HC with the GCM yielded M estimates with the greatest 
immunity to errors in CBF. The hyperoxia-only manipulation, when used with either the GCM and 
Chiarelli model (B) shows a singularity at flow estimates within the typical error bounds on ASL 
measurements.
Percent changes in CMRO2 over visual cortex were computed for each subject 
using ROI-average values for CBF and BOLD increases during the visual task and 
M values obtained from each breathing manipulation (Figure 7 and Table 2). While 
group average values for each technique were similar and a pattern for large inter-
subject variability can be seen, some patterns nevertheless emerge from this 
analysis. The HO-HC technique yielded physiologically plausible estimates of 
relative CMRO2 change in all subjects. HC, on the other hand, yielded very low and 
non-physiological Δ%CMRO2 estimates in two subjects (subjects 2 and 3 in Figure 
7). HO also resulted in a non-physiological, negative Δ%CMRO2 estimate in one 
subject (subject 3 in Figure 7).
96
015
30
45
60
2 3 4 5 6 7 8 average
%
 C
M
R
O
2
HO HC HO-HC
Figure 7. Individual and average CMRO2 estimates over the visual ROI
Individual and group average evoked CMRO2 estimates for the visual task, calculated using M 
values from hyperoxia (HO), hypercapnia (HC) and combined hypercapnia and hyperoxia (HO-HC) 
manipulations (and respective models).
Calibrated fMRI parameters, including cerebrovascular reactivity during HC and 
HO-HC, M, CMRO2 and the coupling parameter n are shown for each subject in 
Table 2. Vascular reactivities were similar in most subjects for HC and HO-HC, 
except in subjects 3 and 7, who exhibited lower flow responses to HO-HC than to 
HC alone. The coupling constant n is defined here as the magnitude of the 
fractional flow change during a stimulus divided by the corresponding fractional 
change in CMRO2. Values for n are expected to be between 2 and 4 (Buxton 
2010). While most n values fall within this range, some values obtained using 
either HC or HO calibration exhibited physiologically suspect values with either 
very high (subjects 2 and 3) or one negative value (subject 3) in the case of HO 
calibration. 
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Subject 
1
Subject 
2
Subject 
3
Subject 
4
Subject 
5
Subject 
6
Subject 
7 Average
Reactivity HC 6.5 8.5 8.3 6.0 8.7 10.7 6.1 7.8
Reactivity 
HO-HC 9.3 10.3 2.3 8.3 8.4 10.1 2.9 7.4
M HC 3.8 3.1 6.1 5.1 6.8 6.2 8.3 5.6
M HO 4.0 3.3 2.7 3.9 7.1 5.6 4.9 4.5
M HO-HC 5.0 4.3 12.6 6.7 8.9 6.4 9.1 7.6
CMRO2 
HC 26.5 6.7 7.9 28.2 28.2 40.8 36.8 25.0
CMRO2 
HO 27.3 8.7 -30.8 21.6 29.1 36.1 25.6 16.8
CMRO2 
HO-HC 31.6 17.5 21.7 32.9 33.1 42.3 38.3 31.1
n HC 2.7 9.4 6.1 2.4 2.5 3.0 2.0 4.0
n HO 2.6 7.2 -1.6 3.2 2.4 3.4 2.9 3.0
n HO-HC 2.2 3.6 2.2 2.1 2.1 2.9 2.0 2.4
Table 2. Calibrated fMRI results
Individual subjects’ and average values for vascular and metabolic parameters. The first section 
shows vascular reactivity (% change CBF/mmHg change in PETCO2) values for hypercapnia (HC) 
and combined hypercapnia and hyperoxia (HO-HC). The second section shows average M values 
over the visual ROI for each breathing manipulation. The third section shows estimates of visually-
evoked CMRO2 using M values calculated with the M value associated with each breathing 
manipulation. Finally, the fourth section shows the coupling constant between CBF and CMRO2 
associated with the estimates obtained from each breathing manipulation. The Chiarelli, Davis and 
GCM formulae were used to process data from the respective gas manipulations.
2.6. Discussion
2.6.1. Estimation of M parameter
Comparison of functional MR calibration methods based respectively on 
hypercapnia, hyperoxia and combined hypercapnia and hyperoxia indicates that 
the hybrid technique may yield more robust and accurate M estimates thanks to 
the reduced range of extrapolation required from the higher measured BOLD 
signals. In the latter assessment we define robustness as the relative immunity 
from physically invalid results such as negative, imaginary, or artifactually large 
values, and accuracy in terms of agreement with the lower bound on M values set 
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by previous direct measures in which high levels of venous saturation were 
produced. Estimates of M based on HO-HC show a trend toward higher values 
than the individual HC and HO approaches (the latter yielding the lowest values). 
2.6.1.1.ROI analysis
Group average M values obtained with the HO-HC method in visual cortex (7.6 ± 
2.8) were similar to the average value of 7.5 ± 1.0 measured directly in a previous 
study using simultaneous hypercapnia and hyperoxia with a higher CO2 content 
(10% CO2/90% O2) to reach very high venous O2 saturation from a larger flow 
response (Gauthier et al. 2011b). The value of 7.5% BOLD signal increase 
measured in Gauthier et al. can be considered a direct measurement of (or at least 
a lower bound on) M, as venous saturation levels exceeding 90% were reached in 
this experiment. Both the HC and HO calibration techniques, on the other hand, 
yielded M estimates of 5.6 ± 1.8 for HC and 4.5 ± 1.5 for HO, well below the 
directly measured lower bound for M cited above. The agreement between directly 
measured BOLD signal changes at very high venous saturations and the M value 
extrapolated here from the smaller HO-HC changes provided by the 
7%CO2/93%O2 carbogen mixture used here indicates that the values obtained with 
this technique may be more accurate. 
The accuracy of M has been shown to have an important impact on the validity of 
task-induced CMRO2 responses estimated through calibrated MRI (Chiarelli et al. 
2007a). The higher BOLD signal values obtained from the combined sources of 
increased oxygen saturation and the larger (and thus more readily measurable) 
flow values obtained from the 7% CO2 content reduce the range of extrapolation 
required to estimate the maximal BOLD response. 
2.6.1.2. Susceptibility-weighted venograms
The distance of measured BOLD responses from (or their proximity to) the 
maximal BOLD signal change can be demonstrated qualitatively by SWI 
venograms acquired during the different breathing manipulations. In one subject 
we acquired venograms during breathing of the following gases: air, 100% O2 
(HO), 7%CO2/93% air (HC), 7% CO2/93% O2 (HO-HC 7%) and 10% CO2/90% O2 
(HO-HC 10%) (Figure 5). This last mixture, 10% CO2/ 90% O2 has been shown in 
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previous studies (Sedlacik et al. 2008; Gauthier et al. 2011b) to yield an almost 
complete loss of venous contrast in SWI due to a very large increase in venous 
oxygenation. This supports use of the BOLD change produced by this manipulation 
as a direct measurement of M and a ground truth against which to compare other 
manipulations (including carbogen breathing at lower CO2 levels). The SWI 
venograms in Figure 5 demonstrate different degrees of reduced susceptibility 
contrast in veins, with the effect of HO-HC at 7% CO2 exceeding those of HC or 
HO alone by a considerable margin. The venogram acquired during HO-HC at 10% 
CO2 demonstrates a complete loss of susceptibility contrast.
2.6.1.3. M mapping
Estimates of M have, in the past, typically been expressed as average values over 
regions of interest. Here we show maps of M values over all voxels in which an 
absolute baseline CBF above 25 mL/100g/min was measured (chosen to exclude 
CSF and white matter), allowing an investigation into the spatial distribution of M 
values.
Maps of M obtained from the hypercapnia manipulation included numerous 
isolated voxels with very high M values (Figure 3 and 4). While M values in larger 
veins are expected to be high, some of these high values obtained with this 
approach appear to be artifactual. This may be due to amplification of noise 
inherent in the broad range over which extrapolation is required, as well as an 
inherent instability of the model for low flow estimates (see Appendix and Figure 6). 
Maps of M generated using hyperoxia alone with the hyperoxia model (Figure 3) 
showed a tendency toward lower M values and appeared to underestimate the 
values in larger veins (which were essentially absent in the maps). Note that many 
of the hyperoxic M maps included large zones in which the grey-matter M was 
negative, which are shown as fully transparent in the image overlays of Figure 5.
2.6.1.4. Spatial heterogeneity of M values
Mark et al. have compared the hypercapnia and hyperoxia manipulation 
techniques. They found the M values obtained with the hyperoxia technique to 
show less inter-subject variability than hypercapnia. Given that the hyperoxia 
technique assumes a fixed flow value in response to hyperoxia and a uniform 
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venous saturation based on end-tidal PO2 measurements, the main contribution to 
noise comes from the BOLD measurement. The hypercapnia method, on the other 
hand, uses the noisier flow response to hypercapnia in its model. 
Though the greater uniformity of hyperoxia-derived M values could be viewed as 
an advantage, it may in fact reflect bias in the technique - particularly where large 
veins are concerned. It is known a priori that veins must have a higher M value 
than parenchyma, since their dHb content is higher. Such veins do in fact show 
higher BOLD increases than grey matter during hyperoxia, but application of the 
hyperoxia model results in M values considerably below those detected using the 
other techniques. This may be due to the assumption of a single fixed flow change 
throughout the brain, or a breakdown of the model in regions with a high venous 
blood volume fraction.
The M parameter maps generated from the combined hypercapnia-hyperoxia 
manipulation with GCM analysis accurately captured the high M values in large 
veins while remaining free of the artifactual hot spots due to model instability seen 
in the hypercapnia maps and the zones of negative M value observed in the 
hyperoxia maps.
2.6.1.5. Robustness of M estimates
As noted above, maps of M generated using the GCM in conjunction with the HO-
HC manipulation appeared to be relatively immune to artifactual hot spots 
compared with maps generated using the Davis model and the hypercapnia 
manipulation. Detailed analysis of M maps together with input maps of CO2-
induced BOLD and CBF responses indicated that improbably high M values in the 
Davis/HC maps tended to occur in voxels where the apparent CBF change was 
atypically low compared with surrounding voxels. Such low flow values in individual 
voxels may reflect a combination of noise excursions from the 'true' grey-matter 
value and bias caused by partial volume with white matter or large veins. The 
simulation results presented in Figure 6 reveal that estimates of M exhibit non-
linear errors for increasing errors in CBF. The degree of error was found to depend 
both on the model used and the gas manipulation employed.
Both the Davis model and the GCM can be used to compute M from data acquired 
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during hypercapnia. Simulation results indicated that hypercapnic M estimates 
using the GCM were somewhat more stable (i.e. non-linearity of the error in M was 
reduced) than those obtained using the Davis model (Figure 6A). This is due to the 
moderating effect of terms in the GCM reflecting arterial O2 content at rest and 
during hypercapnia. While the details of this are presented in the appendix, it is 
interesting to note that incidental increases in arterial PO2 from CO2-induced 
hyperventilation actually tend to stabilize estimates of M derived from hypercapnic 
measures with the GCM.
Data acquired during pure hyperoxia can be analyzed using either the Chiarelli 
model or the GCM. Although the Chiarelli model is often applied using an assumed 
value of the O2-induced CBF decrease, it was important to assess the impact of 
any mis-assignment of this parameter (whether through measurement error or 
incorrect assumption). Our simulations showed that relatively modest errors in the 
O2-induced CBF change could result in extremely large bias in the apparent M 
value (culminating in singularities at CBF errors well within the typical standard 
deviation). This was the case for both the Chiarelli model and the GCM 
formulation, although the specific range of CBF errors where singularity arose was 
different for the two models (Figure 6B). As discussed in the Appendix, this 
instability is due to the lower range of flow values obtained in the hyperoxia 
manipulation, which fall in regimes for both models where division by zero can 
readily occur with typical values of other parameters. It should be noted that 
practical applications of the hyperoxia approach typically use a fixed value for the 
O2-induced decrease in CBF that lies within the stable range for both models.
The simulation results for the GCM in conjunction with the combined hypercapnia/
hyperoxia manipulation demonstrate the relative immunity of this approach to 
typical errors in CBF. The mathematical basis for this stability is discussed in the 
appendix, but it can also be understood on intuitive grounds by considering that, in 
the limit, complete saturation of venous blood would completely eliminate the 
dependence of M on the CBF and CBV terms. Because the combined effects of 
simultaneous hypercapnia and hyperoxia drive the venous system considerably 
closer to this endpoint than other manipulations, and because the GCM is valid for 
such simultaneous manipulations, it offers improved accuracy and robustness in 
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the estimation of M over previous methods.
2.6.2. CMRO2
The M parameters obtained using each breathing manipulation were used as 
intermediate results in the estimation of fractional CMRO2 changes evoked during 
a visual task. While most CMRO2 estimates fell within the range reported in the 
literature for similar visual paradigms (Davis et al. 1998; Hoge et al. 1999a; 
Stefanovic et al. 2006; Leontiev et al. 2007a; Leontiev et al. 2007b; Ances et al. 
2008; Lin et al. 2008; Perthen et al. 2008), some physiologically implausible 
estimates of CMRO2 were also calculated using the hypercapnia and hyperoxia 
calibration methods (Figure 7, Table 2). In Figure 7, subjects 3 and 4 have either 
non-physiological (subject 4) or atypically low (subject 3) CMRO2 responses 
associated with the visual task. In these two subjects, M values estimated with 
combined hypercapnia and hyperoxia were larger than those estimated using the 
other two methods. In the case of subject 3, the M value from HO-HC was about 
1% higher than with the other two methods and this led to the estimation of a 
CMRO2 value around 17.5%, much closer to the expected range (between 15 and 
35%) than the values of 6.7 and 8.7% found by HC and HO respectively. In subject 
4, the very high estimate for M obtained by HO-HC (12.6%) is however the only 
value for M that, when coupled with the task-related signal changes in CBF and 
BOLD, yields a plausible CMRO2 estimate (21.7% as opposed to 7.9 or -30.8% for 
HC and HO respectively). Furthermore, this high M value is within the range of 
values reported in previous studies (Perthen et al. 2008) and is not inconceivable 
for an individual endowed with unusually prominent venous anatomy.
2.6.3. Limitations of the study
Breathing manipulations
High inspired CO2 concentrations are known to be associated with air hunger and 
dyspnea (Banzett et al. 1996). In the present study, we used 7% CO2 for both the 
HC and HO-HC conditions. While this CO2 content is somewhat higher than the 
5% CO2/air mixture often used in the calibrated fMRI literature, it was chosen here 
to ensure high flow increases and venous saturation levels. The discomfort 
associated with this CO2 concentration was, furthermore, found to be mild with an 
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average discomfort rating of 2.1 ± 0.6 on a 7-point scale (Banzett et al. 1996). In 
the future, the high flow and BOLD signal responses measured with combined 
hypercapnia and hyperoxia could be utilized, in frail populations, to reduce CO2 
concentrations while achieving sufficient BOLD and ASL signal levels for adequate 
sensitivity.
Previous studies have, for similar fixed inspired gas concentrations, detected 
higher end-tidal values during hyperoxia (Bulte et al. 2007; Chiarelli et al. 2007b) 
than those reported here. This is probably due to air being entrained into the 
partially unsealed mask used here, especially during breathing manipulations 
involving CO2 and therefore leading to increased minute ventilation. A setup 
allowing the accommodation of larger breathing volumes and rates (including a 
mask with a larger bag and flow regulators allowing larger volumes to be given) 
would allow the mask to be sealed and prevent contamination from room air. This 
would be desirable as it would provide higher oxygenation increases for the same 
inspired gas O2 and CO2 gas concentrations. However the validity of the methods 
presented here depends only on the ability to accurately record the evoked 
changes in end-tidal O2 and CO2, which is ensured by instructing subjects to 
exhale through their nose and sampling via an indwelling nasal cannula. The 
requirement for breathing through the nose could be removed in future patient 
studies using a more closely sealed mask and the use of a one-way valve to 
prevent mixing of inspired and expired gases.
2.6.3.1. M value confounds
The dual-echo pCASL technique used here gave reliable flow and BOLD estimates 
in the grey matter that allowed the GCM to provide consistently plausible M values. 
The relatively higher noise levels in flow and BOLD signal changes measured in 
white matter voxels however yield clearly invalid estimates of M and CMRO2. This 
technique (like the pure hypercapnia and hyperoxia methods) is thus not currently 
suitable for calculating maximal BOLD signal or CMRO2 in white matter.
Because of the low spatial resolution, bias in flow and BOLD estimates from partial 
volume effects is clearly a concern at the interfaces between grey matter and white 
matter or cerebrospinal fluid. Inspection of the M parameter maps indicates that 
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there is indeed a zone in which M falls smoothly to zero along the grey-white 
matter interface. Parameter estimates in regions of homogeneous grey matter are 
thus likely to be more quantitative. Also, caution is needed when interpreting the M 
values that appear to fall in pure white matter as seen in Figure 3, since these in 
fact arise from a partial volume effect of adjacent slices during the resampling of 
the functional data to the anatomical resolution. 
A potential advantage of the combined hyperoxia and hypercapnia calibration is the 
reduced dependence on the assumptions of a fixed flow-volume coupling 
relationship and that CMRO2 does not change during changes in arterial O2 or CO2 
levels (Kety et al. 1948; McPherson et al. 1991; Horvath et al. 1994; Hino et al. 
2000; Jones et al. 2005; Zappe et al. 2008; Chen et al. 2010b; Xu et al. 2011b). 
This can be appreciated by considering the limiting case in which concurrent flow 
and oxygenation increases drive venous O2 saturation to 100%. Under such 
conditions, venous blood volume is no longer relevant since venous blood does not 
contain any deoxygenated hemoglobin. Moreover if venous oxygenation is driven 
to 100%, this means that all metabolic oxygen consumption has been satisfied by a 
combination of O2 carried on hemoglobin and dissolved in blood plasma, 
regardless of whether CMRO2 was constant during the calibration. While this is not 
the case for the submaximal values of venous saturation achieved in the present 
study, it is clear that the influence on M of systematic errors in the CBV term 
(estimated from CBF) and CMRO2 change (assumed to be zero) must become 
progressively smaller with increasing venous saturation (ultimately having no effect 
at 100% saturation as mentioned above). The group average venous saturation 
during combined hyperoxia and hypercapnia in the present study was computed to 
be 87 ± 4% in visual cortex, leaving relatively little deoxyhemoglobin 
(approximately 13% desaturation) and thus considerably reducing the impact of 
venous blood volume. A modest decrease in CMRO2 caused by the administered 
CO2 (Xu et al. 2011b) would imply a slightly higher true saturation value, with 
minimal effect on the computed M value.
In the present study, the model parameters alpha and beta were assigned the 
same values as in prior calibrated MRI literature (e.g. Davis, Chiarelli) (Davis et al. 
1998; Chiarelli et al. 2007b). While the purpose here was to highlight the different 
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model formulations, it should be noted that recent studies have attempted to refine 
these parameters to values that more specifically reflect venous blood volume and 
its regional variations (alpha), and more realistically describe the concentration-
relaxation behavior applicable in gradient-echo EPI at 3 Tesla (beta) (Chen et al. 
2009a; Buxton 2010; Chen et al. 2010c; Mark et al. 2011). As noted above, the 
higher venous saturation values attained during combined HO-HC reduce the 
impact of slight mis-specifications of alpha and beta.
2.7. Conclusion
The combined hypercapnia and hyperoxia procedure with the generalized model 
was found to yield M values that were robust at the individual voxel level and 
consistent with the lower bound determined in a previous study in which M was 
determined during near-complete arterialization of venous blood.
The combined sources of increased venous saturation, in conjunction with the 
added stability of the GCM over previous models, allow a more robust estimation of 
M, with a reduced range of extrapolation. We believe that this provides more 
accurate and robust estimates of stimulus-evoked increases in CMRO2 than 
previous methods.
2.8. Acknowledgements
We thank Carollyn Hurst, André Cyr, Tarik Hafyane and Élodie Boudes for help with 
data acquisition, Cécile Madjar for help with data acquisition, data analysis and 
helpful discussions. We would also like to thank Jiongjiong Wang, who provided 
the pseudo-continuous arterial spin-labeling sequence used. This work was 
supported by the Canadian Institutes for Health Research (MOP 84378, Banting 
and Best Scholarship held by CJG), the Canadian Foundation for Innovation 
(Leaders Opportunity Fund 17380), and the Ministère du développement 
économique, de l’innovation et de l’exportation (PSR-SIIRI-239).
106
2.9. Appendix
The Davis, Chiarelli, and generalized models all use the same basic expression, 
originally derived by Davis, to compute the resting BOLD signal M from CBF and 
BOLD changes measured during a respiratory manipulation:
M =
ΔBOLD
BOLD0
1− CBVCBV0
⎛
⎝⎜
⎞
⎠⎟
[dHb]
[dHb]0
⎛
⎝⎜
⎞
⎠⎟
β .     [9]
All approaches also use Grubb's relation to model the change in venous cerebral 
blood volume:
CBV
CBV0
=
CBF
CBF0
⎛
⎝⎜
⎞
⎠⎟
α
      [10]
where the exponent α may be assigned a value of 0.38 as in the original Grubb 
study, or an alternate value to better reflect the venous portion of blood volume 
(Chen et al. 2009a; Chen et al. 2010c).
Where the models differ is in how they express the baseline-normalized 
concentration of deoxygenated hemoglobin (dHb) in Equation 9. To consider how 
the models differ, we introduce the variable D to represent this dHb term:
D = [dHb][dHb]0
      [11]
In the discussion that follows, we will use the term desaturation to describe the 
fraction of hemoglobin that is deoxygenated (equivalent to one minus the 
saturation expressed as a decimal fraction). We can now proceed to analyze the 
different models.
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2.9.1. Davis model with hypercapnia manipulation
We start by considering the original Davis model, which was intended for use with 
data acquired during a hypercapnic manipulation without changes in arterial 
oxygen tension. In the Davis model, it is assumed that there is no deoxygenated 
hemoglobin in arterial blood (i.e. arterial O2 saturation is 100%), and that metabolic 
oxygen extraction does not change during hypercapnia. In this case the relative 
level of dHb can be expressed simply as
DDavis =
CBF0
CBF .      [12] 
That is, doubling CBF will reduce the venous concentration of dHb by a factor of 
two. There has been considerable discussion of whether oxygen extraction can 
really be assumed to be constant during hypercapnia (McPherson et al. 1991; 
Horvath et al. 1994; Hino et al. 2000; Jones et al. 2005; Zappe et al. 2008; Chen et 
al. 2010b). Moreover, typical arterial O2 saturation values in young volunteers are 
actually slightly less than 100%, and this value could be considerably lower in 
individuals with impaired cardiopulmonary function (e.g. the elderly, respiratory 
patients). Finally it is possible that arterial O2 tension will increase during a 
hypercapnic manipulation, due to CO2-induced hyperventilation.
2.9.2. Chiarelli model with hyperoxia manipulation
The Chiarelli model was conceived for use during a hyperoxic manipulation, during 
which metabolic oxygen extraction is also assumed constant. In this formulation of 
the model, the relative concentration of deoxygenated hemoglobin is expressed as 
the sum of two additive terms:
 
DChiarelli =
1− 1
ϕ[Hb] CaO2 − CaO2 0 ⋅OEF0( )( )
1− 1
ϕ[Hb] ⋅CaO2 0 ⋅ 1−OEF0( )
⎛
⎝
⎜
⎜
⎜⎜
⎞
⎠
⎟
⎟
⎟⎟
B
+
CBF0
CBF −1
⎛
⎝
⎜
⎞
⎠
⎟
C
, [13]
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where φ is the O2 capacity of hemoglobin in ml O2/g Hb, [Hb] represents the 
concentration of hemoglobin in the blood in g Hb/dl blood, OEF0 is the oxygen 
extraction fraction at rest, and CaO2 is the total arterial oxygen content in ml O2/dl 
blood (determined from measurements of end-tidal O2). The above expression 
groups D into two key terms depending, respectively, on end-tidal gas measures 
(B) and cerebral blood flow (C). The term B represents the increase in saturation 
attributable directly to the rise in arterial O2 content from breathing the hyperoxic 
gas mixture, while C reflects variable dilution of venous dHb associated with 
reduced CBF during hyperoxia.
2.9.3. Generalized calibration model (GCM) with hyperoxia and hypercapnia
While the expression for DChiarelli above is reasonably accurate for the small 
changes in CBF expected during normocapnic hyperoxia, the GCM incorporates 
arbitrary CBF changes in a modified version of the B term, resulting in a more 
general and accurate expression for relative deoxyhemoglobin concentration and 
obviating the need for term C. With some reorganization, the modified expression 
that distinguishes the GCM can be expressed as
 
DGCM =
CaO2 0 ⋅OEF0
ϕ[Hb]
1− CaO2 0
ϕ[Hb] 1−OEF0( )
⎛
⎝
⎜
⎜
⎜
⎜⎜
⎞
⎠
⎟
⎟
⎟
⎟⎟
X
CBF0
CBF
⎛
⎝
⎜
⎞
⎠
⎟+
1− CaO2
ϕ[Hb]
1− CaO2 0
ϕ[Hb] 1−OEF0( )
⎛
⎝
⎜
⎜
⎜
⎜⎜
⎞
⎠
⎟
⎟
⎟
⎟⎟
Y
. [14]
In the above expression, the term X is equivalent to the hemoglobin desaturation 
due specifically to resting metabolism, expressed as a fraction of the total resting 
hemoglobin desaturation in the venous compartment. It thus serves to modulate 
the CBF term of the Davis model, accounting for the fact that the arterial O2 
saturation may not be 100% (if resting arterial saturation is 100% then all venous 
dHb comes from metabolism and the term X reduces to unity).
The term Y, which is equivalent to the hyperoxic arterial desaturation as a fraction 
of total resting venous desaturation, reflects additional oxygen available from 
hyperoxic arterial blood for augmenting venous saturation. During hyperoxia, it is 
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possible for the effective arterial desaturation (the numerator in Y) to be negative, 
which reflects the fact that even at 100% arterial Hb saturation, additional O2 
dissolved in arterial plasma will eventually bind to venous dHb (thus reducing the 
venous desaturation). If the total arterial O2 content during the respiratory 
manipulation corresponds exactly to 100% saturation, then the term Y reduces to 
zero. 
Since the X and Y terms respectively reduce to unity and zero for a constant 
arterial O2 content corresponding exactly to 100% arterial saturation, the GCM is 
equivalent to the Davis model under the specific assumptions of that model. The 
GCM is also equivalent to the Chiarelli model in the specific case where there is no 
change in CBF during hyperoxia.
2.9.4. Stability of the models during hypercapnic manipulations
The largest source of error in estimates of M obtained from hypercapnia data is the 
high noise level of the CBF measurements. Because all of the models examined 
here include a CBF term in the denominator of the expression for M, moderate in 
CBF result in very high errors on M due to the non-linearity inherent in the 
reciprocal function. However the degree of non-linearity and resultant stability 
under noisy CBF data vary between the different models.
Both the Davis model and GCM can be used to estimate the resting BOLD signal 
based on measurements during hypercapnia (end-tidal O2 measurements are 
additionally required for the GCM). In the case where end-tidal O2 measurements 
indicate an unchanging arterial saturation of exactly 100%, both models will yield 
identical results. As illustrated in Figure 6A, the Davis model results in a significant 
overestimation of M when CBF is sufficiently underestimated. When the GCM is 
used to analyze the same data, as shown in Figure 6A, the non-linearity of M with 
CBF underestimation is considerably less pronounced. This is due to a slight 
attenuation of the CBF factor in DGCM from the X term (since resting arterial 
saturation is slightly less than 100%) and to the damping effect of the additive Y 
term (which is slightly negative since arterial O2 content actually increases slightly 
due to hyperventilation during CO2 breathing).
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This finding has the interesting consequence that small, incidental increases in 
arterial PaO2 during hypercapnia may actually be advantageous (helping to 
stabilize the model) if they are recorded and input to the GCM. As discussed below, 
the same effect accounts for the dramatic improvement in estimation stability when 
the GCM is used in conjunction with simultaneous hypercapnia and hyperoxia.
Note that, while it is theoretically possible to apply the Chiarelli model to 
measurements of hypercapnically-induced changes in CBF, BOLD, and end-tidal 
O2, the resultant estimates of M are physiologically implausible (negative for the 
input data used here).
2.9.5. Stability of the models during hyperoxia manipulations
Either the Chiarelli model or GCM can be used to compute M from data acquired 
during a hyperoxic manipulation. Figure 6B indicates that M estimates produced in 
this way are also vulnerable to significant bias from measurement errors on CBF, 
regardless of the model used. In this case, the problem arises due to an interaction 
between the lower range of flow values encountered with the hyperoxia 
manipulation and the form of the denominator for M in Equation 9. Moderate 
excursions in CBF can result in a combination of terms for baseline-normalized 
CBV and [dHb] which lead to division by zero. With the Chiarelli formulation, this 
only occurs for values of baseline-normalized CBF exceeding one. Because such 
values may readily arise in noisy ASL measures of small CBF changes, a 
physiologically plausible fixed value is typically assumed.
Stability of GCM during combined hyperoxia and hypercapnia manipulations
As noted above in the comparison with the Davis model, small increases in arterial 
O2 content tend to moderate the sensitivity of M to errors in CBF when the GCM is 
used to process data from hypercapnia manipulations. While this is a somewhat 
subtle effect when hypercapnia is induced under near-normoxic conditions, the 
stabilizing influence of increased arterial PaO2 becomes considerable in a 
combined hyperoxia/hypercapnia manipulation due to the influence of the additive 
Y term (negative) in Equation 14. The hypercapnia component of such 
manipulations tends to reduce the term (CBF0/CBF), further increasing the relative 
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importance of the term based on relatively stable end-tidal measurements. These 
effects lead to considerably lower values of D than can be achieved with 
hypercapnia or hyperoxia alone. Because the term (CBV/CBV0) in Equation 9 is 
multiplied by D, low values of D also serve to reduce the impact of uncertainty on 
the exact exponent α used in Equation 10.
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3.1. Preface
Calibrated fMRI techniques allow the quantification of task-evoked fractional 
CMRO2 change. While this is an important physiologically-specific quantity that can 
be directly compared between groups with different vascular properties, it 
nevertheless suffers from several limitations. Because calibrated fMRI yields a 
relative change from an unknown baseline, groups with different baselines could 
show similar relative changes but in reality consume different quantities of O2 in 
absolute units. Aging and some diseases such as dementia may be associated 
with changes in baseline oxidative metabolic activity (Yamaguchi et al. 1986; 
Leenders et al. 1990; Nagata et al. 2000; Yamauchi et al. 2002; Lu et al. 2011) and 
an MRI measure of this quantity would allow future studies to combine this metric 
with other informative MRI techniques such as measures of blood flow, atrophy or 
white-matter lesions to gain a better understanding of normal and pathological 
physiology.
Also, techniques requiring a task may be more limited in many clinical contexts. 
Task paradigms are difficult to control and differences in performance or 
hemodynamic signals may reflect confounding effects such as anxiety from the 
imaging setting, strategy choice, differences in motivation, arousal and physical 
discomfort (Bonnefond et al. 2011; Satterthwaite et al. 2012; Worthy et al. 2012). 
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Furthermore, some patient groups may experience difficulty in complying with the 
complex instructions of many task paradigms.  
For all these reasons, an MRI technique that allows measurement of resting-state 
CMRO2 would be useful both for basic and clinical research. Several groups have 
recently proposed MRI-based methods to quantify resting CMRO2 (He et al. 2007; 
He et al. 2008; Lu et al. 2008; Xu et al. 2009; Jain et al. 2010; Bolar et al. 2011b; 
Bulte et al. 2011; Fan et al. 2011). While several of these techniques quantify 
resting CMRO2 in a single vessel (He et al. 2007; He et al. 2008; Lu et al. 2008; Xu 
et al. 2009; Jain et al. 2010; Fan et al. 2011), some recent methods can be used 
for mapping of this parameter (Bolar et al. 2011b; Bulte et al. 2011). Here we 
propose an alternative technique based on our generalized calibration model 
presented in Chapter 2. Because this model can be used for any arbitrary change 
of blood oxygen content and flow, different combinations of hypercapnia and 
hyperoxia can be used to derive an experimentally determined value for M and 
resting oxygen extraction fraction (OEF). Resting OEF can then be used with 
measured blood flow and arterial oxygen content to obtain a value for baseline 
CMRO2. Since its publication, we have dubbed the method "QUO2". The use of the 
QUO2 technique to obtain accurate estimates of these parameter in complete grey 
matter is demonstrated here.
3.2. Abstract
We present a method allowing determination of resting cerebral oxygen 
metabolism (CMRO2) from MRI and end-tidal O2 measurements acquired during a 
pair of respiratory manipulations producing different combinations of hypercapnia 
and hyperoxia. The approach is based on a recently introduced generalization of 
calibrated MRI signal models that is valid for arbitrary combinations of blood flow 
and oxygenation change. Application of this model to MRI and respiratory data 
during a predominantly hyperoxic gas manipulation yields a specific functional 
relationship between the resting BOLD signal M and the resting oxygen extraction 
fraction OEF0. Repeating the procedure using a second, primarily hypercapnic, 
manipulation provides a different functional form of M vs. OEF0. These two 
equations can be readily solved for the two unknowns M and OEF0. The procedure 
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also yields the resting arterial O2 content, which when multiplied by resting cerebral 
blood flow provides the total oxygen delivery in absolute physical units. The 
resultant map of oxygen delivery can be multiplied by the map of OEF0 to obtain a 
map of the resting cerebral metabolic rate of oxygen consumption (CMRO2) in 
absolute physical units.
Application of this procedure in a group of seven human subjects provided average 
values of 0.35±0.04 and 6.0±0.7% for OEF0 and M, respectively in grey-matter (M 
valid for 30 ms echo-time at 3 Tesla). Multiplying OEF0 estimates by the individual 
values of resting grey-matter CBF (mean 52±5 ml/100g/min) and the measured 
arterial O2 content gave a group average resting CMRO2 value of 145±30 μmol/
100g/min. The method also allowed the generation of maps depicting resting OEF, 
BOLD signal, and CMRO2.
3.2.1. Keywords
Calibrated MRI, BOLD, OEF, CMRO2, hypercapnia, hyperoxia, carbogen, oxygen, 
metabolism
3.3. Introduction
Oxygen is a key molecule for metabolic energy production in higher organisms, 
and the brain accounts for a significant fraction of the human body's total resting 
oxygen consumption. Conversely, interruption of the brain's oxygen supply - for 
example through occlusion of the carotid arteries - leads to unconsciousness within 
seconds and irreversible tissue damage within minutes (Levy et al. 1975). Much of 
this voracious appetite for oxygen is thought to support ATP-dependent ion 
pumping proteins which are essential for the maintenance of neuronal membrane 
potentials during ongoing synaptic activity (Erecinska et al. 1990). It is thus easy to 
understand how deficits in oxygen delivery might lead to impaired neuronal 
function. Conversely, reductions in synaptic activity from neuronal degeneration 
lead to a decrease in overall cerebral metabolism. This overall reduction in 
metabolism can be manifested as a reduction in the consumption of both oxygen 
and glucose, the substrates used in aerobic metabolism. Thanks to the latter 
postulate, imaging of brain glucose uptake with positron emission tomography 
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(PET) in the diagnosis of dementia has become one of the largest clinical 
applications of any functional neuroimaging method (detection of metabolically 
active metastatic brain lesions being another). PET measures of glucose 
metabolism and resting oxygen extraction fraction (OEF) have been used to 
diagnose and evaluate the prognosis of diseases such as Alzheimer’s disease 
(Nagata et al. 2002; Herholz et al. 2007; Lo et al. 2011; Rodriguez et al. 2011), 
Parkinson’s disease (Hirano et al. 2009; Poston et al. 2010) and stroke (Yamauchi 
et al. 1999; Yamauchi et al. 2009; Zipfel et al. 2009; Isozaki et al. 2010).
PET imaging of 18FDG (fluorodeoxyglucose) uptake offers good sensitivity and 
spatial resolution and, due to the relatively long half-life of 18F, can be performed in 
clinics without an on-site cyclotron. Its disadvantages include ionizing radiation 
exposure from the positron emitting 18F tracer, additional radiation when an 
integrated x-ray CT scanner is employed to provide anatomic information, and the 
need to have access to a regional source of 18F close enough to allow delivery 
given the 110 minute half-life (Miller et al. 2008). The radiation dose considerations 
preclude serial imaging studies that could be of interest in clinical trials of drug 
efficacy, and the necessity of a regional source poses a problem for clinics situated 
in smaller municipalities.
Although used less frequently in clinical applications, the cerebral metabolic rate of 
oxygen consumption (CMRO2, which may reflect total ATP yield more directly than 
glucose uptake) can be obtained using 15O labeled PET tracers. As opposed to the 
straightforward single measurement required for FDG-PET, PET measures of 
CMRO2 require three separate acquisitions with injection of 15O labeled O2, H2O 
and CO. These three measurements are necessary to take into account the 
combined contribution of O2 diffusion into tissue, it’s conversion to water during 
oxidative metabolism, as well as the dependence on blood volume, assessed with 
C15O (Mintun et al. 1984; Buxton 2010). However, the use of three separate 
injections of positron emitting tracers greatly increases the radiation dose 
associated with this measurement. Furthermore, the short half-life (about two 
minutes) of 15O means that this technique is not possible without an on-site 
cyclotron (Miller et al. 2008).
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Because of the above concerns, an MRI-based alternative to PET-FDG and 
CMRO2-PET for imaging resting brain metabolism would be extremely attractive. 
While CMRO2 can be measured in MRI using 17O2 labeling methods (Fiat et al. 
1992; Fiat et al. 1993; Fiat et al. 2004), these techniques are impractical due to the 
limited availability and high cost of 17O. In recent years, efforts to develop proton 
MRI alternatives to PET have yielded some promising avenues to measure OEF 
and oxidative metabolism (CMRO2). While some of the techniques proposed yield 
whole-brain or single vessel estimates (An et al. 2000; Xu et al. 2009; Jain et al. 
2010; Fan et al. 2011), more recent efforts have focussed on mapping of these 
parameters (He et al. 2007; He et al. 2008; Bolar et al. 2011a). In the present 
article we propose a new and straightforward method for generating images of 
resting CMRO2 on a clinical MRI scanner. The technique proposed here is an 
extension of calibrated fMRI methods described previously (Davis et al. 1998; 
Hoge et al. 1999a; Chiarelli et al. 2007b; Gauthier et al. 2011b). Calibrated fMRI is 
an established technique to determine changes in CMRO2 associated with a task 
based partly on measurements acquired during a respiratory manipulation. We 
have previously described a generalization of calibrated MRI methods based 
individually on hypercapnia (Davis et al. 1998) and hyperoxia (Chiarelli et al. 
2007b).  This generalized calibration model (GCM), which is valid for arbitrary 
combinations of hypercapnia and hyperoxia, was used to estimate evoked changes 
in CMRO2 during neuronal stimulation (Gauthier et al. 2011a). In the present article 
we demonstrate that, in addition to the calibration parameter M required to 
estimate task-induced changes in CMRO2, the GCM can also be used to estimate 
resting OEF and ultimately resting CMRO2 in absolute micromolar units. The 
resultant calibration approach also yields resting cerebral blood flow (CBF) and 
cerebrovascular reactivity (CVR). These attributes offer the possibility of a 
comprehensive neurofunctional workup providing rich detail about vascular 
function, oxygen delivery, and tissue integrity in the brain.
3.3.1. Theory
A key component of all calibrated MRI approaches has been estimation of the 
parameter M, which has been commonly described as the maximal BOLD signal 
increase that would be observed upon elimination of all deoxygenated hemoglobin 
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(dHb) in tissues. We prefer the term resting BOLD signal, which reflects the fact 
that M isolates the purely dHb-dependent component of the total MRI signal at rest 
in the same way that arterial spin-labeling (ASL) difference signals isolate the 
purely flow-dependent component of MRI signals at rest. Similarly to ASL 
difference signals, a task-induced change in BOLD signal can be normalized to the 
resting BOLD signal to obtain a physiologically meaningful quantity: the fractional 
change in tissue dHb concentration (although unlike ASL and CBF the relationship 
between BOLD and dHb ratios is a power law rather than linear). This information, 
together with fractional flow changes from ASL, can then be used to determine the 
task-induced fractional change in CMRO2. The latter output is a relative quantity, 
which does not include information about the actual absolute baseline.
Here we present a further extension of our generalized method which allows 
estimation of both the resting BOLD signal M and the resting oxygen extraction 
fraction (OEF0). We then describe how the MRI and respiratory measures acquired 
during this procedure can be combined to estimate resting oxygen consumption.
3.3.1.1. Determination of resting BOLD signal M and OEF
Our initial description of the CGM in Gauthier et al. (Gauthier et al. 2011a; Gauthier 
et al. 2011b) describes its application for providing robust estimates of the MRI 
calibration parameter M during hypersaturation of venous blood produced by 
carbogen inhalation. The extension presented here allows simultaneous 
determination of M and resting OEF using two gas manipulations: one hyperoxic 
and the other hypercapnic. The procedure is based on the original calibrated BOLD 
formulation proposed by Davis (Davis et al. 1998), in which M is modeled as
M =
ΔBOLD
BOLD0
1− CBVCBV0
⎛
⎝⎜
⎞
⎠⎟
dHb[ ]
dHb[ ]0
⎛
⎝⎜
⎞
⎠⎟
β ,
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⎛
⎝⎜
⎞
⎠⎟
≈
CBF
CBF0
⎛
⎝⎜
⎞
⎠⎟
α
 [1]
where the numerator is the fractional change in BOLD signal produced by a gas 
manipulation, and the denominator includes terms representing cerebral blood 
volume (CBV) and blood concentration of deoxygenated hemoglobin [dHb] during 
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the manipulation normalized to their respective baseline values. The exponent α 
(most recently estimated to be ∼0.18 (Chen et al. 2010c)) models the non-linear 
coupling between flow and venous volume changes, while β (∼1.5 (Boxerman et al. 
1995)) represents the non-linear dependence of changes in R2* on 
deoxyhemoglobin concentration.
The Davis formulation modeled the deoxyhemoglobin term in Equation 1 as the 
reciprocal of the increased relative CBF during hypercapnia (from the Fick principle 
of mass conservation), while the subsequent adaptation by Chiarelli estimated the 
same term by modeling increases in blood oxygen content during hyperoxia 
(assuming minimal flow changes). The GCM is an extension of Davis and 
Chiarelli's methods that is valid for arbitrary combinations of changes in arterial 
oxygen content and flow, allowing the baseline-normalized deoxyhemoglobin term 
to be expressed as
dHb[ ]
dHb[ ]0
=
CaO2 0 ⋅OEF0
ϕ[Hb]
1−
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ϕ[Hb] 1−OEF0( )
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⎟
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where CBF0/CBF is the reciprocal of the baseline-normalized cerebral blood flow 
during the gas manipulation (taken directly in the original Davis model to represent 
[dHb]/[dHb]0), φ is the O2 capacity of hemoglobin in ml O2/g Hb, [Hb] represents 
the concentration of total hemoglobin (oxygenated or deoxygenated) in the blood in 
g Hb/ml blood (which can be determined by blood test), OEF0 is the oxygen 
extraction fraction at rest, CaO2 is the total arterial oxygen content in ml O2/ml 
blood during the manipulation, and CaO2|0 is the resting value of the latter. The 
baseline and gas-manipulated values for CaO2 are determined from 
measurements of end-tidal O2 using the Severinghaus equation (Severinghaus 
1989) and plasma solubility of O2 as described by Chiarelli et al. (Chiarelli et al. 
2007b). While the oxygen saturation curve described by the Severinghaus 
equation can be significantly altered during hypercapnia, all measurements 
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involved in this calibration procedure take place at very high saturations where 
shifts in the curve with CO2 concentration are negligible.
The factor (henceforth referred to as X) applied to (CBF/CBF0) in Equation 2 
represents the fraction of resting venous deoxyhemoglobin that is generated 
through local metabolism (as opposed to delivered in arterial blood; typically close 
to 100% of [dHb] in healthy individuals, but less if arterial O2 saturation is 
abnormally low), while the second additive term (which we will call Y) represents 
reductions in total (arterial plus venous) deoxyhemoglobin due to increased arterial 
O2 content during the gas manipulation. The expression reduces to the Davis 
model when arterial O2 saturation remains constant at exactly 100% (CaO2/
(φ[Hb])=CaO2|0/(φ[Hb])=1, so X=1, Y=0), and to the Chiarelli model when the gas-
induced CBF change approaches zero (Gauthier et al. 2011a). The GCM thus 
encompasses previous models under the specific assumptions of those models.
In the original Chiarelli method for hyperoxia-calibrated fMRI, a specific fixed value 
of OEF0 was assumed in their counterpart to Equation 2. Substitution of CBF, 
BOLD, and end-tidal quantities measured during a single gas manipulation would 
then yield a unique value of M. If OEF0 is not fixed, one nonetheless obtains a 
specific functional relationship between M and OEF0:
M = f (OEF0 )     [3]
where the shape of the function f is determined by the measured MRI and end-tidal 
quantities. In the method proposed here, two gas manipulations (hyperoxia and 
hypercapnia) are performed and the two resultant equations for M = f(OEF0) are 
solved to give a unique combination of M and OEF0 corresponding to the 
intersection of the two functions. The solution to such a system of two equations for 
two unknowns can be readily solved to arbitrary precision using numerical 
methods.
3.3.1.2. Determination of resting CMRO2
Once the resting value of OEF is determined via the above procedure, resting 
CMRO2 in ml O2/100g/min can then be computed as
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CMRO2 0 = CaO2 0 ⋅CBF0 ⋅OEF0      [4]
where CBF0 is the resting cerebral blood flow expressed in ml/100g/min. It can be 
seen that the product of the first two terms is equivalent to the rate of O2 delivery, 
which is converted to the rate of O2 consumption after multiplication by the third 
extraction fraction term. Conversion from milliliters to micromolar units can be 
carried out using the following conversion factor:
1000000µmol
mol
⎡
⎣⎢
⎤
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⎤
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22.4L
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1000ml
L
⎡
⎣⎢
⎤
⎦⎥
= 39.34 µmolml
⎡
⎣⎢
⎤
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     [5]
based on the ideal gas law adjusted for physiological temperature.
3.4. Methods
Acquisitions were conducted in eight healthy subjects (seven male and one female, 
aged 21 to 38 years) on a Siemens TIM Trio 3T MRI system (Siemens Medical 
Solutions, Erlangen, Germany) using the vendor-supplied 32-channel receive-only 
head coil for all acquisitions. All subjects gave informed consent and the project 
was approved by the Comité mixte d’éthique de la recherche du Regroupement 
Neuroimagerie/Québec.
3.4.1. Image acquisition
Sessions included an anatomical, 1mm3 MPRAGE acquisition with TR/TE/alpha = 
2300ms/3ms/9°, 256x240 matrix and a GRAPPA acceleration factor of 2 (Griswold 
et al. 2002). 
Functional image series were acquired using a dual-echo pseudo-continuous 
arterial spin labeling (pCASL) acquisition (Wu et al. 2007) to measure changes in 
cerebral blood flow (CBF). The parameters used include: TR/TE1/TE2/alpha = 
3000ms/10ms/30ms/90° with 4x4mm in-plane resolution and 11 slices of 7mm 
(1mm slice gap) on a 64x64 matrix (at 7/8 partial Fourier), GRAPPA acceleration 
factor = 2, post-labeling delay = 900ms, label offset = 100mm, Hanning window-
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shaped RF pulse with duration/space = 500μs/360μs, flip angle of labeling pulse = 
25°, slice-selective gradient = 6mT/m, tagging duration = 1.5s (Wu et al. 2007).
3.4.2. Gas manipulations
Each session included three functional runs each including a different gas 
manipulation. During each gas manipulation run, a single three-minute block of gas 
inhalation was preceded with one minute and followed by two minutes of medical 
air breathing. The three gas manipulations used were: 100% O2 (hyperoxia), 7% 
CO2/21%O2/72%N2 (hypercapnia) and 7% CO2/93% O2 (simultaneous hyperoxia/
hypercapnia). The latter gas is a specific formulation of carbogen, which in general 
may contain different O2/CO2 ratios.
At the beginning of the experiment, subjects were fitted with a non-rebreathing face 
mask (Hudson RCI, #1059, Temecula, California, USA). To avoid discomfort from 
outward gas leakage blowing into the subject’s eyes, skin tape (Tegaderm Film, 
#1626W, 3M Health Care, St-Paul, MN, USA) was used to seal the top of the mask 
to the face. Plastic tubing (AirlifeTM Oxygen tubing #001305, Cardinal Health, 
McGraw Park, IL, USA) and a series of two Y-connectors were used to connect 
pressure/flow-meters for medical air, 100% O2 (hyperoxia), 7% CO2/93% air 
(hypercapnia) and 7% CO2/93% O2 (simultaneous hyperoxia/hypercapnia) tanks 
(Vitalaire, Mississauga, ON, Canada) to the mask. Gas flows were adjusted 
manually on the pressure/flow-meters (MEGS, Ville St-Laurent, QC, Canada) to 
keep a total flow rate of 16L/min. Gas flow was kept at 16L/min at all times except 
during administration of the hyperoxia/hypercapnia and the hypercapnia gas 
mixtures. To accommodate the elevated minute ventilation caused by CO2 
breathing, gas flow rates were increased to the maximal possible rate (25L/min) 
achievable with our pressure/flowmeters. Pulse rate and arterial O2 saturation were 
monitored in all subjects using a pulse-oximeter (InVivo Instruments, Orlando, 
USA) as a safety measure and to observe the effects of carbogen breathing. 
End-tidal O2 and CO2 values were monitored during all acquisitions. Gases were 
sampled via an indwelling (15 mm) nasal cannula (AirlifeTM Nasal Oxygen 
Cannula #001321, Cardinal Health, McGraw Park, IL, USA) using the CO2100C 
and O2100C modules of the MP150 BIOPAC physiological monitoring unit 
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(BIOPAC Systems Inc., Goleta, CA, USA). Calibration of the unit was done by 
taking into account an expired partial pressure of water of 47mmHg (Severinghaus 
1989). Subjects were instructed to breathe through their nose, which ensured that 
only expired gas was sampled by the nasal cannula. End-tidal CO2 and O2 values 
were selected manually from continuous respiratory traces sampled at 200 Hz. The 
first 10 breaths of the first baseline period and the last 10 breaths of the gas-
inhalation block were averaged to give baseline values and gas manipulation 
values respectively.
Following acquisition, all subjects were debriefed to assess the level of discomfort 
associated with the manipulation. The subjects were asked to rate the air hunger 
and breathing discomfort associated with the hypercapnia and carbogen mixtures 
on a French language version of the scale proposed in (Banzett et al. 1996).
3.4.3. Data analysis
The raw EPI series acquired during the three gas manipulation runs were 
preprocessed by motion correction (Cox et al. 1999) and spatial smoothing with a 
3D Gaussian kernel (10 mm FWHM). The CBF signal was isolated from the series 
of first echoes using linear surround subtraction (Liu et al. 2005), while the BOLD 
signal was extracted using linear surround addition of the second echo series 
(multiplicative error on BOLD signal due to ASL contamination is less than 1% of 
the BOLD response with this approach and all time points are utilized).
Fractional changes in BOLD and CBF signals were then determined for each gas 
manipulation by fitting a GLM to the respective signals and dividing the estimated 
effect size by the estimated constant term. Model fits used a single-gamma 
hemodynamic response function (HRF) with parameters described by Glover et al. 
(Glover 1999) and included a first order polynomial to represent baseline signal 
and linear drift (higher order polynomial fits were deemed unsuitable due to the 
single long block during the gas runs). Because the canonical HRF cited above 
actually bears little resemblance to the impulse response describing transitions 
between respiratory states, the first 60 seconds after each transition in gas 
composition were excluded from the analyses by zeroing out relevant rows in the 
GLM computational matrices, to select responses at steady-state. While the 
123
transition data might add statistical power if properly modeled, mis-specification of 
the shape would have the opposite effect and satisfactory results were obtained 
with the simple approach described here.
Image datasets were masked prior to smoothing, based on the intensity of the 
baseline EPI scans, to ensure that only intra-cerebral voxels were analyzed. 
Additional masking was performed to remove large veins that could be readily 
identified as very large (>10%) BOLD increases in unsmoothed EPI data during 
CO2 inhalation. Large arteries exhibited implausibly large decreases in pre-T1-
correction absolute CBF (>50 ml/100g/min decrease, likely due to T1 shortening) 
during O2 inhalation, allowing them to be similarly masked out. All masks were 
generated based on unsmoothed data, and were applied before smoothing in 
subsequent analyses to avoid "bleeding" of large vessel responses into 
parenchymal voxels. Basing masks on the unsmoothed data had the added 
advantage that the contrast of vascular responses against background was greatly 
enhanced at the higher spatial resolution (less partial volume averaging), 
considerably improving specificity. In practice this measure reduced the incidence 
of macrovascular "hot spots" without substantially affecting the distribution of grey 
matter values.
Because the flow changes produced by hyperoxia were considerably smaller than 
the noise level in our ASL acquisitions, a constant fixed value of -3.11% was 
assumed for this CBF change (only for hyperoxia). This value was the average flow 
change determined by first averaging the O2-induced change in ASL signal (after 
correction for T1 changes as described below) over all cortical and sub-cortical 
grey matter in each subject, and then pooling average values from the seven 
subjects. The use of a fixed value for the O2-induced flow response is also 
advocated in the Chiarelli method, as these changes are generally agreed to be 
too small for reliable measurement at the single voxel level with current ASL 
methods and within the range of measurement error they do not contribute 
significantly in the model. 
As noted above, it was necessary to correct maps of the fractional CBF change 
during hyperoxic manipulations to account for changes in the T1 of blood known to 
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occur during changes in the plasma concentration of O2 (which is paramagnetic). 
This was carried out using the approach described in (Chalela et al. 2000; 
Zaharchuk et al. 2008). We estimated arterial blood T1 values based on the end-
tidal O2 (ETO2) measurements obtained in each subject, along with T1 vs. ETO2 
values tabulated in Bulte et al. (Bulte et al. 2007). Since the exact T1 depends on 
the level of dissolved O2 in plasma, and because we obtained slightly different 
ETO2 values at a given fraction of inspired O2 than the latter study, the values were 
interpolated to account for this difference.
Following determination of average end-tidal O2 values as described above, the 
latter were converted to arterial O2 content in ml O2/ml blood as described in 
Chiarelli et al (Chiarelli et al. 2007b). In this approach, end-tidal O2 respiratory 
measures are taken to represent the arterial partial pressure of O2 (PaO2). These 
are translated to arterial hemoglobin saturation (SaO2) using the Severinghaus 
equation (Severinghaus 1979):
SaO2 =
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The total arterial O2 content CaO2 is then determined as the sum of O2 bound to 
hemoglobin and O2 dissolved in plasma:
CaO2 = ϕ ⋅[Hb]⋅SaO 2( ) + PaO2 ⋅ε( ) .     [7]
The following parameters were assumed for all subjects in the latter conversion: φ 
= 1.34 mlO2/gHb, [Hb] = 15 gHb/dl blood, and ε = 0.0031 mlO2/dl blood/mmHg (the 
solubility of O2 in plasma) (Chiarelli et al. 2007b; Rhoades et al. 2009). In two of 
the subjects, [Hb] was also determined through a blood draw as part of their 
participation in another study. It can be seen that the first additive term represents 
O2 bound to hemoglobin, while the second term represents O2 dissolved in plasma.
Prior to modeling of the data, region-of-interest (ROI) masks selecting cortical and 
sub-cortical grey matter were generated based on the high-resolution T1 scan 
using the automated segmentation capabilities of the CIVET software package 
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(Tohka et al. 2004). These ROI masks were then resampled to the resolution of the 
functional EPI scans for use in subsequent analyses.
For the hyperoxic and hypercapnic manipulations, the corresponding fractional 
changes in BOLD and CBF along with arterial O2 content values were substituted 
into the generalized calibration model to determine the M vs. OEF0 curve for each 
gas (the averaging performed on the measured MRI and respiratory values is 
described below). The intersection point of the two curves was then determined 
numerically using the bisection method (Press et al. 1992). A third curve was also 
generated based on the MRI and respiratory responses during carbogen inhalation 
(combined hyperoxia and hypercapnia), and used to confirm the existence of a 
unique intersection point. To assess both the validity of the procedure as well as its 
stability under progressively more challenging SNR conditions, the solution of the 
model was carried out on data generated at three levels of averaging: 1) the group 
average of individual grey-matter ROI averages and respiratory values; 2) 
individual ROI averages and respiratory values; and 3) single voxels in individual 
scans and individual respiratory values.
The group average curves for the three conditions (hyperoxia, hypercapnia, and 
combined) were plotted to confirm intersection at or near a common point. To 
assess the sensitivity of M and OEF0 estimates on the assumed model parameters 
α and β, this procedure was repeated with a range of values for each parameter, 
bracketing the nominal literature values used in the actual analysis. The range of α 
was 0.1 to 0.38, with the upper value being the original Grubb value for total 
(arterial plus venous) blood volume. The range of β parameters was one to two 
(centered on the nominal value of 1.5). To investigate the effect of possible 
changes in CMRO2 during hypercapnia, we conducted additional analyses in which 
both increases (Horvath et al. 1994; Jones et al. 2005) and decreases (Zappe et al. 
2008; Xu et al. 2011b) of 15% in cerebral oxygen consumption were simulated 
during the hypercapnic component of calibrations. This was effectuated by applying 
the appropriate factor (1.15 or 0.85) to the terms in Eq. 2 representing oxygen 
consumption (normally assumed to be constant at the resting value). The value of 
Δ%CMRO2 = ±15% was chosen because it spans the range of values suggested in 
the literature cited above during comparable hypercapnic manipulations.
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Individual ROI data from hyperoxia and hypercapnia were used to determine 
average cortical M and OEF0 solutions for each subject, while voxel-wise analyses 
were used to generate images of M and OEF0 for each subject. Because of the 
reduced signal-to-noise ratio in the voxel-wise case, parameter images were 
computed as the average of the solutions for the hypercapnia-hyperoxia and 
combined-hyperoxia combinations. In cases where one of the latter combinations 
did not intersect (i.e. no solution) the other solution was taken if it existed. To aid in 
assessing anatomic contrast in the computed parameters, individual parametric 
maps were also spatially normalized using FSL (Jenkinson et al. 2001) to allow 
computation of the arithmetic mean image over all seven subjects. To account for 
the fact that images of some subjects contained regions with no solution, the 
averaging procedure took into account the actual number of values (true solutions) 
contributing in the average to prevent bias.
Computation of resting CMRO2 required the absolute resting CBF, which was 
determined from the pCASL data using the approach described by Wang et al. 
(Wang et al. 2003a) assuming blood brain partition coefficient = 0.9, labeling 
efficiency = 0.80, blood T1 = 1.49 s, and grey matter T1 = 1.4 s. For this 
computation, the baseline ASL difference signal estimated in the GLM fit for each 
gas manipulation was divided by an estimate of the baseline (raw) EPI signal 
computed in a similar GLM fit and the resultant ratio converted to absolute CBF 
units based on the parameters above. Maps of resting CMRO2 were obtained by 
computing the product of the resting arterial O2 content for that subject, resting 
CBF, and OEF0. For each of the latter terms, averaging was performed at the three 
levels described above.
Other than the coordinates for intersection of group average M vs. OEF0 curves, 
for which the range of intersection coordinates was used, all uncertainties are 
provided as ± standard deviation.
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3.5. Results
3.5.1. Gas manipulations
Hyperoxic gas manipulations led to increases in end-tidal O2 in all subjects. 
Hypercapnia led to slight increases in some subjects (likely due to modest 
increases in minute ventilation), but overall the change was non-significant. The 
mean resting ETO2 value over all seven subjects, in all gas manipulations, was 
117±14 mmHg. Mean increases in ETO2 were: 424±79 mmHg for hyperoxia, 14±22 
mmHg for hypercapnia, and 300±65 mmHg for combined hyperoxia and 
hypercapnia. The average resting ETCO2 value over all gas manipulation scans 
was 39±3 mmHg. The mean changes in ETCO2 were: -3±5 mmHg during 
hyperoxia, 9±4 mmHg during hypercapnia, and 8±4 mmHg during combined 
hyperoxia and hypercapnia.Table 1
Quantity Value
Hyperoxia
Resting ETO2 116±14 mmHg
Manipulated ETO2 540± 74 mmHg
Δ%CBF -3.1±9%
Δ%BOLD 1.71±0.4%
Hypercapnia
Resting ETO2 120±17 mmHg
Manipulated ETO2 134±14 mmHg
Δ%CBF 37±8%
Δ%BOLD 2.3±0.4%
Hyperoxia + Hypercapnia
(Carbogen)
Resting ETO2 115±13 mmHg
Manipulated ETO2 415± 60 mmHg
Δ%CBF 41± 12%
Δ%BOLD 3.5±0.8%
Table 1
Group average MRI and respiratory measures used to compute GCM solutions for M and OEF0.
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3.5.2. ROI analyses
3.5.2.1. MRI responses
All hypercapnic manipulations led to significant increases in grey-matter CBF. 
Average percent changes in CBF were 37±8% for hypercapnia (mean ΔETCO2 = 
9±4 mmHg), and 41±12% for combined hyperoxia/hypercapnia (ΔETCO2 = 8±4 
mmHg). Hyperoxia produced a mean flow decrease of 3.1±9%, after correction for 
T1 changes. Average resting cerebral blood flow in grey matter was 52±5 ml/100g/
min. The average CO2-mediated cerebrovascular reactivity during hypercapnia was 
5.3±1.6 Δ%CBF/mmHg CO2.
All gas manipulations, both hypercapnic and hyperoxic, led to increases in BOLD 
signal. These were: 1.7±0.4% for hyperoxia, 2.3±0.4% for hypercapnia, and 
3.5±0.8% for combined hyperoxia/hypercapnia.
3.5.2.2. Group average M vs. OEF0 curves
Figure 1 shows plots of the M vs. OEF0 curves for hyperoxia, hypercapnia, and 
combined hyperoxia/hypercapnia, computed by first averaging end-tidal O2 
changes and MRI responses within grey-matter ROI's from all subjects and then 
inputting these group average measurements into the model. The three curves 
intersected very close to a common point situated at OEF0 = 0.37±0.01 and M = 
6.200±0.005% (uncertainties are based on distances of individual intersections 
from midpoint). Curves were generated over the physically possible range of OEF 
values: zero to one (the trivial solution at OEF0 = 0 is ignored). Values of OEF0 
below 0.1 (which are extremely unlikely to arise in practice) resulted in complex 
values of M for the two manipulations that included hyperoxia (only the real part is 
shown - values of OEF0 above 0.1 gave purely real M values in all cases). It can be 
seen that the curve for hyperoxia is somewhat orthogonal to those for the 
manipulations including hypercapnia, which are relatively similar. Because of this, 
we found that solutions between the purely hyperoxic manipulation and the two 
other (solely or partly) hypercapnic conditions were more robust. Group average 
measurements used as inputs to the model are listed in Table 1.
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Figure 1 
Grey matter M vs. OEF0 curves computed with GCM using group average input data for hyperoxia 
(grey), hypercapnia (black), and combined hyperoxia/hypercapnia (dashed). The three intersection 
points coincide closely, centered on OEF0 = 0.37±0.01, M = 6.200±0.005%.
3.5.2.3. Individual grey matter ROI values of OEF0, M, and CMRO2
Figure 2A shows a scatter plot of OEF0 and M values computed from the 
intersection of the hyperoxia curve with those for hypercapnia (circles) and the 
combined manipulations (crosses), generated using input MRI and respiratory data 
averaged over grey matter in each of seven individual subjects. Axis scaling is 
based on the range of OEF0 and M values spanned by the different M vs. OEF0 
curves plotted for group average data in Figure 1. Considering the range of values 
physically possible, the individual values cluster closely around physiologically 
plausible values for M (6.0±0.7) and OEF0 (0.35±0.04). Multiplying individual grey-
matter OEF0 estimates by the corresponding values of CaO2|0 and CBF0 gave 
similarly close distributions of CMRO2 estimates (Figure 2B) with an average value 
of 140±28 μmol/100g/min for hypercapnia and 150±34 μmol/100g/min for the 
combined manipulation (the average of the two manipulations gave 145±30 μmol/
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100g/min). Parameter estimates for individual subjects, including cerebrovascular 
reactivity (CVR), are shown in Table 2.
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Figure 2 
A) Coordinates for intersections of hyperoxia/hypercapnia curves (grey circles) and hyperoxia/
combined curves (black crosses) in grey matter for seven individual healthy subjects. Axis scaling is 
the same as Figure 1, covering the physically possible range of OEF0 and corresponding M values 
for the different gases. Individual solution values are clustered around the average coordinates 
OEF0 = 0.35±0.05, M = 6.0±0.8%. B) Box and whisker plot showing median, quartile, and adjacent 
value ranges of computed CMRO2 for the seven subjects using the solutions between hyperoxia 
and hypercapnia (left) or combined hyperoxia/hypercapnia (right). Average CMRO2 values were 
138±28 μmol/100g/min for hypercapnia, and 149±34 μmol/100g/min for the combined manipulation.Table 2
Subject
Resting CBF
(ml/100g/min)
CVR
(Δ%CBF/mmHg CO2)
M OEF0
Resting CMRO2
(µmol/100g/min)
1 44.0 4.2 7.0 0.32 111.6
2 53.4 3.6 6.3 0.39 164.6
3 52.1 5.0 5.8 0.33 135.7
4 59.8 4.0 6.6 0.42 199.6
5 53.4 7.1 5.9 0.35 149.2
6 46.5 7.6 4.9 0.32 116.8
7 56.2 5.4 5.6 0.32 139.5
average 52±5 5.3±1.6 6.0±0.7 0.35±0.04 145±30
Table 2
Physiological parameters computed in individual subjects.
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3.5.3. Parametric maps
3.5.3.1. Resting BOLD signal M
Figure 3A shows the maps of resting BOLD signal M obtained for the seven 
subjects by solving the GCM at each voxel and averaging (or merging) the 
solutions for hypercapnia and carbogen as described above. The M maps 
demonstrate the expected contrast between grey and white matter (due to the 
higher blood volume in grey matter) and the distribution of values in grey matter 
corresponds well to those obtained above in ROI analyses as well as in previous 
studies (Gauthier et al. 2011a; Gauthier et al. 2011b). The qualitative appearance 
of the maps is good, with plausible grey-white matter contrast and few venous hot 
spots or improbably high values that can result from non-linear amplification of 
noise in BOLD calibration models (Gauthier et al. 2011a). Black patches in grey 
matter (e.g. subject 4) indicate regions in which neither the hypercapnic nor 
carbogen GCM curves intersected with the curve for hyperoxia.
3.5.3.2. Resting oxygen extraction fraction OEF0
Figure 3B shows maps of resting OEF for the seven subjects. Although previous 
PET studies (Frackowiak et al. 1980; Ito et al. 2004; Ashkanian et al. 2008; 
Bremmer et al. 2010; Ibaraki et al. 2010) indicate that OEF is very constant 
throughout the resting brain, the individual OEF0 maps exhibited a degree of 
apparently random spatial heterogeneity as well as a modest grey-white matter 
contrast in most subjects. Nonetheless the values within grey matter tended to be 
distributed within a physiologically plausible range (e.g. the literature standard 0.3 
assumed for healthy tissue in the Chiarelli method (Chiarelli et al. 2007b)) 
consistent with the ROI analyses presented above.
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Figure 3 
Individual maps of (A) resting BOLD signal M, (B) resting OEF, and (C) resting CMRO2 for seven 
subjects, computed as average of hyperoxia-hypercapnia and hyperoxia-combined solutions (image 
left is subject left). When only one out of the two pairs of equations could be solved, that value was 
used. Voxels where no solutions existed were assigned a value of zero (black patches visible in 
some subjects, e.g. #4).
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3.5.3.3. Resting oxygen metabolism CMRO2
Figure 3C shows maps of resting CMRO2 computed for the seven subjects. While 
the effect of noise in the OEF0 maps is apparent, the distribution of grey matter 
CMRO2 values is generally in very good agreement with the ROI values computed 
above.
3.5.3.4. Group average maps
Figure 4 shows average images from spatially normalized individual maps. All 
maps exhibited plausible pattern of anatomic contrast, with quantitative values 
tending towards group average ROI estimates. Grey-white matter contrast is 
absent in the map of resting OEF, as expected for this parameter.
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Figure 4 
Group average (N=7) maps of estimated parameters. Images of M, OEF, CBF, and CMRO2 exhibit 
plausible pattern of anatomic contrast, with quantitative values matching group average ROI 
estimates. Grey-white matter contrast is absent in the map of resting OEF, consistent with previous 
PET studies.
3.5.3.5. Sensitivity to model parameters, possible CMRO2 changes during 
hypercapnia
Figure 5 shows model three-gas model solutions for group average ROI data and a 
range of values for α and β. Some parameter combinations (such as α = 0.38, β = 
1) gave widely divergent solution points for the different gases, while others gave 
coincident solution points but at slightly different values of M and OEF0 from the 
nominal parameters.
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Figure 5 
Dependence of solution coordinates on assumed model parameters α and β with the same group 
average data plotted in Figure 1. The values used, α = 0.18 and β = 1.5, are in the central plot (e). 
The intersection yielded by these nominal values is indicated by the star (same coordinates) in each 
plot. Some parameter combinations (such as c) lead to widely divergent solution points for the 
different gases, while others give coincident solution points but at slightly different values of M and 
OEF0 from the nominal parameters. Axis scaling and units for all plots are as in Figure 1 and 2: the 
horizontal axis is resting OEF, and the vertical axis is M.
Figure 6 shows three-gas solutions for group average ROI data and hypercapnia-
induced CMRO2 changes of -15%, 0, and +15%. Modeling the increase in CMRO2 
during hypercapnia resulted in widely divergent model curves, with the midpoint of 
intersections falling at OEF0 = 0.68 and M = 11%. Modeling a 15% decrease in 
CMRO2 resulted in a more convergent intersection of the three curves. The 
solution coordinates in this case were centered at OEF0 = 0.25 and M = 4.5%.
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Figure 6
Variation of model curves with simulated decreases (A) and increases (C) in CMRO2 during 
hypercapnic phases of calibration. Curves with no CMRO2 change (B) are shown for comparison 
(solution coordinates for Δ CMRO2 = 0 indicated by star on all plots). Simulated CMRO2 increases 
prevented convergence of curves (C), while decreases resulted in very low apparent solution values 
for OEF0 and M.
3.6. Discussion
We have demonstrated GCM-based estimation of resting BOLD signal M, OEF0, 
and CMRO2 in seven healthy volunteers. The intersection of group average M vs. 
OEF0 curves at almost exactly coincident points, as well as the correspondence 
between the coordinates of this point and previous literature values for the above 
parameters, lend strong support for the validity of this method. The individual ROI 
analyses indicate that the approach is feasible at the single-subject level. While 
generating maps of MRI calibration parameters at the single voxel level has proven 
in the past to be quite challenging (the vast majority of calibrated MRI studies have 
reported ROI values rather than maps), the relative stability of individual and group 
average maps of M, OEF, and CMRO2 obtained with the GCM in combination with 
the three-gas calibration approach is also encouraging.
3.6.1. Accuracy
Here we define accuracy as the tendency for data with sufficiently high SNR 
(regional, group averaging) to converge towards physiologically plausible values 
that are in agreement with independent measurements using other techniques 
from literature. 
The parameters estimated in the present study from group average data are in 
good agreement with literature values. Grey-matter average values for M at 3 Tesla 
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(adjusted to TE = 30 ms) have been reported as 7.0±0.7% (hyperoxia (Chiarelli et 
al. 2007b)), 7.9±0.6% (GCM with carbogen (Gauthier et al. 2011a)), 8.8±0.8% 
(hypercapnia (Mark et al. 2011)), and 6.6±0.4% (hyperoxia (Mark et al. 2011)). The 
group average value of 6.0±0.7% overlaps with this range, although at the lower 
end. This is likely due to the fact that, in the present study, we masked out the 
largest veins as described in the methods section, which will remove a slight 
source of upward bias on the average M value over all grey matter. Other 
differences include the fact that the studies by Chiarelli and Mark used pulsed ASL, 
with the additional incorporation of background suppression in the Mark study 
(BOLD acquisitions were interleaved without background suppression). The use of 
background suppression is likely to be an effective means of improving the low 
signal-to-noise ratio in ASL image series.
While OEF values ranging from 0.26±0.02 (Bolar et al. 2011a) through 0.3 
(Perlmutter et al. 1985) to 0.45±0.06 (Ibaraki et al. 2010) have been reported, the 
average value of 0.35±0.04 in the present study falls solidly in the center of this 
range.
Values obtained for resting CMRO2 in grey-matter were also in good agreement 
with literature data. A recent study by Xu et al. (Xu et al. 2009) used the TRUST 
method to estimate the mean whole-brain CMRO2 in healthy volunteers at 132±20 
μmol/100g/min, which is slightly lower than our group average grey-matter value of 
145±30 μmol/100g/min. The latter study also included a survey of literature values 
obtained primarily using PET, for which grey-matter values of 147 and 157 μmol/
100g/min were cited in subjects of various ages (Ishii et al. 1996; Ibaraki et al. 
2010). Other estimates cited in Xu's survey ranged from 118 to 157 μmol/100g/min, 
corresponding very closely to the average value of 145±30 μmol/100g/min for grey-
matter determined with MRI in the present study. Whole brain values are expected 
to be somewhat lower than grey-matter values, given that the bulk of synaptic 
membrane activity takes place in grey matter. An alternate MRI-based method, 
QUIXOTIC, recently proposed by Bolar et al. (Bolar et al. 2011a) yielded an 
average grey-matter CMRO2 value of 125±15 μmol/100g/min, which is somewhat 
lower than the grey-matter measurements cited for PET.
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While the agreement with literature values in healthy volunteers is very 
encouraging, potential sources of bias include the possibility that functional ASL 
measurements during the carbogen manipulation are biased by blood T1 changes. 
However we have taken steps to correct for T1 shortening, using a procedure that 
has been validated in CGM-calibrated MRI with carbogen (Gauthier et al. 2011a) 
against more direct calibration using near-total saturation of venous blood 
(Gauthier et al. 2011b). Moreover in future applications of this approach we believe 
that the carbogen manipulation can be omitted, leaving only hyperoxia and 
hypercapnia. Hypercapnia is not significantly affected by T1 changes, while the 
CBF changes during hyperoxia are so minimal that they can be modeled with a 
small fixed constant value (as done here based on group average data with T1 
correction).
The correct choice of constant model parameters have been another area of 
ongoing concern in calibrated MRI. In particular the parameter α, used to model 
venous blood volume, has been the topic of considerable debate. Recent work 
indicates that the long-assumed value of 0.38 determined by Grubb for the 
aggregate arterio-venous blood volume (Grubb et al. 1974) is too high and should 
be replaced with the lower value of 0.18 measured specifically for the venous 
circulation in which deoxygenated hemoglobin resides. The value of β used here is 
also derived from older literature, having been estimated by Boxerman using 
Monte Carlo simulations and microsphere phantoms (Boxerman et al. 1995). To 
assess the sensitivity of our physiological estimates to these model parameters, we 
repeated the graphical solution originally shown in Figure 1 using a range of 
different α and β values (Figure 5). Performing this analysis with the three gas 
curves had the interesting benefit that it allowed us to rule out some combinations 
of α and β, since they resulted in intersection points for the different curves that 
were widely divergent (e.g. β = 1 did not appear to converge for any value of α). 
For the parameter combinations that did converge, the resultant estimates of M 
and OEF deviated only slightly from the results obtained using the nominal values. 
Given the complexities of multi-compartment modeling of susceptibility-based 
contrast, it should be understood that α and β are more appropriately viewed as 
lumped constants, respectively modeling multiple effects associated with CBV or 
138
[dHb], when applied to the low spatial-resolution single TE data typically acquired 
in calibrated MRI. This issue has recently been explored by Griffeth et al. (Griffeth 
et al. 2011), who used numerical optimization of a multi-compartment model for 
measured data to estimate the values of α and β. The latter study found that 
alternate values of α = 0.14 and β = 0.91 might be more appropriate for the 
measurement conditions considered. While we were able to verify (in separate 
analyses; data not shown) that the latter value of α (0.14) was compatible with a 
unique (M,OEF0) solution for the three gases tested, our data and model appeared 
to be inconsistent with Griffeth's β value (i.e. no combination of other parameters 
gave a unique solution with β = 0.91). While further exploration will be required to 
reconcile these findings, the GCM and Griffeth models provide complementary 
means of exploring the biophysics of BOLD contrast.
In addition to the above MRI parameters, modeling of the arterial and venous 
oxygen contents and saturations are an important component of the method 
presented. Fortunately the parameters involved (hemoglobin O2 capacity φ, 
plasma O2 solubility ε, and blood concentration of hemoglobin [Hb]) are highly 
conserved in healthy individuals (Rhoades et al. 2009). The only potentially 
uncertain parameter is [Hb], which can vary with gender (due to differences in 
hematocrit), disease (e.g. anemia), and acclimation to altitude. Individual values for 
[Hb] can however be readily determined using a simple blood test at the time of the 
exam. Two subjects in the present study had undergone recent blood tests are part 
of their participation in another study. Their respective values for [Hb] were 14.5 
and 15.2 g Hb/dl blood, very close to the assumed value of 15 gHb/dl blood. Given 
the ease with which [Hb] can be measured, we recommend that future imaging 
studies adopting this method include a blood draw.
A potential concern related to oxygen content modeling is that the hemoglobin 
dissociation curve described by the Severinghaus equation may be incorrect during 
hypercapnia. However it is important to note that CO2-dependent shifts in the Hb-
O2 binding curve (the Bohr effect) are mainly significant in the linear middle region 
of this sigmoidal curve. Hypercapnic manipulations in our method occur at very 
high arterial O2 saturation levels (>98% for all conditions; >99.9% for carbogen), 
where the Bohr effect is negligible. We should also emphasize that the 
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Severinghaus equation is only used to estimate arterial saturation, so although the 
venous saturation may be within the range where the Bohr effect is relevant, this 
does not impact the model. In the healthy subjects used in the present study, 
replacing the Severinghaus equation with a constant value of one would result in 
minimal change to the results. However it is quite possible to encounter much 
lower arterial saturation values in patient populations (e.g. impaired 
cardiopulmonary function). To account for this, it would be necessary to use an 
extended form of the Severinghaus equation that that adjusts for variations in 
PCO2 (Dash et al. 2004; Dash et al. 2010).
In the design of the present study, we chose to use a fairly simple gas manipulation 
approach based on switching between different fixed concentrations of inspired 
gases. While this is known to result in variable end-tidal gas responses achieved in 
different individual subjects, our model does not require prospective targeting of 
specific end-tidal values, relying instead on the ability of our model to control 
retrospectively for a wide range of changes in blood flow and end-tidal O2 which 
are measured during the experiment. Moreover there is no requirement that 
hypercapnic manipulations be isoxic, or that hyperoxic manipulations be isocapnic, 
since all manipulations are treated identically and the model is valid for arbitrary 
combinations of flow and oxygenation change. The approach used here does lead 
to a degree of inter-individual variability in the evoked gas responses, and this 
could be reduced by using available technology for prospective targeting of end-
tidal values (Slessarev et al. 2007). Nevertheless, group average measurements in 
our study converged to values that we feel were adequately stable and 
representative for the calculations presented here. It should be noted that modeling 
of M, OEF0, and CMRO2 based on group average MRI and respiratory measures 
yielded results that were very close to the valued obtained by modeling data in 
individual subjects (whose end-tidal values varied) and then averaging individual 
values of M, OEF, and CMRO2.
Another area of discussion has been the impact of hypercapnic manipulations on 
neuronal CMRO2. Currently a variety of findings on this topic have been reported 
including increases in metabolism (Horvath et al. 1994; Jones et al. 2005), 
decreases (Zappe et al. 2008; Xu et al. 2011b), and no detectable change 
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(McPherson et al. 1991; Hino et al. 2000; Chen et al. 2010a). The modeling shown 
in Figure 6 simulating CO2-induced changes in CMRO2 of ±15% allows us to 
assess the impact of these on the model solutions. Our model and data would 
appear to rule out a CMRO2 increase, as the M vs. OEF0 curves for this case are 
widely divergent with pairwise solutions centered over physiologically implausible 
values of OEF0 and M. Although the set of curves modeled with a CMRO2 
decrease are more convergent, the implied values for OEF0 and M bring the 
validity of this scenario into question. The OEF0 value of 0.25 is at the very low end 
of physiologically plausible values cited in prior literature (Perlmutter et al. 1985; 
Ibaraki et al. 2010; Bolar et al. 2011a). Moreover the associated M value of 4.5% is 
well below the value measured directly in grey matter using high CO2-content 
carbogen (Gauthier et al. 2011b). The agreement, in the ΔCMRO2 = 0 case, 
between M values obtained using our previous application of the Davis model 
during hypercapnia (Gauthier et al. 2011a) and M values determined using direct 
hypersaturation of venous blood with 10%CO2/90%O2 (Gauthier et al. 2011b) 
suggests that bias from changes in CMRO2 during hypercapnia is likely to be 
minimal. The agreement between implied values for resting OEF and CMRO2 
modeled with hypercapnic ΔCMRO2 = 0 and prior PET literature also tends to rule 
out such an effect.
Strongly hyperoxic manipulations could also create confounding effects by altering 
the MRI signal in the cerebrospinal fluid (CSF) due to T1 shortening (Hajnal et al. 
1995). However inspection of both smoothed and unsmoothed statistical maps for 
both ASL and BOLD revealed no significant responses in either the ventricles or 
sulci. We also examined regions of susceptibility artifact in our T2*-weighted image 
series for evidence of variability associated with high O2 concentrations in the 
sinuses. There was no indication that hyperoxia modified the pattern of 
susceptibility artifact in these areas, in which fMRI responses are generally 
unreliable even under normoxic conditions. A recent numerical simulation study 
has suggested that hyperoxia may result in pronounced arterial BOLD effects 
(Schwarzbauer et al. 2011). Although we were able to find evidence of T1 
shortening during hyperoxia in voxels containing larger arteries in our short-TE 
ASL data, careful inspection of the same voxels in the long TE image series 
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revealed no discernible modulation of the arterial T2*-weighted signal during 
hyperoxia. Moreover such macrovascular voxels were excluded from analysis 
using masks generated by thresholding maps of hyperoxic response generated 
from unsmoothed ASL data (clearly revealing large arteries).
It should be noted that the accuracy of a unique solution for M and OEF0 will 
depend in part on the degree of orthogonality between the two M vs. OEF0 curves 
implied by the two calibrations used. Pairs of curves that are nearly parallel, such 
as the ones shown in Figure 1 for hypercapnia and carbogen (hyperoxia
+hypercapnia), are likely to less well defined solutions than curves that cross at 
larger angles. Figure 1 also shows that, for a given set of BOLD and ASL 
measurements during hypercapnia, the implied M value has little dependence on 
the associated value of OEF0. In the limit of a 'pure' hypercapnic manipulation, the 
situation can be understood as one in which CO2-induced flow increases result in 
proportional dilution of venous deoxyhemoglobin, all of which is assumed to be 
deposited by local metabolism during capillary transit. The actual rate of 
metabolism (and thus OEF) is unimportant - all that matters is that any increase in 
CBF by a factor F will result in a decrease in venous [dHb] by 1/F, bringing the 
BOLD signal correspondingly closer to the asymptotic value M. Note that, at very 
low OEF0 values, the small amount of deoxyhemoglobin present in arterial blood 
becomes significant, resulting in lower M values and some dependence on OEF0. 
In the limit of 'pure' hyperoxia, the flow-related dilution (the term X applied to (CBF/
CBF0) in Eq. 2) is negligible, and all decreases in blood dHb arise due to increases 
in CaO2. Because CaO2 is expressed as the quantity of O2 in absolute physical 
units (introduced by the end-tidal gas measurement), it can only be linked to 
venous Hb saturation by also modeling CMRO2 in absolute units. OEF thus 
represents the link between measured quantitates (respiratory and MRI) and the 
relative value of tissue [dHb] required to estimate M. This explains the relatively 
strong variation in M value with OEF0 for hyperoxia. Although carbogen is an 
intermediate case, it can be seen that the flow effects tend to dominate and its 
behavior is more similar to that of pure hypercapnia alone over most of the range 
of OEF0. This is due to the fact that fractional changes in CBF are considerably 
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larger than the fractional changes in CaO2 produced by the hyperoxic component 
of this manipulation.
3.6.2. Stability
While the regionally and group-averaged data indicate that the calibration method 
proposed here is capable of yielding valid estimates of resting BOLD signal and 
OEF, the random fluctuations in the OEF maps and the patches in some subject 
where the GCM functions could not be solved indicates that the SNR of single 
voxels is close to the threshold where the stability of the method breaks down. 
Qualitatively, the parametric maps of M demonstrated good stability (immunity from 
hot spots) although these maps are affected by the lack of a solution in some 
regions. Group average maps with seven subjects showed improved stability, 
resulting particularly in a better depiction of the relative invariance of OEF across 
the resting brain. Based on prior PET literature (Frackowiak et al. 1980; Ito et al. 
2004; Ashkanian et al. 2008; Bremmer et al. 2010; Ibaraki et al. 2010), we believe 
that OEF in these young healthy subjects is in fact 'flat' across the brain, lacking 
the pronounced grey-white matter contrast evident in maps of resting CBF and 
CMRO2. However in cases of pathology, increases in OEF may indicate 
insufficiency of the local blood supply relative to local oxygen demand. For future 
clinical applications, it will thus be important to improve the image stability to the 
point where healthy brain OEF0 exhibits minimal noise fluctuations.
The limiting factor in the stability of our approach is the quality of fractional change 
maps for CBF during the various gas manipulations. Since this is a ratio 
calculation, regions with a low denominator (such as white matter) are particularly 
problematic. Fortunately there are a number of strategies that could be used to 
improve this; for example physiological noise correction methods such as 
RETROICOR (Glover et al. 2000; Restom et al. 2006) may help improve signal 
stability and this the quality of fractional change maps. More sophisticated 
modeling of the gas-induced response, based on the actual end-tidal traces, may 
improve GLM fitting. Background suppression techniques (Garcia et al. 2005) may 
also help reduce uncontrolled physiological fluctuations in the ASL signal. In 
general any factor affecting ASL performance and accuracy, such as sensitivity 
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profiles in multi-channel receive coils, must be carefully evaluated to achieve 
optimal results with the method proposed here.
3.6.3. Similar methods
Two other MR techniques have recently been proposed to measure baseline OEF 
and CMRO2. The technique described by He and Yablonskiy, termed quantitative 
BOLD (qBOLD), uses the MR signal modeling of the static dephasing regime to 
determine baseline hemodynamic parameters from a GESSE signal (He et al. 
2007; He et al. 2008). The alternate approach (QUIXOTIC) proposed by Bolar et 
al. uses velocity-sensitive ASL (Bolar et al. 2011a) to target directly the oxygenation 
signal from small venules. By specifically measuring the signal from this 
compartment, a localized measure of oxygen extraction and metabolism can be 
obtained. While both methods have shown promising early results, both techniques 
present complexities which constitute potential obstacles to clinical adoption. The 
qBOLD method depends on a fitting procedure involving a large number of 
parameters, some of which are simultaneously optimized as part of the model fit, 
and others which must be assumed based on previously determined values. The 
uniqueness of parameter combinations yielding convergent fits can be difficult to 
guarantee, and the remaining fixed parameters reflect fundamental magnetic 
properties of tissue which are difficult to measure directly on an individualized 
basis. The QUIXOTIC method requires knowledge of the flow velocity range 
required to selectively image the venular signal, a value that could change 
considerably depending on the age and health of the subject. In spite of the above 
concerns, the emergence of a variety of distinct, MRI-based methods for imaging 
OEF and CMRO2 that yield converging values for these parameters based on 
different aspects of BOLD signal modeling can only serve to improve our 
understanding of brain physiology and neuroimaging signals.
3.6.4. Applications
The method proposed here could be applied in settings where FDG PET is 
currently used, with the added benefit that a rich array of vascular (resting CBF, 
cerebrovascular reactivity) and anatomic (T1, T2 scans) information would be 
provided in a single imaging session of similar duration and comfort to that of a 
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PET exam. The approach may thus be of particular interest in discriminating 
between vascular dementias and other etiologies such as Alzheimer's disease 
(Nagata et al. 2002; Herholz et al. 2007; Lo et al. 2011; Rodriguez et al. 2011). The 
method could also prove interesting for determining physiological changes in the 
brain during chronic ischemia such as that observed in carotid artery disease and 
in the identification and characterization of penumbral tissue is acute ischemia 
(Yamauchi et al. 1999; Yamauchi et al. 2009; Zipfel et al. 2009; Isozaki et al. 2010).
Although high levels of CO2 can cause intense discomfort, the levels administered 
here (average increase in end-tidal CO2 of 8.8 mmHg for hypercapnia and 7.7 
mmHg for carbogen) while perceptible did not produce significant discomfort in our 
subjects. It should be remembered that it is the actual change in ETCO2 that 
determines discomfort, and that this can be strongly modulated by factors like the 
maximum minute ventilation allowed given the gas flow rates. Also the ETCO2 
endpoints attained will vary considerably, even for a given gas mixture, depending 
on the exact mode of delivery. Fluctuations over a moderate range are of no 
significant consequence for the method described here, as long as end-tidal 
measurements are performed.
The need for patients to breathe through their nose to ensure that exhaled gases 
are sampled by the nasal cannula could pose a problem in patients for whom such 
compliance is difficult. This requirement could be alleviated by using a more 
sophisticated valve assembly on the face mask to ensure that expired gas being 
sampled does not mix with the inflowing mixture. We have verified the end-tidal O2 
and CO2 data yielded by the setup used in the present study against alternate 
approaches (Slessarev et al. 2007), and found the values to be in consistent 
agreement with more rigorous reference standards (which were not used here 
because carbogen inhalation was not supported). Whatever approach is used, it 
will be desirable to minimize the need for patients to follow special breathing 
directives for this technique to achieve the broadest applicability.
In addition to possible clinical applications, the non-invasive method proposed may 
prove useful in basic neuroimaging research. Baseline properties are of 
considerable interest for the comparison of fMRI results between groups in aging 
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and disease. Task-induced BOLD signal changes cannot, in standard fMRI 
protocols, be related to a known baseline state. This reduces the strength of 
inferences that can be made about the signal changes measured, since BOLD 
changes are expressed as a function of an unknown baseline with an unknown 
inter-subject and inter-group variability. While we have emphasized resting 
metabolism in this report, the M values provided can still be used to calibrate task-
induced changes in BOLD and ASL signals measured in functional studies. Such a 
study would benefit from access to both the resting CMRO2 and the percent 
functional change.
The emergence of commercially available hybrid PET-MRI instruments also 
creates interesting possibilities for the proposed technique. Given that 18FGD PET 
can be performed without an on-site cyclotron, research and clinical sessions 
providing both glucose and oxygen uptake would be feasible. The combination of 
these two measures may allow more detailed inferences about cellular dysfunction 
(i.e. distinguishing between aerobic and anaerobic metabolism). Moreover the 
impending regulatory approval of 18F-based amyloid imaging agents such as 
florbetapir would allow, on a PET-MRI scanner, a combined amyloid/metabolic/
vascular exam that could offer considerable improvements in diagnostic specificity 
between vascular and Alzheimer's etiologies. Such a tool would be invaluable in 
treatment selection and ongoing assessment of drug efficacy in clinical drug trials 
and personalized medicine.
3.7. Conclusion
We have demonstrated in seven subjects a relatively simple MRI calibration 
procedure allowing estimation of the resting BOLD signal M, resting OEF, and 
resting CMRO2. Considering that the method yielded a rich set of resting 
physiological estimates in excellent agreement with literature values, the number of 
parameters assumed in the approach is remarkably small, and consists of simple 
quantities whose values can be determined with a high degree of certainty.
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4.1. Preface
Aging is known to be associated with changes in cognitive performance. Older 
adults typically perform cognitive tasks more slowly and make more mistakes than 
younger adults. Furthermore, though this is true of many tasks, cognitive 
paradigms including an executive function component may be preferentially 
affected (Langenecker et al. 2004; Cabeza et al. 2005; Spreng et al. 2010). When 
fMRI is used to probe into the neuronal underpinnings of these behavioral 
differences, a series of common patterns emerge for many task paradigms, 
whereby older adults tend to show lower responses in posterior brain regions, and 
higher and more bilateral signal increases in frontal regions. These patterns have 
lead to a series of hypotheses on the mechanisms of cognitive aging (Cabeza 
2002; Davis et al. 2008; Reuter-Lorenz et al. 2008; Park et al. 2009; Reuter-Lorenz 
et al. 2010; Schneider-Garces et al. 2010). 
However, all these theories are based on direct comparisons of hemodynamic 
response amplitude between younger and older adults, with most recent studies 
using the BOLD contrast. While there is solid evidence for a link between BOLD 
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signal amplitude and underlying neuronal activity (Logothetis et al. 2001; Shmuel et 
al. 2002; Logothetis et al. 2004; Magri et al. 2012), the neurovascular coupling that 
determines the amplitude of the hemodynamic response is complex and may be 
affected by age (Girouard et al. 2006; Lecrux et al. 2011; Lu et al. 2011). The 
BOLD response is in other words an ambiguous signal that arises from a 
combination of changes in oxidative metabolism, blood flow and blood volume 
increase, and every component of the response may be affected by age-related 
changes (Yamaguchi et al. 1986; Chen et al. 2011; Lu et al. 2011). Therefore, 
before direct comparison of BOLD signal changes may be used to determine age-
dependent changes in neuronal usage, the age-related biases inherent to the 
contrast mechanism must be identified. 
The study presented in Chapter 4 is an investigation of the physiological changes 
in the brain associated with healthy aging. A calibrated fMRI framework was used 
to probe into these physiological changes and their impact on hemodynamic 
measures of brain activity. While the techniques presented in Chapters 2 and 3 
would have allowed us to obtain some additional physiological information and a 
more robust measurement of M, these techniques were developed in parallel with 
the data acquisition phase of the study presented in this chapter. The design used 
here is therefore that of a hypercapnia calibrated fMRI experiment. Although this 
data did not allow application of the full generalized model for estimation of resting-
state CMRO2, the experiment did provide numerous physiologically-relevant 
parameters in addition to the blood flow and BOLD response to a modified Stroop 
task, including baseline blood flow, cerebrovascular reactivity to CO2, M and 
percent evoked CMRO2. These physiological quantities are used to investigate the 
effects of aging and the confounds present in BOLD-only studies of cognitive 
aging.
4.2. Abstract
Functional MRI studies of cognitive aging have generally compared the amplitude 
and extent of BOLD signal increases evoked by a task in older and younger 
groups. BOLD is thus used as a direct index of neuronal activation and it is 
assumed that the relationship between neuronal activity and the hemodynamic 
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response is unchanged across the lifespan. However, even in healthy aging, 
differences in vascular and metabolic function have been observed that could 
affect the coupling between neuronal activity and the BOLD signal. Here we use a 
calibrated fMRI method to explore vascular and metabolic changes that may bias 
such BOLD comparisons. While BOLD signal changes evoked by a cognitive task 
were found to be similar between a group of younger and older adults (e.g. 0.50 ± 
0.04% vs. 0.50 ± 0.05% in right frontal areas), comparison of BOLD and ASL 
responses elicited in the same set of structures by a controlled global hypercapnic 
manipulation revealed significant differences between the two groups. Older adults 
were found to have lower responses in both BOLD and flow responses to 
hypercapnia (e.g. 1.48 ± 0.07% vs. 1.01 ± 0.06% over grey matter for BOLD and 
24.92 ± 1.37% vs. 20.67 ± 2.58% for blood flow), as well as a generally lower 
maximal BOLD response M (5.76 ± 0.2% vs. 5.00 ± 0.3%). This suggests that a 
given BOLD response in the elderly may represent a larger change in neuronal 
activity than the same BOLD response in a younger cohort. The results of this 
study highlight the importance of ancillary measures such as ASL for the correct 
interpretation of BOLD responses when fMRI responses are compared across 
populations who may exhibit differences in vascular physiology.
4.3. Introduction
Aging is associated with a variety of changes in the brain. While atrophy and white 
matter lesions are observable at the later stages in life (Salat et al. 2004; Brown et 
al. 2011), functional changes can also be observed (Chen et al. 2011; Lu et al. 
2011). The effect of aging on the BOLD signal evoked by a variety of tasks has 
been the subject of intense research in recent years and typical patterns of change 
are starting to emerge. While several theories have been put forward to categorize 
and explain these patterns (Cabeza 2002; Davis et al. 2008; Reuter-Lorenz et al. 
2008; Park et al. 2009; Reuter-Lorenz et al. 2010; Schneider-Garces et al. 2010), 
the complexity of the age-related changes observed indicate that there may be 
several mechanisms at play (Cabeza et al. 2005; Reuter-Lorenz et al. 2010). One 
of the most frequently observed pattern of change is a decreased lateralization of 
frontal BOLD responses, often detected as a decreased left frontal activation but 
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an increased right frontal BOLD signal increase in older participants (Cabeza 2002; 
Reuter-Lorenz et al. 2010). These differences in BOLD signal patterns have 
typically been explained by some form of compensatory neuronal activity in older 
participants to counterbalance the effects of loss of function and decreased primary 
perception or processing capacity (Cabeza 2002; Cabeza et al. 2005; Davis et al. 
2008; Reuter-Lorenz et al. 2008; Park et al. 2009; Reuter-Lorenz et al. 2010). 
Implied in this type of theory is the fact that the additional recruitment should 
provide an advantage in terms of reduced age-related effects, usually observed as 
lower error rates or faster reaction times.
However, most of the results used to devise these theories are based on 
hemodynamic imaging techniques, with BOLD contrast at the forefront. Therefore, 
one of the main sources of potential confounds in functional MRI studies of aging 
stems from the ambiguous nature of the BOLD signal, which makes it difficult to 
draw physiologically specific conclusions from the amplitude and spatial extent of 
observed changes. The increases in BOLD signal observed during tasks arise from 
concomitant local changes in blood flow, blood volume and oxidative metabolism. 
This complicates the direct, quantitative comparison of BOLD signal changes 
between groups, especially when changes in hemodynamic function across groups 
are suspected (Samanez-Larkin et al. 2008; Ances et al. 2009; Chen et al. 2011; 
Lu et al. 2011; Mohtasib et al. 2012). Because BOLD can only be expressed as a 
fractional change from an unknown baseline, differences in the extent or amplitude 
of the BOLD signal may simply reflect an altered baseline state rather than a 
change in neuronal activity. For example, a similar metabolic change or vascular 
response from a lower metabolic or cerebral blood flow (CBF) baseline could 
artificially inflate the BOLD response. 
Changes in BOLD signal may also reflect a decreased vascular reactivity (Lu et al. 
2011). Aging is known to be associated with hardening of blood vessels throughout 
the body (O'Rourke et al. 2007; Brown et al. 2011). Increased rigidity in vessels of 
the brain could lead to a decreased vascular response to a given metabolic 
demand. This would then result in a lower BOLD signal change in older individuals 
with neuronal activity levels similar to those seen in younger individuals. All these 
potential sources of confounds make the interpretation of BOLD signal 
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comparisons between groups more difficult. However, some of these difficulties in 
interpretation could be alleviated by obtaining more physiologically-specific signals. 
The framework of calibrated fMRI, in which ASL and controlled vascular 
manipulations are added to BOLD, may be ideal for this as both the end-result and 
intermediate steps can be informative in determining the sources of age-related 
changes in hemodynamic properties (Gauthier et al. 2012a). 
Calibrated fMRI techniques allow quantitative comparisons between groups by 
isolating the oxidative metabolic component of the BOLD response to a task, which 
can be expressed as the percent change in cerebral metabolic rate of O2 
consumption (CMRO2) (Davis et al. 1998; Chiarelli et al. 2007b; Blockley et al. 
2011b; Gauthier et al. 2012b). The most widely adopted techniques have used 
respiratory manipulations to determine the change in BOLD signal produced by a 
controlled vascular challenge. The gas manipulations used have included 
hypercapnia (Davis et al. 1998; Hoge et al. 1999a) (breathing increased 
concentrations of CO2), hyperoxia (Chiarelli et al. 2007b) (breathing increased 
concentrations of O2) or a combination of both (Gauthier et al. 2011b; Gauthier et 
al. 2012b). Hyperoxia increases the O2 content of blood, while hypercapnia leads 
to large and well characterized changes in blood flow throughout grey matter from 
the vasodilatory properties of CO2. Both these manipulations give rise to 
substantial increases in BOLD signal throughout the brain that can, in combination 
with quantification of the concomitant CBF change evoked, be used to characterize 
the vascular component of the BOLD signal (Hoge et al. 1999b; Stefanovic et al. 
2006; Ito et al. 2008; Goode et al. 2009b; Mark et al. 2010; Tancredi et al. 2012). 
More specifically, calibrated fMRI experiments use the CBF and BOLD response to 
a gas manipulation to estimate the maximum possible BOLD signal change, M. 
This calibration factor M corresponds to the BOLD signal that would be obtained 
from complete elimination of deoxygenated hemoglobin from cerebral veins. Once 
this vascular component is estimated, it can be factored out of the BOLD response 
evoked by an experimental task, to yield an estimate of the CMRO2 component of 
the task-evoked BOLD signal change measured. We have recently described an 
extension of previous models (Davis et al. 1998; Chiarelli et al. 2007b) that takes 
into account arbitrary changes in both blood flow and oxygen content (Gauthier et 
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al. 2012b). This model will be used here to more accurately take into account both 
blood flow and oxygenation changes caused by the breathing manipulation. 
In the present study, we have used hypercapnically calibrated fMRI to investigate 
the effects of aging on the different components of the hemodynamic response, in 
the context of a cognitive task that has often been used to assess age-related 
cognitive deficits. Several studies have reported a larger Stroop effect (increases in 
reaction time and error rates to conflicting textual cues) and task switching cost in 
older compared to younger adults (DiGirolamo et al. 2001; Milham et al. 2002; 
Langenecker et al. 2004; Zysset et al. 2007; Jimura et al. 2010; Prakash et al. 
2011; Wasylyshyn et al. 2011; Yun et al. 2011; Mohtasib et al. 2012). A modified 
Stroop task previously used by our group (Gauthier et al. 2012a) and involving both 
an element of interference and of switching is used here to identify the brain 
regions where age-related effects may be expected. This study therefore 
investigates the effects of two functional challenges: the modified Stroop task, 
which is typical of cognitive tasks that might be explored in a BOLD aging study, 
and a hypercapnic respiratory manipulation. The combination of acquisitions during 
these two functional challenges is used to investigate possible biases and 
confounds associated with BOLD studies of cognitive aging. Calibrated fMRI is 
used to estimate a number of vascular and metabolic parameters that jointly 
determine the final BOLD signal compared between young and old in typical fMRI 
studies of aging. These parameters may be used to assess the validity of direct 
BOLD signal comparisons between age groups. Because baseline blood flow and 
vascular reactivity are both expected to decrease with age (Chen et al. 2011; Lu et 
al. 2011), it may be that the maximal BOLD signal change is lower in older 
individuals, leading to bias in the interpretation of age-related BOLD signal 
differences.
4.4. Methods
4.4.1. Participants
Acquisitions were conducted in 31 young (10 female, with mean age of 24 ± 3 
years) and 31 older (14 female, with mean age of 64 ± 5 years) healthy participants 
on a Siemens TIM Trio 3T MRI system (Siemens Medical Solutions, Erlangen, 
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Germany) using the vendor-supplied 32-channel receive-only head coil for all 
acquisitions. All subjects gave informed consent and the project was approved by 
the local ethics committee (Comité mixte d’éthique de la recherche du 
Regroupement Neuroimagerie/Québec).
Exclusion criteria for this study included claustrophobia, cardiac disease, 
hypertension or taking blood pressure lowering medication, neurological or 
psychiatric illness, smoking, excessive drinking (more than two drinks per day), 
thyroid disease, diabetes, asthma and being under a regular treatment known to be 
vasoactive or psychoactive. Participants were all non-smoking and older 
participants had all been non-smoking for at least five years. Additionally, every 
participant had a fasting blood draw on the morning of the MR acquisition day to 
ensure that their fasting blood glucose and cholesterol levels were normal, and 
older participants met with a geriatric MD to ensure that they did not meet any of 
the exclusion criteria for the study.
All participants completed a short neuropsychological screening battery to assess 
verbal reasoning (Similarities subtest of the Wechsler Adult Intelligence Scale III 
(WAIS-III) (Wechsler 1997), short-term memory (Digit span forward of WAIS-III), 
working memory (Digit span backward of WAIS-III), psychomotor speed (Digit 
Symbol of WAIS-III), attention, and executive functions (Trail Making Test, Part A 
and B and Color-Word Interference Test of the Delis-Kaplan Executive Function 
System (D-KEFS) (Reitan 1958; Delis 2001). Older adults participants also 
completed the Mini-mental state examination (MMSE) (Folstein et al. 1975) to 
screen for global cognitive decline. Participants who scored less than 26 on the 
MMSE were excluded. None of the participants was excluded based on this 
criterion. Table 1 shows the mean scores for each test in both groups. The results 
are within the normal range of performance for all clinical tests.  
Whenever possible, participants needing eyesight correction were asked to wear 
contact lenses on the day of the MRI experiment. For those without contact lenses, 
eyesight was corrected to the nearest possible 0.50D using MRI-compatible 
glasses for the modified Stroop acquisition only. For participants with significant 
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hearing losses, written instructions were projected onto a screen at the end of the 
bore that could be seen by participants through a mirror. 
4.4.2. MR Image acquisition
Sessions included two anatomical, 1mm3 MPRAGE acquisitions with TR/TE/flip 
angle = 2300ms/3ms/9°, 256x240 matrix and a GRAPPA acceleration factor of 2 
(Griswold et al. 2002). Older participants had an additional FLAIR acquisition to 
estimate the presence and severity of white-matter lesions. FLAIR acquisition 
parameters included TR/TE/flip angle=9000ms/107ms/120 with echo train length of 
15, an inversion time of 2500 ms, 512x512 matrix for an in-plane resolution of 0.43 
x 0.43mm and 25 slices of 4.8mm. White matter hyperintensities were quantified 
using the scale from Wahlund and colleagues (Wahlund et al. 2001). Only 
participants with scores of 0 or 1, corresponding to no or few small lesions, were 
included in this study. The score average and standard deviation was 0.67 ± 0.48 
in the older group. 
Functional image series were acquired using a dual-echo pseudo-continuous 
arterial spin labeling (pCASL) acquisition (Wu et al. 2007) to measure 
simultaneously changes in cerebral blood flow (CBF) and BOLD signal. The 
parameters used include: TR/TE1/TE2/flip angle = 3000ms/10ms/30ms/90° with 
4x4mm in-plane resolution and 11 slices of 7mm (1mm slice gap) on a 64x64 
matrix (at 7/8 partial Fourier), GRAPPA acceleration factor = 2, post-labeling delay 
= 900ms, label offset = 100mm, Hanning window-shaped RF pulse with duration/
space = 500μs/360μs, flip angle of labeling pulse = 25°, slice-selective gradient = 
6mT/m, tagging duration = 1.5s (Wu et al. 2007).
Imaging sessions were divided into in two parts. During one part, an MPRAGE, 
FLAIR and modified Stroop functional acquisition was acquired. During the other, 
an MPRAGE and the hypercapnia functional acquisition was performed. 
Participants were taken out of the scanner in between these two acquisition 
segments to either put on, or take off the hypercapnia mask depending on the 
order of acquisitions. Participants were allowed to move or stretch during this 
pause to ensure greater comfort, especially in the older participants.
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4.4.3. Hypercapnic manipulation
Hypercapnic manipulations were achieved using a computer-controlled gas 
delivery system in combination with a sequential gas delivery circuit (RespirActTM, 
Thornhill Research Inc., Toronto, Canada). The RespiractTM system allows 
independent control of end-tidal PCO2 and PO2 using a feed-forward physiological 
model, using as input the measured or predicted baseline O2 consumption and 
CO2 production of a subject (Slessarev et al., 2007). End-tidal partial pressure of 
CO2 (ETCO2) was targeted to be 40mmHg at baseline and 45 mmHg during the 
hypercapnia blocks. End-tidal partial pressure of O2 (ETO2) was targeted to be 
100mmHg throughout the experiment. Gas was sampled continuously at the mouth 
and analyzed for partial pressure of CO2 (PCO2) and O2 (PO2). RespiractTM 
software calculated ETCO2 and ETO2 from the continuous partial pressure data. 
These calculations were confirmed manually in post hoc analysis. During the 
hypercapnic stimulation, volunteers breathed through the circuit via a soft plastic 
mask sealed to the face using adhesive dressing (Tegaderm 3M Healthcare, St. 
Paul MN), as necessary to prevent gas leakage. Participants were asked to 
breathe deeply enough to empty the fresh gas compartment of the breathing circuit 
at every breath during the functional acquisitions (to ensure delivery of the entire 
gas dose delivered by the machine). Generally, subjects did not have difficulty 
complying with this requirement. 
Participants underwent the manipulation twice during the study, once outside the 
scanner before the imaging session to acclimatize the participant to the 
manipulation and once during the MRI session. Subjects were interviewed after the 
acclimatization session to assess their level of respiratory discomfort using the 
seven-point scale published by Banzett and colleagues (Banzett et al. 1996). 
Subjects reporting subjective rating of 5 or higher (significant discomfort) were not 
invited to continue in the study (two cases). 
4.4.4. Stroop task
The Stroop task (Gauthier et al. 2012a) consisted of two 60-second blocks each of 
control and Stroop conditions, interspersed with 60-second rest blocks. In total, 
there were four task and five resting blocks, for a total acquisition length of nine 
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minutes (Figure 1). During task blocks, control or Stroop events always lasted 2.5 
seconds, preceded by 1.5 seconds with a fixation cross to maintain a constant 
gaze direction. The task was presented and the responses recorded using the 
Eprime software (version 1.2, Psychology software tools, inc., Sharpsburg, PA, 
USA). The task was presented to participants using an LCD projector (EMP-8300, 
Epson, Toronto, ON, Canada) onto a translucent screen viewed by subjects 
through a mirror integrated into the Siemens head coil. In all cases, subjects had 
only two possible answers (blue or green), selected using an MRI-compatible 
button box (FIU-005 interface with 8 buttons bimanual response pads, Current 
Designs, Philadelphia, PA, USA). Most subjects were native French speakers or 
had been speaking French on a daily basis for more than thirty years and the color 
words were written in French (‘BLEU’ and ‘VERT’). An English version of this task 
was also available for native English speakers (two in the younger and one in the 
older group). 
During the Stroop/switching condition blocks, two different types of events were 
given in random order. In all cases, letter color and word semantic were non-
congruent. In ten of fifteen cases, when the color word appeared, the correct 
answer was letter color. In five cases out of fifteen, a large white rectangle 
appeared around the word for the whole event, starting during the two seconds 
with the fixation cross. This rectangle indicated to the subject that the rule had 
changed and that the right answer now corresponded to word semantic rather than 
letter color. During the control task blocks (color naming), a series of four X’s were 
written either in blue or green and the participant was asked to give the color of the 
letters.
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Figure 1. Modified Stroop task paradigm
This figure shows the different task conditions and block order of the modified Stroop task used 
during functional acquisition.
4.4.5. Data analysis
All analyses except for group analysis, definition of Stroop ROIs, and registration of 
images to the MNI152 template were done using the NeuroLens data analysis 
software package (www.neurolens.org). All raw EPI series were preprocessed by 
motion correction (Cox et al. 1999) and spatial smoothing with a 3D Gaussian 
kernel (6 mm FWHM). The CBF signal was isolated from the series of first echoes 
using linear surround subtraction (Liu et al. 2005), while the BOLD signal was 
extracted using linear surround addition of the second echo series (Liu et al. 2005; 
Gauthier et al. 2012a; Gauthier et al. 2012c).
Fractional changes in BOLD and CBF signals were then determined for 
hypercapnia by fitting a GLM to the respective signals and dividing the estimated 
effect size by the estimated constant term. Model fits used a single-gamma 
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hemodynamic response function (HRF) with parameters described by Glover et al. 
(Glover, 1999) and included linear, quadratic and third order polynomials to 
represent baseline signal and drifts. CBF and BOLD data for the Stroop task were 
treated similarly. For the Stroop task, a contrast was used to isolate the signal 
changes during the inhibition/switching blocks. Temporal SNR maps were derived 
from the CBF and BOLD datasets for the modified Stroop task. These were 
obtained by dividing the beta of the linear baseline term (DC) by the residuals from 
the GLM at each voxel. The temporal SNR represents the ratio between the 
baseline functional signal and the temporal fluctuations arising from hardware 
thermal noise and physiological sources of fluctuations (Kruger et al. 2001; 
Triantafyllou et al. 2005). 
The average time course for CBF and BOLD of both hypercapnia and modified 
Stroop tasks were determined using a finite impulse response (FIR) analysis, 
which is a parsimonious method for averaging blocked responses within the 
context of a GLM fit that can be used to remove spurious drift terms. For purposes 
of the FIR fit, the 'events' were defined as being the block onsets, shifted earlier in 
time as needed to capture a brief interval of baseline before the task block. The 
number of FIR regressors was then chosen to adequately cover the initial baseline 
period, the task block, and a brief period after the task block. Using this approach, 
the temporal response was measured for 15 seconds before the beginning and 
after the end of each block (either hypercapnia or modified Stroop), to capture the 
rising, plateau and descending phases of the response. All other parameters were 
as in the previously described GLM analysis. The time course amplitudes of the 
regressor of interest (hypercapnia or modified Stroop) were divided by the baseline 
term from the GLM to obtain the time course in units of percent change CBF or 
BOLD. Individual time courses were averaged over all subjects in each group. To 
facilitate comparisons between groups and because the FIR trace does not always 
have an initial baseline of zero as expected, the first five TRs (minus 15 seconds to 
zero) were averaged and the whole trace was shifted by this average offset to 
bring the traces to a baseline of zero. 
Absolute resting CBF was determined from the pCASL data using the approach 
described by Wang et al. (Wang et al. 2003a) assuming blood brain partition 
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coefficient = 0.9, labeling efficiency = 0.80, blood T1 = 1.49 s, and grey matter 
T1 = 1.4 s. For this computation, the baseline ASL difference signal estimated in 
the GLM fit for each gas manipulation was divided by the corresponding un-
subtracted baseline EPI signal from the ASL series, computed in a similar GLM fit 
carried out on the un-subtracted EPI series. The un-subtracted baseline EPI signal 
from the ASL series is used here as a surrogate for the fully relaxed magnetization 
that can alternately be acquired in the form of what is termed an M0 scan. To 
account for incomplete recovery of longitudinal magnetization during the sequence 
TR of 3 seconds, baseline EPI estimates from grey-matter ROI's were corrected 
using the grey matter T1 value cited above. The resultant ratio was converted to 
absolute CBF units based on the parameters above. Cerebrovascular reactivity 
was obtained by dividing the percent BOLD and CBF signal changes during the 
hypercapnia manipulation by the increase in end-tidal PCO2 values during this 
manipulation (Graham et al. 1994; Forbes et al. 1997; Gauthier et al. 2012a).
The GCM method was used as in Gauthier et al. (Gauthier et al. 2012a; Gauthier 
et al. 2012b) to obtain M estimates for each subject. Under the conditions of this 
study, the results should be very similar to those obtained using the hypercapnia 
calibration model (Davis et al. 1998). Small differences may arise if arterial 
saturation is estimated to be below 100% (Gauthier et al. 2012b), but saturation 
values are expected to be very high in healthy individuals. Evoked CMRO2 values 
were obtained using group average values for all input parameters (percent CBF 
and BOLD change during the modified Stroop task and M value). One older 
participant was excluded from this analysis since their CBF response to CO2 and 
the modified Stroop task were found to be outliers. 
ROI quantification was done by weighted averaging of voxels in EPI space, taking 
into account the grey matter volume fraction from automated tissue segmentation 
(described in the next section) at each voxel. All uncertainties are provided as ± 
standard error. Uncertainties on evoked CMRO2 were computed from propagation 
of uncertainties on M, CBF and BOLD as described in Davis et al. (Davis et al. 
1998).
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4.4.6. Regions-of-interest definition
Regions of interest were defined independently for each age-group using their 
respective areas of significant signal changes in the group analysis maps. Group 
analyses and normalization for ROI definition were done using FSL (version 4.1.9). 
All functional data were motion corrected with MCFLIRT (Jenkinson et al. 2002) 
and the brain was extracted using BET (Brain Extraction Tool, version 2.1) (Smith 
2002). A 6mm3 FWHM 3D Gaussian smoothing kernel, high-pass filter (100s cutoff) 
and pre-whitening (FILM) (Woolrich et al. 2001) were applied to the time series. 
Spatial normalization to standard space (MNI152 template) (Jenkinson et al. 2001; 
Jenkinson et al. 2002) was performed (12 degrees of freedom) on the 30ms echo 
time series. Spatial transformation matrices for the 30ms echo time-series were 
used for the 10ms time series, to minimize normalization errors from the bright 
scalp signal in the shorter echo. The flow-dependent component of the first echo 
time series (TE = 10ms) was isolated through sinc interpolation subtraction 
between neighboring points. The BOLD time series was extracted from the second 
echo time series (TE = 30ms) by isolating the control images from the original time 
series. A GLM was performed with the main experimental paradigm convolved with 
a dual gamma function. Temporal derivatives were included in the model. Fixed 
effect group analysis was performed using FLAME1 (Beckmann et al. 2003; 
Woolrich et al. 2004; Woolrich 2008) to generate group average statistical maps for 
the contrast representing the significant BOLD signal increases during the 
inhibition/switching blocks. The intersection of group average maps with Gaussian 
random field voxel-wise thresholding corrected at p = 0.01 for each echo (i.e. the 
intersection of signifiant CBF and BOLD peaks) was used to derive the individual 
ROIs. Four ROIs were drawn using the map of the intersection of significant BOLD 
and ASL maps for the group (Figure 1). Two ROIs focused on significant activation 
over left and right frontal areas. A third ROI was drawn over significantly activated 
bilateral parietal areas. Because changes in laterality of activations is 
predominantly discussed in the context of frontal BOLD signal changes in the 
literature (Cabeza 2002; Park et al. 2009; Cappell et al. 2010; Reuter-Lorenz et al. 
2010), only the frontal component of the activation was separated in lateral ROIs. 
The fourth ROI was derived from automated tissue segmentation of all grey matter. 
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The transformation matrix used to register individual functional acquisitions to MNI 
space was inverted and this inverted transform was applied to each ROI derived 
from the group activation map to obtain ROIs in native space using linear 
interpolation. 
In order to account for the fact that our large EPI voxels inevitably contained a 
mixture of grey matter, white matter, and CSF, average BOLD and ASL responses 
were determined by computing weighted-averages within ROIs, with the weighting 
provided by the estimated grey matter volume fraction in each voxel. The grey 
matter volume fraction was determined using automatic tissue segmentation of 
anatomical images using the FAST module of FSL (Zhang et al., 2001). Grey 
matter probability maps generated by FAST were projected into native EPI space 
using linear interpolation. Binarized individual ROI maps (Stroop task-derived) 
were multiplied by grey matter probability. This approach assumes that the 
responses in white matter and CSF are negligible compared with the grey matter 
response, which is supported by our observations in these tissue compartments 
(data not shown).
4.4.7. Statistical analysis
Statistical analysis of the Stroop behavioral data was done using an analysis of 
variance (ANOVA) as implemented in the SPSS 19.0 software (IBM, Armonk, New 
York, USA). The inhibition/switching cost was calculated by dividing the difference 
in reaction time between the inhibition/switching and control conditions by the 
reaction time of the control task. 
The difference between age groups across physiological measure, functional 
challenge and ROIs was tested using a general linear model analysis, 
as implemented in the Neuroimaging Analysis Kit (http://www.nitrc.org/projects/
niak). First, the effect of age was investigated using a model pooling the measures 
from all the ROIs. The purpose of this model was to test the overall effect of age 
across all the ROIs, regardless of its significance at any particular ROI. The 
explanatory variables of the model included a dummy variable coding for the age 
group of each subject. In addition, the differences between the mean value for 
each of the four ROI were coded using an intercept and 3 dummy variables, 
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following the method described in (Gujarati 2002). The intercept captured the mean 
across all four ROIs. The first variable dummy variable coded for the difference 
between the mean of ROI 1 (grey matter) and the mean of ROI 2 to 4 (left and right 
frontal, and parietal). The second dummy variable coded for the difference between 
the mean of ROIs 1 and 2 and the mean of ROIs 3 and 4. The third dummy 
variable coded for the difference between the mean of ROIs 1 to 3 and the mean of 
ROI 4. The significance level of the overall effect of age across all regions was 
corrected for multiple comparisons across contrasts and experiments using 
Bonferroni's procedure (significance threshold p of 0.05 divided by 11 types of 
estimation, p = 0.0045). For those combinations of physiological measure/
functional challenge where age had an overall effect across ROIs, we further 
tested the significance of age effects at each ROI. This means that for each ROI, 
we used a reduced model including only the measurements coming from this ROI, 
as well as an intercept and age groups coded as a dummy variable for explanatory 
variables. The significance of the effect of age for each region was corrected for 
multiple comparisons across ROIs using the Bonferroni procedure (significance 
threshold p of 0.05 divided by 4 ROIs, p = 0.0125). We did not correct for multiple 
comparisons across physiological measure/functional challenge at this level, as 
we already assumed that the omnibus test for the overall effect of age was 
significant for this particular combination of physiological measure/functional 
challenge.
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Younger Older
Gender (M/F)
Age
Education (years)
MMSE (score)
Similarities (score)
Digit span forward (score)
Digit span backward (score)
Digit symbol (score)
CWIT – Color naming (s)
CWIT – Reading (s)
CWIT – Inhibition (s)
CWIT – Switching (s)
TMT – Part A (s)
TMT – Part B (s)
21/10 17/14
23.74 ± 0.52 63.53 ± 0.87
17.03 ± 0.38 16.01 ± 0.57
- 28.81 ± 0.20
26.16 ± 0.86 23.69 ± 0.85
9.87 ± 0.41 10.69 ± 0.40
7.39 ± 0.41 7.06 ± 0.40
92.48 ± 2.13 66.09 ± 2.32
25.65 ± 0.74 29.65 ± 0.94
19.15 ± 0.49 20.23 ± 0.64
41.89 ± 1.33 57.12 ± 2.22
49.46 ± 2.14 58.33 ± 3.71
26.00 ± 1.45 34.15 ± 1.65
56.55 ± 3.66 78.45 ± 5.14
Table 1. Neuropsychological battery results
This table shows the average ± standard error in each group for all tests included in the battery 
administered to participants. MMSE : Mini-Mental State Examination, CWIT : Color-Word 
Interference Test, TMT : Trail Making Test. The results are within the normal range of performance 
for all clinical tests.
4.5. Results
4.5.1. Modified Stroop task behavioral results
This study explores the hemodynamic and vascular changes in regions implicated 
in a modified Stroop task (Figure 1) thought to be associated with age-related 
changes. Reaction times (RT) and error rates were found do be significantly higher 
in the older group, both during the control and during the inhibition/switching blocks 
(p < 0.0001). Reaction times during the control block were 575.52 ± 25.14 ms and 
696.78 ± 19.63 ms in younger and older adults for the control task, and 898.20 ± 
38.08 ms and 1239.91 ± 34.26 ms for the inhibition/switching blocks in younger 
and older adults respectively (Figure 2A). The group by condition interaction (p < 
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0.0001) showed that the RT increase from the inhibition/switching compared to 
control condition was larger in older than younger adults. The cost in terms of 
reaction time for the inhibition/switching condition was 56.07 ± 4.92% and 77.95 ± 
4.67% for the younger and older adults respectively, indicating a larger age-related 
slowing for inhibition/switching beyond the general slowing seen with age. A 
significant group by condition interaction was also observed in accuracy (p = 0.007) 
(Figure 2B) with older adults showing larger decline in accuracy in the switching 
condition. Percent correct responses in younger and older adults respectively for 
the control task were 99.52 ± 0.24% and 97.58 ± 1.61%. Accuracy during the 
inhibition/switching blocks was 96.19 ± 0.82% and 87.39 ± 2.41% in the younger 
and older groups respectively.
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Figure 2. Modified Stroop behavioral response
Reaction time in ms (A) and accuracy in percent correct responses (B) were both significantly 
different between the younger and older groups (p < 0.0001). The interaction between age group 
and block type (control or inhibition/switching) were also statistically significant (p < 0.0001 for 
reaction time and p = 0.007 for accuracy) and the cost of inhibition/switching was found to be higher 
in older than younger adults, indicating that the inhibition/switching is affected by age beyond the 
general effects of slowing and decreased accuracy seen in the control task (color naming). 
Statistical significance is indicated by a star.
4.5.2. Modified Stroop activation maps
Group analysis of the inhibition/switching blocks revealed significant BOLD and 
ASL signal increases in similar areas for both groups. Significant BOLD and ASL 
increases (Figure 3) were found in several regions over cortex including anterior 
cingulate, part of the frontal, parietal and occipital lobes, as well as some sub-
cortical structures covering mainly the putamen. Frontal activation foci were 
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bilateral and covered part of the middle frontal and inferior frontal gyri. This area of 
activation also extended partially over pre-central gyrus. Activation over parietal 
areas was extensive, covering areas 40 and 7 and extending down into occipital 
areas.  
However, no significant difference was detected in a group average map for the 
contrast old minus young, for either the CBF or BOLD data. ROIs were drawn over 
the frontal and parietal areas significantly activated within each group during the 
inhibition/switching blocks (Figure 4). Responses within these ROI's are discussed 
below.
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Figure 3. Modified Stroop Z-score maps
Group activation maps for BOLD and ASL in response to the Stroop task. These maps show the 
significant signal changes in response to the inhibition/switching blocks of the task. No significant 
difference was detected between maps from younger and older adults.
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Younger Older
Left frontal
Right frontal
Parietal
Figure 4.  Modified Stroop task ROIs
Group activation maps for the modified Stroop task yielded three main foci of cortical significant 
signal changes. These were used to delineate three ROIs in left frontal, right frontal and parietal 
cortex. Signal changes and other physiological estimates were quantified within these ROIs for 
each participant.
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4.5.3. Stroop evoked responses
Percent BOLD and CBF responses to the inhibition/switching blocks of the 
modified Stroop task were quantified in three ROIs: left frontal, right frontal and 
parietal areas.  BOLD response amplitude during the task was similar (p = 0.85) 
between the two groups (Figure 5A and Table 2). Percent BOLD signal responses 
quantified over individual ROIs are shown in Figure 5A and Table 2. 
ASL data shows a somewhat different picture, with a significant general age effect 
(p < 0.0001) (Figure 5B and Table 2). Percent changes have been converted to 
absolute increase in CBF, in units of ml/100g/min for each individual using ROI-
average value of resting blood flow for this comparison. The values in percentage, 
which are used as input into the calibrated fMRI model are shown in Table 2. CBF 
responses were similar between the two groups in the left frontal ROI (p = 0.26), 
while right frontal ROI showed higher responses in the older group (p = 0.002). 
Finally, the parietal CBF change showed a trend towards higher responses in the 
older group (p = 0.04, threshold to account for multiple comparisons of p = 0.013).
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Figure 5. Percent BOLD and CBF responses to the modified Stroop task
Time courses showing BOLD and CBF responses to the modified Stroop task over the three 
functionally-defined ROIs: left frontal, right frontal and parietal areas. Similar BOLD and CBF 
changes were observed in younger and older adults over all ROIs.
4.5.4. Respiratory manipulation
The hypercapnia protocol led to the expected increase in CO2, with stable plateaus 
within a few breaths. End-tidal values were increased by 4.81 ± 0.15 mmHg in the 
younger group and 4.49 ± 0.21 mmHg in the older group, from baseline values of 
38.50 ± 0.23 mmHg and 39.31 ± 0.33 mmHg in the younger and older groups 
respectively. End-tidal CO2 change between the baseline and the hypercapnia 
block did not differ significantly between the two groups. End-tidal O2 values 
increased slightly during the hypercapnia going on average from 106.04 ± 1.12 
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mmHg to 109.32 ± 1.10 mmHg in the younger group and from 101.61 ± 0.99 
mmHg to 105.54 ± 0.94 mmHg in the older group. The manipulation was tolerable 
for participants of both age groups, with discomfort ratings of 2.16 ± 0.17 and 2.26 
± 0.19 for the younger and older groups respectively on a possible range of seven 
points (Banzett et al. 1996).
4.5.5. Vascular parameters
In contrast to the BOLD and CBF responses to the Stroop task, which were similar 
in both groups, other hemodynamic signals were found to be generally decreased 
in the older group. More specifically, BOLD responses to hypercapnia were found 
to be significantly lower in pooled ROIs (p < 0.0001) in the older group as 
compared to the young (Figure 6 and Table 2). Individual ROIs were also 
associated with a significantly lower BOLD signal change in the older adults. 
Responses to the hypercapnia challenge were quantified over the three Stroop 
ROIs, as well as in complete grey matter. Average BOLD signal changes to CO2 in 
grey matter were found to be 1.48 ± 0.07% and 1.01 ± 0.06% for younger and 
older adults respectively (p < 0.0001). All individual ROI average values are shown 
in Table 2.
Blood flow responses showed the same trend and average CBF responses in units 
of ml/100g/min were generally lower in the older group and the main effect of age 
over all ROIs was found to be significant (p < 0.0001) (Figure 7). Individual ROI 
averages can be found in Table 2. CBF changes over gray matter were found to be 
significantly lower in the older group, with values of 14.32 ± 1.01 ml/100g/min in the 
younger and 10.00 ± 1.24 ml/100g/min in the older group (p < 0.01). Left frontal 
estimates were on the other hand similar between the two groups (p = 0.13), while 
right frontal estimates showed the largest difference between groups (p < 0.0002). 
Finally, results in the parietal ROI showed a trend towards lower values in the older 
group (p = 0.02). While flow changes in terms of absolute flow represent a more 
physiologically meaningful quantity, these changes are often reported as 
percentages in the extant literature. To facilitate comparisons with previous 
literature and since percent change values in CBF are used as input into the 
calibrated fMRI model, these values are reported in Table 2. 
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Figure 6. BOLD hypercapnia time courses
Time courses of percent BOLD signal change in response to hypercapnia over all functionally 
determined ROIs (left frontal, right frontal, parietal) and over all grey matter. BOLD responses to 
hypercapnia were lower in all ROIs in the older group (p < 0.0001).
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Figure 7. CBF hypercapnia time courses
Time courses of CBF change with hypercapnia, in absolute units of ml/100g/min over all functionally 
determined ROIs (left frontal, right frontal, parietal) and over all grey matter. Though an overall 
effect of age was found and CBF response to hypercapnia was found to be generally lower in the 
older group (p < 0.003), individual ROIs did not show a significant difference.
Percent BOLD and CBF changes during hypercapnia can also be converted to 
cerebrovascular reactivity (CVR) by dividing the percent change in CBF or BOLD 
by the change in end-tidal PCO2 (Graham et al. 1994; Forbes et al. 1997; Mandell 
et al. 2008; Gauthier et al. 2012a). CVR is likely to be a factor in determining the 
amplitude of task-induced changes in BOLD and CBF, since it quantifies the 
increase in signal per unit of vasodilatory signal. Because end-tidal PCO2 
increases were similar between the two groups, CVR values follow the same trend 
as percent changes. BOLD CVR was found to be significantly lower in the older 
group in pooled ROIs (p < 0.0001), with values of 0.31 ± 0.06 %∆BOLD/mmHg in 
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the younger group and 0.23 ± 0.01 %∆BOLD/mmHg in the older group over grey 
matter. BOLD CVR was also significantly lower in all others individual ROIs (p < 
0.003 in all cases), as shown in Figure 8B and Table 2.  
CBF vascular reactivity was more similar between the two groups than BOLD 
reactivity measured, though generally also significantly lower over all ROIs in the 
older group (p < 0.0001) (Figure 8C and Table 2 for individual ROI quantifications). 
Grey matter and right frontal CVR were found to be significantly lower in the older 
group (p < 0.004), with values of 3.00 ± 0.18 (ml/100g/min)/mmHg in the younger 
and 2.14 ± 0.22 (ml/100g/min)/mmHg in the older group over grey matter. The left 
frontal estimates were similar between the two groups however (p = 0.26), and 
parietal estimates showed a trend towards lower values in the older participants (p 
= 0.04). CVR is often expressed as percentage CBF change in the literature and, 
to facilitate comparison with other studies, these values expressed as percentages 
are included in Table 2.
Baseline CBF was also found to be significantly lower across all ROIs in the older 
group as compared to the younger (p < 0.0001) (Figure 8A and Table 2). Average 
grey matter baseline CBF was 57.94 ± 2.51 ml/100g/min in younger and 50.20 ± 
1.90 ml/100g/min in the older group. Individual ROI averages are shown in Table 2 
and these generally show a trend towards lower values in the older group, with p 
values slightly above the multiple comparison threshold (p values between 0.02 
and 0.05, with threshold for multiple comparisons at p = 0.013). 
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Figure 8. Baseline CBF and CVR
This figure shows baseline CBF values in units of ml/100g/min (A), CBF CVR in units of percent 
CBF change per mmHg end-tidal PCO2 increase (B), and BOLD CVR in units of percent BOLD 
signal change per mmHg end-tidal PCO2 increase (C) for all ROIs, where GM is grey matter, LF is 
left frontal, RF is right frontal and P is parietal. Baseline CBF showed a trend towards a lower 
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baseline flow in the older group over pooled ROIs (p < 0.0001), while only BOLD CVR differed 
significantly over all ROIs (p < 0.002). Significance at the individual ROI level is indicated by a star.
4.5.6. Calibrated fMRI estimates
BOLD and CBF percent changes in response to CO2 can be combined to estimate 
the maximum possible BOLD signal change, also called M in the calibrated fMRI 
literature. The calibration parameter M was quantified in individual subjects and 
ROIs (Figure 9A and Table 2). Values pooled over all ROIs showed a significant 
decrease in M values in the older group (p = 0.003). In individual ROIs, the 
average values in the older group were generally lower than in the younger, and a 
tendency towards significance was identified in grey matter, with values of 5.72 ± 
0.22% and 5.00 ± 0.30% for younger and older participants respectively (p = 0.05). 
Parietal estimates in the older group were found to be significantly lower than in the 
younger group (p = 0.003). Frontal estimates did not differ significantly between the 
two groups (p ≥ 0.09). 
Task-evoked CMRO2 in each ROI was determined using group average values for 
all input parameters to benefit from additional averaging. Evoked CMRO2 
estimates during the modified Stroop task over individual ROIs can be found in 
Figure 9B and Table 2. These estimates are associated with high variance since 
they are derived from a combination of three noisy measurements (percent BOLD 
and CBF evoked by the task and M) and no significant age effect was found across 
ROIs. 
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Figure 9. M and CMRO2 values
This figure compares the calibrated fMRI parameters M (A) and percent evoked CMRO2 to the 
modified Stroop task (B) between the younger and older groups. CMRO2 was only quantified in the 
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functionally-determined ROIs (LF = left frontal, RF = right frontal and P = parietal), while M was 
quantified over an additional grey matter ROI (GM) since it is not a task-based measurement. 
Values of M were found to be generally lower in the older group (p = 0.0002 for pooled ROIs). 
Similar CMRO2 estimates may reflect the fact that variance on this estimate is high since it is a 
composite estimate from four measurements. Significance at the individual ROI level is indicated by 
a star.
4.5.7. Temporal SNR
Temporal SNR of BOLD and CBF was quantified using the Stroop time series. This 
quantity represents the average baseline term over each time series, divided by 
the residuals from the GLM fit, averaged over all participants within each group. 
Temporal SNR is a measure of the signal to noise ratio associated with temporal 
fluctuations in the signal, arising from a combination of instrumental thermal noise 
and fluctuations from physiological sources (e.g. cardiac and respiratory). As can 
be qualitatively ascertained in the maps shown in Figure 9A, tSNR of the ASL data 
was lower in the older group as compared to the younger. This decrease seems 
especially pronounced in more frontal areas. BOLD tSNR however, was similar 
between the two groups (Figure 10A). Quantifications within the different ROIs 
confirmed that tSNR was significantly lower in all ROIs used in this study for ASL (p 
< 0.0001) (Figure 10B and Table 2), but no significant difference was identified for 
BOLD data (p = 0.48) (Figure 10C and Table 2). BOLD temporal SNR values were 
225.55 ± 7.71 and 205.35 ± 9.25 in grey matter for young and older respectively. 
ASL temporal SNR was generally fairly low and even lower across all ROIs in the 
older group (p < 0.0001), with values of 2.80 ± 0.13 and 1.81 ± 0.13 in the younger 
and older group respectively in the grey matter ROI (p < 0.0001). All ROI average 
values can be found in Table 2.
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Figure 10. Temporal SNR of CBF and BOLD measurements
Temporal SNR maps of ASL and BOLD (A) show a decrease in ASL tSNR over all grey matter in the 
older group, with some spatial heterogeneity. Quantification of tSNR in functionally-defined and grey 
matter ROIs show that ASL tSNR (A) was significantly lower in all ROIs (p < 0.0001), while BOLD 
tSNR (B) was found to be fairly stable across age. Significance at the individual ROI level is 
indicated by a star.
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Table 2. ROI quantification results
This table compiles all the group average ROI results. BOLD responses to the Stroop and 
hypercapnia are expressed as percent changes, CBF responses to the Stroop and hypercapnia 
challenges are expressed in ml/100g/min and percent change, evoked CMRO2 is expressed in 
percent change, baseline CBF in ml/100g/min and the M value represents a percent. Temporal SNR 
values are also shown for each ROI. Stroop responses were only quantified in the three 
functionally-defined ROIs (left frontal, right frontal and parietal), while responses to the hypercapnia 
challenge and baseline properties were additionally quantified in complete grey matter. Significance 
of results are expressed using stars with one, two and three stars being used to show p < 0.05, 0.01 
and 0.001 respectively. An alpha level equivalent to 0.013 is used to assess significance when 
correcting for multiple comparisons across all measures (CBF changes where only compared 
between groups in ml/100g/min) (following page).
4.6. Discussion
Neuroimaging studies of cognition typically use the BOLD signal to localize brain 
regions involved in the performance of a task. Cognitive studies of aging often 
compare the BOLD signal changes in groups of young and older adults in the 
context of tasks known to be associated with significant behavioral age-related 
differences. The assumption made in such studies is that the BOLD signal can be 
taken as a direct index of neuronal activity. However, there is reason to believe that 
this simplifying assumption may not be valid when comparing groups of widely 
different age, given that significant vascular changes are known to occur during 
adult life (O'Rourke et al. 2007; Samanez-Larkin et al. 2008; Chen et al. 2011; Lu 
et al. 2011). The results of the present study indicate that caution must be 
exercised when making these direct comparisons and that there are in fact 
profound vascular biases associated with age. Age-related vascular changes may 
mask some metabolic differences and lead to erroneous conclusions when only 
BOLD results are taken into account to make inferences about the neuronal 
resources used during performance of a task. 
4.6.1. BOLD measurement of the cognitive task
The results presented here go beyond the standard sets of measures usually 
collected in the context of a cognitive imaging study of aging, but do in fact include 
them. If one were to look simply at the BOLD data evoked by the modified Stroop 
task collected here (Figures 3 and 5), one would draw the conclusion that older 
adults use similar neuronal resources to perform this task as younger individuals, 
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but that this similarity stands in contrast to the widely differing behavioral 
responses (Figure 2). The lower behavioral performance of older adults in the 
context of similar brain responses could be suggestive of a ceiling effect, possibly 
due to brain atrophy in older adults (Reuter-Lorenz et al. 2008; Schneider-Garces 
et al. 2010). This task is fairly difficult, since a set of two rules and two possible 
answers must be kept in mind at all times, and any set of rules and answer may be 
required at any time during the inhibition/switching blocks. It could therefore be that 
the older adults have reached their own maximal usage of neuronal resources and 
that they in fact perform more poorly on the task because they could not recruit the 
additional resources they needed to match the performance of younger adults 
(Park et al. 2009; Reuter-Lorenz et al. 2010). One could speculate this to be due to 
atrophy or other changes such as decreased perceptual acuity and 
dedifferentiation from changes in neuromodulatory system (Baltes et al. 1997; Li et 
al. 2002; Park et al. 2009).
The results obtained from a BOLD-only acquisition of a cognitive task do not 
however allow us to answer these questions, given the physiological ambiguity of 
the BOLD signal. While studies have shown that the amplitude and shape of the 
BOLD response is related to synaptic activity in individual primate subjects 
(Logothetis et al. 2001; Shmuel et al. 2002), the relationship between synaptic 
activity measured using local field potential electrophysiology and BOLD signal 
amplitude and shape is complex and non-linear (Magri et al. 2012). Neuronal 
activity leads to the release of a variety of vasoactive signals (Girouard et al. 2006; 
Lecrux et al. 2011) that determine the characteristics of the hemodynamic 
response measured using the BOLD contrast. Though the main mediators of 
neurovascular coupling are fairly well established, the quantitative relationship 
between these molecules and the blood flow and volume increase is unknown 
(Girouard et al. 2006; Lecrux et al. 2011). Furthermore, we do not as yet know how 
all these mechanisms are affected by aging. More specific vascular and metabolic 
information is needed to better interpret the observed BOLD responses in terms of 
neuronal activity, since BOLD alone cannot be readily converted into a quantitative 
measure of synaptic activity and since the factors that determine this relationship 
are likely to be affected by age.
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4.6.2. Blood flow measurements during the cognitive task
While these questions cannot all be answered with the present dataset, the 
additional information provided does improve our understanding of the 
physiological events occurring. One pertinent piece of information is provided by 
blood flow changes during the task. ASL techniques allow the measurement of 
changes in cerebral blood flow (Williams et al. 1992), which represents a more 
physiologically-specific quantity and can inform us on one of the factors 
contributing to the BOLD signal. Here we can see that the CBF change evoked by 
the task was in most ROIs, as seen for BOLD, similar between the two groups in 
terms of amplitude and shape (Figure 3 and 5). Therefore, this measurement also 
leads us to believe that similar neural resources are used by younger and older 
adults for the performance of this task. A modest trend towards higher CBF 
increases in all ROIs and a statistically significant difference in the right frontal ROI 
indicate, however, that there may be a tendency for older individuals to have a 
larger increase in metabolism and hence, presumably, in neuronal activity during 
the task. This higher response may furthermore be highest in some regions, which 
agrees well with previous literature on lateralization changes in cognitive studies of 
aging (Cabeza 2002; Park et al. 2009; Cappell et al. 2010; Reuter-Lorenz et al. 
2010; Schneider-Garces et al. 2010).
4.6.3. Hypercapnic responses
It may, however, be that similar signal changes in younger and older adults reflect 
different metabolic expenditures if the hemodynamic properties of older brains are 
changed due to vascular impairments. Aging has been shown to be associated 
with vascular impairments such as arterial hardening from increased collagen 
content of arterial walls and decreased vascular density (Sonntag et al. 1997; 
O'Rourke et al. 2007; Brown et al. 2011). Because these have the potential to 
profoundly affect cerebral blood flow, they could also affect the BOLD signal 
amplitude measured in response to the task. The clearest indication that this may 
be the case is that the BOLD response to a hypercapnia challenge was found to be 
significantly reduced in the older adults. CO2 has vasodilatory properties and its 
inhalation triggers an increase in blood flow throughout grey matter. Furthermore, 
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previous studies have shown that this increase in blood flow, and hence in BOLD 
signal, is linearly proportional to the concentration of CO2 in the inspired air, when 
CO2 is given as here in small concentrations (Hoge et al. 1999b; Stefanovic et al. 
2006; Mark et al. 2010). The reduced BOLD responses to hypercapnia in older 
adults confirm the capability of BOLD to capture age-related physiological 
differences in the brain regions probed in the present study. It also indicates that 
there are some underlying hemodynamic changes in the elderly, not visible from 
BOLD measurements of task alone. A reduced reactivity to CO2 could indicate that 
the coupling of vasodilatory signal to flow increase is degraded in older subjects. 
This could be because of vessel hardening, especially since the brain is known to 
be one of the only organs in the body without protection against the pulsatile 
effects of flow, and may hence be more sensitive to long-term damage (O'Rourke 
et al. 2007). However, because the BOLD signal is intrinsically ambiguous and 
arises from a combination of sources, we cannot know from this alone which 
components of the response is affected by aging.
Once again, we can turn to the ASL data to get a more physiologically specific 
measurement. An additional advantage of ASL over BOLD measurements is that 
resting blood flow in absolute units of ml/100g/min can readily be obtained. This is 
not only an important parameter of itself, but can also be used to convert percent 
changes into flow change in absolute units. This allows quantitative comparisons 
between groups, such as in younger and older adults, known to exhibit differences 
in baseline flow (Chen et al. 2011). Both baseline blood flow and absolute changes 
in response to hypercapnia were found to be lower in older adults across pooled 
ROIs. This may be indicative of a lower vascular tone in the older adults, possibly 
due to damage to blood vessel walls from the pulsatile effect of blood (O'Rourke et 
al. 2007). This finding is furthermore in agreement with previous literature also 
showing age-related decreases in flow CVR (Ances et al. 2009; Lu et al. 2011).   
4.6.4. Calibrated fMRI measurements
Taken together, CBF and BOLD response to hypercapnia can be used to calculate 
the BOLD calibration factor M. This corresponds to the BOLD signal attenuation at 
rest, attributable to the baseline deoxyhemoglobin (dHb) brain content. Because 
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this is calculated using a ratio of BOLD and CBF, this measurement suffers 
however from having a low SNR. Values of M were found to be significantly lower 
in the older group than in the younger group for pooled ROI values. A similar trend 
towards lower M values in older adults has been observed in other calibrated fMRI 
studies of aging (Ances et al. 2009; Mohtasib et al. 2012). This means that in the 
older group, the amplitude scaling of BOLD for a given fractional change in dHb is 
reduced due to a lower initial dHb content of venous blood. Because blood flow 
increases more than metabolism following neuronal activity (Hoge et al. 1999a; 
Buxton 2010), it is in part the dHb concentration present at rest that determines 
how much BOLD signal can increase during performance of a task (since baseline 
dHb is one of the sources of decreased BOLD signal that is diluted by activity-
dependent flow increases). Because the BOLD amplitude scaling is reduced, it 
may therefore be that a larger amount of oxidative metabolism is needed to evoke 
a similar CBF and BOLD response. 
The measurement of BOLD and CBF responses to the task, combined with the M 
parameter estimated before, can be used to estimate the fractional change in 
CMRO2 evoked by the task. This parameter represents a more specific 
physiological property than the BOLD signal, and may be compared between 
groups. Furthermore, since the greater part of the metabolism evoked following 
neuronal activity is thought to be oxidative (Ishii et al. 1996; Mintun et al. 2002; 
Yamauchi et al. 2002; Hattori et al. 2004; Ito et al. 2005; Ibaraki et al. 2008; Ibaraki 
et al. 2010), it is also a quantity more directly related to neuronal function than 
BOLD signal or measurements of CBF. The precision of this estimate is 
unfortunately limited, given that it is computed as a function of four low-SNR 
measures. Although no significant differences were thus detected in this group, the 
differences in BOLD and CBF responses to CO2 were consistent with a trend 
towards an increase in CMRO2 in the older group in response to the task, despite 
the similarity in the measured responses to the task.
4.6.5. Potential confounds
In this study, we sought to isolate the effects of age and selected our older cohort 
using very strict selection criteria to exclude older adults with vascular risk factors 
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such as high blood pressure (including medically-controlled blood pressure), 
hypercholesterolemia and smoking. However, the Canadian Health Measure 
Survey indicates that adults in the age range included in this study (55 to 75 years) 
may be at a vulnerable time of life for developing heart conditions. Within this age 
range the incidence of high blood pressure increases very steeply from 18.4% in 
the 40-69 years population to 53.2% observed for the next two decades. Adults 
included in this study were also highly educated, with an average number of years 
of education at 16.3 ± 3.4, corresponding to five years of post-secondary education 
in the province of Quebec. This is above the national average of 13.2 years for 
adults between the ages of 25 and 54 years reported from the 1996 Canadian 
census. Therefore, the results of this study likely represent an underestimation of 
the effects observable in the general aging population, given that these individuals 
are in better health and more educated than the general population within the 
same age range. If the effects of age on BOLD signal properties are expected to 
stem from deteriorating vascular health, then the healthier the arteries, the smaller 
the effects of age will be. In this case, since our exclusion criteria ensured that 
none of our participants had the usual hallmarks of poor vascular health, such as 
high blood pressure, high blood cholesterol and fasting glucose levels, we expect 
these older adults to be much more similar in terms of vascular health to young 
participants than less healthy older adults.
The relatively small amplitude of difference between the two groups may also be 
attributable to several other factors. The sample sizes used here, though larger 
than those used in most other calibrated fMRI studies, may still be too small to 
detect the small differences present in a group of very healthy older adults, 
particularly when only a single scanning run of the modified Stroop task was 
performed. In typical cognitive fMRI studies, several repetitions of the task are 
usually performed to maximize statistical power. However, time constraints in this 
comprehensive imaging protocol, which also included a thoracic MRI exam to be 
discussed in a separate publication, precluded the acquisition of additional 
modified Stroop runs. Finally, baseline CMRO2 may be different in the two groups. 
There is some indication that baseline CMRO2 may be changed in older adults, 
though the existing literature does not agree on the direction of the change, with 
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PET results showing a decrease with age (Yamaguchi et al. 1986; Leenders et al. 
1990; Marchal et al. 1992) and results from a recent MRI study showing an 
increase (Lu et al. 2011). Therefore, even if equivalent fractional changes in 
CMRO2 are estimated, it may be that there is in fact a difference in evoked CMRO2 
in absolute units between the two groups, when expressed in terms of micromolar 
O2 usage for a given tissue volume. While we cannot determine here if this is the 
case, future studies using a method recently developed in our group will address 
this issue (Gauthier et al. 2012c).
Another parameter that was noted to be significantly different in the two age groups 
was the temporal signal-to-noise ratio of ASL (tSNR) as illustrated in Fig 10B. 
Temporal SNR takes into account the temporal fluctuations in time series. These 
fluctuations are thought to be a combination of instrumental thermal noise and 
fluctuations from physiological sources such as heart beats and respiration 
changes (Kruger et al. 2001; Triantafyllou et al. 2005). This difference in ASL tSNR 
can be contrasted to the BOLD tSNR in grey matter, which was much more 
comparable between the two groups and for which the difference did not attain 
statistical significance (Fig. 10C). As the variance of BOLD signals in grey matter is 
believed to be dominated by physiological noise under the conditions of our study 
(3 Tesla, large voxels), it would appear that the age-related differences ASL tSNR 
might be due to physical noise sources that affect the actual MRI signal strength 
and instrumentation noise. This is also supported by the observation that BOLD 
tSNR in the young group was substantially higher in white matter (Fig. 10A), where 
instrumental noise is likely to be more predominant. Higher instrumental noise in 
older subjects could be associated with differences in coil loading or shimming 
associated with systematic postural and anatomical differences that were noted 
(e.g. kiphotic spine, higher body fat). Alternatively, the lower ASL tSNR could reflect 
an increased variability in the ASL labeling signal, in addition to a reduction in its 
mean amplitude. Such an increase in variability might be due to differences in 
heart rate and blood flow velocity in the two groups, or other physiological factors. 
The impact of age on ASL labeling parameters for pseudo-continuous ASL 
sequences are unknown, but reduced labeling efficiency has been previously 
demonstrated for pulsed ASL sequences (Campbell et al. 2006). This means that 
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age-dependent comparisons of neuronal activation based solely on the spatial 
extent of significant ASL response in a functional study must be treated with 
caution as this metric may be biased by the different tSNR levels.
4.6.6. Limitations
The sample size and limited data averaging possible in this study did not permit the 
investigation of the difference contrast between the inhibition/switching and control 
components of the task. While this does not prevent asking questions about the 
physiological properties of the areas of the brain involved in the task, it allows only 
a limited discussion of their implications in the context of cognitive aging. 
Furthermore, it may be that the task used in this study was not optimal for finding 
differences between young and old adults. Tasks with a switching component, such 
as the modified Stroop task used here, are expected to yield bilateral prefrontal 
activation, since these areas are involved both in inhibition and task switching 
(Dove et al. 2000; Leung et al. 2000; MacDonald et al. 2000; DiGirolamo et al. 
2001; Milham et al. 2002; Langenecker et al. 2004; Yeung et al. 2006; Zysset et al. 
2007; Prakash et al. 2011). Studies of aging using the Stroop task have generally 
found an increased extent or amplitude of the hemodynamic response in the older 
group than in the younger group during inhibition (Langenecker et al. 2004; Zysset 
et al. 2007; Prakash et al. 2011), though at least one study found the opposite 
trend (Milham et al. 2002). There are few fMRI studies of switching tasks with 
aging, but one study (DiGirolamo et al. 2001) found that both older and younger 
adults recruit similarly DLPFC and MFC areas. However, while younger adults did 
not recruit these areas during non-switch trials, older adults did. In this case, we 
also found similar BOLD signal patterns during inhibition/switching blocks in both 
age groups. We cannot however, with the mixed block design used here, identify 
differences in activation patterns during non-switch trials. Furthermore, since our 
control task was a color naming, rather than a block of incongruous Stroop task 
trials, we cannot use it to uncover the type of patterns shown by DiGirolamo et al. 
Another study of switching during aging found however older adults to show 
smaller BOLD signal changes in response to the task both in frontal and parietal 
regions (Gold et al. 2010), which is not the pattern observed here. The task used in 
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that study was however different and the group of participants smaller, with less 
stringent selection criteria, indicating a perhaps less healthy cohort. 
Different breathing manipulations may be used for calibrated fMRI and a common 
concern with hypercapnia is that it may lead to breathing discomfort in participants. 
Breathing discomfort was rated using the seven-point rating scale presented by 
Banzett et al. (Banzett et al. 1996) and average ratings were 2.16 ± 0.17 and 2.26 
± 0.19 in the younger and older groups respectively. This corresponds to a rating of 
between no discomfort and mild discomfort. Therefore, discomfort of the breathing 
manipulation is unlikely to have acted as a significant confound in our data. 
Another subject of debate with hypercapnia is whether it causes any changes in 
oxidative metabolism when small doses are administered. Results from the 
literature are unclear, with some reports of increases in metabolism (Horvath et al., 
1994; Jones et al., 2005), decreases (Xu et al., 2011b; Zappe et al., 2008), and no 
detectable change (Chen and Pike, 2010a; Hino et al., 2000; McPherson et al., 
1991). Because the literature lacks consensus on this topic, we have elected to 
preserve the assumption of no evoked metabolism usual for this this type of study. 
However, were a consensus to be reached or a way of measuring a potential 
change in metabolism arise, this could be taken into account in the modeling in 
future studies. 
4.6.7. Future directions
The present study identifies potential sources of bias in BOLD studies of cognitive 
aging and suggests that simple BOLD signal comparisons may not fully reflect the 
metabolic response elicited by a task in older brains. Interpretation would be further 
aided if absolute measures of resting CMRO2 were available in our subjects. Since 
the calibrated fMRI method used here yields a fractional change from an unknown 
and possibly population-dependent baseline, we cannot determine from this result 
if the oxidative metabolism in micromolar units is truly different between groups. 
We have recently reported a technique, dubbed QUO2, which allows determination 
of resting OEF and CMRO2 using two breathing manipulations (Gauthier et al. 
2012c). Future studies using this or other related techniques (Bulte et al. 2011) will 
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add much-needed information on the metabolic aspects of aging and the possible 
impact of these changes on hemodynamic imaging techniques.
4.7. Conclusion
The present study indicates that BOLD-only studies of cognitive aging may be 
subject to biases that lead to underestimation of the oxidative metabolism 
underlying the BOLD signal changes seen in the elderly. BOLD and CBF 
responses to a hypercapnia functional challenge indicate that the reactivity and 
range of these imaging contrasts in older adults, masking to some extent increases 
in oxidative metabolism. These results warrant greater caution in the interpretation 
of BOLD signal changes observed in different age groups and highlight the 
importance of ancillary measures such as baseline blood flow and CO2 reactivity 
provide important information for the understanding of age-related functional 
imaging changes.
4.8. Acknowledgments
We thank Carollyn Hurst and André Cyr for help with data acquisition, Christopher 
Steele for help with data analysis and presentation, and Felipe Tancredi for helpful 
discussions on data analysis. We would also like to thank Jiongjiong Wang at 
UCLA, who provided the pseudo-continuous arterial spin-labeling sequence used. 
This work was supported by the Canadian Institutes for Health Research (MOP 
84378, Banting and Best Scholarship held by CJG), the Canadian Foundation for 
Innovation (Leaders Opportunity Fund 17380), the Canadian National Sciences 
and Engineering Research Council (R0018142), and the Ministère du 
développement économique, de l’innovation et de l’exportation (PSR-SIIRI-239).
188
5. Relationship between cardiovascular health, 
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5.1. Preface
The brain is known to undergo vascular and cognitive changes with age (Cabeza 
et al. 2005; Chen et al. 2011; Lu et al. 2011). These changes may be preceded by 
arterial hardening starting at the aorta (Redheuil et al. 2010), then spreading to 
other organs including the brain as pulsations become less efficiently absorbed by 
the aorta. Therefore, there may be a link between age-related arterial stiffening and 
loss of elasticity in the brain vasculature (O'Rourke et al. 2007). Some of these 
processes may furthermore underly the decreased cognitive performance and 
changes in patterns of hemodynamic signal changes observed in fMRI studies of 
cognitive aging (Brown et al. 2011). While these effects may contribute to even 
healthy aging, cardiovascular fitness may act as modulator to slow down the 
progression towards stiffer vessels (Churchill et al. 2002; Brown et al. 2010; 
Davenport et al. 2012). 
The study presented in Chapter 5 seeks to address these questions by combining 
measures of central and cerebral vascular health, cognitive performance on an 
executive function task and cardiovascular fitness in a group of younger and older 
adults. Parameters found to differ significantly between young and old are then 
examined to identify correlations within the older group and identify links between 
vascular health, fitness and cognition. 
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The data presented here represents a subset of a larger dataset. The data from 31 
younger and 31 older adults is presented, but this same set of measures was 
acquired in an additional 25 older participants not included in this preliminary 
analysis. Furthermore, the measures presented here is also a subset of the 
measures acquired in this cohort, which included also a series of blood tests 
(fasting glucose, cholesterol, triglycerides, hemoglobin and C-reactive protein), 
body mass index, a neuropsychological battery, additional aortic metrics, fMRI of 
the Stroop task, time domain near-infrared measure of baseline hemoglobin 
(oxygenated and deoxygenated), and a near-infrared acquisition during the Stroop 
task. These additional measures and participants will be included in the final 
analysis of this study. Despite its preliminary nature, this study was included since 
it demonstrates the breadth of experimental work carried out in the thesis project. 
Although the additional statistical power provided by the complete cohort will be 
necessary to confirm the correlations noted in the present analysis and uncover 
other important relationships between different aspects of vascular and cognitive 
health, the smaller cohort is nevertheless indicative of interesting age-related 
changes and confirms some of the expected links between central vascular health, 
cerebral vascular and metabolic function, cognition and cardiovascular fitness.
5.2. Abstract
The aging brain exhibits both vascular and cognitive changes. While arteries 
throughout the body are known to become stiffer with age, this vessel hardening is 
believed to start at the level of the aorta and progress to other organs, including the 
brain. The progression of this vascular impairment may contribute to cognitive 
changes observed with aging. Furthermore, it may be that regular exercise acts as 
a modulator to partially attenuate the effects of age on vascular and metabolic 
physiology. The present study seeks to address these questions by identifying 
vascular, metabolic and cognitive properties that change within a cohort of thirty-
one younger and older adults. We then sought to identify cardiovascular and 
neurological parameters exhibiting significant correlations within the older group. 
Decreases in aortic elasticity were found in the older group, both in terms of aortic 
pulse-wave velocity (PWV) and augmentation index (AI). The older group was 
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furthermore found to have a lower cerebrovascular BOLD reactivity to hypercapnia 
and a lower baseline BOLD signal (measured as the parameter M from calibrated 
fMRI methods). Finally, older adults were found to show a lower performance on an 
executive function task and show reduced cardiovascular fitness (VO2max). 
Results within the older group indicate that there may be a relationship between 
VO2max, AI and cognitive performance, as well as between AI and M. The results 
of this study therefore support the hypothesis that greater cardiovascular fitness is 
associated with improvements in central vascular function, contributing in turn to 
improved brain vascular health and cognition.
5.3. Introduction
The arterial network has two main functions: to deliver blood to all tissues in the 
body and dampen heart pulsations so that when blood reaches the capillaries, flow 
is continuous rather than pulsatile (O'Rourke et al. 2007). The dampening of 
pulsatile flow is achieved by laminae of the protein elastin in blood vessel walls. 
This protein acts like rubber to allow vessel walls to be distended during the 
systolic phase of the cardiac cycle and return to their original shape during the 
diastolic phase (O'Rourke et al. 2007; Fritze et al. 2012). Elastin has a half-life of 
decades but, like all material, it undergoes mechanical fatigue (Rigby 1964). Over 
a lifetime of stretching at every heart beat, the elastin laminae fracture and loose 
efficiency (Quaglino et al. 1996; Fritze et al. 2012). The laminae become thinner 
and the space created between laminae is filled with collagen. Collagen is not 
elastic, so decreased elastin to collagen ratio results in stiffer blood vessels with a 
larger diameter and prevents large deformations of blood vessel walls (Fritze et al. 
2012). 
Arterial hardening is a general process that affects the arteries of the whole body, 
though not all at the same pace. The aorta is the first artery to be affected since 
much of the pulsatile flow absorption and therefore the mechanical damage to 
elastin laminae occurs at this level (Laurent et al. 2007; Redheuil et al. 2010). 
Furthermore, measures of aortic stiffening (including pulse-wave velocity and 
augmentation index) have been shown to be independent risk factor for all cause 
mortality and a variety of conditions including cardiovascular events and fatal 
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stroke (Boutouyrie et al. 2002; Laurent et al. 2003; Laurent et al. 2006). Therefore, 
it may be that measures of aortic stiffening are the most sensitive test of general 
hardening. 
The brain may be particularly vulnerable to the effects of arterial hardening and 
there may be a link between arterial stiffening and cognitive decline (Waldstein et 
al. 2008; Elias et al. 2009; Brown et al. 2011). The brain is one of the only organs 
without protection against the pulsatile nature of blood flow and cerebral arteries 
may therefore be more sensitive to loss of elastin (Laurent et al. 2007; O'Rourke et 
al. 2007). Furthermore, animal studies have shown that the brain experiences an 
age-related decrease in microvascular density (Sonntag et al. 1997). The 
increased pulsatility associated with less elastic arteries may lead to distal cerebral 
lesions and impaired microcirculation (O'Rourke et al. 2007), and vascular lesions 
in white matter have been shown to be associated with cognitive decline and 
dementia (Sierra et al. 2004). Finally, impaired endothelial function leading to 
circulation of cellular debris may contribute to microvascular lesions and hence 
cognitive deficits (O'Rourke et al. 2007; Wang et al. 2007; Wang et al. 2009).  
5.3.1. Effects of cardiorespiratory fitness
A healthy diet and regular exercise are the most widely recognized recognized 
means to preserving autonomy and quality of life during aging (Wallace 2005). 
Physically fit older adults have been shown to have lower blood pressures and 
higher cerebrovascular reserve (Brown et al. 2010). Cross-sectional studies have 
suggested that regular exercise may be partly protective against dementia 
(Podewils et al. 2005; Larson et al. 2006) and cognitive decline (Rogers et al. 
1990; Yaffe et al. 2001; Churchill et al. 2002; Etnier et al. 2006; Kramer et al. 2006; 
Brown et al. 2010; Brown et al. 2011). A meta-analysis of fitness training studies 
has showed that fitness training results in improved cognitive scores, especially for 
tasks requiring executive control processes (Colcombe et al. 2003). The 
improvement may, however, depend on many factors including the time spent 
exercising on the day of the experiment and genetic polymorphisms (Hopkins et al. 
2012).  
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In a recent study on the hemodynamic properties of the aging brain, we have 
shown that older adults show a reduced hemodynamic response to a global CO2 
challenge, as well as reduced baseline blood flow and baseline BOLD signal 
throughout the brain (Chapter 4). The participants included in that study also 
underwent MRI scanning of the aorta to assess hardening in this major artery, as 
well as a test of cardiorespiratory fitness. Here we document age-related 
differences in aortic elasticity, in cerebral vascular and metabolic properties, as well 
as changes in fitness and cognition within these older adults. Furthermore, 
correlations between these changes indicate that there may be a link between 
central vascular health and fitness, cerebral hemodynamics, and cognition. 
5.4. Methods
5.4.1. Participants
Acquisitions were conducted in 31 young (10 female, with mean age of 24 ± 3 
years) and 31 older (14 female, with mean age of 64 ± 5 years) healthy participants 
on a Siemens TIM Trio 3T MRI system (Siemens Medical Solutions, Erlangen, 
Germany). All subjects gave informed consent and the project was approved by the 
Comité mixte d’éthique de la recherche du Regroupement Neuroimagerie/Québec.
Exclusion criteria for this study included claustrophobia, cardiac disease, 
hypertension or taking blood pressure lowering medication, neurological or 
psychiatric illness, smoking, excessive drinking (more than two drinks per day), 
thyroid disease, diabetes, asthma and being under a regular treatment known to be 
vasoactive or psychoactive. Participants were all non-smoking and older 
participants had been non-smoking for at least five years. All older participants met 
with a geriatric MD to ensure that they did not meet any of the exclusion criteria for 
the study. Furthermore, all participants underwent a neuropsychological battery to 
ensure the absence of cognitive impairment. 
5.4.2. Maximal continuous graded exercise test
All participants underwent an exercise test to estimate their cardiorespiratory 
fitness at the time of the study. All tests were done within one month of the MRI 
session. Initial workload was set at the individual body weight and increased by 15 
193
W every minute until voluntary exhaustion. Strong verbal encouragement was 
given throughout the test. Oxygen uptake (in ml/min/kg) was determined 
continuously on a 30-second basis using an automated cardiopulmonary exercise 
system (Moxus, AEI Technologies, Naperville, IL). The highest over a 30-second 
period during the test was considered as the peak oxygen uptake (peak, in ml/min/
kg). For older participants, a cardiologist was available in case of difficulties during 
the test and the ECG trace was reviewed by the cardiologist to ensure that it was 
normal.
5.4.3. Modified Stroop task
The modified Stroop task consisted of two 60-second blocks each of control and 
inhibition/switching Stroop conditions, interspersed with 60-second rest blocks. The 
details of this task have been described in a previous study (see Chapter 4).
5.4.4. MR Image acquisition
The imaging session was divided in two segments: one for the acquisition of brain 
images and the other for aortic images. Participants were taken out of the scanner 
in between these two acquisition segments to change the equipment. Participants 
were allowed to move or stretch during this pause to ensure greater comfort.
5.4.4.1. Brain exam
The vendor-supplied 32-channel receive-only head coil was used for all 
acquisitions. Sessions included an anatomical, 1mm3 MPRAGE acquisition and 
older participants had an additional FLAIR acquisition to assess the presence and 
severity of white-matter lesions. MPRAGE and FLAIR acquisition parameters have 
been described in a previous study using the same protocol (Chapter 4). White 
matter hyperintensities were quantified using the scale from Wahlund and 
colleagues (Wahlund et al. 2001). Only participants with scores of 0 or 1 were 
included in this study, for an average and standard deviation of 0.67 ± 0.48 in the 
older group. 
Functional image series were acquired using a dual-echo pseudo-continuous 
arterial spin labeling (pCASL) acquisition (Wu et al. 2007) to measure 
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simultaneously changes in cerebral blood flow (CBF) and BOLD signal. The 
parameters for this sequence have been previously described (Chapter 4).
5.4.4.2. Aortic exam
The session also included an aortic exam with simultaneous brachial pressure 
recording (Model 53000, Welch Allyn, Skaneateles Falls, NY, USA). Aortic images 
were acquired using the six-element body matrix and 24-element spine matrix 
coils. All acquisitions were ECG gated and acquired during cued breath holding. A 
series of black blood turbo spin echo (TSE) images were acquired to visualize the 
aortic arch with parameters: TR/TE/alpha: 700ms/6.5ms/180o, with 1.4x1.4mm in-
plane resolution and two slices of 7.0mm. Once these images were acquired, a 
plane perpendicular to the ascending and descending aorta was defined, at the 
level of the pulmonary artery. In this plane, a phase-contrast velocity encoded 
series was acquired with parameters: TR/TE/alpha: 28.6 ms/1.99 ms/30o, with 
1.5x1.5 mm in-plane resolution and a single slice of 5.5 mm, during 60 phases of 
the cardiac cycle, acquired in three segments, with a velocity encoding of 180 cm/s 
through plane. Brachial pressures were acquired at the beginning of the aortic 
exam, and before and after the phase-contrast sequence.
5.4.5. Tonometry
Carotid applanation tonometry was performed right after the MRI session in an 
adjoining room. Participants were supine and the data was acquired using a 
Pulsepen device (DiaTecne, Milan, Italy). Simultaneous pulse waveform and ECG 
trace was acquired on both carotids. Brachial blood pressure measure was taken 
right before leaving the MR room. Post-processing was done using the 
manufacturer’s software. Augmentation index (AI; in %) was determined for both 
carotids as the ratio of augmented pressure (determined as the height of the last 
systolic peak above the inflection point) to the pulse pressure (the difference 
between systolic and diastolic pressure).
5.4.6. Hypercapnic manipulation
Hypercapnic manipulations were achieved using a computer-controlled gas 
delivery system in combination with a sequential gas delivery circuit (RespirActTM, 
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Thornhill Research Inc., Toronto, Canada). For details on the hypercapnia 
manipulation, see Chapter 4. Subjects underwent the manipulation twice during the 
study, one outside the scanner before the imaging session to acclimatize the 
participant to the manipulation and once during the MRI session. Subjects were 
debriefed after the acclimatization session to assess their level of respiratory 
discomfort using the seven-point scale published by Banzett and colleagues 
(Banzett et al. 1996). All participants had a rating below 5 (significant discomfort). 
5.4.7. Data analysis
5.4.7.1. Brain data
All analyses were done using the NeuroLens data analysis software package 
(www.neurolens.org). Functional data analyses were done as described in Chapter 
4.
5.4.7.2. Aortic data
The aortic data was analyzed using the ARTFUN software (Herment et al. 2010). 
Pulse wave velocity (PWV) was regionally computed between ascending and 
descending aorta from phase contrast and cine images. Using amplitude phase 
contrast cine images, the aortic lumen contours of the ascending aorta and 
descending aorta were automatically segmented and flow profiles were estimated 
using the phase information within these contours (Herment et al. 2010). Delay 
times (Δt) between the two flow profiles were computed by least squares 
minimization of the delay between the up slopes of the two curves. The 3D length 
of the aortic arch (La) between the ascending and descending aorta was computed 
using additional TSE images (including coronal views and axial views) by manually  
selecting markers in the central line of the aorta. PWV was defined as the ratio 
between La and Δt (Dogui et al. 2011). 
5.4.8. Statistical analysis
Statistical analysis of all data was done using SPSS 19.0 (IBM, Armonk, New York, 
USA). Comparisons between groups were done using one-tailed Student’s t-tests. 
One-tailed partial correlations were done using only the 31 participants in the older 
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group, taking into account the effects of age and gender. All measures reported in 
the text are average values ± standard error.
5.5. Results
Aging is known to be associated both with decreases in cognitive performance and 
in vascular health. Here we quantify reductions in aortic elasticity and 
cardiorespiratory fitness in older participants, as well as cognitive performance on 
an executive function task and brain vascular and metabolic function. The results 
presented here indicate that measures of central vascular health and 
cardiorespiratory fitness may be predictive of an individual's level of cerebral and 
cognitive health. 
5.5.1. Central vascular health and fitness
Aortic elasticity was assessed using pulse-wave velocity and augmentation index 
measures. Results show that there was a significant difference between younger 
and older participants in both these measures (p < 0.0001 for both). PWV was 
found to be 3.95 ± 0.15 cm/s in the younger group and 8.92 ± 0.58 cm/s in the 
older group (Figure 1A), while AI was found to be -9.32 ± 3.53 and 19.43 ± 2.44 in 
the younger and older group respectively (Figure 1B). 
Cardiorespiratory fitness was assessed using a VO2max test. VO2max was also 
found to be different between the two groups (p < 0.0001) with values of 42.32 ± 
1.31 ml/min/kg in the younger and 31.66 ± 1.26 ml/min/kg in the older group 
(Figure 1C).
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Figure 1. Central vascular health and cardiorespiratory fitness
Measures of central arterial elasticity including aortic pulse-wave velocity (PWV) (A) and 
augmentation index (B) were found to be significantly affected by age (p < 0.0001). 
Cardiorespiratory fitness, measured in terms of VO2max (C), was also found to be significantly 
decreased with age (p < 0.0001).
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5.5.2. Cerebral measures
Cerebral measures included both reaction time in responding to a cognitive task 
and measures of cerebrovascular and metabolic health. Imaging parameters, 
including baseline BOLD hypercapnia reactivity and the baseline BOLD signal M 
were quantified globally within grey matter. 
The modified Stroop task used here included two types of blocks: inhibition/
switching blocks and control blocks. The reaction times presented here correspond 
to the subtraction between inhibition/switching reaction times and control task 
reaction times. These were found to be significantly different between the two 
groups (p < 0.0001), with values of 322.67 ± 24.53 ms in the younger and 543.13 ± 
28.74 ms in the older group (Figure 2). Average values for each task component 
are also shown in Figure 2.
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Figure 2. Stroop task performance
Performance on the modified Stroop task was assessed using reaction time. Older adults were 
found to have slower reaction times for both the control and inhibition/switching (Stroop) parts of the 
task. The difference in reaction time between these two parts was furthermore significantly different 
between the two groups (p < 0.0001).
Group average maps of vascular reactivity and baseline BOLD signal show that 
these properties may be lower throughout grey matter in the older adults (Figure 
3). BOLD CVR was obtained by dividing the group average percent BOLD signal 
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change in response to a hypercapnia stimulus by the change in expired CO2 
concentration in mmHg. The amplitude of this response is thought to be related to 
the distensibility of cerebral arteries. BOLD CVR measures were found to be 
significantly lower in the older group (p < 0.0001), with values of 0.31 ± 0.02 
%∆BOLD/mmHg and 0.23 ± 0.01 %∆BOLD/mmHg in the younger and older 
participants respectively (Figure 3). 
The M parameter is defined as the maximal theoretical possible BOLD signal 
change. It represents the BOLD signal attenuation from paramagnetic 
deoxyhemoglobin present in venous blood. It is therefore an indirect measure of 
baseline metabolism, with a contribution from baseline blood flow and volume. 
Values for this parameter were found to be marginally significantly different 
between the two groups (p = 0.048), with values of 5.76 ± 0.22% in the younger 
and 5.00 ± 0.30 in the older group (Figure 3). 
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Figure 3. Cerebral hemodynamic properties
This figure shows average BOLD CVR maps in younger and older adults, as well as maps of the M 
parameter for these two groups. Quantification of these two parameters over all grey matter for 
younger and older adults are shown in the bottom part of this figure. BOLD CVR was found to be 
significantly lower in older adults (p < 0.001), while a marginally significant decrease in M parameter 
was also seen in the older group (p = 0.048).
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5.5.3. Correlations between parameters
Partial correlations between the above-mentioned parameters showing age-related 
differences were assessed within the older group, taking into account the effects of 
age and gender (Table 1). 
AI VO2max Stroop RT BOLD CVR M
AI
1.000 -0.314 0.290 0.057 -0.336 Cor
. 0.052 0.067 0.387 0.040 Sig
VO2max
1.000 -0.494 -0.310 0.079 Cor
. 0.004 0.054 0.345 Sig
Stroop RT
1.000 0.215 0.006 Cor
. 0.135 0.488 Sig
BOLD CVR
1.000 -0.017 Cor
. 0.465 Sig
M
1.000 Cor
. Sig
Table 1. Partial correlations between health indices in the older subjects
This table shows the results of a partial correlation analysis within the 31 older participants showing 
the relationship between various vascular, metabolic and cognitive health indices. This analysis was 
done taking into account the effects of age and gender. For each combination of parameters, the 
strength of the correlation (cor) and significance (sig) of the association is given. Parameters 
included are augmentation index (AI), VO2max (in ml/min/kg), reaction time difference between the 
inhibition/switching and control parts of the modified Stroop task (Stroop RT; in ms), 
cerebrovascular reactivity to CO2 measured using the BOLD signal (BOLD CVR; in %∆BOLD/
mmHg CO2) and the M parameter (in %).
VO2max was found to be correlated significantly with the difference between 
inhibition/switching reaction time and reaction time on the control task (Stroop RT 
in Table 1) with a coefficient of r = -0.494 (p = 0.004). A trend towards significance 
was observed between the augmentation index and VO2max (r = -0.314; p = 
201
0.052), as well as with the M parameter (r = -0.336; p = 0.040) and, to a lesser 
extent, Stroop reaction time (r = 0.290; p = 0.067). Finally, VO2max was also found 
to have a trend towards an association with BOLD CVR (r = -0.310; p = 0.054). 
Pulse-wave velocity was not found to the associated with any other measures 
within the older group. 
5.6. Discussion
Results shown here indicate that there may be a link between central vascular 
health, cardiorespiratory fitness, cerebral vascular and metabolic health with aging. 
There may additionally be a link between these measures of vascular and 
metabolic health and cognitive performance on a type of task thought to be 
affected by age.
5.6.1. Differences between age groups
The data presented here show that age is associated with a variety of vascular and 
metabolic changes centrally and in the brain. Aging is associated with increased 
pulse-wave velocity and augmentation index at the level of the aorta. This agrees 
well with literature showing progressive hardening of central vessels with age 
(Boutouyrie et al. 2002; Binder et al. 2006; Laurent et al. 2007; Waldstein et al. 
2008; Redheuil et al. 2010). Vascular changes are also known to occur in the brain 
during aging (Chen et al. 2011; Lu et al. 2011). This was ascertained in our sample, 
with older adults showing lower BOLD reactivity to CO2. CO2 is a potent vasodilator 
and inhaling increased concentrations of CO2 leads to a global increase in blood 
flow throughout grey matter which may be sensitively captured using the BOLD 
technique (Leontiev et al. 2007a; Mandell et al. 2008; Goode et al. 2009b). A lower 
BOLD reactivity to CO2 may be indicative of vessel hardening at the level of the 
brain (Mandell et al. 2008; Goode et al. 2009a; Goode et al. 2009b). Furthermore, 
the parameter M was also found to be lower in the older group, in agreement with 
previous calibrated fMRI studies of aging (Ances et al. 2009; Mohtasib et al. 2012). 
The M parameter represents the maximum possible BOLD signal change from 
baseline and arises from the deoxyhemoglobin content of venous blood at rest 
(Davis et al. 1998; Hoge et al. 1999a). As such, it is an indirect composite measure 
of baseline oxidative metabolism, with contributions from baseline blood flow and 
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volume. It can be taken to be the baseline BOLD signal, since it represents BOLD 
attenuation at rest. While not as physiologically-specific as a direct measure of 
oxidative metabolism, it nevertheless provides some information on baseline 
metabolic and vascular health.
Two other measures were assessed for changes with aging. The capacity to 
metabolize O2 during exercise was found, as elsewhere, to be affected by age 
(Lazarus et al. 2010; Andersson et al. 2011). This physiological property, while 
generally thought to be decreased with age is, however, highly dependent on 
lifestyle and the type and amount of regular exercise done by older adults 
(Colcombe et al. 2006; Hagner et al. 2009; Sergi et al. 2010; Davenport et al. 
2012). Because vascular health is thought to be at least partly determined by 
lifestyle and because vascular health is thought to improve with greater fitness 
(Binder et al. 2006; Arena et al. 2009; Davenport et al. 2012), this change in O2 
metabolic capacity with exercise may be an important modulating factor of the 
effects of aging. Finally, performance on a cognitive task including an executive 
function component was assessed and found to be lower in the older group. While 
performance in terms of reaction time and accuracy on a wide variety of cognitive 
tasks has been found to be decreased with aging, executive functions may be 
particularly sensitive to the effects of aging (Langenecker et al. 2004; Cabeza et al. 
2005; Spreng et al. 2010). Performance on this task was measured in terms of 
reaction time difference between the inhibition/switching blocks (which contain an 
executive function component) and the control blocks.  
5.6.2. Correlations within older participants
While the different vascular, metabolic and cognitive properties assessed here 
have all been used in previous studies to investigate the effects of aging, this is the 
first time that these were assessed within a single cohort. The fact that all these 
properties differ within the same group of individuals allows a more in depth 
investigation of the relationships between these parameters during healthy aging. 
Therefore, partial correlations between these parameters were assessed within the 
older group, while taking into account the confounding effects of age and gender. 
Because the group of subjects included in this analysis was fairly small (31 
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participants) and because the inclusion and exclusion criteria for this study were 
very strict (and hence make the population more homogeneous in terms of 
vascular health), the correlations remain, however, somewhat modest.  We are in 
the process of extracting quantitative measures from additional older subjects, who 
will be added to the cohort analyzed here with the hope of increasing statistical 
power.
The augmentation index, a measure of aortic elasticity thought to be an early 
indicator of arterial hardening (Pase et al. 2010; Redheuil et al. 2010), was found 
here to correlate with cardiorespiratory fitness in terms of VO2max. While we 
cannot establish a causal link, this is consistent with the well-established link 
between preservation of vascular health in the elderly and regular cardiovascular 
exercise (Binder et al. 2006; Arena et al. 2009). The data presented here confirm 
the results by Binder et al. showing an association between augmentation index 
and VO2max (Binder et al. 2006). Augmentation index was furthermore found to 
correlate with the M parameter, establishing a link between central vascular health 
and cerebral hemodynamic properties. This may indicate that older adults with less 
healthy central arteries may also show reduced metabolic equilibrium in the brain, 
since a reduced M may be indicative of a change in metabolic production of 
deoxyhemoglobin or a changed balance between deoxyhemoglobin concentration 
and the baseline cerebral blood flow that dilutes it. Further research is, however, 
needed to explore this link, given the ambiguous nature of the M parameter. 
Finally, augmentation index was found to have a trend towards an association with 
reaction time difference between the inhibition/switching and control blocks of the 
modified Stroop task. The addition of data from more study participants may help 
confirm this link, in agreement with other studies showing a link between measures 
of central vascular health and cognition (Pase et al. 2010; Gorelick et al. 2011; 
Mitchell et al. 2011; Sahathevan et al. 2012).
The strongest association found here was between VO2max and the reaction time 
difference in the cognitive task. This association could, however, be related to 
motivation, since voluntary exhaustion is used to interrupt the VO2max test and 
since motivation and attention will influence performance on the cognitive task 
(Bonnefond et al. 2011; Satterthwaite et al. 2012). But other associations between 
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vascular parameters support the conclusion this effect is at least partly vascular in 
nature. VO2max was also found to show a trend towards an association with 
BOLD CVR. This would be consistent with another study showing lower 
hypercapnia blood flow response in sedentary older adults (Brown et al. 2010; 
Davenport et al. 2012). Furthermore, the study by Brown and colleagues also 
identified a link between cardiovascular fitness and cognitive function. This 
association between fitness and cognition has also been seen in several other 
studies (Rogers et al. 1990; Yaffe et al. 2001; Churchill et al. 2002; Etnier et al. 
2006; Kramer et al. 2006; Brown et al. 2010; Hopkins et al. 2010; Brown et al. 
2011; Hopkins et al. 2012). 
The results presented here support the view that with age comes a general arterial 
hardening, beginning at the aorta and progressing to other organs including the 
brain (O'Rourke et al. 2007; Waldstein et al. 2008; Redheuil et al. 2010). This 
vessel hardening is thought to be a contributing factor in the cognitive decline 
observed with aging (Waldstein et al. 2008; Brown et al. 2010; Iadecola 2010; 
Brown et al. 2011; Gorelick et al. 2011). Finally, the results of this cross-sectional 
study agree with the view that lifestyle factors, such as cardiorespiratory fitness, 
act as modulators of these vascular effects and that regular exercise may help 
mitigate the detrimental effects of aging on cognition (Rogers et al. 1990; Yaffe et 
al. 2001; Churchill et al. 2002; Etnier et al. 2006; Kramer et al. 2006; Brown et al. 
2010; Hopkins et al. 2010; Brown et al. 2011; Hopkins et al. 2012). Improved 
statistical power with the larger final cohort will hopefully allow a more nuanced 
discussion of these effects. Furthermore, the addition of more physiologically-
specific measures, such as blood flow and baseline oxidative metabolism could in 
the context of a future study, help improve our understanding of these effects. 
5.7. Conclusion
The results of this study support a link between aging and degradations in vascular 
and metabolic health, both centrally and in the brain, as well as an association 
between declining vascular health and decreased cognitive performance. The 
results presented here also support the notion that regular exercise, by increasing 
cardiorespiratory fitness, may help prevent some of the negative effects of aging 
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on the vasculature and on cognition. However, more work is needed to firmly 
establish these relationship and future longitudinal work including more 
physiologically-specific parameters may help establish the mechanisms by which 
these effects arise. 
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6. General Discussion
Functional magnetic resonance imaging has been steadily gaining in popularity 
from its first description in 1992 (Kwong et al. 1992; Ogawa et al. 1992). The BOLD 
contrast is a sensitive measure of the hemodynamic response that follows synaptic 
activity and offers advantages in terms of spatial resolution over competing 
functional imaging methods such as near-infrared spectroscopy and PET. 
Unfortunately however, the BOLD signal suffers from being physiologically 
unspecific. Increases in BOLD signal during tasks arise from an ambiguous 
combination of increases in oxidative metabolism, blood flow and blood volume. 
While this may not be an overly detrimental limitation when assessing the 
localization of brain activity within a group of homogeneous participants, it does 
however limit the inferences that may be drawn from group comparisons of signal 
amplitudes and extent when these groups are suspected to differ in vascular or 
metabolic function (Samanez-Larkin et al. 2008). 
The present thesis is an attempt to explore the ways in which MRI methods may be 
used to make the BOLD contrast more physiologically specific and understand the 
physiological differences that underly changes in BOLD signals. An extension of 
previous calibrated fMRI techniques is first presented in Chapter 2 to extract more 
robust and accurate estimates of task-evoked oxidative metabolism. Chapter 3 
presented a method to estimate baseline CMRO2 based on combinations of gas 
manipulations and the calibrated fMRI model described in Chapter 2. In Chapter 4, 
the more traditional hypercapnia calibrated fMRI frame was used to explore age-
related changes in brain physiology and the possible biases that BOLD-only 
studies of cognitive aging are subject to. Finally, an investigation into the possible 
underlying vascular causes of age-related changes are presented in Chapter 5. In 
summary, this thesis presents methods to extract more physiologically-specific 
information from the BOLD signal, then uses the concepts provided by these 
methods to explore the physiological changes associated with healthy aging and 
the confounds that BOLD studies of aging are subject to.
All the manuscripts included in this thesis use concepts adapted from prior 
calibrated fMRI work to explore the meaning of BOLD signal changes. Calibrated 
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fMRI techniques have existed and been used for now almost fifteen years. Though 
the original Davis approach using hypercapnia was for long the only method 
available (Davis et al. 1998), other techniques have started to emerge in the last 
few years. The second technique to be proposed was the hyperoxia calibration 
method (Chiarelli et al. 2007b). The purported advantage of this technique is a 
reduced discomfort of the breathing manipulation since changes in O2 composition 
is not perceived by participants. However, this technique comes with its own set of 
assumptions and it may be more susceptible to systematic biases than other 
techniques (Blockley et al. 2011b; Gauthier et al. 2012b). In the last year, two more 
techniques were proposed. One uses the information in spin and gradient echoes 
to calibrate the signal without the need for a separate breathing manipulation 
(Blockley et al. 2011b) and the other is an extension of the hyperoxia calibration 
model that can be used with any combination of hypercapnia and hyperoxia. This 
second method is presented in Chapter 2 and used throughout all the thesis’s 
manuscripts. 
6.1. Calibrated fMRI method comparisons
The Davis method has stood the test of time and has been shown to provide a set 
of robust simplifications that compare well with more complex modeling 
approaches (Buxton 2010; Blockley et al. 2011b; Griffeth et al. 2011). While these 
studies have demonstrated the robustness of the method in the context of 
observations made in healthy young subjects, the assumptions made by the model 
may not hold as well in the context of older individuals. More specifically, this 
model includes the implicit assumption that arterial blood is completely saturated 
with oxygen, which may not hold true as aging results in decreases in gas 
exchange and perfusion efficiency (Janssens et al. 1999; Sharma et al. 2006). 
The hyperoxia calibration model generated much enthusiasm from the reduced 
discomfort associated with hyperoxia as opposed to hypercapnia. While the M 
values obtained using this technique show reduced variance (Mark et al. 2011), 
this arises from the fact that the amplitude of the CBF decrease in response to 
hyperoxia is generally assumed. This flow assumption is made because the real 
flow change is too small to be measured using standard CBF measurements in 
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most experimental contexts (Bulte et al. 2007). However, since ASL of gas changes 
is the lowest SNR measure in any of these techniques, assuming a CBF change 
artificially lowers the variance across subjects and creates the impression that the 
intra- and inter-individual differences are lower than they really are. In Chapter 2 of 
this thesis, we have shown that this technique is highly sensitive to misassignment 
of this CBF change. Even modest errors within the physiological range in the CBF 
value input into the model can result in large errors and even singularities in the 
computed M value (Figure 6B in Chapter 2). Blockley et al. have also shown that 
this model is very sensitive to errors in the assignment of baseline OEF (Blockley 
et al. 2011b).
The Generalized calibration model (GCM) was devised to take into account both 
arbitrary changes in blood flow and blood oxygenation. It is based on a 
modification of the hyperoxia calibration model to take into account blood flow 
changes in the equation relating changes arterial content of O2 to venous content 
of O2 (Equation 2, Chapter 2). While the hyperoxia model formulation used by 
Chiarelli et al. (Chiarelli et al. 2007b) is correct for manipulations, such as mild 
hyperoxia, which are not thought to result in changes in CBF, it is not appropriate 
for manipulations including a substantial change in CBF. Because the GCM takes 
into account both arterial oxygenation and changes in CBF, it may in fact be more 
robust to measurement error in CBF than either of the two original model (Chapter 
2, Figure 6). Furthermore, because it can be used in combination with breathing 
manipulations that include simultaneous hypercapnia and hyperoxia (carbogen 
breathing) the M value can be estimated more robustly using higher SNR 
measurements as input. 
6.2. Accuracy of measurement
In a previous study, we have performed a direct measurement of the M parameter 
(Appendix A). Since M corresponds to the BOLD signal change from complete 
removal of all baseline dHb, this was achieved using a breathing manipulation that 
greatly increases both CBF and arterial oxygenation. Participants were asked to 
breathe a mixture of 10% CO2 in 90% O2 (carbogen-10), ensuring both a very large 
CBF increase (around 100%), as well as a substantial amount of dissolved oxygen 
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in arterial blood. This study worked under the hypothesis that it is possible to 
increase arterial saturation enough so that the dissolved O2 in arteries will meet all 
O2 extraction from metabolism. In other words, venous blood would become almost 
or completely saturated with O2 and be the virtual equivalent of arterial blood. The 
BOLD signal increase observed during such a manipulation would correspond to 
M. 
In this manuscript (Appendix A) we have shown, by titrating the BOLD signal with 
increasing fractions of carbogen-10 in the presence and absence of a visual 
stimulation, that we could saturate the BOLD signal. BOLD data was acquired 
while subjects breathed four different fractional concentrations of carbogen-10 
(25%, 50%, 75% and 100%). This lead to an increased BOLD signal at each 
concentration step, up to a maximal BOLD signal change of 7.5% when subjects 
breathed 100% carbogen-10. The experiment was then repeated with a single 
minute of visual stimulation using a flashing checkerboard in the middle of the 
carbogen-10 breathing blocks (Figure 3, Appendix A). As an ever larger fraction of 
inspired gas was composed of carbogen-10 instead of air, the BOLD signal evoked 
by a flashing checkerboard decreased to finally completely disappear at a 100% 
carbogen-10 inhalation (Figure 3 and 5, Appendix A). In other words, as more and 
more O2 was present from the carbogen inhaled, it could fill the binding sites on 
hemoglobin as O2 was extracted to fill sustain metabolic activity from visual 
stimulation. At 100% carbogen-10 inhalation, BOLD measurements within visual 
cortex with and without visual stimulation was identical at 7.5%. Furthermore, the 
fact that the CBF response to the visual stimulation was maintained even during 
breathing of 100% carbogen-10 (even while there is no more measured BOLD 
response) indicates that BOLD signal saturation does not arise from an absence of 
CBF response some feedback mechanism in situations of O2 overabundance 
(Figure 7, Appendix A).
Because the BOLD signal measure during carbogen-10 inhalation is a direct 
measurement of M, this BOLD measurement can be used as a ‘gold standard’ 
against which to compare the three methods mentioned above. As shown in 
Chapter 2, hypercapnia and hyperoxia with their respective models resulted in an 
underestimation of the value of M in visual cortex. The combination of GCM with 
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carbogen inhalation (simultaneous hypercapnia and hyperoxia) resulted in M 
estimates in closer agreement to the values measured in Appendix A (Figure 2A). 
While the hyperoxia method still resulted in the underestimation of M in grey 
matter, hypercapnia yielded similar values as the GCM with combined carbogen 
inhalation in this ROI (Figure 2B). This however may stem from averaging of lower 
parenchymal values with hotspots of putative venous origin with hypercapnia, to 
yield similar end results as the new technique (Figure 4). These hotspots may arise 
from flow measurement error (Figure 6) and may become problematic if large veins 
are not removed when drawing ROIs.
It seems therefore that the GCM provides advantages over previous models in that 
it more accurately takes into account individual physiology to yield more robust M 
estimates from a reduced sensitivity to error in flow measurement. The GCM used 
in combination with combined hypercapnia and hyperoxia provides the further 
advantage of more accurate M estimates from a reduced degree of extrapolation 
towards the limit.
6.3. Baseline metabolism
While the task-evoked percent CMRO2 change is a useful measure to compare 
group responses, this technique may be limited in many clinical contexts. Task-
based functional imaging may often be impractical from the difficulties inherent in 
controlling such confounding task-related effects as strategy choice, motivation, 
attention, perception acuity and performance. Techniques with the capacity to 
measure baseline states may in general have more straightforward clinical utility, 
especially since some patient groups may experience a reduced ability to comply 
with complex instructions. Another limitation to clinical utility is that BOLD signal 
changes to complex cognitive tasks are generally small and can rarely be 
quantified on an individualized basis (Glover 2011). Since evoked CMRO2 changes 
are derived from task-evoked BOLD and ASL measurements, they suffer from the 
same limitation. Furthermore, though the relative CMRO2 changes obtained using 
calibrated fMRI can be compared across groups, these may reflect different 
absolute O2 consumptions if the baseline CMRO2 differs between the groups. For 
example, there are indications that older adults may show changes in baseline 
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CMRO2 (Yamaguchi et al. 1986; Leenders et al. 1990; Marchal et al. 1992; Lu et al. 
2011) and neurogenerative diseases are likely associated with a large decrease in 
baseline CMRO2 (Frackowiak et al. 1981; Nagata et al. 2000). Therefore, a method 
to measure baseline CMRO2 would not only allow better interpretation of task-
evoked changes, but also be a pertinent clinical measure on its own. 
Several groups have developed MR techniques to image baseline oxidative 
metabolism in the last few years. Some of these techniques yield single vessel 
values (An et al. 2000; He et al. 2007; He et al. 2008; Xu et al. 2009; Fan et al. 
2011) and are therefore limited in that they can only detect global changes in 
oxygenation. The method presented by Fan and colleagues (Fan et al. 2011) can 
be used to estimate oxidative metabolism in a cortical vein, but can so far only be 
used in a single large vein parallel to the main magnetic field axis. So while these 
methods have some potential for clinical applications, they are severely limited in 
cases of regional heterogeneity of metabolic changes. 
Two methods allow quantification of regional CMRO2. The method presented by 
Bolar and colleagues (Bolar et al. 2011b) uses velocity encoding to isolate blood in 
venules, then quantifies T2 in this compartment to obtain venous saturation. 
Venous saturation can then be converted to CMRO2 knowing arterial saturation, 
hematocrit and baseline CBF. This technique is very promising in that it is a direct 
measurement of CMRO2 and yields a voxel-wise estimate. However, this method 
may be difficult to use in the context of aging or disease since some populations 
may have different venular and capillary blood flow velocity. The second method for 
determining regional values of CMRO2 was presented by Bulte et al. (Bulte et al. 
2011) and is in fact conceptually related to the method presented in Chapter 3 of 
this thesis. However, the use of two models (the hypercapnia model to derive M 
and the hyperoxia calibration model to obtain OEF) with different sets of 
assumptions to derive M and resting OEF makes this model less correct than the 
one presented in Chapter 3. 
6.3.1. QUO2 technique
The QUO2 technique presented in Chapter 3 allows estimation of three baseline 
parameters: M, OEF and CMRO2. The value for M obtained using this technique 
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may be validated against the value of M derived using carbogen-10 (Appendix A). 
While the value of 6.0 ± 0.7% from QUO2 over all grey matter is somewhat lower 
than the value of 7.5 ± 1.0% found in the study presented in Appendix A, this may 
reflect the fact that the value of 7.5% was measured in visual cortex rather than in 
complete grey matter. There are some indications that values of M may be higher 
in visual areas than in some other part of the brain (Mark et al. 2011) (Chapter 2, 
Figure 2). 
The use of this technique has also been demonstrated in functionally-defined 
ROIs. This data is presented in Appendix B. While the reduced averaging inherent 
to the smaller functional ROIs resulted in reduced convergence of the lines for 
each breathing manipulations in the intersection plots (Figure 3, Appendix B), the 
values obtained for all parameters were nevertheless within the expected 
physiological range. The values of M obtained within the functionally-defined ROIs 
presented in Appendix B are also somewhat lower than the direct measures 
observed in the study presented in Appendix A. This may reflect some additional 
changes in ROI-drawing techniques. In the data presented in Appendix B, gray 
matter probability for each voxel was used to reduce the contribution of other tissue 
types to the estimates of M, OEF and CMRO2. This was done mainly to account for 
the presence of white matter and CBF within voxels, but may also have reduced 
the contribution of large veins in the ROIs. An indication that this may be the case 
is that a more stringent removal of non-grey matter voxels from the ROIs used in 
Appendix A resulted in a lower directly measured M value of 5.27 ± 0.5% (data not 
shown). The reduced convergence of lines in the intersection plots shown in this 
experiment highlights, however, the fact that for these techniques to be applicable 
to the small signal changes observed during cognitive tasks, large groups of 
subjects are necessary to obtain sufficient SNR.
Validation of the accuracy of estimates of OEF and CMRO2 is not as 
straightforward as for M. Though PET measures exist for these quantities, the 
precision of these estimates is also difficult to guarantee. PET methods require 
administration of three compounds (15O2, H15O2 and C15O) and complex modeling 
to yield an estimate which cannot be compared to a ‘gold standard’ (Buxton 2010). 
The PET values may furthermore be subject to different biases than the MRI-based 
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method, since the modeling aspects are based on different principles. Therefore, 
though the values for these parameters is compared, both in Chapter 3 and in 
Appendix B, to the PET literature, some differences in values do not invalidate the 
present methods. Despite this qualification, some work is needed to improve the 
precision of the QUO2 method to make it applicable in lower SNR settings and in 
single subjects. Results from Chapter 3 in grey matter and Appendix B in visual 
cortex show, however, that the current implementation of the QUO2 method does 
perform adequately in small groups of subjects given enough averaging (grey 
matter averages in Chapter 3) or the readily detectable large signal changes of 
primary sensory areas (Appendix B).
6.3.2. Future improvements
As discussed in Chapter 3 and Appendix B, ASL is a low SNR measurement and a 
more stable implementation of the technique would no doubt improve the precision 
and robustness of OEF and CMRO2 estimates at the single subject level and in 
small, functionally-defined ROIs. Strategies to improve ASL quality could include 
using multiple delay times to capture the temporal profile of tag delivery at each 
voxel (Buxton et al., 1998) and the implementation of background suppression 
techniques to reduce the physiological or instrumental modulation of the 
background "static" tissue signal that is unrelated to flow (Dixon et al., 1991; Maleki 
et al., 2011). Also, since the group of participants included in the studies presented 
in Chapter 3 and Appendix B is fairly small, some of the decreased convergence 
seen with the smaller ROIs of Appendix B may stem from insufficient averaging. 
Furthermore, the stability of the data could be improved by using a metronome 
during the breathing manipulations. Preliminary data in our group suggests that the 
use of a metronome, by making breathing more constant across all conditions and 
participants, results in improved quality of the MRI time series. Therefore, future 
implementations of this technique will seek to improve the results on three fronts: 
improving the quality of the ASL data, acquisition of data in a larger cohort to allow 
greater averaging and will include the use of a metronome.  
While ideally the QUO2 method would have been applied in the studies of aging 
presented in Chapters 4 and 5 of this thesis, the method was developed after 
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commencing the data acquisition phase on the older cohort. When the aging 
studies were designed, neither the GCM or the QUO2 methods existed. Therefore, 
the experiment was designed based on the Davis model in the context of a 
hypercapnia manipulation. While later results make this choice non-ideal, future 
studies will benefit from these new developments.
6.4. Calibrated fMRI of aging
While the research community that uses fMRI to study cognitive aging is aware 
that there may be vascular and metabolic confounds to the use of the BOLD 
technique in age comparisons (Cabeza et al. 2005; Samanez-Larkin et al. 2008), 
authors tend to minimize this contribution by saying that other mechanisms than 
the simply vascular must be at play (DiGirolamo et al. 2001; Cabeza 2002; Milham 
et al. 2002; Samanez-Larkin et al. 2008; Cappell et al. 2010; Reuter-Lorenz et al. 
2010). While there is little doubt that this is the case, the field would benefit from a 
better understanding of the patterns of vascular and metabolic changes that occur 
with aging, and of their impact on hemodynamic measurements of brain activity. 
The study presented in Chapter 4 of this thesis sought to shed light on these 
questions and identified important biases that may undermine the conclusions 
drawn from BOLD signal comparisons between younger and older populations.
Calibrated fMRI was originally devised and is generally used to extract a measure 
of the fractional change in CMRO2 evoked by a given task. This quantity allows 
direct comparisons between groups and may be more representative of the 
amount of synaptic activity expended during performance of the task, since 
metabolism in the brain in now understood to be predominantly oxidative (Ishii et 
al. 1996; Mintun et al. 2002; Yamauchi et al. 2002; Hattori et al. 2004; Ito et al. 
2005; Ibaraki et al. 2008; Ibaraki et al. 2010). However, beyond the estimation of 
CMRO2 changes, the calibrated fMRI framework provides a series of other 
physiologically-relevant parameters that can contribute to our understanding of the 
aging process. Calibrated fMRI techniques that include a hypercapnia manipulation 
may be particularly interesting since they provide measures of cerebrovascular 
reactivity. CVR has been shown to be affected in a variety of contexts, including 
aging, stroke and dementia (Nagata et al. 2002; Cantin et al. 2011; Carrera et al. 
215
2011; Lu et al. 2011). Furthermore, the ASL data acquired in the context of the 
calibrated fMRI experiment can be used to quantify baseline blood flow, a measure 
also altered in aging (Chen et al. 2011). Finally, the parameter M is estimated as an 
intermediate step in the procedure. While the M parameter preserves the same 
ambiguity as the BOLD signal (since it is the maximal possible BOLD signal 
change from baseline), it is nevertheless informative in that it determines the 
dynamic range of the BOLD signal. The dynamic range is one of the properties that 
determine the amplitude of the BOLD response mounted for a given amount of 
metabolism. Also, since it arises from the magnetic properties of baseline 
deoxyhemoglobin, it is an indirect measure of its concentration in the resting brain 
(Hoge et al. 1999a). 
The data presented in Chapter 4 show that direct comparisons of BOLD 
measurements between younger and older adults may lead to an underestimation 
of the metabolic response in the elderly. This is because decreased BOLD 
reactivity and to a lesser extent in CBF reactivity may result in a reduced BOLD 
dynamic range. Equivalent BOLD signals measured between younger and older 
adults in response to a task may in the older adults reflect a larger proportion of the 
maximal possible dynamic range and thereby be associated with a larger metabolic 
contribution (Chapter 4, Figure 10). 
6.4.1. Calibrated fMRI of aging literature
Two other calibrated fMRI studies of aging can be found in the literature (Ances et 
al. 2009; Mohtasib et al. 2012). The results from these studies differ in some 
respects from those presented here. While one study was also based on a 
hypercapnia manipulation, the other was however based on hyperoxia calibration, 
so it does not include BOLD and CBF reactivity. BOLD and CBF reactivity were not 
found to differ between the two groups in the study presented by Ances et al. 
However, the number of subjects included in that study was smaller (10 adults in 
each group) and the participants included in the older group were fairly young 
(45-60 years). In that study as in the one presented here, baseline CBF was found 
to differ between groups. This is also in agreement with other ASL data in the 
literature (Chen et al. 2011; Lu et al. 2011). While M values were here, as in the 
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study by Ances et al., found to differ between the groups, the M values themselves 
were more similar between the two groups in our study. This may reflect however 
differences in ROI-drawing techniques and possible regional differences.
The study by Mohtasib et al. (Mohtasib et al. 2012) shows a different picture, with 
similar baseline CBF and M between the two groups. The absence of a difference 
in baseline CBF may reflect poor ASL data quality however, since both PET and 
MRI literature agree in showing age-related decreased baseline flow (Marchal et al. 
1992; Ances et al. 2009; Chen et al. 2011; Lu et al. 2011). The older group showed 
a shallow decrease in M values. This may reflect the fact that these changes are 
difficult to detect in small functionally-defined ROIs. Furthermore, because the 
authors assumed an a priori value for the flow decrease with hyperoxia based on 
literature values for young adults (Bulte et al. 2007), this may have masked 
differences due to altered vascular reactivity in the elderly subjects.
The amplitude of the difference in M between younger and older cohorts may also 
be dependent on the health status of the older participants enrolled in the study. 
While the results from Chapter 5 should be confirmed within a larger cohort of older 
adults, they do indicate that there may be a link between central vascular health 
and the value of the M parameter. If M is related to vascular health (as seen in the 
association between augmentation index and M in Chapter 5), then it may be that 
healthier older cohorts would be closer to younger subjects in terms of aortic 
elasticity and M parameter than the participants included in a study with laxer 
inclusion criteria. Inclusion criteria should therefore be considered when comparing 
the value of the M parameter between different aging studies. 
6.4.2. Future improvements
While the study presented in Chapter 4 of this thesis demonstrates some 
interesting changes with aging, both in terms of physiology of aging and in terms of 
identifying the possible biases inherent to direct comparisons of BOLD signal 
changes between age groups, future studies could incorporate some 
improvements. The inclusion of an additional hyperoxia manipulation, in 
conjunction with the improvements in ASL methods described above, would allow 
the estimation of baseline OEF and CMRO2 using QUO2. This would make it 
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possible, not only to compare these baseline parameters between the two groups, 
but also to calculate the change in CMRO2 during a task in terms of absolute 
micromolar units. This would remove the confound present in current calibrated 
fMRI studies that compare relative changes from an unknown baseline. 
As mentioned throughout this thesis, the quality of the ASL data is an important 
limiting factor for all these techniques. While ASL is in general a low SNR 
technique, global challenges such as hypercapnia may pose particular problems to 
most ASL implementations (Bolar et al. 2012; Tancredi et al. 2012). Improvements 
in the ASL techniques mentioned above would be beneficial also within the context 
of calibrated fMRI studies of aging. Aging studies suffer in fact not only from these 
other sources of bias, but may also be subject to other confounds if declining 
vascular health in the older adults results in important decreases in blood velocity. 
In that case, the standard set of tagging parameters and imaging delays may result 
in underestimation of blood flow (Campbell et al. 2006), though pseudo-continuous 
implementations may not be as sensitive to these effects. Future studies could 
therefore benefit from an investigation into the validity and optimization of the 
parameter set used for ASL measurements in older adults. 
Future functional studies would benefit from additional repetitions of the task in 
each participant. This would improve the power to detect task-related significant 
signal changes, and might, depending on the challenge, allow individualized 
mapping. This is usually possible for primary sensory challenges and, in our 
experience, greatly improves the quality of estimates of vascular parameters, since 
the ROI drawn is uniquely adapted to the anatomy and physiology of each 
participant. Furthermore, tasks known to yield regional BOLD signal differences 
between young and old could be investigated. While the modified Stroop task used 
here is known to show behavioral differences between younger and older subjects 
(Figure 1, Chapter 4), the results presented here and elsewhere (DiGirolamo et al. 
2001) for switching tasks indicate that this difference in behavior may not be 
reflected in the hemodynamic response to the task (Figure 2, Chapter 4). 
Therefore, the use of a task well-characterized using fMRI and known to show 
differences in BOLD signal patterns and amplitude across age groups may 
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contribute to a better understanding of the biases and differenced in cerebral 
physiology reported in Chapter 4.
6.5. Vascular changes with aging
While Chapter 4 addressed the changes in cerebral physiology seen with aging, it 
did not address questions on the origin and consequences of these changes in 
terms of vascular and cognitive health. In Chapter 5, by investigating the link 
between cerebral hemodynamic changes and changes in general vascular and 
metabolic health, as well as cognitive performance, some more general 
hypotheses can start to emerge.
The studies presented in Chapters 4 and 5 confirmed within a single group of 
younger and older adults some important vascular, metabolic and cognitive 
changes known to occur with aging. Within our cohort of sixty-two younger and 
older adults, we were able to show differences in several cerebral hemodynamic 
properties, including baseline CBF, BOLD and CBF vascular reactivity to CO2 and 
changes in the baseline BOLD signal M (Ances et al. 2009; Chen et al. 2011; Lu et 
al. 2011; Mohtasib et al. 2012) (Figure 7 and 8A, Chapter 4 and Figure 3, Chapter 
5). In addition to these changes in cerebral hemodynamics, older adults were 
shown to perform more poorly on an executive function task (Figure 1, Chapter 4 
and Figure 2, Chapter 5). The brain does not however act in isolation and declining 
vascular health in the brain is likely preceded by central arterial stiffening 
(O'Rourke et al. 2007; Redheuil et al. 2010). This was ascertained here and older 
adults were shown to have decreased aortic elasticity, as measured by aortic 
pulse-wave velocity and augmentation index (Figure 1A and B, Chapter 5). Finally, 
older adults were shown to have a reduced capacity to use oxygen during a 
maximal effort exercise test (VO2max) (Figure 1C, Chapter 5). 
A set of hypotheses on the mechanisms of vascular aging is starting to emerge 
from current literature whereby aortic health may, by determining the amplitude of 
the pressure wave throughout the vascular tree, determine the health of vessels 
elsewhere in the body (Laurent et al. 2007; O'Rourke et al. 2007; Redheuil et al. 
2010; Brown et al. 2011). Because the brain is not protected against the pulsatile 
nature of blood flow, arteries in the brain may suffer mechanical damage leading to 
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stiffer arteries and a decreased ability to regulate vascular tone,  leading eventually 
to metabolic deficits, lesions and cognitive decline (Wallace 2005; Girouard et al. 
2006; O'Rourke et al. 2007; Iadecola 2010; Brown et al. 2011; Gorelick et al. 2011; 
Mitchell et al. 2011). Some of these aging effects may however be partly mitigated 
by the effects of regular exercise. Regular exercise which may help reduce 
metabolic deficits and lead to neurogenesis and angiogenesis, thereby improving 
vascular health and cognition (Rogers et al. 1990; Churchill et al. 2002; Colcombe 
et al. 2003; Swain et al. 2003; Vaynman et al. 2004; Binder et al. 2006; Colcombe 
et al. 2006; Larson et al. 2006; Arena et al. 2009; Hagner et al. 2009; Kadoglou et 
al. 2009; Brown et al. 2010; Hopkins et al. 2010; Lazarus et al. 2010; Voss et al. 
2010; Davenport et al. 2012; Hopkins et al. 2012). The correlations between the 
physiological parameters presented in Chapter 5 support these hypotheses, with 
links between augmentation index and M parameter, VO2max and, to a lesser 
extent, cognitive performance. A link between VO2max and cognitive performance 
further supports this hypothesis framework (Table 1, Chapter 5). 
As mentioned in Chapter 5 however, a larger cohort would likely be needed to 
explore these effects in greater depth, given the fact that the cohort used here is 
fairly homogeneous and most correlations only marginally significant. We have in 
fact acquired data on an additional twenty-five participants and will combine these 
two cohorts for the final published version of this study. Furthermore, some data 
acquired in this cohort was not used in the studies presented in Chapters 4 and 5. 
Fasting blood draws were performed on the morning of the MRI session and all 
participants underwent a neuropsychological battery of tests, as well as optical 
imaging of baseline hemoglobin (oxygenated and deoxygenated) concentrations 
and task-evoked oxy- and deoxyhemoglobin changes. This data has not so far 
been incorporated with the aortic and brain imaging data. However, once 
integrated, other interesting relationships may emerge with parameters known to 
be associated with cognitive performance and vascular health such as glucose 
levels, C-reactive protein levels and lipid profile (Yaffe et al. 2003; Wallace 2005; 
Kadoglou et al. 2009; Wolf 2012). Furthermore, though performance on one task 
was examined here in relation to vascular and metabolic health, other cognitive 
skills could be examined in the future to explore the possibility that some aspects 
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of cognition may be more sensitive to declining vascular health than others. Other 
technical improvements could be considered for future studies.
6.5.1. Future improvements
The aorta may be an early marker of arterial damage (Redheuil et al. 2010), but it 
may not always be the most sensitive means of assessing vascular health in adults 
over the age of fifty.  Several markers of aortic health exist and some, such as 
ascending aorta distensibility may reach a plateau around middle age and provide 
little information on declining vascular health in later life (Redheuil et al. 2010). 
Valuable information may nevertheless be obtained from the aorta, since while the 
study by Redheuil et al. shows that this is true for distensibility measures, pulse-
wave velocity and augmentation index may continue to change into later decades. 
However, other vessels may also provide valuable information, especially in the 
context of possible relationships with cerebrovascular health. The carotids are the 
main vessels that carry blood to the brain and carotid stenosis is an important 
factor in determining CBF and the likelihood of stroke (Bokkers et al. 2011; Tomura 
et al. 2011; Davies et al. 2012; Momjian-Mayor et al. 2012). Imaging of the carotids 
could, in future studies, help provide missing information on intermediate steps on 
the relationship between aortic vascular health and cerebrovascular help.
More permissive selection criteria could also be considered. While inclusion of 
older adults with additional vascular risk factors increases the number of potential 
confounding effects, it also ensures a greater variance within the sample, which 
may be informative for detection of correlations between various vascular 
parameters. Tabulation of risk factors and their inclusion as covariates in statistical 
models could be help to better understand the physiological correlates of vascular 
aging. 
Finally, as mentioned in the discussion relating to Chapter 4, improvements in ASL 
methodology and inclusion of a baseline CMRO2 measure using the QUO2 
technique (as presented in Chapter 3) would allow to draw a more complete picture 
of the vascular and metabolic changes in the brain. Improvements in ASL would 
allow more robust measurement of CBF on an individualized basis and yield 
improved composite measures arising from ratio calculations (such as M and 
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CMRO2). Baseline CMRO2 on the other hand would permit the exploration of 
hypotheses on the mitochondrial nature of aging and disease (Wallace 2005). 
6.6. Future studies
The studies presented in this thesis are all in their own way proof-of-concept 
studies. An ambitious research program was used as a starting point for this thesis 
and various avenues for quantification of physiological properties using functional 
MRI were explored to yield new metrics, improve on existing ones and to 
investigate the vascular and metabolic changes of the aging process. Future 
studies will no doubt improve on these techniques to make them more robust and 
precise, and the lessons learned in the work presented here will allow the design of 
better experiments for the study of aging. 
Future work on vascular aging would benefit from the use of the QUO2 technique. 
This technique would allow to retain all the information included in the present 
aging studies, while providing new physiologically-specific metrics (OEF and 
resting CMRO2). Measurements during breathing manipulation would benefit from 
the use of a metronome to regulate breathing rate. Furthermore, imaging of the 
carotids could replace imaging of the aorta, while retaining central aortic stiffening 
information with applanation tonometry (augmentation index). This would allow a 
more complete understanding of the state of vascular health and blood delivery to 
the brain. Further improvements could include quantification of white matter 
hyperintensities (Brickman et al. 2011). While only a three-point rating scale was 
used in the studies presented, quantification could provide important additional 
vascular information, since white matter lesion burden has been shown to be an 
important factor in determining cerebral hemodynamic properties and cognition 
(Sierra et al. 2004; Au et al. 2006). Finally, future studies could dispense with the 
inclusion of a task. While regional heterogeneity of vascular parameters in the 
brain is of interest for the interpretation of cognitive fMRI findings, this could be 
addressed using atlas-based region of interest. The scan time freed by removal of 
fMRI acquisition during a task could be used to perform the additional gas 
manipulations necessary for the QUO2 method. Finally, the link between cognitive 
performance and vascular and metabolic physiology could be addressed using 
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behavioral measures. This protocol would allow the in-depth investigation of 
vascular and metabolic physiology in the brain, as well as the exploration of the link 
between these properties and cognition, cardiovascular fitness and elasticity of 
large arteries in both health and disease.  
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Conclusion
In summary, the work included in this thesis presents some new quantitative 
approaches to estimate resting and task-evoked oxidative metabolism using 
magnetic resonance imaging, as well as an exploration of age-related vascular and 
metabolic changes and their impact on hemodynamic functional imaging 
techniques. First, a generalization of calibrated fMRI methods which offers some 
advantages in terms of accuracy and robustness was presented. Then, a new 
technique to measure baseline oxidative metabolism using gas manipulations and 
the calibrated fMRI framework was demonstrated. In the second part of this thesis, 
age-related changes in vascular and metabolic physiology were studied, both in 
terms of biases these changes create in the interpretation of BOLD signal 
comparisons between age groups, and in terms of the relationship between these 
cerebral properties and general vascular health, cardiovascular fitness and 
cognitive performance. The results presented in this thesis show that functional 
magnetic resonance imaging may be used to characterize vascular and metabolic 
function in the brain and that these methods may provide valuable information on 
the physiological processes of aging. Aging was shown to lead to decreased 
vascular health both centrally and in the brain. Furthermore, there may be an 
association between these changes and cognitive performance, which may be 
partly alleviated by greater cardiovascular fitness. Future work on already available 
data and on data acquired using the new techniques described in the first part of 
this thesis will explore the physiological correlates of healthy aging, and could be 
provide much needed information for the study of diseases such as dementia and 
stroke.
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A. Appendix - Elimination of visually evoked BOLD 
responses during carbogen inhalation: 
implications for calibrated MRI
Gauthier, C.J.1,2, Madjar, C.2, Tancredi, F.B.1,2, Stefanovic, B.3, Hoge, R.D.1,2 
1 Physiology/Biomedical Engineering, Université de Montréal, Montreal, Quebec, 
Canada, 2 CRIUGM, Montreal, Quebec, Canada, 3 Medical Biophysics, University 
of Toronto, Toronto, Canada
NeuroImage, 54 (2011) 1001–1011
A.1. Abstract
Breathing a mixture of 10% CO2 with 90%O2 (referred to here as carbogen-10) 
increases blood flow due to the vasodilatory effect of CO2, and raises blood O2 
saturation due to the enriched oxygen level. These effects both tend to reduce the 
level of deoxygenated hemoglobin in brain tissues, thereby reducing the potential 
for further increases in BOLD contrast. In the present study, blocks of intense 
visual stimulation (60s) were presented amid longer blocks (180s) during which 
subjects breathed various fractional concentrations (0-100%) of carbogen-10 
diluted with medical air. When breathing undiluted carbogen-10, the BOLD 
response to visual stimulation was reduced below the level of noise against the 
background of the carbogen-10 response. At these concentrations, the total (visual 
+ carbogen) BOLD response amplitude (7.5 ± 1.0%, n = 6) converged toward that 
seen with carbogen alone (7.5 ± 1.0%, n = 6). In spite of the almost complete 
elimination of the visual BOLD response, pseudo-continuous arterial spin-labeling 
on a separate cohort indicated a largely preserved perfusion response (89 ± 34%, 
n = 5) to the visual stimulus during inhalation of carbogen-10.
The above observations suggest that venous saturation can be driven to very high 
levels during carbogen inhalation, a finding which has significant implications for 
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calibrated MRI techniques. The latter methods involve estimation of the relative 
change in venous O2 saturation by expressing activation-induced BOLD signal 
increases as a fraction of the maximal BOLD signal M that would be observed as 
venous saturation approaches 100%. While the value of M has generally been 
extrapolated from much smaller BOLD responses induced using hypercapnia or 
hyperoxia, our results suggest that these effects could be combined through 
carbogen inhalation to obtain estimates of M based on larger BOLD increases. 
Using a hybrid BOLD calibration model taking into account changes in both blood 
flow and arterial oxygenation, we estimated that inhalation of carbogen-10 led to an 
average venous saturation of 91%, allowing us to compute an estimated M value of 
9.5%.
Keywords: calibrated MRI, carbogen, hypercapnia, hyperoxia, oxygen metabolism, 
venous saturation
A.2. Introduction
During increased brain activity, BOLD contrast in functional MRI reflects a 
reduction in deoxygenated hemoglobin (dHb) concentration in the venous 
circulation local to the activated region. This reduction is caused by an increase in 
the local arterial blood flow, which is generally sufficient to increase the mean O2 
saturation along the capillary bed, supporting, according to the oxygen limitation 
model (Buxton et al. 1997), an increase in delivery of O2 to neural tissues under 
diffusion limited conditions. In principle, the BOLD signal increase observed during 
a particular event carries information about the change in venous dHb 
concentration. Since virtually all dHb in the venous circulation of healthy individuals 
is generated as a result of metabolic O2 extraction, then the relative change in 
venous dHb level during stimulation should depend partly on the relative change in 
the cerebral metabolic rate of O2 consumption, or CMRO2 (Buxton et al. 1997). If 
the changes in blood flow and volume can be factored out, then in theory it should 
be possible to obtain a quantitative estimate of the fractional change in CMRO2 
that occurred as a result of stimulation. Although the latter notion is indeed the 
foundation for various MRI-based methods for CMRO2 estimation (Davis et al. 
1998; Chiarelli et al. 2007b), the BOLD signal change observed during activation is 
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not itself sufficient to determine the relative change in venous dHb concentration. 
Such a determination requires expressing the activation-induced BOLD response 
as a fraction of the maximum possible BOLD signal increase that would be 
observed upon complete elimination of all dHb from tissues (usually denoted M in 
literature). For this reason, various calibration methods have been proposed in 
which the total attenuation of T2*-weighted signal attributable to dHb at baseline 
(conversely equivalent to the maximum possible BOLD signal increase) is 
estimated through extrapolation of BOLD signal increases observed during mild 
hypercapnia (Davis et al. 1998) or hyperoxia (Chiarelli et al. 2007b). In the 
hypercapnia method, M is extrapolated from the BOLD and flow responses during 
mild hypercapnia (typically achieved by having subjects breathe 5-10% CO2 in air). 
This is the earliest calibration method introduced by Davis et al. and has since 
been employed in numerous studies (Davis et al. 1998; Hoge et al. 1999b; 
Stefanovic et al. 2006; Leontiev et al. 2007b; Ances et al. 2008; Lin et al. 2008; 
Perthen et al. 2008; Ances et al. 2009; Bulte et al. 2009; Chen et al. 2009b). In the 
more recently introduced hyperoxia calibration method, a similar model is used to 
estimate M from the BOLD response to hyperoxia (usually induced through 
inhalation of 50-100% O2). This model uses end-tidal PO2 (partial pressure of 
oxygen) values to estimate the venous deoxygenated hemoglobin fraction, with the 
additional assumption of an unchanged CBF in the case of mild hyperoxia or of a 
fixed, pre-determined CBF decrease in the case of higher inspired O2 
concentrations (Chiarelli et al. 2007b; Goodwin et al. 2009). 
Because of the uncertainties inherent when resorting to extrapolation, as well as 
some speculative aspects of the BOLD signal models applied, the validity of such 
calibration methods has been difficult to confirm (Hoge et al. 1999a; Hoge et al. 
2001; Buxton et al. 2004; Stefanovic et al. 2006; Chiarelli et al. 2007a; Ances et al. 
2008; Zappe et al. 2008; Chen et al. 2010a). Previous studies using hypercapnia or 
hyperoxia have reported M values ranging from 3.7 to 22 percent. An important 
consideration when comparing such data is that the measured value is specific not 
only to a particular anatomic region, but also to the applicable measurement 
conditions, including field strength, echo time, and the degree of vascular weighting 
(use of diffusion crusher gradients, prevalence of veins in ROI's). Since the 
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parameter M is, implicitly, a linear function of the echo time used in the experiment 
(see Eq. 7 in Hoge et al. 1999), it is necessary to correct by the ratio of echo times 
when comparing M values from different experiments. After adjustment to an 
equivalent echo-time of 30 ms, percent M values measured in visual cortex at 1.5 
Tesla (only hypercapnic calibration has been used at this field strength) include 3.4 
(Davis et al. 1998), 4.6 (Stefanovic et al. 2006), and 13.2 (Hoge et al. 1999b; Hoge 
et al. 1999a). Hypercapnically-determined visual cortex M values at 3 Tesla, 
adjusted to a common TE of 30 ms, include 5.3 (Bulte et al. 2009), 5.7 (Ances et 
al. 2008), 6.5 and 7.3 (Ances et al. 2009), 6.7 (Chen et al. 2009b), 10.5 (Lin et al. 
2008), 11.1 (Leontiev et al. 2007b) and 11.6 and 12.1 (Perthen et al. 2008) for 
hypercapnia. A value of 7.0 percent was measured by Chiarelli et al. in visual 
cortex at 3 Tesla (TE=30 ms) using hyperoxic calibration (Chiarelli et al. 2007b). 
While some of the variability in reported M values may reflect differences in venous 
weighting associated with the ROI selection or other factors, it is also clear that the 
majority of estimated M values represent BOLD signal increases that are 
considerably higher than those typically measured during even the most intense 
stimulation paradigms. Although this is to be expected in a value that is supposed 
to represent the maximum possible signal increase, the veracity of such large 
signal changes has been understandably questioned (Chiarelli et al. 2007a; 
Chiarelli et al. 2007b) given their basis in extrapolation via biophysical models 
which unavoidably include a certain degree of speculation. Methods in which 
hypercapnia is used may further suffer from the low-signal-to-noise ratio of arterial 
spin-labeling measures needed to measure flow changes during this type of 
calibration. Use of an appropriate M value is critical in calibrated MRI, as incorrect 
values can lead to substantial bias in estimated CMRO2 values as well as in 
apparent CBF-CMRO2 coupling relations, as has been pointed out by Chiarelli et 
al. (Chiarelli et al. 2007a).
If a method could be devised to raise the venous O2 saturation close to 100%, then 
the maximum achievable BOLD signal could be determined more directly for a 
given physiological baseline state. The objective of the present study was therefore 
to explore the use of a breathing gas mixture consisting of 10% carbon dioxide and 
90% oxygen (referred to here as carbogen-10 since the term carbogen alone is 
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used to describe any mixture of CO2 with balance 100% O2) as a means of 
producing very high levels of venous O2 saturation. Hypercapnia, induced using 
carbon dioxide concentrations of 4 to 10%, has been explored extensively in the 
past as a means of producing robust BOLD signals due to the vasodilatory action 
of CO2 (Kim et al. 1999; Kemna et al. 2001a; Posse et al. 2001; Chiarelli et al. 
2007a; Leontiev et al. 2007a; Leontiev et al. 2007b; Ances et al. 2008; Perthen et 
al. 2008; Ances et al. 2009; Bulte et al. 2009; Chen et al. 2009a; Mark et al. 2010), 
and carbogen has been explored to evaluate susceptibility-weighted imaging 
methods and in the study of tumor oxygenation (van der Sanden et al. 1999; 
Landuyt et al. 2001; Dunn et al. 2002; Rauscher et al. 2005a; Ashkanian et al. 
2008; Sedlacik et al. 2008; Ashkanian et al. 2009). The use of a relatively high CO2 
content (10%) combined with enrichment of O2 (90% as opposed to 21% in 
atmospheric composition air) should lead to very high venous O2 saturations 
(Ogawa et al. 1990a; Rauscher et al. 2006; Sedlacik et al. 2007; Sedlacik et al. 
2008; Bulte et al. 2009; Sedlacik et al. 2009). To further increase venous O2 in 
specific cortical areas, and to assess the degree to which BOLD reactivity 
approaches saturation against a background of very high venous saturation, we 
applied intense visual stimulation during during periods of carbogen-10 inhalation. 
Titration studies in which subjects breathed various concentrations of carbogen-10 
in air, with and without intense visual stimulation, suggested that inhalation of pure 
carbogen-10 results in almost complete elimination of venous dHb in visual cortex 
and thus allows a more direct estimation of the asymptotic BOLD signal increase 
M. 
A.3. Methods 
Acquisitions were conducted in nine healthy subjects, seven males and two 
females, aged 21 to 32 years, on a Siemens TIM Trio 3T MRI system (Siemens 
Medical Solutions, Erlangen, Germany) using the Siemens 32-channel receive-only  
head coil for all acquisitions. All subjects gave informed consent and the project 
was approved by the Comité mixte d’éthique de la recherche du Regroupement 
Neuroimagerie/Québec. Two types of scanning session were performed, each on a 
subset of six of the nine subjects. The first type of session consisted of the BOLD 
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titration experiments in which varying fractions of carbogen-10 were administered 
either with or without simultaneous visual stimulation. The second session type 
focused on perfusion imaging with pseudo-continuous arterial spin-labeling 
(pCASL) during combined carbogen inhalation and visual stimulation. 
BOLD titration sessions included an anatomical, 1mm3 MPRAGE acquisition (TR/
TE/alpha = 2300ms/3ms/9°, 256x240 matrix) and nine BOLD functional runs (TR/
TE/alpha = 2000ms/30ms/90° with 4x4x4mm voxels, 64x64 matrix and 33 slices). 
During these BOLD acquisitions, subjects underwent a titration of carbogen-10 
(10% CO2, 90% O2) (Vitalaire Santé, Montreal, QC, Canada). Two runs of each of 
the four carbogen fractions (25%, 50%, 75%, 100%) with balance air were 
performed (see Table 1 for gas concentrations associated with each fraction). For 
each fraction, one run was conducted with a single three-minute carbogen block, 
after an initial 90 seconds of air breathing (all percent change values in this report 
are expressed relative to the air-breathing baseline). A second run was performed 
for each carbogen/air fraction with the addition of a one-minute block of visual 
stimulation. The visual stimulus was a black and white radial checkerboard, annuli 
scaled logarithmically with eccentricity, luminance modulated in a temporal 
squarewave at 8 Hz (equivalent to 16 contrast reversals per second) presented 
using a LCD projector (EMP-8300, Epson, Toronto, ON, Canada) onto a 
translucent screen viewed by subjects through a mirror integrated into the Siemens 
head coil. This stimulation was initiated 90 seconds into the carbogen block (actual 
run order was randomized). An additional run was done with the visual stimulus 
presented without carbogen, with the stimulus starting 180 seconds into the run as 
in the other acquisitions. 
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%CO2 %O2 %N2
Medical air
25% carbogen-10
50% carbogen-10
75% carbogen-10
100% carbogen-10
0 21 79
2.5 38.25 59.25
5 55.5 39.5
7.5 72.75 19.75
10 90 0
Table 1. Gas mixture compositions
Concentration of each component gas of the mixtures administered to the subjects in the course of 
this titration experiment.
Additional acquisitions were performed on some subjects. In one subject, two 
susceptibility-weighted images (SWI) (Reichenbach et al. 2001; Rauscher et al. 
2005b) were obtained to provide a qualitative assessment of the venous 
oxygenation increase with carbogen. One image was acquired during medical air 
breathing and one during carbogen-10 inhalation. The image obtained during 
carbogen breathing was acquired after an initial 1-min period of carbogen 
breathing to allow oxygen saturation and vasodilation to reach a plateau. 
Parameters used for the SWI acquisition were: TR/TE/alpha = 27ms/20ms/15° with 
0.9x0.9mm in-plane resolution with 56 slices of 1.5mm on a 256x192 matrix. 
To determine the effect of carbogen more specifically on the visually-evoked 
perfusion response, a pseudo-continuous arterial spin labeling (pCASL) acquisition 
(Wu et al. 2007) was used to measure changes in cerebral blood flow (CBF) in six 
subjects during combined carbogen-10 inhalation and visual stimulation. The data 
from one subject could not be used due to excessive movement. The same 
experimental timing and visual paradigm was used to deliver carbogen-10 during 
this acquisition. The parameters used in the pCASL sequence were: TR/TE/alpha = 
3000ms/10ms/90° with 4x4mm in-plane resolution and 16 slices of 6mm (1mm 
slice gap) on a 64x64 matrix (at 7/8 partial Fourier), GRAPPA acceleration factor = 
2 (Griswold et al. 2002), post-labeling delay = 900ms, Hanning window-shaped RF 
pulse with duration/space = 500μs/920μs, flip angle of labeling pulse = 25°, slice-
selective gradient = 6mT/m, tagging duration = 2s (Wu et al. 2007).
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A.3.1. Gas manipulations
At the beginning of the experiment, subjects were fitted with a non-rebreathing face 
mask (Hudson RCI, #1059, Temecula, California, USA). To avoid discomfort from 
outward gas leakage blowing into the subject’s eyes, skin tape (Tegaderm Film, 
#1626W, 3M Health Care, St-Paul, MN, USA) was used to seal the top of the mask 
to the face. Plastic tubing (AirlifeTM Oxygen tubing #001305, Cardinal Health, 
McGraw Park, IL, USA) and a Y-connector were used to connect pressure/flow-
meters for medical air and carbogen-10 tanks (Vitalaire, Missisauga, ON, Canada) 
to the mask. Gas flows were adjusted manually on the pressure/flow-meters 
(MEGS, Ville St-Laurent, QC, Canada) to keep a total flow rate of 16L/min. Gas 
flow was kept at 16L/min at all times except during administration of the highest 
carbogen concentration. From the control room, the reservoir bag affixed to the 
non-rebreathing mask could be seen. For subjects found to hyperventilate beyond 
the gas delivery used in the other acquisitions (causing the reservoir bag to 
collapse fully at the end of each breath and some atmospheric air to be entrained 
into the mask), gas flow rates were increased to the maximal possible rate (25L/
min) achievable with our pressure/flowmeters for the highest carbogen-10 
concentration acquisitions. Pulse rate and arterial O2 saturation were monitored in 
all subjects using a pulse-oximeter (InVivo Instruments, Orlando, USA) as a safety 
measure and to observe the effects of carbogen breathing. 
End-tidal O2 and CO2 values were monitored in five subjects. Gases were sampled 
via an indwelling nasal cannula (AirlifeTM Nasal Oxygen Cannula #001321, 
Cardinal Health, McGraw Park, IL, USA) using the CO2100C and O2100C 
modules of the MP150 BIOPAC physiological monitoring unit (BIOPAC Systems 
Inc., Goleta, CA, USA). Calibration of the unit was done by taking into account an 
expired partial pressure of water of 47mmHg (Severinghaus 1989). Subjects were 
instructed to breathe through their nose, which ensured that only expired gas was 
sampled by the nasal cannula.
Following acquisition, all subjects were debriefed to assess the level of discomfort 
associated with the manipulation. The subjects were asked to rate the air hunger 
and breathing discomfort associated with the maximal carbogen-10 concentration 
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on a French language version of the scale proposed by Banzett et al. (Banzett et 
al. 1996). Subjects were asked to rate the discomfort of the carbogen-breathing 
block in three parts: the first half of the block, the second half, and over the whole 
manipulation. 
A.3.2. Data analysis
All MRI data were analyzed using the Neurolens data analysis software package 
(www.neurolens.org). BOLD data were motion corrected (Cox et al. 1999) and 
spatially smoothed with a 6 mm 3D Gaussian kernel. ASL data were similarly 
processed, and the CBF signal was isolated through surround subtraction using 
linear interpolation between neighboring points (Liu et al. 2005). A general linear 
model (GLM) assuming a hemodynamic response function (HRF) consisting of a 
single gamma function (Glover 1999) and a linear drift and constant offset terms 
was applied, to obtain effect sizes and T-maps for each condition (visual and/or 
carbogen). The first 60s after gas transitions were excluded from the analyses by 
zeroing out relevant matrix rows in the GLM computation, as the transition periods 
would not be accurately modeled by the HRF used in the GLM fit (as can be 
appreciated from Fig. 3). 
Regions of interest (ROIs) were derived from thresholded (p ≤ 0.01 corrected) 
(Worsley et al. 2002) visual activation T-maps (Fig. 1). Fractional changes were 
then calculated by dividing effect sizes over the visual ROI by the constant DC 
term from the GLM averaged within the region. Group average values ± standard 
error are reported here. Time courses were obtained by averaging the fractional 
signal change traces for five subjects at each carbogen concentration. The linear 
trend and DC terms from the full linear model were removed from the pre-
processed ROI-average signal traces of each subject before averaging signal 
traces (converted to percent change) between subjects. One subject was excluded 
from this analysis because of a missing acquisition for one carbogen concentration. 
Separate visual ROIs were made for ASL acquisitions with the same statistical (p = 
0.01) threshold as for BOLD acquisitions.
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Subject 1 Subject 2 Subject 3
Subject 4 Subject 5 Subject 6
Figure 1. Visual cortex regions of interest for each subject
Regions of interest (ROI) for each subject, defined from significantly activated voxels (p ≤ 0.01) from 
the visual-only BOLD acquisition of each subject. This procedure yielded diffuse ROIs over visual 
areas.
To estimate the incremental response due to visual stimulation against the 
background of carbogen-10 breathing in BOLD and CBF signals, a linear model 
was fit to the group average time course for the respective signals (BOLD and ASL, 
expressed as percent change) for the visual stimulation + carbogen experiment. 
For the BOLD signal, the regressors consisted of a carbogen response term based 
on the group average data (after de-trending and normalization) for carbogen 
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alone, plus a 60 second square pulse representing the visual response term. Other 
GLM parameters (HRF, etc.) were as described above. 
End-tidal CO2 and O2 values were picked manually and averaged over all subjects, 
for the first five breaths of the experiment, when subjects were breathing air, and 
for the last ten breaths of the carbogen-10 breathing block. 
Arterial spin-labeling measurements acquired during carbogen inhalation were 
corrected for T1 changes using the approach described in (Chalela et al. 2000; 
Zaharchuk et al. 2008). Arterial blood T1 values of 1660 ms and 1487 ms were 
used, respectively, for normoxia and the hyperoxic state produced by carbogen-10 
(from T1 vs. FiO2 values tabulated in Bulte at al. (Bulte et al. 2007). Since the T1 
depends specifically on the level of dissolved O2 in the plasma, and since we 
obtained different PaO2 (arterial partial pressure of O2) values at a given FiO2 
(fraction of inspired O2) than the latter study (their PaO2 values were higher, likely 
due to the use of a tightly sealed face mask), the values were interpolated to 
account for this difference (i.e. the table from Bulte was converted to T1 vs. group 
average PaO2, and the T1 corresponding to our group average PaO2 during 
inhalation of carbogen-10 was interpolated). The T1 correction factor was thus 
determined to be 1.07 (i.e. flow would be underestimated by 7% without 
correction). Values for the absolute blood flow at the air-breathing baseline were 
computed using Equation 1 from Wang et al. (Wang et al. 2003b), assuming the 
same constant values as in this reference.
A.4. Results 
Visual stimulation alone resulted in extensive BOLD activation throughout visual 
cortex, as shown in ROI masks in Fig. 1. Inhalation of carbogen-10 caused large 
BOLD signal increases in cortical and sub-cortical grey matter (Fig. 2), with the 
incremental contribution from the addition of visual stimulation becoming 
successively smaller at higher fractional carbogen concentrations (Fig. 3 and 5). 
Percent changes for both stimuli (carbogen-10 alone and carbogen-10 + visual) 
averaged over visually-activated areas in individual subjects show a universal 
tendency to converge towards a common maximal signal change (Fig. 4). Group 
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average response curves for carbogen-10 inhalation alone and carbogen-10 plus 
visual stimulation show an apparent convergence of response amplitudes at the 
highest carbogen fractions (Fig. 5). Unpaired two-tailed t-tests on ROI group 
averages for each level, comparing with and without visual stimulation, reveal a 
decreasing significance level of the difference with increasing carbogen fraction 
(p=0.002 at 25% carbogen-10 to p = 0.96 at 100% carbogen-10). The average 
percent signal change over subjects was 7.5% ± 1.0 in visual cortex for 
carbogen-10 inhalation alone. This was equal within measurement error to the 
average signal change of 7.5% ± 1.0 for carbogen-10 breathing combined with 
intense visual stimulation (Fig. 3 and 5). The visually-evoked BOLD signal change 
of 2.0 ± 0.1% measured during visual stimulation alone (i.e. breathing air) was thus 
largely eliminated against the carbogen background. Pulse oximetry showed a 
tendency for arterial O2 saturation to rise from baseline levels (typically 98%) 
toward 100% in all subjects.
Visual Carbogen + visual Carbogen
4 8 12 16 20 24 28
Figure 2. Percent BOLD response maps from example subject 
Example maps of percent change in a representative subject for each stimulus paradigm: visual 
only (left), carbogen only (right) and superimposition of both stimuli (center). Maps show high 
percent BOLD signal increase throughout grey matter in response to carbogen-10 inhalation. The 
spatial distribution of BOLD response during the combined stimulus paradigm demonstrates 
236
saturation of the visually evoked component, as the latter is not discernible against the background 
of carbogen response.
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Figure 3. BOLD Time course for carbogen inhalation and carbogen + visual stimulation
Average over five subjects of BOLD time course in visual cortex ROI during carbogen-10 inhalation 
alone (A) and carbogen-10 inhalation plus visual stimulation (B). This figure shows a diminishing 
contribution of visually-evoked BOLD signal when combined with carbogen breathing. Maximal 
signal changes obtained with and without visual stimulation during carbogen-10 breathing are 
equal, within measurement error.
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Figure 4. Individual BOLD percent changes in visual ROI
Visual ROI average percent changes (± SD) measured in each individual subject at the different 
fractional carbogen-10 concentrations, with and without the additional visual stimulation. All subjects 
demonstrated convergent responses for the two conditions. The average end-tidal gas changes for 
the 100% carbogen-10 condition were 59.2 ± 2.4 mmHg for CO2 and 387.9 ± 34.1 mmHg for O2.
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Figure 5. Group-average BOLD response amplitudes
Group average percent BOLD signal change over a visual ROI (solid lines) within standard error 
bounds (grey shading) for each stimulus paradigm. The convergence of the two curves suggests 
saturation of the total BOLD response at values above 7.5%.
Due to technical limitations, end-tidal O2 and CO2 values were only acquired on a 
subset of five subjects during carbogen-10 inhalation. Average baseline end-tidal 
values were 44.4 ± 1.1 mmHg for CO2 and 120.0 ± 3.8 mmHg for O2. The group 
average end-tidal values during the last ten breaths of carbogen-10 inhalation were 
59.2 ± 2.4 mmHg for CO2 and 387.9 ± 34.1 mmHg for O2.
A.4.1. Additional tests
SWI data acquired in one subject during air and carbogen-10 breathing 
demonstrated an almost complete loss of venous contrast during carbogen-10 
breathing (Fig. 6). Analysis of ASL data acquired in five subjects revealed a 
substantial visually induced flow increase (88.9 ± 34.2%) against the background 
of carbogen inhalation, in spite of the greatly reduced visual BOLD response under 
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similar conditions (Fig. 7). The group average flow increase from carbogen-10 
inhalation was 104.5 ± 24.0% from an absolute baseline of 51.4 ± 7.0 ml/100g/min.
Air Carbogen-10
Figure 6. Susceptibility-weighted venogram 
SWI data acquired during air and carbogen-10 inhalation in a single subject. There is an almost 
complete loss of venous contrast during carbogen inhalation, demonstrating the high venous 
oxygen saturation attained.
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Figure 7. BOLD and ASL time courses for visual stimulation during carbogen-10 breathing
Visual ROI time-course averages (five subjects) for BOLD (A) and ASL (B). The average time 
courses are shown in black, along with the GLM fits in grey. Although the visually evoked BOLD 
response is barely detectable, the perfusion response to the visual stimulus is distinctly apparent 
240
against the background perfusion increase from breathing carbogen-10. This suggests that a largely 
intact visual flow response may be invoked in spite of the background hyperoxia due to 
carbogen-10 inhalation, and even though the BOLD response component has been all but 
eliminated. 
A.4.2. Subjective discomfort rating
Subjects reported a moderate to high degree of discomfort from carbogen-10 
breathing. All subjects reported sensations of air hunger and hot flushes (a 
generalized feeling of warmth) during carbogen inhalation, which increased 
progressively over time during the carbogen block. All subjects included in this 
study had prior experience as MRI volunteers and most had already participated in 
at least one study including hypercapnia. Subjects were briefed extensively on the 
importance of reporting discomfort and reminded regularly that the experiment 
could be stopped immediately at their discretion if it became too uncomfortable. 
Two subjects asked to interrupt the experiment to request a higher gas flow rate 
during the highest carbogen concentration. Increasing the flow rate of carbogen 
beyond 16L/min for subjects reporting a difficulty breathing relieved much of the 
discomfort and allowed them to complete the experiment (illustrating the subjective 
nature of air hunger and complex interplay between CO2 level and ventilation 
parameters (Lansing et al. 2009)). Average discomfort ratings were 4.7 ± 0.5 out of 
a possible of 7 for the whole block, with all subjects reporting a discomfort rating 
one to two points higher for the second half of the carbogen-inhalation block, as 
compared to the first half.
A.5. Discussion 
The diminishing incremental response from visual stimulation at high carbogen 
concentrations suggests that the BOLD signal obtained with this manipulation 
approaches the saturation plateau M. We observed a convergence of percent 
signal changes towards a common value of 7.5 ± 1.0% for both carbogen-10 
inhalation alone and combined with intense visual stimulation (Fig. 3 and 5). This 
saturation effect was found to be robust and was observed in all individual subjects 
data (Fig. 4). While investigation of the visually evoked BOLD component against a 
varying background of carbogen inhalation was the primary objective of this study, 
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additional measures were also performed to elucidate the mechanisms of the 
observed behavior. These ancillary measures are discussed below. 
A.5.1. Arterial spin-labeling
Analysis of pseudo-continuous arterial spin labeling data acquired in five subjects 
confirms that the saturation effect observed in the BOLD signal response to 
carbogen-10 does not arise from a reduction of the perfusion response to the 
visual stimulus against the carbogen background. The signal time courses 
averaged over the visually-activated areas of both subjects show a substantial 
perfusion increase in response to visual stimulation (88.9 ± 34.2%) that is distinctly 
visible against the superimposed flow response to carbogen (Fig. 7B). This is in 
spite of the striking abolition of virtually any apparent visual contribution in the 
BOLD signal (Fig. 7A), and the profound tissue hyperoxia that must exist under this 
condition (further confirmation that activation-induced perfusion increases are 
unlikely to be be triggered by decreased tissue pO2 during activation). 
It should be noted that two competing effects represent potential confounds to flow 
quantification in the ASL acquisitions: T1 lengthening due to an increased arterial 
O2 saturation and T1 shortening due to increased plasma O2 concentration (Buxton 
et al. 1998a; Bulte et al. 2007). Because we expect T1 shortening to be the 
predominant effect (Bulte et al. 2007; Bulte et al. 2009), this should result in the 
underestimation of blood flow changes during carbogen inhalation. The effects of 
T1 shortening were therefore taken into account here according to the signal 
formulation for continuous ASL (Chalela et al. 2000; Zaharchuk et al. 2008). The 
values for arterial blood T1 were adjusted from literature values (Bulte et al. 2007) 
for the PaO2 reached in our experiments. 
The perfusion increase of 104.5 ± 24.0% measured in the present study during 
inhalation of carbogen-10 is similar to values found for similar end-tidal PCO2 values 
in previous studies using radiotracer methods (Kety et al. 1948; Kemna et al. 
2001b). Recent studies using pulsed ASL (PASL) have yielded smaller estimates of 
flow changes in response to inhalation of 10% CO2 (Stefanovic et al. 2006; Mark et 
al. 2010). A number of authors have discussed the difficulty of acquiring accurate 
PASL measures of CBF change under conditions where the arterial transit time 
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undergoes a large variation (such as hypercapnia) (Wong et al. 1997; Buxton et al. 
1998a; Yang et al. 2000). A reduced dependence of the calibration procedure on 
ASL measures is indeed one of the motivations for the hyperoxia method (Chiarelli 
et al. 2007b; Goodwin et al. 2009). We have found (in a parallel study, manuscript 
in preparation) that the pseudo-continuous ASL method used in the present study 
may avoid downward bias on flow estimates during global challenges which may 
be inherent in some pulsed ASL implementations due to shifts in the timing of label 
delivery during such manipulations (i.e. if global blood flow increases sufficiently, 
then the trailing edge of the tag bolus may leave the tagging region before the time 
TI1 at which QUIPSS 2 saturation pulses are applied (Wong et al. 1997)). This may 
explain the higher average flow value obtained in the present study.
A.5.2. Susceptibility-weighted imaging
Saturation of BOLD signal with carbogen-10 inhalation is demonstrated by the 
marked loss of venous contrast in SWI data acquired during carbogen-10 
inhalation, when compared to data acquired during air breathing in the single 
subject thus studied (Fig. 6). Carbogen-5 (95% O2, 5% CO2) inhalation has been 
shown before to lead to an almost complete loss of susceptibility contrast in SWI 
(susceptibility-weighted imaging) images (Rauscher et al. 2005b; Sedlacik et al. 
2007; Sedlacik et al. 2008; Sedlacik et al. 2009). Sedlacik et al., have used SWI to 
quantify venous oxygenation in response to carbogen breathing in both a single 
vessel and whole brain approach (Sedlacik et al. 2007; Sedlacik et al. 2008; 
Sedlacik et al. 2009). The linear relationship between the CO2 content of carbogen 
and venous oxygenation observed by this group predicts a complete O2 saturation 
at around 6.3% CO2 content of carbogen (Sedlacik et al. 2008), well below the 
10% CO2 concentration used here (although the latter study used a continuous 
positive airway pressure system, which may be more efficient at raising saturation 
at a given fraction of inspired CO2).
A.5.3. Implications for calibrated MRI
As noted in the introduction, existing calibrated MRI methods for estimating 
changes in CMRO2 involve determination of the BOLD signal increase M that 
would correspond to complete elimination of deoxygenated hemoglobin in tissues. 
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This intermediate step has been performed in previous studies by measuring 
increases in cerebral blood flow and BOLD signal during hypercapnia (Davis et al. 
1998) and also by measuring BOLD and end-tidal O2 changes during hyperoxia 
(Chiarelli et al. 2007b). The large changes in both flow and arterial oxygenation 
that occur during inhalation of carbogen offer the possibility of a unified calibration 
method that consolidates the two approaches mentioned above. In the Appendix, 
we provide an example of how a modified form of the equations used in Chiarelli et 
al. (Chiarelli et al. 2007b) can be used to integrate both flow and oxygenation 
changes to provide an estimate of the M parameter that is extrapolated from a 
BOLD signal increase that is much closer to the ‘true’ value (and thus potentially 
more robust). The example calculation in the Appendix is performed using our 
group average values for end-tidal O2 and changes in CBF and BOLD signal, since 
these measurements were not simultaneously acquired in all subjects (the primary 
focus being on saturation of visually evoked BOLD signals). Application of this 
modified calibration procedure to our group average data (see Appendix) indicated 
that venous O2 saturation rose to 91% during inhalation of carbogen-10 (from a 
baseline value of 70%), and the ‘true’ M value was extrapolated to be 9.5%. If this 
is correct, then the BOLD signal increase measured directly during carbogen-10 
breathing was 75% of the true M value, which represents a considerably closer 
starting point for extrapolation than the measured BOLD values used in 
hypercapnic methods (with typical BOLD increases of 2-3%; e.g. (Ances et al. 
2008; Perthen et al. 2008; Ances et al. 2009; Bulte et al. 2009) or hyperoxia (typical 
BOLD increases of 4%; (Chiarelli et al. 2007b), adjusted to TE of 30 ms). The 
implied values for saturation and M reported above should be considered an 
illustrative approximation, since the input measurements were acquired at different 
times in cohorts which, while overlapping, were not identical. Nonetheless the 
calculations shown in the Appendix demonstrate a unified calibration framework 
that could be used to process imaging and blood gas data acquired during 
manipulations, such as carbogen inhalation, which change both blood flow and 
arterial O2 content.
Regardless of the approximations involved, the BOLD signal measured in 
response to carbogen-10 puts a lower bound of 7.5% on the possible value of M in 
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visual cortex under the conditions of our experiment (TE = 30ms, 3 Tesla). This is 
in the middle range of literature values reported for similar populations (Table 2) 
and adjusted to the TE used in our experiment (Stefanovic et al. 2006; Leontiev et 
al. 2007a; Leontiev et al. 2007b; Ances et al. 2008; Lin et al. 2008; Perthen et al. 
2008; Ances et al. 2009; Bulte et al. 2009; Chen et al. 2009b). Figure 8 shows 
maps of the BOLD signal change measured during inhalation of carbogen-10 for all 
subjects, which show clear delineation of cortical and vascular anatomy at 
response amplitudes are likely to be much closer to the maximum possible BOLD 
signal increase than was possible with other calibration methods. Calibrated MRI 
maps of CMRO2 change based on such data may prove more robust, due to the 
reduced range of extrapolation involved in estimating the M parameter.
Calibration 
technique
M
Bulte 2009 HC (4%) 5.3
Ances 2008a HC (5%) 5.7
Ances 2008b HC (5%) 6.5
Chen 2009 HC (5%) 6.7
Chiarelli 2007 HO 7.0
Ances 2008b HC (5%) 7.3
Current data CG (10%) ∼9.5
Lin 2008 HC (5%) 10.5
Leontiev 2007 HC (5%) 11.1
Perthen 2008 HC (5%) 11.6
12.1
Table 2. Literature M values at 3 Tesla 
Literature M values for visual cortex from calibrated MR studies at 3 Tesla, adjusted to TE = 30ms 
(commonly used at 3 T as in the present study). HC = hypercapnia (CO2/air mixture), HO = 
hyperoxia, CG = carbogen (CO2/O2 mixture). The M value of 9.5%, approximated from group 
average values in the current study, is in the middle range of literature values.
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Figure 8. Maps of percent BOLD increase during carbogen-10 breathing
Individual percent BOLD change maps in response to carbogen-10 inhalation. The percent change 
values observed represent a lower bound on regional M values.
A.5.3.1. Pitfalls and future directions
While the potential of calibrated MRI using carbogen-10 inhalation appears 
promising, the discomfort associated with this high level of CO2 is likely to preclude 
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its application in frail and aging populations. This limitation is largely a question of 
comfort, and the procedure was found to be safely tolerated by young healthy 
volunteers. This is consistent with prior studies in which the safety of hypercapnia 
has been demonstrated at levels comparable to those used in the present study 
(Kemna et al. 2001a; Kemna et al. 2001b; Posse et al. 2001; Stefanovic et al. 
2006; Goode et al. 2009b; Mark et al. 2010). Higher levels of hypercapnia are 
routinely attained in clinical procedures such as permissive hypercapnia, during 
which end-tidal CO2 may reach 100 mmHg without adverse effects in patients who 
do not have elevated intra-cranial pressure (Feihl et al. 1994).
Inhalation of 10% CO2 has been used in several previous studies and these 
studies report only moderate degrees of discomfort from their subject. All subjects 
that participated in this study had previous experience as MRI subjects. Most had 
already taken part in hypercapnia studies and reported mild discomfort ratings on 
the Banzett scale to the level of hypercapnia typically used in our experiments (e.g. 
5 mmHg increase from baseline). In the experiments presented here with 
carbogen-10, the average air hunger rating was 4.7±0.5 on the Banzett scale over 
the whole block (representing a moderate degree of discomfort) and 5.7±0.7 during 
the end of the block. All subjects reported feeling a much milder degree of 
discomfort during the first half of the 3-min carbogen block and the two reports of 
extreme discomfort occurred within 10 seconds of the end of the block. This is 
clearly a concern when considering adoption of the carbogen-10 manipulation as a 
general calibration method for fMRI. It is nonetheless possible that a lower CO2 
concentration (e.g. 7% CO2) could be used to achieve similar results with less 
discomfort. 
The degree of hypercapnia and hyperoxia induced in our subjects during inhalation 
of carbogen-10 may have been influenced by mixing of ambient air with the 
inspired gases. Though the mask fit well most subjects and despite the sealing of 
the top portion with tape, it is possible that there was some air entrained into the 
mask during periods of hyperventilation. However, to minimize this effect, the 
volume of the reservoir bag was monitored visually and gas inflow rate was 
adjusted to ensure that some small residual capacity remained in the bag at all 
times.
247
Alternate approaches to determine the maximal BOLD signal could include 
measurement of the BOLD signal produced with a combination of hyperoxia (100% 
O2 breathing) with acetazolamide challenge. This would circumvent the discomfort 
of CO2 inhalation and allow a controlled investigation of the increased perfusion 
needed to saturate venous blood and the BOLD signal. Time domain optical 
measures (Gagnon et al. 2008) could also be used to investigate tissue deoxy- and 
oxyhemoglobin concentrations with carbogen breathing. Furthermore, animal 
studies in which more invasive measurements (e.g. intrinsic optical imaging on 
exposed cortex) and manipulations including broader blood gas manipulations 
using hyperbaric conditions would also allow a more thorough study of these 
effects.
A.6. Conclusion
Carbogen-10 breathing, through direct O2 enrichment combined with the 
vasodilatory action of CO2, can be used to saturate the BOLD fMRI signal to the 
point where the response to intense sensory stimulation is reduced below the level 
of measurement error (the same BOLD signal increase of 7.5% was found during 
both carbogen-10 inhalation alone and during carbogen-10 plus visual stimulation). 
These observations put a lower bound on M that is in the middle range of TE-
adjusted values from the literature. While the discomfort associated with the high 
level of CO2 employed here would rule out its application in frail or aging 
populations, lower concentrations may be more tolerable. The robustness of the 
BOLD signal measured with carbogen inhalation makes it attractive as a new 
option for calibrated MRI, and for validation of existing calibrated MRI methods in 
which M is extrapolated over a larger range. We are currently carrying out more in-
depth studies incorporating dual-echo pCASL and different carbogen compositions 
to explore the interplay between the flow and oxygenation responses under the 
conditions explored in the present study. These studies also aim to compare M 
values and CMRO2 response estimates obtained using carbogen, in conjunction 
with the hybrid calibration model shown in the appendix, with those determined 
using hypercapnia or hyperoxia.
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A.8. Appendix
The hyperoxia calibration method introduced by Chiarelli et al., was derived for 
conditions where cerebral blood flow would be expected to undergo a small 
decrease during hyperoxia. Equation 12 in Chiarelli can be modified to be valid 
under an arbitrary change in cerebral blood flow:
CBF ⋅CVO2 = CBF ⋅CaO2 − CBF0 ⋅ CaO2 0 ⋅OEF0( )     [1]
where, as in Chiarelli, CBF is the cerebral blood flow in milliliters per second, CvO2 
is the venous oxygen content in milliliters of O2 per deciliter of blood, CaO2 is the 
arterial oxygen content (also in ml O2/dl blood), and OEF is the oxygen extraction 
fraction (dimensionless, and assumed here to be 0.3 as in Chiarelli et al.). The 
subscript ‘0’ is used to denote resting values for CaO2, OEF, and CBF (note that 
only the resting OEF value, which has been shown to be remarkably constant 
throughout the brain and across individuals (Frackowiak et al. 1980; Ito et al. 2004; 
Ashkanian et al. 2008; Bremmer et al. 2010; Sedlacik et al. 2010), is required). The 
above expression can be easily solved for the venous O2 content during an 
arbitrary change in blood flow and oxygenation:
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CvO2 = CaO2 −
CaO2 0 ⋅OEF0( )
CBF
CBF0
⎛
⎝⎜
⎞
⎠⎟ .      [2]
With the above expression for CvO2, the CBF correction term ‘C’ in Equation 8 of 
Chiarelli et al. can be dropped, resulting in a more explicit modeling of cerebral 
blood flow effects. 
We can approximate the effect of increased arterial O2 content and CBF increase 
from carbogen using our group average end-tidal O2 value of 387 ± 34 mmHg, 
which can be used as a surrogate for PaO2, the arterial partial pressure of O2. We 
can then calculate the total arterial O2 content during carbogen-10 breathing as in 
Equation 11 of Chiarelli:
 
CaO2 = ϕ ⋅ Hb[ ] ⋅SaO2( )+ PaO2 ⋅ε( )
= 1.34 mlO2gHb
⎡
⎣
⎢
⎤
⎦
⎥⋅15 gHbdlblood
⎡
⎣
⎢
⎤
⎦
⎥⋅0.9996
⎛
⎝
⎜
⎞
⎠
⎟+ 387 mmHg[ ] ⋅0.0031 mlO2dlblood ⋅mmHg
⎡
⎣
⎢
⎤
⎦
⎥
⎛
⎝
⎜
⎞
⎠
⎟
= 20.09 mlO2dlblood
⎡
⎣
⎢
⎤
⎦
⎥
Hb
+1.20 mlO2dlblood
⎡
⎣
⎢
⎤
⎦
⎥
plasma
= 21.29 mlO2dlblood
⎡
⎣
⎢
⎤
⎦
⎥
    [3]
where φ is the O2 carrying capacity of hemoglobin, [Hb] is the concentration of 
hemoglobin in blood, SaO2 is the hemoglobin saturation (estimated from our group 
average PaO2 value using the Severinghaus equation as in Equation 10 in Chiarelli 
et al.), and ε represents the solubility of O2 in plasma. The values used are the 
same as those in Chiarelli et al., except for SaO2 and PaO2 which are based on our 
group average end-tidal O2 values. Units for the different quantities are indicated in 
square brackets. The second last line shows the relative contributions of O2 bound 
to Hb and O2 dissolved in plasma, indicating that the plasma holds approximately 
six percent of the total arterial O2 content during carbogen-10 inhalation. At 
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normoxia the group average arterial O2 content of hemoglobin was similar (19.83 
ml O2/dl blood) but, as expected, the arterial plasma O2 content was substantially 
lower (0.37 ml O2/dl blood, or 2% of the total arterial O2 content) than the value 
obtained during inhalation of carbogen-10.
We can then proceed to estimate the venous O2 content, CvO2, during carbogen-10 
breathing, using Equation 2:
CvO2 = CaO2 −
CaO2 0 ⋅OEF0( )
CBF
CBF0
⎛
⎝⎜
⎞
⎠⎟
= 21.29 mlO2dlblood
⎡
⎣
⎢
⎤
⎦
⎥ −
20.21 mlO2dlblood
⎡
⎣
⎢
⎤
⎦
⎥ ⋅0.3
⎛
⎝⎜
⎞
⎠⎟
2.04
= 18.33 mlO2dlblood
⎡
⎣
⎢
⎤
⎦
⎥
      [4]
where the value for CaO2|0 is determined using the group average PaO2 value at 
normoxia (120 ± 4 mmHg), the OEF0 value of 0.3 is assumed from literature, and 
the baseline-normalized CBF value of 2.04 is the group average over five subjects 
who underwent carbogen-10 breathing during pCASL imaging. As expected, the 
venous O2 content was lower during normoxia, with a value of 14.14 ml O2/dl 
blood.
As a penultimate step, we can estimate the venous O2 saturation during breathing 
of carbogen-10 using Equation 14 from Chiarelli (setting the negligible venous 
plasma O2 content to zero) and the CvO2 value computed above:
SvO2 =
CvO2 − PvO2 ⋅ ε( )
ϕ ⋅ Hb[ ]
=
18.33 mlO2dlblood
⎡
⎣
⎢
⎤
⎦
⎥
1.34 mlO2gHb
⎡
⎣
⎢
⎤
⎦
⎥ ⋅15
gHb
dlblood
⎡
⎣
⎢
⎤
⎦
⎥
= 0.91         [5]
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from which it is seen that, based on group average results, the venous O2 
saturation has been driven to 91% during inhalation of carbogen-10.
We can now estimate an M value based on our group average values for SvO2, 
BOLD signal increase, and CBF increase during inhalation of carbogen-10. With 
variable CBF incorporated explicitly in our revised expression for CvO2, we can 
drop the CBF correction term ‘C’ from Equation 8 in Chiarelli, yielding:
ΔBOLD
BOLD0
= M 1− CBFCBF0
⎛
⎝⎜
⎞
⎠⎟
α [dHb]
[dHb]0
⎛
⎝⎜
⎞
⎠⎟
β⎛
⎝
⎜
⎞
⎠
⎟
= M 1− CBFCBF0
⎛
⎝⎜
⎞
⎠⎟
α (1− SvO2 )
(1− SvO2 0 )
⎛
⎝
⎜
⎞
⎠
⎟
β⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
      [6]
where the term (CBF/CBF0)α is used to model cerebral blood volume, assuming α 
= 0.38 (Grubb et al., 1974), and β = 1.5 is used to model the influence of 
deoxygenated hemoglobin on transverse relaxation (Boxerman et al. 1995). The 
above expression can be readily solved for M:
M =
ΔBOLD
BOLD0
1− CBFCBF0
⎛
⎝⎜
⎞
⎠⎟
α (1− SvO2 )
(1− SvO2 0 )
⎛
⎝
⎜
⎞
⎠
⎟
β
=
0.075
1− 2.04( )0.38 (1− 0.91)(1− 0.70)
⎛
⎝⎜
⎞
⎠⎟
1.5
= 0.095       [7]
which indicates a true maximal BOLD signal increase of 9.5%.
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B.1. Abstract
We have recently described an extension of calibrated MRI, which we term QUO2 
(for QUantitative O2 imaging), providing absolute quantification of resting oxidative 
metabolism (CMRO2) and oxygen extraction fraction (OEF0). By combining BOLD, 
arterial spin labeling (ASL) and end-tidal O2 measurements in response to 
hypercapnia, hyperoxia and combined hyperoxia/hypercapnia manipulations, and 
the same MRI measurements during a task, a comprehensive set of vascular and 
metabolic measurements can be obtained using a generalized calibration model 
(GCM). These include the baseline absolute CBF in units of ml/100g/min, 
cerebrovascular reactivity (CVR) in units of %Δ CBF/mmHg, M in units of percent, 
OEF0 and CMRO2 at rest in units of μmol/100g/min, percent evoked CMRO2 during 
the task and n, the value for flow-metabolic coupling associated with the task. The 
M parameter is a calibration constant corresponding to the maximal BOLD signal 
that would occur upon removal of all deoxyhemoglobin. We have previously shown 
that the GCM provides estimates of the above resting parameters in grey matter 
that are in excellent agreement with literature. Here we demonstrate the method 
using functionally-defined regions-of-interest in the context of an activation study. 
We applied the method under high and low signal-to-noise conditions, 
corresponding respectively to a robust visual stimulus and a modified Stroop task. 
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The estimates fall within the physiological range of literature values, showing the 
general validity of the GCM approach to yield non-invasively an extensive array of 
relevant vascular and metabolic parameters.      
Keywords: calibrated fMRI, baseline oxygen use, evoked oxidative metabolism, 
Stroop task, hypercapnia, hyperoxia.
B.2. Introduction
Blood oxygen-level dependent (BOLD) fMRI has been used extensively since its 
discovery to investigate non-invasively the brain activity associated with a large 
variety of tasks. Though BOLD contrast is a sensitive measure of activity, it is 
unfortunately also an ambiguous one, as it arises from a combination of changes in 
oxidative metabolism, blood flow and blood volume. Calibrated fMRI techniques 
were developed to isolate the oxidative metabolic component of the BOLD signal, a 
quantity thought to better reflect the underlying synaptic activity of neurons. These 
techniques use gas manipulations such as hypercapnia (Davis et al. 1998; Hoge et 
al. 1999a), hyperoxia (Chiarelli et al. 2007b) or a combination of both (Gauthier et 
al. 2012b) to estimate the purely vascular component of the BOLD response and 
remove it from the BOLD signal measured during a task. The resulting estimate of 
percent cerebral metabolic rate of O2 (CMRO2) change evoked by that specific task 
can then be directly compared between groups, even if these groups are known to 
differ in their hemodynamic function.
The importance of the baseline state in understanding the meaning of vascular and 
metabolic dynamic changes is becoming more and more appreciated. Task-
induced BOLD signal changes cannot, in standard fMRI protocols, be related to a 
known baseline state. This reduces the strength of inferences that can be made 
about the signal changes measured, since not only are these BOLD changes 
ambiguous physiologically, but they are expressed as a function of an unknown 
baseline with an unknown inter-subject and inter-group variability. Until recently, 
calibrated fMRI studies have suffered from a related weakness in that even though 
the actual percent changes in CMRO2 have a physiological meaning that allows 
direct group comparisons, these percent changes arise from an unknown baseline, 
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thereby limiting the conclusions that may be drawn from the observation of group 
differences. 
Efforts to characterize the resting state of the brain have lead to the development 
of a number of new imaging and analysis techniques for the measurement of 
baseline metabolism (He et al. 2007; He et al. 2008; Bolar et al. 2011a; Bulte et al. 
2011; Fan et al. 2011). We have recently proposed an extension of our Generalized 
calibration model (GCM) technique (Gauthier et al. 2012b) that takes advantage of 
the common and orthogonal information contained in the MRI and end-tidal partial 
pressure of expired O2 (ETO2) measured in response to different combinations of 
hypercapnia and hyperoxia to get an estimate of baseline properties including M, 
the oxygen extraction fraction at rest (OEF0) and oxidative metabolism at rest 
(CMRO2) in micromolar units (Gauthier et al. 2012c). The parameter M 
corresponds to the BOLD signal attenuation at rest from baseline deoxyhemolobin 
content and is used in calibrated fMRI experiments to calibrate task-evoked BOLD 
signal changes. It is estimated using a BOLD biophysical model by extrapolation 
from the signal changes observed during gas manipulations to the maximal 
possible BOLD signal increase that would theoretically occur upon complete 
removal of deoxyhemoglobin. The technique to measure baseline properties 
(Gauthier et al. 2012c), combined with the established calibrated fMRI of task-
evoked metabolism, provides a rich array of vascular and metabolic parameters 
including measures of oxygen delivery, resting cerebral blood flow, CO2-mediated 
cerebrovascular reactivity, the resting BOLD signal M, flow-metabolic coupling, as 
well as both absolute measures of baseline and task-evoked oxidative metabolism. 
This approach, which we have dubbed QUO2 MRI (for QUantitative O2), could be 
of great value in the interpretation of basic neuroscience research results, but also 
in the investigation of complex diseases that include functional and hemodynamic 
deficits. 
Here we present the framework by which these different aspects of the model can 
be combined to characterize the brain vasculature and metabolism using two 
widely used paradigms: intense stimulation of primary visual areas using a flashing 
checkerboard and a modified version of the Stroop task, producing much more 
subtle brain responses. New functional imaging techniques are often tested using 
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simple visual paradigms, since these tasks represent a best case scenario for 
functional imaging, giving rise to well characterized, very large signal changes 
readily observable even with low signal-to-noise ratio (SNR) techniques. While this 
provides a good proof-of-concept framework for testing new techniques, cognitive 
tasks used in basic neuropsychology and clinical settings typically produce much 
smaller responses and are thus more challenging to image than primary sensory 
stimulation. The modified Stroop task (Bohnen et al. 1992) used here includes both 
an inhibition and a task switching component. This makes this task interesting for 
an in-depth study of local physiology since these executive functions have been 
shown to be specifically affected by aging and some diseases (Milham et al. 2002; 
Wasylyshyn et al. 2011; Yun et al. 2011). It is therefore possible that the regions 
implicated in these tasks show signs of a more fragile underlying physiology that 
would explain their vulnerability to age and disease. 
B.3. Methods
Acquisitions were conducted in seven healthy male subjects (aged 21 to 38 years) 
on a Siemens TIM Trio 3T MRI system (Siemens Medical Solutions, Erlangen, 
Germany) using the vendor-supplied 32-channel receive-only head coil for all 
acquisitions. All subjects gave informed consent and the project was approved by 
the Comité mixte d’éthique de la recherche du Regroupement Neuroimagerie/
Québec.
B.3.1. Image acquisition
Sessions included an anatomical, 1mm3 MPRAGE acquisition with TR/TE/alpha = 
2300ms/3ms/9°, 256x240 matrix and a GRAPPA acceleration factor of 2 (Griswold 
et al. 2002). 
Functional image series were acquired using a dual-echo pseudo-continuous 
arterial spin labeling (pCASL) acquisition (Wu et al. 2007) to measure changes in 
cerebral blood flow (CBF). The parameters used include: TR/TE1/TE2/alpha = 
3000ms/10ms/30ms/90° with 4x4mm in-plane resolution and 11 slices of 7mm 
(1mm slice gap) on a 64x64 matrix (at 7/8 partial Fourier), GRAPPA acceleration 
factor = 2, post-labeling delay = 900ms, label offset = 100mm, Hanning window-
256
shaped RF pulse with duration/space = 500μs/360μs, flip angle of labeling pulse = 
25°, slice-selective gradient = 6mT/m, tagging duration = 1.5s (Wu et al. 2007).
B.3.2. Gas manipulations
Each session included three functional runs each including a different gas 
manipulation. During each gas manipulation run, a single three-minute block of gas 
inhalation was preceded with one minute and followed by two minutes of medical 
air breathing. The three gas manipulations used were: 100% O2 (hyperoxia), 7% 
CO2/21%O2/72%N2 (hypercapnia) and 7% CO2/93% O2 (simultaneous hyperoxia/
hypercapnia). The latter gas is a specific formulation of carbogen, which in general 
may contain different O2/CO2 ratios.
At the beginning of the experiment, subjects were fitted with a non-rebreathing face 
mask (Hudson RCI, #1059, Temecula, California, USA). To avoid discomfort from 
outward gas leakage blowing into the subject’s eyes, skin tape (Tegaderm Film, 
#1626W, 3M Health Care, St-Paul, MN, USA) was used to seal the top of the mask 
to the face. Plastic tubing (AirlifeTM Oxygen tubing #001305, Cardinal Health, 
McGraw Park, IL, USA) and a series of two Y-connectors were used to connect 
pressure/flow-meters for medical air, 100% O2 (hyperoxia), 7% CO2/93% air 
(hypercapnia) and 7% CO2/93% O2 (simultaneous hyperoxia/hypercapnia) tanks 
(Vitalaire, Mississauga, ON, Canada) to the mask. Gas flows were adjusted 
manually on the pressure/flow-meters (MEGS, Ville St-Laurent, QC, Canada) to 
keep a total flow rate of 16L/min. Gas flow was kept at 16L/min at all times except 
during administration of the hyperoxia/hypercapnia and the hypercapnia gas 
mixtures. To accommodate the elevated minute ventilation caused by CO2 
breathing, gas flow rates were increased to the maximal possible rate (25L/min) 
achievable with our pressure/flowmeters. Pulse rate and arterial O2 saturation were 
monitored in all subjects using a pulse-oximeter (InVivo Instruments, Orlando, 
USA) as a safety measure and to observe the effects of the different gas 
manipulations. 
End-tidal O2 and CO2 values were monitored during all acquisitions. Gases were 
sampled via an indwelling (15 mm) nasal cannula (AirlifeTM Nasal Oxygen 
Cannula #001321, Cardinal Health, McGraw Park, IL, USA) using the CO2100C 
257
and O2100C modules of the MP150 BIOPAC physiological monitoring unit 
(BIOPAC Systems Inc., Goleta, CA, USA). Calibration of the unit was done by 
taking into account an expired partial pressure of water of 47mmHg (Severinghaus 
1989). Subjects were instructed to breathe through their nose, which ensured that 
only expired gas was sampled by the nasal cannula. End-tidal PCO2 and PO2 
values were selected manually from continuous respiratory traces sampled at 200 
Hz. The first 10 breaths of the first baseline period and the last 10 breaths of the 
gas-inhalation block were averaged to give baseline values and gas manipulation 
values respectively.
After the experiment, all subjects were debriefed to assess the level of discomfort 
associated with the breathing manipulations. The subjects were asked to rate the 
air hunger and breathing discomfort associated with the hypercapnia and carbogen 
mixtures on a French language version of the scale proposed in (Banzett et al. 
1996). 
B.3.3. Visual stimulus
The visual stimulus used was a black and white radial checkerboard, with annuli 
scaled logarithmically with eccentricity, luminance modulated in a temporal 
squarewave at 8 Hz (equivalent to 16 contrast reversals per second) presented 
using an LCD projector (EMP-8300, Epson, Toronto, ON, Canada) onto a 
translucent screen viewed by subjects through a mirror integrated into the Siemens 
head coil. This stimulation was initiated one minute into the acquisition and lasted 
three minutes, followed by two minutes of rest.
B.3.4. Stroop task
The Stroop task consisted of two 60-second blocks each of control and Stroop 
conditions, interspersed with 60-second rest blocks. In total, there were therefore 
four task and five resting blocks, for an acquisition of nine minutes. During task 
blocks, control or Stroop events always lasted two seconds, preceded by two 
seconds with a fixation cross to maintain focus. In all cases, subjects had only two 
possible answers (blue or green), selected using an MRI-compatible button box 
(FIU-005 interface with 8 buttons bimanual response pads, Current Designs). All 
subjects were native French speakers and the color words were written in French 
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(‘BLEU’ and ‘VERT’). The task was presented to the participant using the same 
setup as for the visual task.
During the Stroop/switching condition blocks, two different types of events were 
given in random order. In all cases, letter color and word semantic were non-
congruent. In ten of fifteen cases, when the color word appeared, the correct 
answer was letter color. In five cases out of fifteen, a large white rectangle 
appeared around the word for the whole event, starting during the two seconds 
with the fixation cross. This rectangle indicated to the subject that the rule had 
changed and that the right answer now corresponded to word semantic rather than 
letter color. During the control task blocks (color naming), a series of four X’s were 
written either in blue or green and the participant was asked to give the color of the 
letters.
B.3.5. Data analysis
All analyses except for Stroop ROIs definition were done using the NeuroLens data 
analysis software package (www.neurolens.org). The raw EPI series were 
preprocessed by motion correction (Cox et al. 1999) and spatial smoothing with a 
3D Gaussian kernel (6 mm FWHM). The CBF signal was isolated from the series 
of first echoes using linear surround subtraction (Liu et al. 2005), while the BOLD 
signal was extracted using linear surround addition of the second echo series.
Fractional changes in BOLD and CBF signals were then determined for each gas 
manipulation by fitting a GLM to the respective signals and dividing the estimated 
effect size by the estimated constant term. Model fits used a single-gamma 
hemodynamic response function (HRF) with parameters described by Glover et al. 
(Glover, 1999) and included a first order polynomial to represent baseline signal 
and linear drift (higher order polynomial fits were deemed unsuitable due to the 
single long block during the gas runs). Because the canonical HRF cited above 
actually bears little resemblance to the impulse response describing transitions 
between respiratory states, the first 60 seconds after each transition in gas 
composition were excluded from the analyses by zeroing out relevant rows in the 
GLM computational matrices, to select responses at steady-state. CBF and BOLD 
data for the visual and Stroop tasks were treated similarly, but no frames were 
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excluded. For the Stroop task, a third order drift polynomial was used in the GLM 
and a contrast was used to isolate the signal changes during the Stroop/switching 
blocks. 
Because the flow changes produced by hyperoxia were considerably smaller than 
the noise level in our ASL acquisitions, a constant fixed value of -3.11% was 
assumed for this CBF change (only for hyperoxia). This value was the average flow 
change determined by first averaging the O2-induced change in ASL signal (after 
correction for T1 changes as described below) over all cortical and sub-cortical 
grey matter in each subject, and then pooling average values from the seven 
subjects. The use of a fixed value for the O2-induced flow response is also 
advocated in the Chiarelli method (Chiarelli et al. 2007b), as these changes are 
generally agreed to be too small for reliable measurement at the single voxel level 
with current ASL methods.      
As noted above, it was necessary to correct values of the fractional CBF change 
during hyperoxic manipulations to account for changes in the T1 of blood known to 
occur during changes in the plasma concentration of O2 (which is paramagnetic). 
This was carried out using the approach described in (Chalela et al. 2000; 
Zaharchuk et al. 2008). We estimated arterial blood T1 values based on the end-
tidal O2 (ETO2) measurements obtained in each subject, along with T1 vs. FiO2 
values tabulated in Bulte et al. (Bulte et al. 2007) and PaO2 vs FiO2 values 
tabulated by Chiarelli et al. (Chiarelli et al. 2007b). Since the exact T1 depends on 
the level of dissolved O2 in plasma, and because we obtained slightly different 
ETO2 values at a given fraction of inspired O2 than in these studies because of 
differences in gas delivery techniques, the values were linearly interpolated to 
account for this difference.
Following determination of average end-tidal O2 values as described above, the 
latter were converted to arterial O2 content in ml O2/ml blood as described in 
Chiarelli et al. (Chiarelli et al. 2007b). The following parameters were assumed for 
all subjects in the latter conversion: φ = 1.34 mlO2/gHb, [Hb] = 15 gHb/dl blood, 
and ε = 0.0031 mlO2/dl blood/mmHg (the solubility of O2 in plasma) (Chiarelli et al. 
2007b; Rhoades et al. 2009). While hemoglobin concentration was assumed here 
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to be 15 gHb/dl blood, this value can be determined more accurately through a 
blood draw for each subject. Two of our participants underwent this test as part of 
another study and their blood hemoglobin concentrations were 14.5 and 15.2 gHb/
dl blood, close to the assumed value of 15 gHb/dl blood.
For the three gas manipulations, the corresponding fractional changes in BOLD 
and CBF along with arterial O2 content values were substituted into the generalized 
calibration model to determine the M vs. OEF0 curve for each gas (the averaging 
performed on the measured MRI and respiratory values is described below). The 
intersection point of the two curves was then determined numerically using the 
bisection method (Press et al. 1992), starting from an OEF0 value of 1. The 
midpoint between the intersection between the hypercapnia (HC) and hyperoxia 
(HO) curves and the intersection point between the combined hyperoxia/
hypercapnia (HO-HC) and hyperoxia (HO) curves was used to determine the M vs. 
OEF0 solution coordinates used in further analyses.
Computation of resting CMRO2 required the absolute resting CBF, which was 
determined from the pCASL data using the approach described by Wang et al. 
(Wang et al. 2003a) assuming blood brain partition coefficient = 0.9, labeling 
efficiency = 0.80, blood T1 = 1.49 s, and grey matter T1 = 1.4 s. For this 
computation, the baseline ASL difference signal estimated in the GLM fit for each 
gas manipulation was divided by an estimate of the baseline (raw) EPI signal 
computed in a similar GLM fit. The resultant ratio converted to absolute CBF units 
based on the parameters above. 
Evoked percent CMRO2 changes during the visual and modified Stroop tasks were 
determined using the GCM as in Gauthier et al. (Gauthier et al. 2012b) and the M 
values estimated using the procedure described above over each task-specific ROI 
(Gauthier et al. 2012c). 
Other than the coordinates for intersection of group average M vs. OEF0 curves, 
for which the range of intersection coordinates was used, all uncertainties are 
provided as ± standard error. Uncertainties on evoked CMRO2 were computed 
from uncertainties on M, CBF and BOLD as described in Davis et al. (Davis et al. 
1998).
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B.3.6. Visual ROI
Because responses to the flashing checkerboard are large enough to be 
detectable at the single subject level, regions of interest (ROIs) were derived from 
the intersection of the flow and BOLD thresholded (p ≤ 0.01 corrected) (Worsley et 
al. 2002) visual activation T-maps for each individual subject from the NeuroLens 
analysis. One subject (subject 1) fell asleep during the visual task and was 
therefore excluded from all analyses requiring a visual ROI. The ROIs for the visual 
task are the same as presented in a previous report (Gauthier et al. 2012b). The M 
parameter and evoked CMRO2 data were included in that publication and are 
reproduced here to facilitate comparison with the other ROIs. Baseline OEF0 and 
CMRO2 measures over this ROI represent however a novel result. 
B.3.7. Stroop ROIs definition
Because the modified Stroop task yields smaller signal changes not readily 
detectable at the single subject level for a single run, individual subject ROIs for the 
Stroop task were defined from the significant BOLD signal changes during the 
inhibition/switching blocks for the seven participants included in this study. Two 
regions of interest were drawn for this task, one over bilateral frontal areas and one 
over parietal areas.      
This analysis was done using FSL. All functional data were motion corrected with 
MCFLIRT (Jenkinson et al. 2002) and the brain was extracted using BET (Brain 
Extraction Tool, version 2.1) (Smith 2002). A 6mm3 FWHM 3D Gaussian smoothing 
kernel, high-pass filter (100s cutoff) and pre-whitening (FILM) (Woolrich et al. 2001) 
were applied to the time series. Spatial normalization to standard space (MNI152 
template) (Jenkinson et al. 2001; Jenkinson et al. 2002) was performed (12 
degrees of freedom) on the 30ms echo time series. The BOLD time series was 
extracted from the second echo time series (TE = 30ms) by isolating the control 
images from the original time series. A GLM was performed with the main 
experimental paradigm convolved with a dual gamma function. Temporal 
derivatives were included in the model. Fixed effect group analysis was performed 
using FLAME1 (Beckmann et al. 2003; Woolrich et al. 2004; Woolrich 2008) to 
generate group average statistical maps for the contrast representing the 
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subtraction of the control blocks from the Stroop blocks (isolating the areas 
specifically involved in inhibition/switching). The group average map thresholded at 
Z = 2.3 for the 30ms echo was used to derive the individual ROIs. The 
transformations for spatial normalization of the seven subjects were inverted to 
project the group ROIs into individual subject space (Figure 1) to perform ROI 
quantifications in native space. 
In order to account for the fact that our large EPI voxels inevitably contained a 
mixture of grey matter, white matter, and CSF, average BOLD and ASL responses 
were determined by computing weighted-averages within ROIs, with the weighting 
provided by the estimated grey matter volume fraction in each voxel. The grey 
matter volume fraction was determined using automatic tissue segmentation of 
anatomical images using the FAST module of FSL (Zhang et al. 2001). Grey matter 
probability maps generated by FAST were projected into native EPI space using 
linear interpolation. Binarized individual ROI maps (both visual and Stroop task-
derived) were multiplied by grey matter probability. This approach assumes that the 
responses in white matter and CSF are negligible compared with the grey matter 
response, which is supported by our observations in these tissue compartments 
(data not shown).
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Frontal Parietal
Figure 1. ROI for Stroop task
ROIs for the modified Stroop task determined using the significant (Z ≥ 2.3) signal increases in 
BOLD group maps. Two regions were drawn to reflect the bilateral frontal and parietal components 
to the task.
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B.4. Results
B.4.1. Gas manipulations
All gas manipulations lead to the expected changes in end-tidal gas partial 
pressures (Table 1). Breathing of 100% O2 lead to an increase in ETO2 of 425.83 ± 
31.28 mmHg during the hyperoxia block. A slight hypocapnia was induced by the 
manipulation with a decrease in ETCO2 of 3.21 ± 0.37 mmHg. Breathing the 7% 
CO2 in air mixture lead to an average increase ETCO2 of 9.04 ± 1.31 mmHg, with a 
concomitant increase in ETO2 from hyperventilation during the CO2 block of 14.22 
± 2.08 mmHg. Both ETO2 and ETCO2 were successfully elevated during breathing 
of 7% CO2 in 93% O2, with an ETCO2 increase of 7.41 ± 0.65 mmHg and an ETO2 
increase of 304.26 ± 26.85 mmHg. The ETCO2 and ETO2 values during each 
breathing manipulations are given in Table 1.
Hyperoxia Hypercapnia Combined
Baseline ETCO2 
(mmHg)
Manipulated ETCO2  
(mmHg)
Baseline ETO2  
(mmHg)
Manipulated ETO2  
(mmHg)
40.11 ± 0.95 40.21 ± 0.68 40.63 ± 0.61
36.90 ± 0.88 49.26 ± 0.94 48.04 ± 0.82
117.54 ± 5.49 121.63 ± 6.68 116.92 ± 5.08
543.37 ± 30.00 135.84 ± 5.29 421.18 ± 23.44
Table 1. Respiratory parameters
End-tidal CO2 and O2 values (mmHg) for each breathing manipulations (hypercapnia, hyperoxia 
and combined hyperoxia/hypercapnia). These values are used in the GCM as a surrogate for 
arterial concentrations of gases.
The percent BOLD and CBF changes evoked by the three breathing manipulations 
are shown in Figure 2. Percent CBF changes (Figure 2A) are shown only for the 
hypercapnia (HC) and combined hyperoxia/hypercapnia (HO-HC) manipulations, 
since a fixed flow decrease was assumed for hyperoxia (see Methods). Similar 
average percent CBF changes were obtained for HC and HO-HC over all ROIs. 
Percent BOLD signal changes (Figure 2B) are shown in response to all breathing 
manipulations. In general, as shown before (Gauthier et al. 2012c; Gauthier et al. 
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2012b), the amplitude of percent BOLD changes in response to hyperoxia and 
hypercapnia are approximately half of that found for combined hyperoxia/
hypercapnia. Both percent CBF and BOLD changes show a trend towards lower 
amplitude signals in more frontal areas. 
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Figure 2. Percent CBF and BOLD changes during breathing manipulations
Percent CBF (A) and BOLD (B) changes in response to hyperoxia (HO), hypercapnia (HC) and 
combined hyperoxia/hypercapnia (HO-HC) over the different functionally-determined ROIs. CBF 
changes to the hyperoxia manipulation are not given as they are too small to be measured reliably 
in small ROIs. Error bars represent the inter-subject standard error.
B.4.2. M, OEF0 and resting CMRO2
Percent changes in BOLD and CBF, as well as end-tidal PO2 values at baseline 
and during the breathing manipulations were input into the GCM to construct the M 
vs. OEF0 curves and solve for a unique value of M and OEF0. Figure 3 shows the 
graphs for each ROI, with a star representing the value used in subsequent 
analyses. The value for grey matter was taken from a previous study for visual 
comparison (Gauthier et al. 2012c). It can be seen from these graphs that, while 
the three lines intersect at a common point for grey matter, they form a small 
triangle of intersection points around physiological values for the functionally-
determined ROIs. The resulting M, OEF0 and CMRO2 estimates over the functional 
ROIs are shown in Figure 4 and Table 2. M values were found to be similar over all 
areas, with values of 6.09 ± 1.11%, 6.11 ± 1.20% and 5.94 ± 1.08% for the frontal, 
parietal and visual ROIs respectively. OEF0 values were found to be close to 
literature values, with values of 0.45 ± 0.07, 0.29 ± 0.06 and 0.29 ± 0.05 for the 
frontal, parietal and visual ROIs respectively. Baseline CMRO2 values of 173.62 ± 
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27.74 μmol/100g/min, 99.59 ± 18.83 μmol/100g/min and 125.09 ± 21.82 μmol/
100g/min were measured for the frontal, parietal and visual ROIs respectively.
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Figure 3. Intersection plots for all ROIs. 
Plots of the M vs. OEF0 curves estimated using the three gas manipulations over all ROIs. The star 
represents the solution for M and OEF0. S lid grey lines show the curve for hyperoxia, solid black 
lines for hypercapnia and dashed black lines for combined hyperoxia/hypercapnia. The plot for grey 
matter (GM) group average values for the same group is taken from another study and included for 
comparison.
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Figure 4. M, OEF0 and resting CMRO2 values over all ROIs 
Graphs of the M (A), OEF0 (B) and resting CMRO2 (C) values obtained over all ROIs. Error bars 
show the range of values used and represent the intersection point of the hypercapnia and 
hyperoxia curves and the intersection point of the combined hyperoxia/hypercapnia (carbogen) and 
hyperoxia curves. 
B.4.3. Task-evoked CMRO2 
The M value used for evoked CMRO2 calculations was taken as the average of the 
intersection point for the hypercapnia and hyperoxia curves and the intersection 
point for the combined hyperoxia/hypercapnia (carbogen) and the hyperoxia curves 
(represented by a star in each subplot within Figure 3). Percent CBF (A) and BOLD 
(B) changes in response to the visual and Stroop tasks over their specific ROI 
(frontal and parietal ROIs for the Stroop task and the visual ROI for the flashing 
checkerboard stimulus) are shown in Figure 5. CBF and BOLD percent changes in 
response to the visual task (68.54 ± 8.95% and 1.31 ± 0.11% for CBF and BOLD 
respectively) were much larger than the percent changes in response to the 
modified Stroop task. The percent CBF changes during the Stroop task were 8.98 
± 1.36% and 14.47 ± 1.84% for frontal and parietal ROIs respectively. Percent 
BOLD signal changes during the Stroop task were 0.33 ± 0.04% and 0.43 ± 0.07% 
for frontal and parietal ROIs respectively. Percent CMRO2 change evoked by the 
task were 3.87 ± 1.20% and 7.33 ± 1.62% over the frontal and parietal ROIs during 
performance of the modified Stroop task. The visual task evoked a larger 34.02 ± 
7.43% increase in metabolism over the visual ROI. The percent increase in 
oxidative metabolism evoked by the tasks over the ROIs in units of μmol/100g/min 
units are shown in Figure 6. 
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Figure 5. Task-evoked percent CBF and BOLD changes
Average percent CBF (A) and BOLD (B) changes evoked by the modified Stroop (in Frontal and 
Parietal ROIs) and the visual (Visual) tasks. Error bars represent the inter-subject standard error.
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Figure 6. Task-evoked percent CMRO2 change
Percent task-evoked CMRO2 change for the modified Stroop (in Frontal and Parietal ROIs) and the 
visual (Visual) tasks. Error bars represent the standard error obtained using the error analysis 
presented by Davis et al. (Davis et al. 1998).
B.4.4. Vascular and metabolic profile
Table 2 summarizes the vascular and metabolic information to be obtained from 
our technique. It includes the baseline absolute CBF in units of ml/100g/min, 
cerebrovascular reactivity (CVR) in units of %Δ CBF/mmHg, M in units of percent, 
OEF0 and CMRO2 at rest in units of μmol/100g/min, percent evoked CMRO2 during 
the two tasks and n, the value for flow-metabolic coupling. CVR corresponds to the 
increase in CBF per unit increase in ETCO2 during the hypercapnia manipulation. 
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The flow-metabolic coupling parameter n represents the percent flow increase 
during a task divided by the CMRO2 increase during that same task.   
Frontal Parietal Visual
Baseline CBF 
(ml/100g/min) 
CVR
(%ΔCBF/mmHg)
M 
(%)
OEF0
CMRO2
(μmol/100g/min)
%∆ CMRO2
n
48.88 ± 0.92 42.75 ± 3.00 54.45 ± 3.10
5.44 ± 0.70 6.57 ± 0.94 7.48 ± 0.53
6.09 ± 1.11 6.11 ± 1.20 5.94 ± 1.08
0.45 ± 0.07 0.29 ± 0.06 0.29 ± 0.05
173.62 ± 27.74 99.59 ± 18.83 125.09 ± 21.82
3.87 ± 1.20 7.33 ± 1.62 34.02 ± 7.43
3.32 ± 1.18 1.98 ± 0.80 2.01 ± 0.78
Table 2. Vascular and metabolic profile
Values obtained from the different elements of our procedure to provide an overview of the vascular 
and metabolic properties of the different ROIs. It includes the baseline absolute CBF in units of ml/
100g/min, cerebrovascular reactivity (CVR) in units of %Δ CBF/mmHg, M in units of percent, OEF0 
and CMRO2 at rest in units of μmol/100g/min, percent evoked CMRO2 during the two tasks and n, 
the value for flow-metabolic coupling. CVR corresponds to the increase in CBF per unit increase in 
ETCO2 during the hypercapnia manipulation. n represents the percent flow increase during a task 
divided by the CMRO2 increase during that same task.   
B.5. Discussion
We have shown that our GCM framework allows absolute quantification of CMRO2 
and other physiological parameters both at rest and during task activation. In a 
previous report (Gauthier et al. 2012c), we demonstrated the possibility of using 
the GCM with different combinations of hypercapnia and hyperoxia to estimate 
resting values of M and OEF0 throughout grey matter. We have shown here that 
this approach can also be applied in the context of a task activation study. The M 
and OEF0 values determined at rest can subsequently be combined with BOLD 
and CBF changes measured in response to a functional challenge, to yield task-
evoked changes in CMRO2 and flow-metabolism coupling. In all ROIs, a 
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physiological value was estimated for the absolute resting CBF, cerebrovascular 
reactivity, the calibration factor M, OEF0, CMRO2 at rest, percent evoked CMRO2 
during both a visual and a modified Stroop task and n, the value for flow-
metabolism coupling. 
B.5.1. Accuracy of estimates
The values for M, OEF0, baseline CMRO2 and task-evoked CMRO2 estimated 
using the method described here fall within the physiological range. While other 
MRI methods exist to obtain an estimate of these parameters (Davis et al. 1998; 
Chiarelli et al. 2007b; He et al. 2007; Xu et al. 2009; Jain et al. 2010; Bolar et al. 
2011b; Bulte et al. 2011; Fan et al. 2011), all methods rely on complex modeling 
and a certain number of assumptions. The M parameter is specific to MRI, since it 
represents the magnetic properties of baseline deoxyhemoglobin content, but 
nuclear medicine techniques can be used to assess oxidative metabolism. PET 
measurements of CMRO2 and OEF rely on three separate acquisitions with 
injection of 15O labeled O2, H2O and CO. These three measurements are 
necessary to model the combined contribution of O2 diffusion into tissue, its 
conversion to water during oxidative metabolism, as well as the dependence on 
blood volume, assessed with C15O (Mintun et al. 1984; Buxton 2010). While these 
PET measures of oxygen utilization are also indirect, and subject to their own sets 
of confounds, they can be used as a benchmark measure to assess qualitatively 
the accuracy of the estimates obtained using our technique. 
B.5.1.1. Visual
Stimulation of primary visual cortex is commonly used to test new imaging 
techniques as it yields very large and reliably detectable signal changes. The M 
value detected here for visual cortex of 5.94 ± 1.08 was at the lower end of the 
range of values found in literature. In a previous survey of 3T M values in visual 
cortex (in which M values were adjusted to reflect values at a TE of 30ms) 
(Gauthier et al. 2012b), we found values ranging from 5.3 (Bulte et al. 2009) to 
12.1 (Perthen et al. 2008). Our own values, derived from simultaneous 
hypercapnia and hyperoxia manipulations (carbogen breathing) have in the past 
been typically slightly higher (Gauthier et al. 2011b; Gauthier et al. 2012c; Gauthier 
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et al. 2012b). This may however reflect the contribution in this case from all three 
gas manipulations in the determination of M and OEF0, since hypercapnia and 
hyperoxia are associated with lower estimates for these parameters (Figure 3) 
(Gauthier et al. 2012b). Also, it is possible that the current estimate is a more 
accurate representation of grey matter values. The ROIs presented here include a 
reduced contribution from veins and other tissue types since we have corrected for 
grey matter probability when averaging over the ROIs. 
The robust CBF and BOLD signal changes evoked by a flashing checkerboard led 
to a 34.02 ± 7.43% increase in oxidative metabolism from the value of 125.09 ± 
21.82 μmol/100g/min determined at rest. The values for percent evoked 
metabolism and flow metabolism coupling ratio (n = 2.01 ± 0.78) found here were 
both consistent with previous reports using similar visual stimuli at 3T (Leontiev et 
al. 2007b; Ances et al. 2008; Lin et al. 2008; Ances et al. 2009). The value for 
visual resting CMRO2 determined here (125.09 ± 21.82 μmol/100g/min) is 
somewhat lower than values obtained using 15O-PET techniques in visual cortex, 
with values ranging from 169.2 ± 31.5 μmol/100g/min to 206.5 ± 22.8 μmol/100g/
min (Ishii et al. 1996; Mintun et al. 2002; Yamauchi et al. 2002; Ibaraki et al. 2008). 
However, this may be due to the fact that the techniques use very different 
approaches to estimate metabolism, with different biases. Furthermore, since 
visual information is still present at rest, the value for baseline visual cortex 
metabolism must depend on the particular implementation of “rest”. In this case, 
subjects had their eyes open, with gaze fixed on a white dot in the center of a 
uniform grey screen, with lights turned off in the scanner bore. 
Literature MRI estimates of baseline OEF and CMRO2 are not available for the 
visual cortex, but the value we observe for occipital cortex is well within the range 
observed for grey matter or whole brain, with values of 132 ± 20 μmol/100g/min 
(Xu et al. 2009), 125 ± 15 μmol/100g/min (Bolar et al. 2011a), 127 ± 6 (Jain et al. 
2010), 151 ± 15 μmol/100g/min (Fan et al. 2011) and 155 ± 39 μmol/100g/min 
(Bulte et al. 2011) for MRI-derived estimates. This is also true of PET-derived grey-
matter values, as indicated by a survey of literature PET values in Xu et al. (Xu et 
al. 2009) showing values in young subjects spanning the range from 110.2 ± 19.6 
μmol/100g/min to 149.5 ± 27.5 μmol/100g/min (Ishii et al. 1996; Hattori et al. 2004; 
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Ito et al. 2004; Ito et al. 2005; Coles et al. 2006; Ibaraki et al. 2008; Ibaraki et al. 
2010). The conversion from ml/100g/min to μmol/100g/min was done using 
Equation 5 from Gauthier et al. (Gauthier et al. 2012c) starting with the values in 
the original papers rather than the values reported by Xu et al., which explains the 
slight discrepancies in the reported values.
Our OEF0 estimate over visual cortex of 0.29 ± 0.05 is within the physiological 
range. Though this value is somewhat lower than values reported in the PET 
literature, going from 0.36 ± 0.03 to 0.59 ± 0.06 (Mintun et al. 2002; Yamauchi et al. 
2002; Ito et al. 2005; Ibaraki et al. 2008), it is similar to the value for grey matter 
(0.26 ± 0.02) and whole brain (0.36 ± 0.02 and 0.38 ± 0.14) found using three other 
MRI techniques (Bolar et al. 2011a; Bulte et al. 2011). PET values over all grey 
matter from the literature range from 0.36 ± 0.06 to 0.44 ± 0.06. The fact that these 
are systematically higher than all MR-based estimated may indicate that the 
assumptions or noise biases for these two modalities pull estimates in opposite 
directions (Yamaguchi et al. 1986; Ito et al. 2004; Ibaraki et al. 2008). Further 
exploration is clearly warranted to assess the accuracy of these values.
B.5.1.2. Stroop
Cognitive tasks give rise to much more subtle signal changes than primary sensory 
stimuli and are generally used to assess neurological correlates of specific 
cognitive subcomponents. To reproduce this situation with the modified Stroop task 
used here, blocks of a more complex version of the task, that included components 
of inhibition and switching, were interspersed with blocks of a simpler version of the 
task that only required color-naming (no inhibition or switching). Though the signal 
changes to each version of the task were readily detectable, the difference 
between them was not. This is most likely due to both the small number of subjects 
included in this proof-of-concept study, but also to the fact that a single acquisition 
with the modified Stroop task was obtained for each subject. Because of this, we 
elected to use only the signal changes obtained during the inhibition/switching 
blocks, without subtracting from them the signal changes obtained in the control, 
simpler version of the task. It is to be noted that the lack of a significant difference 
in the fMRI signal changes obtained during the inhibition/switching and control 
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blocks in the small cohort of subjects presented here is not due to an absence of 
behavioral effect of the task. This is indicated by the fact that participants 
performed significantly better both in terms of reaction time (p = 0.003) and 
accuracy (p = 0.004) during the control blocks as compared to the inhibition/
switching blocks.
Testing the accuracy of values associated with the modified Stroop task is made 
more difficult by the fact that there are many versions of this task. The extent and 
exact localization of the significant signal changes will depend on the exact 
implementation of the task, but also on the SNR of the imaging technique used to 
detect the changes. Lower SNR techniques, such as ASL, may not be as efficient 
for the detection of small signal changes, especially in areas known to be more 
affected by distortions and signal losses due to susceptibility effects. Even with 
these potential confounds, the modified Stroop task has the advantage of having 
been extensively characterized using a variety of imaging techniques and some 
robust and conserved signal changes exist across modalities. Two main positive 
signal change foci were found here: an extensive bilateral frontal component 
covering parts of Brodmann areas 6, 9, 45 and 46, with partial extension into 
cingulate cortex around Brodmann area 32 and into part of the frontal pole. The 
second focus encompassed regions in parietal areas, covering mainly parts of 
bilateral Brodmann areas 7, 39 and 40. The frontal component corresponds well to 
the literature on the localization of activation during the inhibition component of 
Stroop and during task switching (Leung et al. 2000; MacDonald et al. 2000; Brass 
et al. 2002; Milham et al. 2002; Derrfuss et al. 2005; Zysset et al. 2007), while 
parietal activation has been observed during task switching (Dove et al. 2000; 
Kimberg et al. 2000; MacDonald et al. 2000; Brass et al. 2002; Yeung et al. 2006). 
A contribution from anterior cingulate cortex (Brodmann 32) was also detected, as 
expected in this type of task (Leung et al. 2000; MacDonald et al. 2000; Brass et al. 
2002; Milham et al. 2002; Derrfuss et al. 2005; Zysset et al. 2007). We also 
detected a frontal pole component, thought to reflect the flexibility required to inhibit 
automatic responses in the context of changing stimulus contingencies (Nobre et 
al. 1999).
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Only three calibrated fMRI studies have so far looked at cognitive tasks (Restom et 
al. 2008; Goodwin et al. 2009; Mohtasib et al. 2012), two of them using the Stroop 
task with the hyperoxia calibration method (Goodwin et al. 2009; Mohtasib et al. 
2012). In Goodwin et al. (Goodwin et al. 2009), M values were found to be higher 
than in the present study both in frontal (9.0 ± 5.8 and 7.4 ± 4.0 for left and right 
middle frontal gyri respectively) and parietal (10.2 ± 4.9 and 7.7 ± 4.4 for left and 
right parietal lobules respectively) regions, though the value found here is within 
the standard deviation of that study. The M values obtained using the same task in 
a slightly larger cohort in Mohtasib et al. (Mohtasib et al. 2012) of 5.6 ± 0.7 and 6.0 
± 0.6 for left and right middle frontal gyri respectively agrees closely with the value 
of 6.09 ± 1.11 found here for bilateral frontal areas. Values for the flow-metabolism 
coupling parameter n in medial frontal areas in Mohtasib et al. (Mohtasib et al. 
2012) were in good agreement with the value for frontal areas found here. 
Literature flow metabolism coupling values are not available for the regions 
corresponding to our other ROIs, but these fall within the physiological expected 
range with values close to two (Table 2). 
OEF0 values for medial frontal areas fell within the expected range with a value of 
0.45 ± 0.07. This estimate is consistent with the literature estimates in frontal areas 
of 0.41 ± 0.07 and 0.35 ± 0.06 (Ishii et al. 1996; Ibaraki et al. 2008). Our parietal 
estimate was however below literature estimates with a value of 0.29 ± 0.06 as 
compared to the literature values of 0.41 ± 0.07 and 0.40 ± 0.05 for that region 
(Ishii et al. 1996; Ibaraki et al. 2008). The accuracy of CMRO2 estimates shows a 
similar pattern as OEF values. Our frontal values of 173.62 ± 27.74 μmol/100g/min 
for the frontal ROI is somewhat higher than literature estimates of 133.8 ± 23.6 and 
137.7 ± 25.2 μmol/100g/min for frontal lobes (Ishii et al. 1996; Ibaraki et al. 2008). 
Our parietal estimate of 99.59 ± 18.83 μmol/100g/min is however lower than 
literature values of 153.4 ± 31.4 and 141.6 ± 23.6 μmol/100g/min (Ishii et al. 1996; 
Ibaraki et al. 2008). The discrepancy between the values presented here and the 
PET literature values may reflect the fact that more subjects are required for robust 
characterization of a cognitive task, since signal changes in the areas involved are 
more subtle. 
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A recent paper by Bulte et al. (Bulte et al. 2011) uses a technique similar to ours to 
measure the same set of physiological parameters. In brief, this study uses a 
hypercapnia manipulation to derive M using the Davis model (Davis et al. 1998), 
then uses this M value in the context of a hyperoxia manipulation to calculate OEF0 
using the Chiarelli model (Chiarelli et al. 2007b). Conceptually very close to the 
method proposed here, we would expect the values obtained by both methods to 
be quite similar. Though the method proposed by Bulte and colleagues has so far 
only been applied to complete grey matter, the values agree very well with our own 
grey matter values published in a previous report (Gauthier et al. 2012c). Though 
values are not available for smaller ROIs, the close agreement in the values 
obtained through both methods in different subjects is an encouraging sign that 
these techniques may provide valid estimates of baseline OEF and CMRO2. 
B.5.2. Implementation biases and confounds
All baseline measures were found to be in the physiological range, but somewhat 
different from PET-derived estimates. This could be due to inherent biases 
associated with each method and their underlying assumptions, especially since all 
methods include a substantial component of modeling. While we feel that the 
current results support the general validity of the GCM framework, the ultimate 
precision of the method will clearly benefit from further optimization. Moreover, the 
small number of subjects included in this proof-of-concept study highlights the 
increased challenge of quantifying cognitive responses compared with the much 
more robust responses to primary sensory stimulation. While the intersection plots 
obtained in grey matter are generally robust and adequate for quantification, data 
obtained in smaller ROIs show a reduced precision and robustness to errors in 
measurement. While visual estimates may be somewhat spared given the large 
signal changes obtained in visual cortical areas, it is clear that a much larger cohort 
would be required for robust characterization of cognitive effects. 
The precision of this method in dependent on the coincidence of intersection points 
between the curves generated from the three breathing manipulations. Inspection 
of the three curve plots from Figure 3 shows that since the three intersection points 
are not coincident in these ROIs, the value of the final estimate depends on the 
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relative position of the curves. In all cases, the curve for the combined hyperoxia/
hypercapnia (HO-HC) breathing manipulation intersects the O2 manipulation (HO) 
curve at a higher point (for both M and OEF0) than the hypercapnia manipulation 
(HC) curve. Since the estimate reported here corresponds to the average between 
these two intersection points, a systematic downward bias in the HC curve (or 
upward bias in the combined HO-HC curve) will result in a similar bias in the final 
estimate. 
While we cannot rule out conclusively the possibility that this relationship between 
the curves is due to a systematic error introduced by our model, the fact that with 
enough averaging (as in the case of complete grey matter ROIs) we obtain tight 
convergence suggests that this divergence may instead be due to systematic bias 
arising from the lower SNR obtained with small ROIs. The model includes ratio 
estimates and non-linear terms, which are prone to bias under low SNR conditions. 
Since the quality of the ultimate measurements is mainly limited by the quality of 
the ASL data, and since accurate CBF measurements of the changes associated 
with breathing manipulations are known to be difficult to obtain (Tancredi et al. 
2012), it is possible that this systematic bias may arise from suboptimal 
measurement of flow changes during gas manipulations. To rule this out, future 
studies will use ASL methods yielding improved measurements of gas 
manipulations. Strategies to improve ASL quality could include using multiple delay 
times to capture the temporal profile of tag delivery at each voxel, which can then 
be fit with a kinetic model (Buxton et al. 1998a) to provide a more accurate 
estimate of flow (Bulte et al. 2011). Another possibility would be to implement 
background suppression techniques to reduce the physiological or instrumental 
modulation of the background "static" tissue signal that is unrelated to flow (Dixon 
et al. 1991; Maleki et al. 2011).
Alternatively, this effect could arise from errors in the BOLD signal change 
measurement. The BOLD response to hypercapnia has a lower amplitude than the 
BOLD response to combined HO-HC. This smaller response means that the 
contrast-to-noise ratio (CNR) of the hypercapnia BOLD experiment is lower than 
that of combined HO-HC, given a similar level of noise in both measurements. This 
reduced CNR could lead to an underestimation of the BOLD response to 
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hypercapnia, thereby leading to an underestimation of the M value associated with 
a given OEF. This underestimation would be reduced for combined HO-HC, since 
the measured BOLD changes are larger and therefore easier to measure against a 
similar level of noise.
The values for all parameters were estimated over functionally-defined ROIs using 
fairly large voxels. It is likely therefore that the measurements suffer from biases 
due to some inclusion of cerebro-spinal fluid (CSF) and white matter through partial 
volume effects. ASL is a low SNR technique and large voxels are therefore 
necessary to obtain meaningful measurement values. For the same reason, good 
quality single voxel and small ROI estimates are difficult to obtain. However, by 
weighting each voxel within the ROI by the grey matter volume, estimated for that 
voxel using automatic tissue segmentation, this is unlikely to be the major factor at 
play to explain divergence of the curves.      
The technique chosen to administer the gases, by delivering gases of fixed mixture 
concentrations through an unsealed face mask gives rise to somewhat variable 
end-tidal gas concentrations. While other techniques exist to more accurately 
control and target specific end-tidal values of CO2 and O2 (Slessarev et al. 2007; 
Mark et al. 2010), fluctuations over a moderate range are of no significant 
consequence for the method described here, as long as end-tidal measurements 
are performed. The variability in end-tidal values could furthermore be reduced by 
using a mask with a larger inflow bag and a regulator allowing higher flow rates. 
This would allow the mask to be sealed to the face and prevent room air from 
being entrained into the mask during periods of hyperventilation. Also, the use of a 
metronome to control breathing rate could help reduce inter-subject and inter-run 
variability. Finally, inhalation of CO2 may be uncomfortable in high concentrations 
and lead to important changes in breathing pattern and attentional state that could 
potentially affect the results obtained using this approach. In this case however, 
subjects in general found the inhalation of 7% CO2 to be quite tolerable with this 
specific setup, as indicated by the range of responses given on our subjective 
rating questionnaire. Average rating was 2.1 ± 0.6 over all subject, indicating a very  
low level of breathing discomfort.
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One of the most debated assumptions of calibrated fMRI is that gas manipulations 
do not affect oxidative metabolism. Short periods of hyperoxia are not usually 
assumed to change metabolism, though some groups report a suppressive effect 
of O2 on oxidative metabolism (Xu et al. 2011a). Furthermore, there is no 
consensus about the effects of hypercapnia with some studies reporting increases 
in metabolism (Horvath et al. 1994; Jones et al. 2005), decreases (Zappe et al. 
2008; Xu et al. 2011b), and no detectable change (McPherson et al. 1991; Hino et 
al. 2000; Chen et al. 2010a). In a previous report (Gauthier et al. 2012c), we have 
modeled the effects of both decreased and increased CMRO2 on our model. 
Modeling the effects of decreases or increases in CMRO2 during hypercapnia 
manipulations resulted in reduced convergence towards a unique solution for the 
intersection of the HC, HO and combined HO-HC curves. Because this intersection 
point corresponds to a baseline physiological property of the brain, a single point is 
expected. While the latter observations were not compatible with a significant CO2-
induced change in CMRO2, results of other studies (Zappe et al. 2008; Xu et al. 
2011b) have suggested there may be such an effect. It is clear that further 
exploration of the impact of CO2 on CMRO2 in different brain systems and under 
different conditions is required.
The selection of values for model parameters α and β has also been the subject of 
some contention. We used here values of α = 0.18 and β = 1.5. This value for α is 
taken from experimental measurements of venous blood volume change (Chen et 
al. 2009a; Chen et al. 2010c). Though β was originally taken to reflect the field-
specific effects of deoxyhemoglobin on R2*, it can instead be viewed as a lumped 
constant encompassing additional physiological and physical factors. Numerical 
simulations published by Griffeth et al. suggested that, in an application of the 
original Davis model, consistency with an alternate multi-compartment model was 
maximized using a value of β = 0.91 (Griffeth et al. 2011). Although we have 
chosen to adhere to the original definitions and currently "standard" values of α 
and β for the present study, alternate values such as those proposed by Griffeth 
could readily be inserted in the method presented here.
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B.6. Conclusion
We have demonstrated that QUO2 MRI allows absolute quantification of CMRO2 
both at rest and in the context of a functional challenge. Additional quantitative 
information on resting physiology is also furnished, including resting CBF, CVR, M 
and OEF0. The sensitivity of the method is limited mainly by the low SNR inherent 
in currently available ASL techniques, so while reliable quantification was achieved 
for visual stimulation, a substantially larger cohort would be required for precise 
characterization of a cognitive process like the inhibition and switching components 
of the modified Stroop task. The lower SNR conditions prevailing in the functionally  
defined ROIs highlight the possibility of systematic error related either to noise bias 
or regional differences that are not captured in the model, motivating further 
experimental and theoretical exploration. Significant improvements in ASL 
performance will be required for application of this method in individual patients or 
subjects.
B.7. Acknowledgments
We thank Carollyn Hurst, André Cyr and Tarik Hafyane for help with data 
acquisition, Felipe Tancredi and Maude Laguë-Bauvais for helpful discussions. We 
would also like to thank Jiongjiong Wang, who provided the pseudo-continuous 
arterial spin-labeling sequence used. This work was supported by the Canadian 
Institutes for Health Research (MOP 84378, Banting and Best Scholarship held by 
CJG), the Canadian Foundation for Innovation (Leaders Opportunity Fund 17380), 
and the Ministère du développement économique, de l’innovation et de 
l’exportation (PSR-SIIRI-239).
280
 Bibliography
Abounader, R. and Hamel, E., 1997. Associations between neuropeptide Y nerve 
terminals and intraparenchymal microvessels in rat and human cerebral 
cortex. J Comp Neurol 388: 444-453.
Aleardi, A. M., Benard, G., Augereau, O., Malgat, M., Talbot, J. C., Mazat, J. P., 
Letellier, T., Dachary-Prigent, J., Solaini, G. C. and Rossignol, R., 2005. 
Gradual alteration of mitochondrial structure and function by beta-amyloids: 
importance of membrane viscosity changes, energy deprivation, reactive 
oxygen species production, and cytochrome c release. J Bioenerg 
Biomembr 37: 207-225.
Amar, J., Ruidavets, J. B., Peyrieux, J. C., Mallion, J. M., Ferrieres, J., Safar, M. E. 
and Chamontin, B., 2005. C-reactive protein elevation predicts pulse 
pressure reduction in hypertensive subjects. Hypertension 46: 151-155.
An, H. and Lin, W., 2000. Quantitative measurements of cerebral blood oxygen 
saturation using magnetic resonance imaging. J Cereb Blood Flow Metab 
20: 1225-1236.
Anantharaman, M., Tangpong, J., Keller, J. N., Murphy, M. P., Markesbery, W. R., 
Kiningham, K. K. and St Clair, D. K., 2006. Beta-amyloid mediated nitration 
of manganese superoxide dismutase: implication for oxidative stress in a 
APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of 
Alzheimer's disease. Am J Pathol 168: 1608-1618.
Ances, B. M., Leontiev, O., Perthen, J. E., Liang, C., Lansing, A. E. and Buxton, R. 
B., 2008. Regional differences in the coupling of cerebral blood flow and 
oxygen metabolism changes in response to activation: implications for 
BOLD-fMRI. Neuroimage 39: 1510-1521.
Ances, B. M., Liang, C. L., Leontiev, O., Perthen, J. E., Fleisher, A. S., Lansing, A. 
E. and Buxton, R. B., 2009. Effects of aging on cerebral blood flow, oxygen 
metabolism, and blood oxygenation level dependent responses to visual 
stimulation. Hum Brain Mapp 30: 1120-1132.
281
Andersson, E. A., Lundahl, G., Wecke, L., Lindblom, I. and Nilsson, J., 2011. 
Maximal aerobic power versus performance in two aerobic endurance tests 
among young and old adults. Gerontology 57: 502-512.
Andreasson, K., 2010. Emerging roles of PGE2 receptors in models of neurological 
disease. Prostaglandins Other Lipid Mediat 91: 104-112.
Arena, R., Arrowood, J. A., Fei, D. Y., Helm, S. and Kraft, K. A., 2009. Maximal 
aerobic capacity and the oxygen uptake efficiency slope as predictors of 
large artery stiffness in apparently healthy subjects. J Cardiopulm Rehabil 
Prev 29: 248-254.
Ashkanian, M., Borghammer, P., Gjedde, A., Ostergaard, L. and Vafaee, M., 2008. 
Improvement of brain tissue oxygenation by inhalation of carbogen. 
Neuroscience 156: 932-938.
Ashkanian, M., Gjedde, A., Mouridsen, K., Vafaee, M., Hansen, K. V., Ostergaard, 
L. and Andersen, G., 2009. Carbogen inhalation increases oxygen transport 
to hypoperfused brain tissue in patients with occlusive carotid artery 
disease: increased oxygen transport to hypoperfused brain. Brain Res 1304: 
90-95.
Au, R., Massaro, J. M., Wolf, P. A., Young, M. E., Beiser, A., Seshadri, S., 
D'Agostino, R. B. and DeCarli, C., 2006. Association of white matter 
hyperintensity volume with decreased cognitive functioning: the 
Framingham Heart Study. Arch Neurol 63: 246-250.
Baltes, P. B. and Lindenberger, U., 1997. Emergence of a powerful connection 
between sensory and cognitive functions across the adult life span: a new 
window to the study of cognitive aging? Psychol Aging 12: 12-21.
Banzett, R. B., Lansing, R. W., Evans, K. C. and Shea, S. A., 1996. Stimulus-
response characteristics of CO2-induced air hunger in normal subjects. 
Respir Physiol 103: 19-31.
Bartley, M. G., Marquardt, K., Kirchhof, D., Wilkins, H. M., Patterson, D. and 
Linseman, D. A., 2012. Overexpression of amyloid-beta protein precursor 
induces mitochondrial oxidative stress and activates the intrinsic apoptotic 
cascade. J Alzheimers Dis 28: 855-868.
282
Beckmann, C. F., Jenkinson, M. and Smith, S. M., 2003. General multilevel linear 
modeling for group analysis in FMRI. Neuroimage 20: 1052-1063.
Bhardwaj, A., Northington, F. J., Carhuapoma, J. R., Falck, J. R., Harder, D. R., 
Traystman, R. J. and Koehler, R. C., 2000. P-450 epoxygenase and NO 
synthase inhibitors reduce cerebral blood flow response to N-methyl-D-
aspartate. Am J Physiol Heart Circ Physiol 279: H1616-1624.
Binder, J., Bailey, K. R., Seward, J. B., Squires, R. W., Kunihiro, T., Hensrud, D. D. 
and Kullo, I. J., 2006. Aortic augmentation index is inversely associated with 
cardiorespiratory fitness in men without known coronary heart disease. Am J 
Hypertens 19: 1019-1024.
Blockley, N. P., Griffeth, V. E. and Buxton, R. B. (2011a). Can the calibrated BOLD 
scaling factor M be estimated just from R2′ in the baseline state without 
administering gases? International Society for Magnetic Resonance in 
Medicine, Montreal, Canada.
Blockley, N. P., Griffeth, V. E. and Buxton, R. B., 2011b. A general analysis of 
calibrated BOLD methodology for measuring CMRO(2) responses: 
Comparison of a new approach with existing methods. Neuroimage.
Bohnen, N., Jolles, J. and Twijnstra, A., 1992. Modification of the Stroop Color 
Word Test improves differentiation between patients with mild head injury 
and matched controls. Clinical Neuropsychologist 6: 178-184.
Bokkers, R. P., van Osch, M. J., Klijn, C. J., Kappelle, L. J. and Hendrikse, J., 2011. 
Cerebrovascular reactivity within perfusion territories in patients with an 
internal carotid artery occlusion. J Neurol Neurosurg Psychiatry 82: 
1011-1016.
Bolar, D. S., Rosen, B. R., Sorensen, A. G. and Adalsteinsson, E., 2011a. 
QUantitative Imaging of eXtraction of oxygen and TIssue consumption 
(QUIXOTIC) using venular-targeted velocity-selective spin labeling. Magn 
Reson Med.
Bolar, D. S., Rosen, B. R., Sorensen, A. G. and Adalsteinsson, E., 2011b. 
QUantitative Imaging of eXtraction of oxygen and TIssue consumption 
(QUIXOTIC) using venular-targeted velocity-selective spin labeling. Magn 
Reson Med 66: 1550-1562.
283
Bolar, D. S., Tancredi, F. B., Lajoie, I., Benner, T., Adalsteinsson, E., Mandeville, J. 
B., Sorensen, A. G. and Hoge, R. D., 2012. Pulsed arterial spin-labeling MRI 
of hypercapnic challenge in brain: Tag width and timing effects. PLoS One In 
review.
Bonda, D. J., Lee, H. P., Lee, H. G., Friedlich, A. L., Perry, G., Zhu, X. and Smith, 
M. A., 2010. Novel therapeutics for Alzheimer's disease: an update. Curr 
Opin Drug Discov Devel 13: 235-246.
Bonnefond, A., Doignon-Camus, N., Hoeft, A. and Dufour, A., 2011. Impact of 
motivation on cognitive control in the context of vigilance lowering: an ERP 
study. Brain Cogn 77: 464-471.
Boutouyrie, P., Tropeano, A. I., Asmar, R., Gautier, I., Benetos, A., Lacolley, P. and 
Laurent, S., 2002. Aortic stiffness is an independent predictor of primary 
coronary events in hypertensive patients: a longitudinal study. Hypertension 
39: 10-15.
Boxerman, J. L., Hamberg, L. M., Rosen, B. R. and Weisskoff, R. M., 1995. MR 
contrast due to intravascular magnetic susceptibility perturbations. Magn 
Reson Med 34: 555-566.
Brass, M. and von Cramon, D. Y., 2002. The role of the frontal cortex in task 
preparation. Cereb Cortex 12: 908-914.
Bremmer, J. P., van Berckel, B. N., Persoon, S., Kappelle, L. J., Lammertsma, A. 
A., Kloet, R., Luurtsema, G., Rijbroek, A., Klijn, C. J. and Boellaard, R., 
2010. Day-to-Day Test-Retest Variability of CBF, CMRO(2), and OEF 
Measurements Using Dynamic (15)O PET Studies. Mol Imaging Biol.
Brickman, A. M., Sneed, J. R., Provenzano, F. A., Garcon, E., Johnert, L., 
Muraskin, J., Yeung, L. K., Zimmerman, M. E. and Roose, S. P., 2011. 
Quantitative approaches for assessment of white matter hyperintensities in 
elderly populations. Psychiatry Res 193: 101-106.
Brown, A. D., McMorris, C. A., Longman, R. S., Leigh, R., Hill, M. D., Friedenreich, 
C. M. and Poulin, M. J., 2010. Effects of cardiorespiratory fitness and 
cerebral blood flow on cognitive outcomes in older women. Neurobiol Aging 
31: 2047-2057.
284
Brown, W. R. and Thore, C. R., 2011. Review: cerebral microvascular pathology in 
ageing and neurodegeneration. Neuropathol Appl Neurobiol 37: 56-74.
Bulte, D. P., Chiarelli, P. A., Wise, R. G. and Jezzard, P., 2007. Cerebral perfusion 
response to hyperoxia. J Cereb Blood Flow Metab 27: 69-75.
Bulte, D. P., Drescher, K. and Jezzard, P., 2009. Comparison of hypercapnia-based 
calibration techniques for measurement of cerebral oxygen metabolism with 
MRI. Magn Reson Med 61: 391-398.
Bulte, D. P., Kelly, M., Germuska, M., Xie, J., Chappell, M. A., Okell, T. W., Bright, 
M. G. and Jezzard, P., 2011. Quantitative measurement of cerebral 
physiology using respiratory-calibrated MRI. Neuroimage.
Buxton, R. B., 2010. Interpreting oxygenation-based neuroimaging signals: the 
importance and the challenge of understanding brain oxygen metabolism. 
Front Neuroenergetics 2: 8.
Buxton, R. B. and Frank, L. R., 1997. A model for the coupling between cerebral 
blood flow and oxygen metabolism during neural stimulation. J Cereb Blood 
Flow Metab 17: 64-72.
Buxton, R. B., Frank, L. R., Wong, E. C., Siewert, B., Warach, S. and Edelman, R. 
R., 1998a. A general kinetic model for quantitative perfusion imaging with 
arterial spin labeling. Magn Reson Med 40: 383-396.
Buxton, R. B., Uludag, K., Dubowitz, D. J. and Liu, T. T., 2004. Modeling the 
hemodynamic response to brain activation. Neuroimage 23 Suppl 1: 
S220-233.
Buxton, R. B., Wong, E. C. and Frank, L. R., 1998b. Dynamics of blood flow and 
oxygenation changes during brain activation: the balloon model. Magn 
Reson Med 39: 855-864.
Cabeza, R., 2002. Hemispheric asymmetry reduction in older adults: the HAROLD 
model. Psychol Aging 17: 85-100.
Cabeza, R., McIntosh, A. R., Tulving, E., Nyberg, L. and Grady, C. L., 1997. Age-
related differences in effective neural connectivity during encoding and 
recall. Neuroreport 8: 3479-3483.
Cabeza, R., Nyberg, L. and Park, D. C. (2005). Cognitive neuroscience of aging: 
Linking cognitive and cerebral aging. Oxford, Oxford University Press.
285
Campbell, A. M. and Beaulieu, C., 2006. Pulsed arterial spin labeling parameter 
optimization for an elderly population. J Magn Reson Imaging 23: 398-403.
Canevari, L., Clark, J. B. and Bates, T. E., 1999. beta-Amyloid fragment 25-35 
selectively decreases complex IV activity in isolated mitochondria. FEBS 
Lett 457: 131-134.
Cantin, S., Villien, M., Moreaud, O., Tropres, I., Keignart, S., Chipon, E., Le Bas, J. 
F., Warnking, J. and Krainik, A., 2011. Impaired cerebral vasoreactivity to 
CO2 in Alzheimer's disease using BOLD fMRI. Neuroimage 58: 579-587.
Cappell, K. A., Gmeindl, L. and Reuter-Lorenz, P. A., 2010. Age differences in 
prefontal recruitment during verbal working memory maintenance depend 
on memory load. Cortex 46: 462-473.
Carrera, E., Kim, D. J., Castellani, G., Zweifel, C., Smielewski, P., Pickard, J. D., 
Kirkpatrick, P. J. and Czosnyka, M., 2011. Cerebral arterial compliance in 
patients with internal carotid artery disease. Eur J Neurol 18: 711-718.
Chalela, J. A., Alsop, D. C., Gonzalez-Atavales, J. B., Maldjian, J. A., Kasner, S. E. 
and Detre, J. A., 2000. Magnetic resonance perfusion imaging in acute 
ischemic stroke using continuous arterial spin labeling. Stroke 31: 680-687.
Chen, J. J. and Pike, G. B., 2009a. BOLD-specific cerebral blood volume and 
blood flow changes during neuronal activation in humans. NMR Biomed 22: 
1054-1062.
Chen, J. J. and Pike, G. B., 2010a. Global cerebral oxidative metabolism during 
hypercapnia and hypocapnia in humans: implications for BOLD fMRI. J 
Cereb Blood Flow Metab 30: 1094-1099.
Chen, J. J. and Pike, G. B., 2010b. Global cerebral oxidative metabolism during 
hypercapnia and hypocapnia in humans: implications for BOLD fMRI. J 
Cereb Blood Flow Metab.
Chen, J. J. and Pike, G. B., 2010c. MRI measurement of the BOLD-specific flow-
volume relationship during hypercapnia and hypocapnia in humans. 
Neuroimage 53: 383-391.
Chen, J. J., Rosas, H. D. and Salat, D. H., 2011. Age-associated reductions in 
cerebral blood flow are independent from regional atrophy. Neuroimage 55: 
468-478.
286
Chen, Y. and Parrish, T. B., 2009b. Caffeine dose effect on activation-induced 
BOLD and CBF responses. Neuroimage 46: 577-583.
Chiarelli, P. A., Bulte, D. P., Piechnik, S. and Jezzard, P., 2007a. Sources of 
systematic bias in hypercapnia-calibrated functional MRI estimation of 
oxygen metabolism. Neuroimage 34: 35-43.
Chiarelli, P. A., Bulte, D. P., Wise, R., Gallichan, D. and Jezzard, P., 2007b. A 
calibration method for quantitative BOLD fMRI based on hyperoxia. 
Neuroimage 37: 808-820.
Churchill, J. D., Galvez, R., Colcombe, S., Swain, R. A., Kramer, A. F. and 
Greenough, W. T., 2002. Exercise, experience and the aging brain. 
Neurobiol Aging 23: 941-955.
Colcombe, S. and Kramer, A. F., 2003. Fitness effects on the cognitive function of 
older adults: a meta-analytic study. Psychol Sci 14: 125-130.
Colcombe, S. J., Erickson, K. I., Scalf, P. E., Kim, J. S., Prakash, R., McAuley, E., 
Elavsky, S., Marquez, D. X., Hu, L. and Kramer, A. F., 2006. Aerobic 
exercise training increases brain volume in aging humans. J Gerontol A Biol 
Sci Med Sci 61: 1166-1170.
Coles, J. P., Fryer, T. D., Bradley, P. G., Nortje, J., Smielewski, P., Rice, K., Clark, J. 
C., Pickard, J. D. and Menon, D. K., 2006. Intersubject variability and 
reproducibility of 15O PET studies. J Cereb Blood Flow Metab 26: 48-57.
Coskun, P., Wyrembak, J., Schriner, S., Chen, H. W., Marciniack, C., Laferla, F. 
and Wallace, D. C., 2011. A mitochondrial etiology of Alzheimer and 
Parkinson disease. Biochim Biophys Acta.
Cotman, C. W., Berchtold, N. C. and Christie, L. A., 2007. Exercise builds brain 
health: key roles of growth factor cascades and inflammation. Trends 
Neurosci 30: 464-472.
Cox, R. W. and Jesmanowicz, A., 1999. Real-time 3D image registration for 
functional MRI. Magn Reson Med 42: 1014-1018.
Dai, W., Garcia, D., de Bazelaire, C. and Alsop, D. C., 2008. Continuous flow-
driven inversion for arterial spin labeling using pulsed radio frequency and 
gradient fields. Magn Reson Med 60: 1488-1497.
287
Dash, R. K. and Bassingthwaighte, J. B., 2004. Blood HbO2 and HbCO2 
dissociation curves at varied O2, CO2, pH, 2,3-DPG and temperature levels. 
Ann Biomed Eng 32: 1676-1693.
Dash, R. K. and Bassingthwaighte, J. B., 2010. Erratum to: Blood HbO2 and 
HbCO2 dissociation curves at varied O2, CO2, pH, 2,3-DPG and 
temperature levels. Ann Biomed Eng 38: 1683-1701.
Davenport, M. H., Hogan, D. B., Eskes, G. A., Longman, R. S. and Poulin, M. J., 
2012. Cerebrovascular reserve: the link between fitness and cognitive 
function? Exerc Sport Sci Rev.
Davies, K. J., Thapar, A., Kasivisvanathan, V., Shalhoub, J. and Davies, A. H., 
2012. Review of Trans-Atlantic Cardiovascular Best Medical Therapy 
Guidelines Recommendations for Asymptomatic Carotid Atherosclerosis. 
Curr Vasc Pharmacol.
Davis, S. W., Dennis, N. A., Daselaar, S. M., Fleck, M. S. and Cabeza, R., 2008. 
Que PASA? The posterior-anterior shift in aging. Cereb Cortex 18: 
1201-1209.
Davis, T. L., Kwong, K. K., Weisskoff, R. M. and Rosen, B. R., 1998. Calibrated 
functional MRI: mapping the dynamics of oxidative metabolism. Proc Natl 
Acad Sci U S A 95: 1834-1839.
Delis, D. C., Kaplan, E., & Kramer, J. H. (2001). Delis-Kaplan Executive Function 
System (D-KEFS), The Psychological Corporation.
Derrfuss, J., Brass, M., Neumann, J. and von Cramon, D. Y., 2005. Involvement of 
the inferior frontal junction in cognitive control: meta-analyses of switching 
and Stroop studies. Hum Brain Mapp 25: 22-34.
Detre, J. A., Rao, H., Wang, D. J., Chen, Y. F. and Wang, Z., 2012. Applications of 
arterial spin labeled MRI in the brain. J Magn Reson Imaging 35: 
1026-1037.
Devaraj, S., Kumaresan, P. R. and Jialal, I., 2011. C-reactive protein induces 
release of both endothelial microparticles and circulating endothelial cells in 
vitro and in vivo: further evidence of endothelial dysfunction. Clin Chem 57: 
1757-1761.
288
Devor, A., Sakadzic, S., Saisan, P. A., Yaseen, M. A., Roussakis, E., Srinivasan, V. 
J., Vinogradov, S. A., Rosen, B. R., Buxton, R. B., Dale, A. M. and Boas, D. 
A., 2011. "Overshoot" of O is required to maintain baseline tissue 
oxygenation at locations distal to blood vessels. J Neurosci 31: 
13676-13681.
DiGirolamo, G. J., Kramer, A. F., Barad, V., Cepeda, N. J., Weissman, D. H., 
Milham, M. P., Wszalek, T. M., Cohen, N. J., Banich, M. T., Webb, A., 
Belopolsky, A. V. and McAuley, E., 2001. General and task-specific frontal 
lobe recruitment in older adults during executive processes: a fMRI 
investigation of task-switching. Neuroreport 12: 2065-2071.
Dirnagl, U., Lindauer, U. and Villringer, A., 1993. Role of nitric oxide in the coupling 
of cerebral blood flow to neuronal activation in rats. Neurosci Lett 149: 
43-46.
Dixon, W. T., Sardashti, M., Castillo, M. and Stomp, G. P., 1991. Multiple inversion 
recovery reduces static tissue signal in angiograms. Magn Reson Med 18: 
257-268.
Dogui, A., Redheuil, A., Lefort, M., DeCesare, A., Kachenoura, N., Herment, A. and 
Mousseaux, E., 2011. Measurement of aortic arch pulse wave velocity in 
cardiovascular MR: comparison of transit time estimators and description of 
a new approach. J Magn Reson Imaging 33: 1321-1329.
Donahue, M. J., Lu, H., Jones, C. K., Edden, R. A., Pekar, J. J. and van Zijl, P. C., 
2006. Theoretical and experimental investigation of the VASO contrast 
mechanism. Magn Reson Med 56: 1261-1273.
Dove, A., Pollmann, S., Schubert, T., Wiggins, C. J. and von Cramon, D. Y., 2000. 
Prefrontal cortex activation in task switching: an event-related fMRI study. 
Brain Res Cogn Brain Res 9: 103-109.
Dunn, J. F., O'Hara, J. A., Zaim-Wadghiri, Y., Lei, H., Meyerand, M. E., Grinberg, O. 
Y., Hou, H., Hoopes, P. J., Demidenko, E. and Swartz, H. M., 2002. 
Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI 
and EPR oximetry study. J Magn Reson Imaging 16: 511-521.
Edelman, R. R., Siewert, B., Darby, D. G., Thangaraj, V., Nobre, A. C., Mesulam, 
M. M. and Warach, S., 1994. Qualitative mapping of cerebral blood flow and 
289
functional localization with echo-planar MR imaging and signal targeting with 
alternating radio frequency. Radiology 192: 513-520.
Elias, M. F., Robbins, M. A., Budge, M. M., Abhayaratna, W. P., Dore, G. A. and 
Elias, P. K., 2009. Arterial pulse wave velocity and cognition with advancing 
age. Hypertension 53: 668-673.
Erecinska, M. and Dagani, F., 1990. Relationships between the neuronal sodium/
potassium pump and energy metabolism. Effects of K+, Na+, and adenosine 
triphosphate in isolated brain synaptosomes. J Gen Physiol 95: 591-616.
Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., 
Kim, J. S., Heo, S., Alves, H., White, S. M., Wojcicki, T. R., Mailey, E., Vieira, 
V. J., Martin, S. A., Pence, B. D., Woods, J. A., McAuley, E. and Kramer, A. 
F., 2011. Exercise training increases size of hippocampus and improves 
memory. Proc Natl Acad Sci U S A 108: 3017-3022.
Etnier, J. L., Nowell, P. M., Landers, D. M. and Sibley, B. A., 2006. A meta-
regression to examine the relationship between aerobic fitness and 
cognitive performance. Brain Res Rev 52: 119-130.
Fan, A. P., Benner, T., Bolar, D. S., Rosen, B. R. and Adalsteinsson, E., 2011. 
Phase-based regional oxygen metabolism (PROM) using MRI. Magn Reson 
Med.
Feihl, F. and Perret, C., 1994. Permissive hypercapnia. How permissive should we 
be? Am J Respir Crit Care Med 150: 1722-1737.
Fiat, D., Hankiewicz, J., Liu, S., Trbovic, S. and Brint, S., 2004. 17O magnetic 
resonance imaging of the human brain. Neurol Res 26: 803-808.
Fiat, D. and Kang, S., 1992. Determination of the rate of cerebral oxygen 
consumption and regional cerebral blood flow by non-invasive 17O in vivo 
NMR spectroscopy and magnetic resonance imaging: Part 1. Theory and 
data analysis methods. Neurol Res 14: 303-311.
Fiat, D. and Kang, S., 1993. Determination of the rate of cerebral oxygen 
consumption and regional cerebral blood flow by non-invasive 17O in vivo 
NMR spectroscopy and magnetic resonance imaging. Part 2. Determination 
of CMRO2 for the rat by 17O NMR, and CMRO2, rCBF and the partition 
coefficient for the cat by 17O MRI. Neurol Res 15: 7-22.
290
Folstein, M. F., Folstein, S. E. and McHugh, P. R., 1975. "Mini-mental state". A 
practical method for grading the cognitive state of patients for the clinician. J 
Psychiatr Res 12: 189-198.
Forbes, M. L., Hendrich, K. S., Kochanek, P. M., Williams, D. S., Schiding, J. K., 
Wisniewski, S. R., Kelsey, S. F., DeKosky, S. T., Graham, S. H., Marion, D. 
W. and Ho, C., 1997. Assessment of cerebral blood flow and CO2 reactivity 
after controlled cortical impact by perfusion magnetic resonance imaging 
using arterial spin-labeling in rats. J Cereb Blood Flow Metab 17: 865-874.
Fox, M. D., Snyder, A. Z., Vincent, J. L., Corbetta, M., Van Essen, D. C. and 
Raichle, M. E., 2005. The human brain is intrinsically organized into 
dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A 102: 
9673-9678.
Fox, P. T. and Raichle, M. E., 1986. Focal physiological uncoupling of cerebral 
blood flow and oxidative metabolism during somatosensory stimulation in 
human subjects. Proc Natl Acad Sci U S A 83: 1140-1144.
Frackowiak, R. S., Lenzi, G. L., Jones, T. and Heather, J. D., 1980. Quantitative 
measurement of regional cerebral blood flow and oxygen metabolism in 
man using 15O and positron emission tomography: theory, procedure, and 
normal values. J Comput Assist Tomogr 4: 727-736.
Frackowiak, R. S., Pozzilli, C., Legg, N. J., Du Boulay, G. H., Marshall, J., Lenzi, G. 
L. and Jones, T., 1981. Regional cerebral oxygen supply and utilization in 
dementia. A clinical and physiological study with oxygen-15 and positron 
tomography. Brain 104: 753-778.
Fritze, O., Romero, B., Schleicher, M., Jacob, M. P., Oh, D. Y., Starcher, B., 
Schenke-Layland, K., Bujan, J. and Stock, U. A., 2012. Age-related changes 
in the elastic tissue of the human aorta. J Vasc Res 49: 77-86.
Gagnon, L., Gauthier, C., Hoge, R. D., Lesage, F., Selb, J. and Boas, D. A., 2008. 
Double-layer estimation of intra- and extracerebral hemoglobin 
concentration with a time-resolved system. J Biomed Opt 13: 054019.
Garcia, D. M., Duhamel, G. and Alsop, D. C., 2005. Efficiency of inversion pulses 
for background suppressed arterial spin labeling. Magn Reson Med 54: 
366-372.
291
Gauthier, C. J., Desjardins-Crépeau, L., Madjar, C., Bherer, L. and Hoge, R. D., 
2012a. Absolute quantification of resting oxygen metabolism and metabolic 
reactivity during functional activation using QUO2 MRI. Neuroimage In 
press.
Gauthier, C. J. and Hoge, R. D., 2011a. A generalized procedure for calibrated MRI 
incorporating hyperoxia and  hypercapnia. Hum Brain Mapp In press.
Gauthier, C. J. and Hoge, R. D., 2012b. A generalized procedure for calibrated MRI 
incorporating hyperoxia and  hypercapnia. Hum Brain Mapp In press.
Gauthier, C. J. and Hoge, R. D., 2012c. Magnetic resonance imaging of resting 
OEF and CMRO2 using a generalized calibration model for hypercapnia and 
hyperoxia. Neuroimage In press.
Gauthier, C. J., Madjar, C., Tancredi, F. B., Stefanovic, B. and Hoge, R. D., 2011b. 
Elimination of visually evoked BOLD responses during carbogen inhalation: 
Implications for calibrated MRI. Neuroimage 54: 1001-1011.
Girouard, H. and Iadecola, C., 2006. Neurovascular coupling in the normal brain 
and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 100: 
328-335.
Glover, G. H., 1999. Deconvolution of impulse response in event-related BOLD 
fMRI. Neuroimage 9: 416-429.
Glover, G. H., 2011. Overview of functional magnetic resonance imaging. 
Neurosurg Clin N Am 22: 133-139, vii.
Glover, G. H., Li, T. Q. and Ress, D., 2000. Image-based method for retrospective 
correction of physiological motion effects in fMRI: RETROICOR. Magn 
Reson Med 44: 162-167.
Golay, X., Silvennoinen, M. J., Zhou, J., Clingman, C. S., Kauppinen, R. A., Pekar, 
J. J. and van Zij, P. C., 2001. Measurement of tissue oxygen extraction 
ratios from venous blood T(2): increased precision and validation of 
principle. Magn Reson Med 46: 282-291.
Gold, B. T., Powell, D. K., Xuan, L., Jicha, G. A. and Smith, C. D., 2010. Age-
related slowing of task switching is associated with decreased integrity of 
frontoparietal white matter. Neurobiol Aging 31: 512-522.
292
Goode, S. D., Altaf, N., Auer, D. P. and MacSweeney, S. T., 2009a. Carotid 
endarterectomy improves cerebrovascular reserve capacity preferentially in 
patients with preoperative impairment as indicated by asymmetric BOLD 
response to hypercapnia. Eur J Vasc Endovasc Surg 38: 546-551.
Goode, S. D., Krishan, S., Alexakis, C., Mahajan, R. and Auer, D. P., 2009b. 
Precision of cerebrovascular reactivity assessment with use of different 
quantification methods for hypercapnia functional MR imaging. AJNR Am J 
Neuroradiol 30: 972-977.
Goodwin, J. A., Vidyasagar, R., Balanos, G. M., Bulte, D. and Parkes, L. M., 2009. 
Quantitative fMRI using hyperoxia calibration: reproducibility during a 
cognitive Stroop task. Neuroimage 47: 573-580.
Gorelick, P. B., Scuteri, A., Black, S. E., Decarli, C., Greenberg, S. M., Iadecola, C., 
Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., Petersen, R. C., 
Schneider, J. A., Tzourio, C., Arnett, D. K., Bennett, D. A., Chui, H. C., 
Higashida, R. T., Lindquist, R., Nilsson, P. M., Roman, G. C., Sellke, F. W. 
and Seshadri, S., 2011. Vascular contributions to cognitive impairment and 
dementia: a statement for healthcare professionals from the american heart 
association/american stroke association. Stroke 42: 2672-2713.
Grady, C. L., Maisog, J. M., Horwitz, B., Ungerleider, L. G., Mentis, M. J., Salerno, 
J. A., Pietrini, P., Wagner, E. and Haxby, J. V., 1994. Age-related changes in 
cortical blood flow activation during visual processing of faces and location. 
J Neurosci 14: 1450-1462.
Graham, G. D., Zhong, J., Petroff, O. A., Constable, R. T., Prichard, J. W. and 
Gore, J. C., 1994. BOLD MRI monitoring of changes in cerebral perfusion 
induced by acetazolamide and hypercarbia in the rat. Magn Reson Med 31: 
557-560.
Griffeth, V. E. and Buxton, R. B., 2011. A theoretical framework for estimating 
cerebral oxygen metabolism changes using the calibrated-BOLD method: 
modeling the effects of blood volume distribution, hematocrit, oxygen 
extraction fraction, and tissue signal properties on the BOLD signal. 
Neuroimage 58: 198-212.
293
Griswold, M. A., Jakob, P. M., Heidemann, R. M., Nittka, M., Jellus, V., Wang, J., 
Kiefer, B. and Haase, A., 2002. Generalized autocalibrating partially parallel 
acquisitions (GRAPPA). Magn Reson Med 47: 1202-1210.
Grubb, R. L., Jr., Raichle, M. E., Eichling, J. O. and Ter-Pogossian, M. M., 1974. 
The effects of changes in PaCO2 on cerebral blood volume, blood flow, and 
vascular mean transit time. Stroke 5: 630-639.
Gsell, W., Burke, M., Wiedermann, D., Bonvento, G., Silva, A. C., Dauphin, F., 
Buhrle, C., Hoehn, M. and Schwindt, W., 2006. Differential effects of NMDA 
and AMPA glutamate receptors on functional magnetic resonance imaging 
signals and evoked neuronal activity during forepaw stimulation of the rat. J 
Neurosci 26: 8409-8416.
Hagner, W., Hagner-Derengowska, M., Wiacek, M. and Zubrzycki, I. Z., 2009. 
Changes in level of VO2max, blood lipids, and waist circumference in the 
response to moderate endurance training as a function of ovarian aging. 
Menopause 16: 1009-1013.
Hajnal, J. V., Saeed, N., Oatridge, A., Williams, E. J., Young, I. R. and Bydder, G. 
M., 1995. Detection of subtle brain changes using subvoxel registration and 
subtraction of serial MR images. J Comput Assist Tomogr 19: 677-691.
Hattori, N., Bergsneider, M., Wu, H. M., Glenn, T. C., Vespa, P. M., Hovda, D. A., 
Phelps, M. E. and Huang, S. C., 2004. Accuracy of a method using short 
inhalation of (15)O-O(2) for measuring cerebral oxygen extraction fraction 
with PET in healthy humans. J Nucl Med 45: 765-770.
He, X. and Yablonskiy, D. A., 2007. Quantitative BOLD: mapping of human cerebral 
deoxygenated blood volume and oxygen extraction fraction: default state. 
Magn Reson Med 57: 115-126.
He, X., Zhu, M. and Yablonskiy, D. A., 2008. Validation of oxygen extraction fraction 
measurement by qBOLD technique. Magn Reson Med 60: 882-888.
Herholz, K., Carter, S. F. and Jones, M., 2007. Positron emission tomography 
imaging in dementia. Br J Radiol 80 Spec No 2: S160-167.
Herment, A., Kachenoura, N., Lefort, M., Bensalah, M., Dogui, A., Frouin, F., 
Mousseaux, E. and De Cesare, A., 2010. Automated segmentation of the 
aorta from phase contrast MR images: validation against expert tracing in 
294
healthy volunteers and in patients with a dilated aorta. J Magn Reson 
Imaging 31: 881-888.
Hino, J. K., Short, B. L., Rais-Bahrami, K. and Seale, W. R., 2000. Cerebral blood 
flow and metabolism during and after prolonged hypercapnia in newborn 
lambs. Crit Care Med 28: 3505-3510.
Hirano, S., Eckert, T., Flanagan, T. and Eidelberg, D., 2009. Metabolic networks for 
assessment of therapy and diagnosis in Parkinson's disease. Mov Disord 24 
Suppl 2: S725-731.
Hoge, R. D., Atkinson, J., Gill, B., Crelier, G. R., Marrett, S. and Pike, G. B., 1999a. 
Investigation of BOLD signal dependence on cerebral blood flow and 
oxygen consumption: the deoxyhemoglobin dilution model. Magn Reson 
Med 42: 849-863.
Hoge, R. D., Atkinson, J., Gill, B., Crelier, G. R., Marrett, S. and Pike, G. B., 1999b. 
Linear coupling between cerebral blood flow and oxygen consumption in 
activated human cortex. Proc Natl Acad Sci U S A 96: 9403-9408.
Hoge, R. D. and Pike, G. B., 2001. Oxidative metabolism and the detection of 
neuronal activation via imaging. J Chem Neuroanat 22: 43-52.
Hopkins, M. E. and Bucci, D. J., 2010. BDNF expression in perirhinal cortex is 
associated with exercise-induced improvement in object recognition 
memory. Neurobiol Learn Mem 94: 278-284.
Hopkins, M. E., Davis, F. C., Vantieghem, M. R., Whalen, P. J. and Bucci, D. J., 
2012. Differential effects of acute and regular physical exercise on cognition 
and affect. Neuroscience.
Horvath, I., Sandor, N. T., Ruttner, Z. and McLaughlin, A. C., 1994. Role of nitric 
oxide in regulating cerebrocortical oxygen consumption and blood flow 
during hypercapnia. J Cereb Blood Flow Metab 14: 503-509.
Iadecola, C., 2010. The overlap between neurodegenerative and vascular factors 
in the pathogenesis of dementia. Acta Neuropathol 120: 287-296.
Ibaraki, M., Miura, S., Shimosegawa, E., Sugawara, S., Mizuta, T., Ishikawa, A. and 
Amano, M., 2008. Quantification of cerebral blood flow and oxygen 
metabolism with 3-dimensional PET and 15O: validation by comparison with 
2-dimensional PET. J Nucl Med 49: 50-59.
295
Ibaraki, M., Shinohara, Y., Nakamura, K., Miura, S., Kinoshita, F. and Kinoshita, T., 
2010. Interindividual variations of cerebral blood flow, oxygen delivery, and 
metabolism in relation to hemoglobin concentration measured by positron 
emission tomography in humans. J Cereb Blood Flow Metab 30: 1296-1305.
Ishii, K., Sasaki, M., Kitagaki, H., Sakamoto, S., Yamaji, S. and Maeda, K., 1996. 
Regional difference in cerebral blood flow and oxidative metabolism in 
human cortex. J Nucl Med 37: 1086-1088.
Isozaki, M., Arai, Y., Kudo, T., Kiyono, Y., Kobayashi, M., Kubota, T., Kikuta, K. and 
Okazawa, H., 2010. Clinical implication and prognosis of normal baseline 
cerebral blood flow with impaired vascular reserve in patients with major 
cerebral artery occlusive disease. Ann Nucl Med 24: 371-377.
Ito, H., Ibaraki, M., Kanno, I., Fukuda, H. and Miura, S., 2005. Changes in cerebral 
blood flow and cerebral oxygen metabolism during neural activation 
measured by positron emission tomography: comparison with blood 
oxygenation level-dependent contrast measured by functional magnetic 
resonance imaging. J Cereb Blood Flow Metab 25: 371-377.
Ito, H., Kanno, I., Ibaraki, M., Suhara, T. and Miura, S., 2008. Relationship between 
baseline cerebral blood flow and vascular responses to changes in PaCO2 
measured by positron emission tomography in humans: implication of inter-
individual variations of cerebral vascular tone. Acta Physiol (Oxf) 193: 
325-330.
Ito, H., Kanno, I., Kato, C., Sasaki, T., Ishii, K., Ouchi, Y., Iida, A., Okazawa, H., 
Hayashida, K., Tsuyuguchi, N., Kuwabara, Y. and Senda, M., 2004. 
Database of normal human cerebral blood flow, cerebral blood volume, 
cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen 
measured by positron emission tomography with 15O-labelled carbon 
dioxide or water, carbon monoxide and oxygen: a multicentre study in 
Japan. Eur J Nucl Med Mol Imaging 31: 635-643.
Jain, V., Langham, M. C. and Wehrli, F. W., 2010. MRI estimation of global brain 
oxygen consumption rate. J Cereb Blood Flow Metab 30: 1598-1607.
Janssens, J. P., Pache, J. C. and Nicod, L. P., 1999. Physiological changes in 
respiratory function associated with ageing. Eur Respir J 13: 197-205.
296
Jenkinson, M., Bannister, P., Brady, M. and Smith, S., 2002. Improved optimization 
for the robust and accurate linear registration and motion correction of brain 
images. Neuroimage 17: 825-841.
Jenkinson, M. and Smith, S., 2001. A global optimisation method for robust affine 
registration of brain images. Med Image Anal 5: 143-156.
Jimura, K. and Braver, T. S., 2010. Age-related shifts in brain activity dynamics 
during task switching. Cereb Cortex 20: 1420-1431.
Jones, M., Berwick, J., Hewson-Stoate, N., Gias, C. and Mayhew, J., 2005. The 
effect of hypercapnia on the neural and hemodynamic responses to 
somatosensory stimulation. Neuroimage 27: 609-623.
Kadoglou, N. P., Iliadis, F., Angelopoulou, N., Sailer, N., Fotiadis, G., Voliotis, K., 
Vitta, I., Liapis, C. D. and Alevizos, M., 2009. Cardiorespiratory capacity is 
associated with favourable cardiovascular risk profile in patients with Type 2 
diabetes. J Diabetes Complications 23: 160-166.
Kemna, L. J. and Posse, S., 2001a. Effect of respiratory CO(2) changes on the 
temporal dynamics of the hemodynamic response in functional MR imaging. 
Neuroimage 14: 642-649.
Kemna, L. J., Posse, S., Tellmann, L., Schmitz, T. and Herzog, H., 2001b. 
Interdependence of regional and global cerebral blood flow during visual 
stimulation: an O-15-butanol positron emission tomography study. J Cereb 
Blood Flow Metab 21: 664-670.
Kety, S. S. and Schmidt, C. F., 1948. The nitrous oxide method for the quantitative 
determination of cerebral blood flow in man; theory, procedure and normal 
values. J Clin Invest 27: 476-483.
Kilner, J. M., Mattout, J., Henson, R. and Friston, K. J., 2005. Hemodynamic 
correlates of EEG: a heuristic. Neuroimage 28: 280-286.
Kim, S. G. and Ogawa, S., 2012. Biophysical and physiological origins of blood 
oxygenation level-dependent fMRI signals. J Cereb Blood Flow Metab.
Kim, S. G., Rostrup, E., Larsson, H. B., Ogawa, S. and Paulson, O. B., 1999. 
Determination of relative CMRO2 from CBF and BOLD changes: significant 
increase of oxygen consumption rate during visual stimulation. Magn Reson 
Med 41: 1152-1161.
297
Kimberg, D. Y., Aguirre, G. K. and D'Esposito, M., 2000. Modulation of task-related 
neural activity in task-switching: an fMRI study. Brain Res Cogn Brain Res 
10: 189-196.
Kocharyan, A., Fernandes, P., Tong, X. K., Vaucher, E. and Hamel, E., 2008. 
Specific subtypes of cortical GABA interneurons contribute to the 
neurovascular coupling response to basal forebrain stimulation. J Cereb 
Blood Flow Metab 28: 221-231.
Kontush, A., Berndt, C., Weber, W., Akopyan, V., Arlt, S., Schippling, S. and 
Beisiegel, U., 2001. Amyloid-beta is an antioxidant for lipoproteins in 
cerebrospinal fluid and plasma. Free Radic Biol Med 30: 119-128.
Kramer, A. F., Erickson, K. I. and Colcombe, S. J., 2006. Exercise, cognition, and 
the aging brain. J Appl Physiol 101: 1237-1242.
Kruger, G. and Glover, G. H., 2001. Physiological noise in oxygenation-sensitive 
magnetic resonance imaging. Magn Reson Med 46: 631-637.
Kubota, Y., Hattori, R. and Yui, Y., 1994. Three distinct subpopulations of 
GABAergic neurons in rat frontal agranular cortex. Brain Res 649: 159-173.
Kuschinsky, W., Wahl, M., Bosse, O. and Thurau, K., 1972. Perivascular potassium 
and pH as determinants of local pial arterial diameter in cats. A 
microapplication study. Circ Res 31: 240-247.
Kwong, K. K., Belliveau, J. W., Chesler, D. A., Goldberg, I. E., Weisskoff, R. M., 
Poncelet, B. P., Kennedy, D. N., Hoppel, B. E., Cohen, M. S., Turner, R. and 
et al., 1992. Dynamic magnetic resonance imaging of human brain activity 
during primary sensory stimulation. Proc Natl Acad Sci U S A 89: 
5675-5679.
Landuyt, W., Hermans, R., Bosmans, H., Sunaert, S., Beatse, E., Farina, D., 
Meijerink, M., Zhang, H., Van Den Bogaert, W., Lambin, P. and Marchal, G., 
2001. BOLD contrast fMRI of whole rodent tumour during air or carbogen 
breathing using echo-planar imaging at 1.5 T. Eur Radiol 11: 2332-2340.
Langenecker, S. A., Nielson, K. A. and Rao, S. M., 2004. fMRI of healthy older 
adults during Stroop interference. Neuroimage 21: 192-200.
Lansing, R. W., Gracely, R. H. and Banzett, R. B., 2009. The multiple dimensions 
of dyspnea: review and hypotheses. Respir Physiol Neurobiol 167: 53-60.
298
Larson, E. B., Wang, L., Bowen, J. D., McCormick, W. C., Teri, L., Crane, P. and 
Kukull, W., 2006. Exercise is associated with reduced risk for incident 
dementia among persons 65 years of age and older. Ann Intern Med 144: 
73-81.
Laurent, S. and Boutouyrie, P., 2007. Recent advances in arterial stiffness and 
wave reflection in human hypertension. Hypertension 49: 1202-1206.
Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, 
D., Pannier, B., Vlachopoulos, C., Wilkinson, I. and Struijker-Boudier, H., 
2006. Expert consensus document on arterial stiffness: methodological 
issues and clinical applications. Eur Heart J 27: 2588-2605.
Laurent, S., Katsahian, S., Fassot, C., Tropeano, A. I., Gautier, I., Laloux, B. and 
Boutouyrie, P., 2003. Aortic stiffness is an independent predictor of fatal 
stroke in essential hypertension. Stroke 34: 1203-1206.
Lauritzen, M. and Gold, L., 2003. Brain function and neurophysiological correlates 
of signals used in functional neuroimaging. J Neurosci 23: 3972-3980.
Lazarus, N. R. and Harridge, S. D., 2010. Exercise, physiological function, and the 
selection of participants for aging research. J Gerontol A Biol Sci Med Sci 
65: 854-857.
Lecrux, C. and Hamel, E., 2011. The neurovascular unit in brain function and 
disease. Acta Physiol (Oxf) 203: 47-59.
Leenders, K. L., Perani, D., Lammertsma, A. A., Heather, J. D., Buckingham, P., 
Healy, M. J., Gibbs, J. M., Wise, R. J., Hatazawa, J., Herold, S. and et al., 
1990. Cerebral blood flow, blood volume and oxygen utilization. Normal 
values and effect of age. Brain 113 ( Pt 1): 27-47.
Leontiev, O. and Buxton, R. B., 2007a. Reproducibility of BOLD, perfusion, and 
CMRO2 measurements with calibrated-BOLD fMRI. Neuroimage 35: 
175-184.
Leontiev, O., Dubowitz, D. J. and Buxton, R. B., 2007b. CBF/CMRO2 coupling 
measured with calibrated BOLD fMRI: sources of bias. Neuroimage 36: 
1110-1122.
299
Leung, H. C., Skudlarski, P., Gatenby, J. C., Peterson, B. S. and Gore, J. C., 2000. 
An event-related functional MRI study of the stroop color word interference 
task. Cereb Cortex 10: 552-560.
Levy, D. E., Brierley, J. B., Silverman, D. G. and Plum, F., 1975. Brief hypoxia-
ischemia initially damages cerebral neurons. Arch Neurol 32: 450-456.
Li, S. C. and Sikstrom, S., 2002. Integrative neurocomputational perspectives on 
cognitive aging, neuromodulation, and representation. Neurosci Biobehav 
Rev 26: 795-808.
Lin, A. L., Fox, P. T., Yang, Y., Lu, H., Tan, L. H. and Gao, J. H., 2008. Evaluation of 
MRI models in the measurement of CMRO2 and its relationship with CBF. 
Magn Reson Med 60: 380-389.
Lindauer, U., Megow, D., Matsuda, H. and Dirnagl, U., 1999. Nitric oxide: a 
modulator, but not a mediator, of neurovascular coupling in rat 
somatosensory cortex. Am J Physiol 277: H799-811.
Liu, P., Xu, F. and Lu, H., 2012. Test-retest reproducibility of a rapid method to 
measure brain oxygen metabolism. Magn Reson Med.
Liu, T. T. and Wong, E. C., 2005. A signal processing model for arterial spin labeling 
functional MRI. Neuroimage 24: 207-215.
Lo, R. Y., Hubbard, A. E., Shaw, L. M., Trojanowski, J. Q., Petersen, R. C., Aisen, 
P. S., Weiner, M. W. and Jagust, W. J., 2011. Longitudinal Change of 
Biomarkers in Cognitive Decline. Arch Neurol.
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T. and Oeltermann, A., 2001. 
Neurophysiological investigation of the basis of the fMRI signal. Nature 412: 
150-157.
Logothetis, N. K. and Wandell, B. A., 2004. Interpreting the BOLD signal. Annu Rev  
Physiol 66: 735-769.
Lu, H. and Ge, Y., 2008. Quantitative evaluation of oxygenation in venous vessels 
using T2-Relaxation-Under-Spin-Tagging MRI. Magn Reson Med 60: 
357-363.
Lu, H., Golay, X., Pekar, J. J. and Van Zijl, P. C., 2003. Functional magnetic 
resonance imaging based on changes in vascular space occupancy. Magn 
Reson Med 50: 263-274.
300
Lu, H. and van Zijl, P. C., 2012a. A review of the development of Vascular-Space-
Occupancy (VASO) fMRI. Neuroimage.
Lu, H., Xu, F., Grgac, K., Liu, P., Qin, Q. and van Zijl, P., 2012b. Calibration and 
validation of TRUST MRI for the estimation of cerebral blood oxygenation. 
Magn Reson Med 67: 42-49.
Lu, H., Xu, F., Rodrigue, K. M., Kennedy, K. M., Cheng, Y., Flicker, B., Hebrank, A. 
C., Uh, J. and Park, D. C., 2011. Alterations in cerebral metabolic rate and 
blood supply across the adult lifespan. Cereb Cortex 21: 1426-1434.
MacDonald, A. W., 3rd, Cohen, J. D., Stenger, V. A. and Carter, C. S., 2000. 
Dissociating the role of the dorsolateral prefrontal and anterior cingulate 
cortex in cognitive control. Science 288: 1835-1838.
Magri, C., Schridde, U., Murayama, Y., Panzeri, S. and Logothetis, N. K., 2012. 
The amplitude and timing of the BOLD signal reflects the relationship 
between local field potential power at different frequencies. J Neurosci 32: 
1395-1407.
Maleki, N., Dai, W. and Alsop, D. C., 2011. Optimization of background 
suppression for arterial spin labeling perfusion imaging. MAGMA.
Mandell, D. M., Han, J. S., Poublanc, J., Crawley, A. P., Stainsby, J. A., Fisher, J. A. 
and Mikulis, D. J., 2008. Mapping cerebrovascular reactivity using blood 
oxygen level-dependent MRI in Patients with arterial steno-occlusive 
disease: comparison with arterial spin labeling MRI. Stroke 39: 2021-2028.
Marchal, G., Rioux, P., Petit-Taboue, M. C., Sette, G., Travere, J. M., Le Poec, C., 
Courtheoux, P., Derlon, J. M. and Baron, J. C., 1992. Regional cerebral 
oxygen consumption, blood flow, and blood volume in healthy human aging. 
Arch Neurol 49: 1013-1020.
Mark, C. I., Fisher, J. A. and Pike, G. B., 2011. Improved fMRI calibration: Precisely 
controlled hyperoxic versus hypercapnic stimuli. Neuroimage 54: 1102-1111.
Mark, C. I., Slessarev, M., Ito, S., Han, J., Fisher, J. A. and Pike, G. B., 2010. 
Precise control of end-tidal carbon dioxide and oxygen improves BOLD and 
ASL cerebrovascular reactivity measures. Magn Reson Med.
Mattay, V. S., Fera, F., Tessitore, A., Hariri, A. R., Berman, K. F., Das, S., Meyer-
Lindenberg, A., Goldberg, T. E., Callicott, J. H. and Weinberger, D. R., 2006. 
301
Neurophysiological correlates of age-related changes in working memory 
capacity. Neurosci Lett 392: 32-37.
McPherson, R. W., Derrer, S. A. and Traystman, R. J., 1991. Changes in cerebral 
CO2 responsivity over time during isoflurane anesthesia in the dog. J 
Neurosurg Anesthesiol 3: 12-19.
Milham, M. P., Erickson, K. I., Banich, M. T., Kramer, A. F., Webb, A., Wszalek, T. 
and Cohen, N. J., 2002. Attentional control in the aging brain: insights from 
an fMRI study of the stroop task. Brain Cogn 49: 277-296.
Miller, P. W., Long, N. J., Vilar, R. and Gee, A. D., 2008. Synthesis of 11C, 18F, 
15O, and 13N radiolabels for positron emission tomography. Angew Chem 
Int Ed Engl 47: 8998-9033.
Mintun, M. A., Raichle, M. E., Martin, W. R. and Herscovitch, P., 1984. Brain 
oxygen utilization measured with O-15 radiotracers and positron emission 
tomography. J Nucl Med 25: 177-187.
Mintun, M. A., Vlassenko, A. G., Shulman, G. L. and Snyder, A. Z., 2002. Time-
related increase of oxygen utilization in continuously activated human visual 
cortex. Neuroimage 16: 531-537.
Mitchell, G. F., van Buchem, M. A., Sigurdsson, S., Gotal, J. D., Jonsdottir, M. K., 
Kjartansson, O., Garcia, M., Aspelund, T., Harris, T. B., Gudnason, V. and 
Launer, L. J., 2011. Arterial stiffness, pressure and flow pulsatility and brain 
structure and function: the Age, Gene/Environment Susceptibility--Reykjavik 
study. Brain 134: 3398-3407.
Mohtasib, R. S., Lumley, G., Goodwin, J. A., Emsley, H. C., Sluming, V. and 
Parkes, L. M., 2012. Calibrated fMRI during a cognitive Stroop task reveals 
reduced metabolic response with increasing age. Neuroimage 59: 
1143-1151.
Momjian-Mayor, I., Burkhard, P., Murith, N., Mugnai, D., Yilmaz, H., Narata, A. P., 
Lovblad, K., Pereira, V., Righini, M., Bounameaux, H. and Sztajzel, R. F., 
2012. Diagnosis of and treatment for symptomatic carotid stenosis: an 
updated review. Acta Neurol Scand.
Nagata, K., Maruya, H., Yuya, H., Terashi, H., Mito, Y., Kato, H., Sato, M., Satoh, 
Y., Watahiki, Y., Hirata, Y., Yokoyama, E. and Hatazawa, J., 2000. Can PET 
302
data differentiate Alzheimer's disease from vascular dementia? Ann N Y 
Acad Sci 903: 252-261.
Nagata, K., Sato, M., Satoh, Y., Watahiki, Y., Kondoh, Y., Sugawara, M., Box, G., 
Wright, D., Leung, S., Yuya, H. and Shimosegawa, E., 2002. Hemodynamic 
aspects of Alzheimer's disease. Ann N Y Acad Sci 977: 391-402.
Ngai, A. C., Coyne, E. F., Meno, J. R., West, G. A. and Winn, H. R., 2001. Receptor 
subtypes mediating adenosine-induced dilation of cerebral arterioles. Am J 
Physiol Heart Circ Physiol 280: H2329-2335.
Niwa, K., Araki, E., Morham, S. G., Ross, M. E. and Iadecola, C., 2000. 
Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel 
cortex. J Neurosci 20: 763-770.
Nobre, A. C., Coull, J. T., Frith, C. D. and Mesulam, M. M., 1999. Orbitofrontal 
cortex is activated during breaches of expectation in tasks of visual 
attention. Nat Neurosci 2: 11-12.
Nolde, S. F., Johnson, M. K. and Raye, C. L., 1998. The role of prefrontal cortex 
during tests of episodic memory. Trends Cogn Sci 2: 399-406.
O'Rourke, M. F. and Hashimoto, J., 2007. Mechanical factors in arterial aging: a 
clinical perspective. J Am Coll Cardiol 50: 1-13.
Ogawa, S., Lee, T. M., Kay, A. R. and Tank, D. W., 1990a. Brain magnetic 
resonance imaging with contrast dependent on blood oxygenation. Proc Natl 
Acad Sci U S A 87: 9868-9872.
Ogawa, S., Lee, T. M., Nayak, A. S. and Glynn, P., 1990b. Oxygenation-sensitive 
contrast in magnetic resonance image of rodent brain at high magnetic 
fields. Magn Reson Med 14: 68-78.
Ogawa, S., Tank, D. W., Menon, R., Ellermann, J. M., Kim, S. G., Merkle, H. and 
Ugurbil, K., 1992. Intrinsic signal changes accompanying sensory 
stimulation: functional brain mapping with magnetic resonance imaging. 
Proc Natl Acad Sci U S A 89: 5951-5955.
Park, D. C. and Reuter-Lorenz, P., 2009. The adaptive brain: aging and 
neurocognitive scaffolding. Annu Rev Psychol 60: 173-196.
303
Parkes, L. M., Rashid, W., Chard, D. T. and Tofts, P. S., 2004. Normal cerebral 
perfusion measurements using arterial spin labeling: reproducibility, stability, 
and age and gender effects. Magn Reson Med 51: 736-743.
Pase, M. P., Pipingas, A., Kras, M., Nolidin, K., Gibbs, A. L., Wesnes, K. A., 
Scholey, A. B. and Stough, C., 2010. Healthy middle-aged individuals are 
vulnerable to cognitive deficits as a result of increased arterial stiffness. J 
Hypertens 28: 1724-1729.
Perlmutter, J. S., Herscovitch, P., Powers, W. J., Fox, P. T. and Raichle, M. E., 
1985. Standardized mean regional method for calculating global positron 
emission tomographic measurements. J Cereb Blood Flow Metab 5: 
476-480.
Perthen, J. E., Lansing, A. E., Liau, J., Liu, T. T. and Buxton, R. B., 2008. Caffeine-
induced uncoupling of cerebral blood flow and oxygen metabolism: a 
calibrated BOLD fMRI study. Neuroimage 40: 237-247.
Petrides, M., 2005. Lateral prefrontal cortex: architectonic and functional 
organization. Philos Trans R Soc Lond B Biol Sci 360: 781-795.
Pialoux, V., Brown, A. D., Leigh, R., Friedenreich, C. M. and Poulin, M. J., 2009. 
Effect of cardiorespiratory fitness on vascular regulation and oxidative stress 
in postmenopausal women. Hypertension 54: 1014-1020.
Podewils, L. J., Guallar, E., Kuller, L. H., Fried, L. P., Lopez, O. L., Carlson, M. and 
Lyketsos, C. G., 2005. Physical activity, APOE genotype, and dementia risk: 
findings from the Cardiovascular Health Cognition Study. Am J Epidemiol 
161: 639-651.
Posse, S., Kemna, L. J., Elghahwagi, B., Wiese, S. and Kiselev, V. G., 2001. Effect 
of graded hypo- and hypercapnia on fMRI contrast in visual cortex: 
quantification of T(*)(2) changes by multiecho EPI. Magn Reson Med 46: 
264-271.
Poston, K. L. and Eidelberg, D., 2010. FDG PET in the Evaluation of Parkinson's 
Disease. PET Clin 5: 55-64.
Prakash, R. S., Voss, M. W., Erickson, K. I., Lewis, J. M., Chaddock, L., Malkowski, 
E., Alves, H., Kim, J., Szabo, A., White, S. M., Wojcicki, T. R., Klamm, E. L., 
304
McAuley, E. and Kramer, A. F., 2011. Cardiorespiratory fitness and 
attentional control in the aging brain. Front Hum Neurosci 4: 229.
Press, W. H., Flannery, B. P., Teukolsky, S. A. and Vetterling, W. T. (1992). 
Numerical Recipes in C: The Art of Scientific Computing, Cambridge 
University Press.
Quaglino, D., Jr., Bergamini, G., Boraldi, F. and Pasquali Ronchetti, I., 1996. 
Ultrastructural and morphometrical evaluations on normal human dermal 
connective tissue--the influence of age, sex and body region. Br J Dermatol 
134: 1013-1022.
Rauscher, A., Sedlacik, J., Barth, M., Haacke, E. M. and Reichenbach, J. R., 
2005a. Nonnvasive assessment of vascular architecture and function during 
modulated blood oxygenation using susceptibility weighted magnetic 
resonance imaging. Magn Reson Med 54: 87-95.
Rauscher, A., Sedlacik, J., Deistung, A., Mentzel, H. J. and Reichenbach, J. R., 
2006. Susceptibility weighted imaging: data acquisition, image 
reconstruction and clinical applications. Z Med Phys 16: 240-250.
Rauscher, A., Sedlacik, J., Fitzek, C., Walter, B., Hochstetter, A., Kalff, R., Kaiser, 
W. A. and Reichenbach, J. R., 2005b. High resolution susceptibility weighted 
MR-imaging of brain tumors during the application of a gaseous agent. Rofo 
177: 1065-1069.
Raz, N., Ghisletta, P., Rodrigue, K. M., Kennedy, K. M. and Lindenberger, U., 2010. 
Trajectories of brain aging in middle-aged and older adults: regional and 
individual differences. Neuroimage 51: 501-511.
Redheuil, A., Yu, W. C., Wu, C. O., Mousseaux, E., de Cesare, A., Yan, R., 
Kachenoura, N., Bluemke, D. and Lima, J. A., 2010. Reduced ascending 
aortic strain and distensibility: earliest manifestations of vascular aging in 
humans. Hypertension 55: 319-326.
Reichenbach, J. R. and Haacke, E. M., 2001. High-resolution BOLD venographic 
imaging: a window into brain function. NMR Biomed 14: 453-467.
Reitan, R. M., 1958. Validity of the Trail Making Test as an indicator of organic brain 
damage. Perceptual and Motor Skills 8: 271-276.
305
Restom, K., Behzadi, Y. and Liu, T. T., 2006. Physiological noise reduction for 
arterial spin labeling functional MRI. Neuroimage 31: 1104-1115.
Restom, K., Perthen, J. E. and Liu, T. T., 2008. Calibrated fMRI in the medial 
temporal lobe during a memory-encoding task. Neuroimage 40: 1495-1502.
Reuter-Lorenz, P. A. and Cappell, K. A., 2008. Neurocognitive aging and the 
compensation hypothesis. Curr Dir in Psych Sc 17: 177-182.
Reuter-Lorenz, P. A., Jonides, J., Smith, E. E., Hartley, A., Miller, A., Marshuetz, C. 
and Koeppe, R. A., 2000. Age differences in the frontal lateralization of 
verbal and spatial working memory revealed by PET. J Cogn Neurosci 12: 
174-187.
Reuter-Lorenz, P. A. and Park, D. C., 2010. Human neuroscience and the aging 
mind: a new look at old problems. J Gerontol B Psychol Sci Soc Sci 65: 
405-415.
Reuter-Lorez, P. A. and Cappell, K. A., 2008. Neurocognitive aging and the 
compensation hypothesis. Curr Dir in Psych Sc 17: 177-182.
Rhoades, R. and Bell, D. R. (2009). Medical physiology : principles for clinical 
medicine. Philadelphia, Pa. ; London, Lippincott Williams & Wilkins.
Rigby, B. J., 1964. Effect of Cyclic Extension on the Physical Properties of Tendon 
Collagen and Its Possible Relation to Biological Ageing of Collagen. Nature 
202: 1072-1074.
Robbins, M. A., Elias, M. F., Elias, P. K. and Budge, M. M., 2005. Blood pressure 
and cognitive function in an African-American and a Caucasian-American 
sample: the Maine-Syracuse Study. Psychosom Med 67: 707-714.
Rodriguez, G., Arnaldi, D. and Picco, A., 2011. Brain functional network in 
Alzheimer's disease: diagnostic markers for diagnosis and monitoring. Int J 
Alzheimers Dis 2011: 481903.
Rogers, R. L., Meyer, J. S. and Mortel, K. F., 1990. After reaching retirement age 
physical activity sustains cerebral perfusion and cognition. J Am Geriatr Soc 
38: 123-128.
Sahathevan, R., Brodtmann, A. and Donnan, G. A., 2012. Dementia, stroke, and 
vascular risk factors; a review. Int J Stroke 7: 61-73.
306
Salat, D. H., Buckner, R. L., Snyder, A. Z., Greve, D. N., Desikan, R. S., Busa, E., 
Morris, J. C., Dale, A. M. and Fischl, B., 2004. Thinning of the cerebral 
cortex in aging. Cereb Cortex 14: 721-730.
Salat, D. H., Williams, V. J., Leritz, E. C., Schnyer, D. M., Rudolph, J. L., Lipsitz, L. 
A., McGlinchey, R. E. and Milberg, W. P., 2012. Inter-individual variation in 
blood pressure is associated with regional white matter integrity in generally 
healthy older adults. Neuroimage 59: 181-192.
Samanez-Larkin, G. R. and D'Esposito, M., 2008. Group comparisons: imaging the 
aging brain. Soc Cogn Affect Neurosci 3: 290-297.
Satterthwaite, T. D., Ruparel, K., Loughead, J., Elliott, M. A., Gerraty, R. T., Calkins, 
M. E., Hakonarson, H., Gur, R. C., Gur, R. E. and Wolf, D. H., 2012. Being 
right is its own reward: load and performance related ventral striatum 
activation to correct responses during a working memory task in youth. 
Neuroimage 61: 723-729.
Schneider-Garces, N. J., Gordon, B. A., Brumback-Peltz, C. R., Shin, E., Lee, Y., 
Sutton, B. P., Maclin, E. L., Gratton, G. and Fabiani, M., 2010. Span, 
CRUNCH, and beyond: working memory capacity and the aging brain. J 
Cogn Neurosci 22: 655-669.
Schwarzbauer, C. and Deichmann, R., 2011. Vascular component analysis of 
hyperoxic and hypercapnic BOLD contrast. Neuroimage.
Sedlacik, J., Kutschbach, C., Rauscher, A., Deistung, A. and Reichenbach, J. R., 
2008. Investigation of the influence of carbon dioxide concentrations on 
cerebral physiology by susceptibility-weighted magnetic resonance imaging 
(SWI). Neuroimage 43: 36-43.
Sedlacik, J., Rauscher, A. and Reichenbach, J. R., 2007. Obtaining blood 
oxygenation levels from MR signal behavior in the presence of single 
venous vessels. Magn Reson Med 58: 1035-1044.
Sedlacik, J., Rauscher, A. and Reichenbach, J. R., 2009. Quantification of 
modulated blood oxygenation levels in single cerebral veins by investigating 
their MR signal decay. Z Med Phys 19: 48-57.
Sedlacik, J. and Reichenbach, J. R., 2010. Validation of quantitative estimation of 
tissue oxygen extraction fraction and deoxygenated blood volume fraction in 
307
phantom and in vivo experiments by using MRI. Magn Reson Med 63: 
910-921.
Sergi, G., Coin, A., Sarti, S., Perissinotto, E., Peloso, M., Mulone, S., Trolese, M., 
Inelmen, E. M., Enzi, G. and Manzato, E., 2010. Resting VO2, maximal VO2 
and metabolic equivalents in free-living healthy elderly women. Clin Nutr 29: 
84-88.
Severinghaus, J. W., 1979. Simple, accurate equations for human blood O2 
dissociation computations. J Appl Physiol 46: 599-602.
Severinghaus, J. W., 1989. Water vapor calibration errors in some capnometers: 
respiratory conventions misunderstood by manufacturers? Anesthesiology 
70: 996-998.
Sharma, G. and Goodwin, J., 2006. Effect of aging on respiratory system 
physiology and immunology. Clin Interv Aging 1: 253-260.
Shmuel, A., Yacoub, E., Pfeuffer, J., Van de Moortele, P. F., Adriany, G., Hu, X. and 
Ugurbil, K., 2002. Sustained negative BOLD, blood flow and oxygen 
consumption response and its coupling to the positive response in the 
human brain. Neuron 36: 1195-1210.
Sierra, C., De La Sierra, A., Salamero, M., Sobrino, J., Gomez-Angelats, E. and 
Coca, A., 2004. Silent cerebral white matter lesions and cognitive function in 
middle-aged essential hypertensive patients. Am J Hypertens 17: 529-534.
Slessarev, M., Han, J., Mardimae, A., Prisman, E., Preiss, D., Volgyesi, G., Ansel, 
C., Duffin, J. and Fisher, J. A., 2007. Prospective targeting and control of 
end-tidal CO2 and O2 concentrations. J Physiol 581: 1207-1219.
Smith, S. M., 2002. Fast robust automated brain extraction. Hum Brain Mapp 17: 
143-155.
Sonntag, W. E., Lynch, C. D., Cooney, P. T. and Hutchins, P. M., 1997. Decreases 
in cerebral microvasculature with age are associated with the decline in 
growth hormone and insulin-like growth factor 1. Endocrinology 138: 
3515-3520.
Spoelgen, R., Meyer, A., Moraru, A., Kirsch, F., Vogt-Eisele, A., Plaas, C., Pitzer, C. 
and Schneider, A., 2011. A novel flow cytometry-based technique to 
measure adult neurogenesis in the brain. J Neurochem 119: 165-175.
308
Spreng, R. N., Wojtowicz, M. and Grady, C. L., 2010. Reliable differences in brain 
activity between young and old adults: a quantitative meta-analysis across 
multiple cognitive domains. Neurosci Biobehav Rev 34: 1178-1194.
Stefanovic, B. and Pike, G. B., 2005. Venous refocusing for volume estimation: 
VERVE functional magnetic resonance imaging. Magn Reson Med 53: 
339-347.
Stefanovic, B., Warnking, J. M., Rylander, K. M. and Pike, G. B., 2006. The effect 
of global cerebral vasodilation on focal activation hemodynamics. 
Neuroimage 30: 726-734.
Stella, N., Tence, M., Glowinski, J. and Premont, J., 1994. Glutamate-evoked 
release of arachidonic acid from mouse brain astrocytes. J Neurosci 14: 
568-575.
Swain, R. A., Harris, A. B., Wiener, E. C., Dutka, M. V., Morris, H. D., Theien, B. E., 
Konda, S., Engberg, K., Lauterbur, P. C. and Greenough, W. T., 2003. 
Prolonged exercise induces angiogenesis and increases cerebral blood 
volume in primary motor cortex of the rat. Neuroscience 117: 1037-1046.
Tancredi, F. B., Gauthier, C. J., Madjar, C., Bolar, D. S., Fisher, J. A., Wang, D. J. 
and Hoge, R. D., 2012. Comparison of pulsed and pseudocontinuous 
arterial spin-labeling for measuring CO(2) -induced cerebrovascular 
reactivity. J Magn Reson Imaging.
Tohka, J., Zijdenbos, A. and Evans, A., 2004. Fast and robust parameter estimation 
for statistical partial volume models in brain MRI. Neuroimage 23: 84-97.
Tomura, N., Otani, T., Koga, M. and Ishiyama, K., 2011. Correlation Between 
Severity of Carotid Stenosis and Vascular Reserve Measured by 
Acetazolamide Brain Perfusion Single Photon Emission Computed 
Tomography. J Stroke Cerebrovasc Dis.
Toro, R., Fox, P. T. and Paus, T., 2008. Functional coactivation map of the human 
brain. Cereb Cortex 18: 2553-2559.
Triantafyllou, C., Hoge, R. D., Krueger, G., Wiggins, C. J., Potthast, A., Wiggins, G. 
C. and Wald, L. L., 2005. Comparison of physiological noise at 1.5 T, 3 T 
and 7 T and optimization of fMRI acquisition parameters. Neuroimage 26: 
243-250.
309
Valtschanoff, J. G., Weinberg, R. J., Kharazia, V. N., Schmidt, H. H., Nakane, M. 
and Rustioni, A., 1993. Neurons in rat cerebral cortex that synthesize nitric 
oxide: NADPH diaphorase histochemistry, NOS immunocytochemistry, and 
colocalization with GABA. Neurosci Lett 157: 157-161.
van der Sanden, B. P., Heerschap, A., Hoofd, L., Simonetti, A. W., Nicolay, K., van 
der Toorn, A., Colier, W. N. and van der Kogel, A. J., 1999. Effect of 
carbogen breathing on the physiological profile of human glioma xenografts. 
Magn Reson Med 42: 490-499.
van Zijl, P. C., Eleff, S. M., Ulatowski, J. A., Oja, J. M., Ulug, A. M., Traystman, R. J. 
and Kauppinen, R. A., 1998. Quantitative assessment of blood flow, blood 
volume and blood oxygenation effects in functional magnetic resonance 
imaging. Nat Med 4: 159-167.
Vaynman, S., Ying, Z. and Gomez-Pinilla, F., 2004. Hippocampal BDNF mediates 
the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci 
20: 2580-2590.
Voss, M. W., Prakash, R. S., Erickson, K. I., Basak, C., Chaddock, L., Kim, J. S., 
Alves, H., Heo, S., Szabo, A. N., White, S. M., Wojcicki, T. R., Mailey, E. L., 
Gothe, N., Olson, E. A., McAuley, E. and Kramer, A. F., 2010. Plasticity of 
brain networks in a randomized intervention trial of exercise training in older 
adults. Front Aging Neurosci 2.
Wahlund, L. O., Barkhof, F., Fazekas, F., Bronge, L., Augustin, M., Sjogren, M., 
Wallin, A., Ader, H., Leys, D., Pantoni, L., Pasquier, F., Erkinjuntti, T. and 
Scheltens, P., 2001. A new rating scale for age-related white matter changes 
applicable to MRI and CT. Stroke 32: 1318-1322.
Waldstein, S. R., Rice, S. C., Thayer, J. F., Najjar, S. S., Scuteri, A. and 
Zonderman, A. B., 2008. Pulse pressure and pulse wave velocity are related 
to cognitive decline in the Baltimore Longitudinal Study of Aging. 
Hypertension 51: 99-104.
Wallace, D. C., 2005. A mitochondrial paradigm of metabolic and degenerative 
diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev 
Genet 39: 359-407.
310
Wallace, D. C., 2011. Bioenergetic Origins of Complexity and Disease. Cold Spring 
Harb Symp Quant Biol.
Wang, J., Aguirre, G. K., Kimberg, D. Y., Roc, A. C., Li, L. and Detre, J. A., 2003a. 
Arterial spin labeling perfusion fMRI with very low task frequency. Magn 
Reson Med 49: 796-802.
Wang, J., Alsop, D. C., Song, H. K., Maldjian, J. A., Tang, K., Salvucci, A. E. and 
Detre, J. A., 2003b. Arterial transit time imaging with flow encoding arterial 
spin tagging (FEAST). Magn Reson Med 50: 599-607.
Wang, J. M., Huang, Y. J., Wang, Y., Xu, M. G., Wang, L. C., Wang, S. M. and Tao, 
J., 2007. Increased circulating CD31+/CD42- microparticles are associated 
with impaired systemic artery elasticity in healthy subjects. Am J Hypertens 
20: 957-964.
Wang, J. M., Su, C., Wang, Y., Huang, Y. J., Yang, Z., Chen, L., Wu, F., Xu, S. Y. 
and Tao, J., 2009. Elevated circulating endothelial microparticles and 
brachial-ankle pulse wave velocity in well-controlled hypertensive patients. J 
Hum Hypertens 23: 307-315.
Wasylyshyn, C., Verhaeghen, P. and Sliwinski, M. J., 2011. Aging and task 
switching: a meta-analysis. Psychol Aging 26: 15-20.
Wechsler, D. (1997). WAIS-III administration and scoring manual, The 
Psychological Corporation.
Williams, D. S., Detre, J. A., Leigh, J. S. and Koretsky, A. P., 1992. Magnetic 
resonance imaging of perfusion using spin inversion of arterial water. Proc 
Natl Acad Sci U S A 89: 212-216.
Wolf, P. A., 2012. Contributions of the Framingham Heart Study to Stroke and 
Dementia Epidemiologic Research at 60 Years. Arch Neurol.
Wong, E. C., Buxton, R. B. and Frank, L. R., 1997. Implementation of quantitative 
perfusion imaging techniques for functional brain mapping using pulsed 
arterial spin labeling. NMR Biomed 10: 237-249.
Wong, E. C., Buxton, R. B. and Frank, L. R., 1998. Quantitative imaging of 
perfusion using a single subtraction (QUIPSS and QUIPSS II). Magn Reson 
Med 39: 702-708.
311
Woolrich, M., 2008. Robust group analysis using outlier inference. Neuroimage 41: 
286-301.
Woolrich, M. W., Behrens, T. E., Beckmann, C. F., Jenkinson, M. and Smith, S. M., 
2004. Multilevel linear modelling for FMRI group analysis using Bayesian 
inference. Neuroimage 21: 1732-1747.
Woolrich, M. W., Ripley, B. D., Brady, M. and Smith, S. M., 2001. Temporal 
autocorrelation in univariate linear modeling of FMRI data. Neuroimage 14: 
1370-1386.
Worsley, K. J., Liao, C. H., Aston, J., Petre, V., Duncan, G. H., Morales, F. and 
Evans, A. C., 2002. A general statistical analysis for fMRI data. Neuroimage 
15: 1-15.
Worthy, D. A. and Maddox, W. T., 2012. Age-based differences in strategy use in 
choice tasks. Front Neurosci 5: 145.
Wu, W. C., Fernandez-Seara, M., Detre, J. A., Wehrli, F. W. and Wang, J., 2007. A 
theoretical and experimental investigation of the tagging efficiency of 
pseudocontinuous arterial spin labeling. Magn Reson Med 58: 1020-1027.
Xu, F., Ge, Y. and Lu, H., 2009. Noninvasive quantification of whole-brain cerebral 
metabolic rate of oxygen (CMRO2) by MRI. Magn Reson Med 62: 141-148.
Xu, F., Liu, P. and Lu, H., 2011a. Effect of graded O2 challenge on vascular and 
metabolic parameters. Proc. Intl. Soc. Mag. Reson. Med. 19th annual 
meeting: 765.
Xu, F., Uh, J., Brier, M. R., Hart, J., Jr., Yezhuvath, U. S., Gu, H., Yang, Y. and Lu, 
H., 2011b. The influence of carbon dioxide on brain activity and metabolism 
in conscious humans. J Cereb Blood Flow Metab 31: 58-67.
Xu, F., Uh, J., Liu, P. and Lu, H., 2011c. On improving the speed and reliability of 
T(2) -relaxation-under-spin-tagging (TRUST) MRI. Magn Reson Med.
Yablonskiy, D. A. and Haacke, E. M., 1994. Theory of NMR signal behavior in 
magnetically inhomogeneous tissues: the static dephasing regime. Magn 
Reson Med 32: 749-763.
Yaffe, K., Barnes, D., Nevitt, M., Lui, L. Y. and Covinsky, K., 2001. A prospective 
study of physical activity and cognitive decline in elderly women: women 
who walk. Arch Intern Med 161: 1703-1708.
312
Yaffe, K., Lindquist, K., Penninx, B. W., Simonsick, E. M., Pahor, M., Kritchevsky, 
S., Launer, L., Kuller, L., Rubin, S. and Harris, T., 2003. Inflammatory 
markers and cognition in well-functioning African-American and white elders. 
Neurology 61: 76-80.
Yamaguchi, T., Kanno, I., Uemura, K., Shishido, F., Inugami, A., Ogawa, T., 
Murakami, M. and Suzuki, K., 1986. Reduction in regional cerebral 
metabolic rate of oxygen during human aging. Stroke 17: 1220-1228.
Yamauchi, H., Fukuyama, H., Nagahama, Y., Nabatame, H., Ueno, M., Nishizawa, 
S., Konishi, J. and Shio, H., 1999. Significance of increased oxygen 
extraction fraction in five-year prognosis of major cerebral arterial occlusive 
diseases. J Nucl Med 40: 1992-1998.
Yamauchi, H., Nishii, R., Higashi, T., Kagawa, S. and Fukuyama, H., 2009. 
Hemodynamic compromise as a cause of internal border-zone infarction 
and cortical neuronal damage in atherosclerotic middle cerebral artery 
disease. Stroke 40: 3730-3735.
Yamauchi, H., Okazawa, H., Kishibe, Y., Sugimoto, K. and Takahashi, M., 2002. 
Changes in blood flow and oxygen metabolism during visual stimulation in 
carotid artery disease: effect of baseline perfusion and oxygen metabolism. 
Stroke 33: 1294-1300.
Yang, G. and Iadecola, C., 1996. Glutamate microinjections in cerebellar cortex 
reproduce cerebrovascular effects of parallel fiber stimulation. Am J Physiol 
271: R1568-1575.
Yang, Y., Engelien, W., Xu, S., Gu, H., Silbersweig, D. A. and Stern, E., 2000. 
Transit time, trailing time, and cerebral blood flow during brain activation: 
measurement using multislice, pulsed spin-labeling perfusion imaging. Magn 
Reson Med 44: 680-685.
Yeung, N., Nystrom, L. E., Aronson, J. A. and Cohen, J. D., 2006. Between-task 
competition and cognitive control in task switching. J Neurosci 26: 
1429-1438.
Yun, J. Y., Lee, D. Y., Seo, E. H., Choo, I. H., Park, S. Y., Kim, S. G. and Woo, J. I., 
2011. Neural Correlates of Stroop Performance in Alzheimer's Disease: A 
FDG-PET Study. Dement Geriatr Cogn Dis Extra 1: 190-201.
313
Zaharchuk, G., Martin, A. J. and Dillon, W. P., 2008. Noninvasive imaging of 
quantitative cerebral blood flow changes during 100% oxygen inhalation 
using arterial spin-labeling MR imaging. AJNR Am J Neuroradiol 29: 
663-667.
Zappe, A. C., Uludag, K., Oeltermann, A., Ugurbil, K. and Logothetis, N. K., 2008. 
The influence of moderate hypercapnia on neural activity in the anesthetized 
nonhuman primate. Cereb Cortex 18: 2666-2673.
Zhang, Y., Brady, M. and Smith, S., 2001. Segmentation of brain MR images 
through a hidden Markov random field model and the expectation-
maximization algorithm. IEEE Trans Med Imaging 20: 45-57.
Zhou, R. H., Vendrov, A. E., Tchivilev, I., Niu, X. L., Molnar, K. C., Rojas, M., Carter, 
J. D., Tong, H., Stouffer, G. A., Madamanchi, N. R. and Runge, M. S., 2012. 
Mitochondrial oxidative stress in aortic stiffening with age: the role of smooth 
muscle cell function. Arterioscler Thromb Vasc Biol 32: 745-755.
Zipfel, G. J., Sagar, J., Miller, J. P., Videen, T. O., Grubb, R. L., Jr., Dacey, R. G., Jr. 
and Derdeyn, C. P., 2009. Cerebral hemodynamics as a predictor of stroke 
in adult patients with moyamoya disease: a prospective observational study. 
Neurosurg Focus 26: E6.
Zonta, M., Angulo, M. C., Gobbo, S., Rosengarten, B., Hossmann, K. A., Pozzan, 
T. and Carmignoto, G., 2003. Neuron-to-astrocyte signaling is central to the 
dynamic control of brain microcirculation. Nat Neurosci 6: 43-50.
Zysset, S., Schroeter, M. L., Neumann, J. and von Cramon, D. Y., 2007. Stroop 
interference, hemodynamic response and aging: an event-related fMRI 
study. Neurobiol Aging 28: 937-946.
314
